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Chapter 1

Harm From Tobacco Use
and Secondhand Smoke

Chapter Objectives
1. Distinguish between harm caused by primary smoke and
secondhand smoke.
2. Estimate stages of the epidemic curve of tobacco-related
mortality.
3. Recognize the Surgeon General’s Report as the authority in
establishing causality between diseases and smoking.
4. Describe the relationship between lung cancer and active
smoking or exposure to secondhand smoke.
5. Recognize the dose-response relationship between
smoking and morbidity/mortality.
6. Explain how combustion is the primary mechanism of
action causing harm.

Chapter 1 - Harm From Tobacco Use and Secondhand Smoke

Section 1 - Cigarettes are Instruments of Death
It is difficult to exaggerate the harm that cigarettes have caused to the human race. Robert Proctor, a
historian at Stanford University, recently published a book titled The Golden Holocaust: Origins of
the Cigarette Catastrophe and the Case for Abolition, in which he refers to cigarettes as “the
deadliest artifact in the history of human civilization.” The cigarette, remarks Proctor, is “the only
consumer product that kills when used as directed.” In 2016, even tobacco giant Philip Morris USA is
compelled to agree “with the overwhelming medical and scientific consensus that cigarette smoking
causes lung cancer, heart disease, emphysema and other serious diseases in smokers.” And it is just
as widely known that half of lifetime smokers will die of a
tobacco-related disease.
The 20th century has been called the “cigarette century”
due to the pervasive impact that smoking has had on
public health, as well as on the culture and politics of this
period (Movie 1.1). The tobacco epidemic has left an
indelible mark on every country in the world, and in this
chapter, we will examine global trends in tobacco use and
its impact, as well as country-specific studies.
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Movie 1.1 Why You Should Quit
Commercial

Figure 1.1 models how the
tobacco epidemic spread

Figure 1.1 The Tobacco Epidemic Today: Stages of the Cigarette
Epidemic on Entering its Second Century

over the course of the
century. Alan Lopez and
colleagues defined four
stages based on the
comparative levels of
smoking prevalence and
smoking-related deaths in
men and women in
economically developed
countries such as the
United States, the United
Kingdom and Australia
from 1900 to 2000. From
Figure 1.1 we can see that male smoking prevalence peaks around the mid-1950s; then, about 30-40
years later, there is a corresponding peak in the proportion of male deaths attributed to smoking. It
Key Takeaway
The epidemic curve of tobacco-related
mortality traces a similar pattern for men
and women. A peak in smoking
prevalence is followed 30-40 years later
by a peak in the proportion of deaths
attributed to smoking.
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may seem strange that smoking-attributable deaths are rising
even as smoking prevalence is on the decline, this is explained by
the fact that current mortality is most closely related to previous,
not current, levels of cigarette consumption.

Figure 1.2 Projected Deaths Caused by Tobacco
During 21st Century

The dashed red line shows that female
smoking prevalence follows the pattern for
men, just a few years behind. And, as is the
case with men, the peak in female smoking
prevalence is then followed 30-40 years
later by a corresponding peak in the
proportion of female deaths attributed to
smoking. While the proportion of smokers
and of smoking-related deaths has always
remained lower for women than for men,
Figure 1.1 illustrates the concerning fact
that women are beginning to approximate
male patterns in both these regards.
We have witnessed the morbidity and
mortality caused by smoking in the 20th
century. If smoking prevalence rates
remain unchanged, we can expect one
billion deaths from tobacco in the 21st
century (Figure 1.2).
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Prabhat Jha is the Founding Director of the Center for Global Health and Research at St. Michael’s
Hospital in Toronto, Canada. As a physician and economist, he offers his expert opinion on the burden
of tobacco use in the global context, as well as in the more specific context of India. In Movie 1.2, he
comments on a study published in the New England Journal of Medicine in January 2013 that looks at
the hazards of smoking in the United States.

Movie 1.2 Hear from the Experts: Prabhat Jha
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Table 1.1 Deadly Chemicals in Tobacco Smoke
Tobacco Smoke Includes:

As Found In:

Why is smoking so deadly? The harm
of smoking is caused, to a large
extent, by combustion. Burning a

Acetone

paint stripper

Acetylene

welding torches

Arsenic

ant poison

Benzene

Napalm

Butane

lighter fuel

Cadmium

car batteries

Carbon monoxide

car exhaust fumes

DDT

insecticide

Formaldehyde

embalming fluid

Hydrogen cyaninde

capital punishment by gas

Lead

old paint, leaded gasoline

Methanol

rocket fuel

Nicotine

cockroach poison

Phenol

toilet bowl disinfectant

Polonium 210

nuclear weapons

benzene, which are added during the

Toluene

industrial solvent

manufacturing process, the full impact

Vinyl chloride

plastics

of which is still unknown. In 1994, five

cigarette creates 7,000 chemicals and
compounds, hundreds of which are
toxic, and at least 69 are cancercausing. More specifically, the
carcinogens found in cigarette smoke
are known as tobacco-specific
nitrosamines (TSNAs). These
substances are inhaled into the body
repeatedly, and perpetual exposure
over time leads to deadly disease
(Table 1.1).
A further cause for concern are
ingredients, such as ammonia and

major cigarette companies released a
list of ingredients added to cigarettes. There are 599 ingredients included on this list.
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Most of the harm caused by

Figure 1.3 Smoking Highway

smoking occurs in the
tissue that is directly
exposed to smoke. In the
early 1930s, the term
“smoking highway” was
coined by Angel Roffo, an
Argentine doctor who
studied the relationship
between tobacco and
cancer. The smoking
highway refers to the tissue
in the body that becomes
exposed to tars during the
act of smoking (i.e., lips,
cheeks, tongue, throat,
bronchial passages, etc.)
Key Takeaway
Much of the harm from smoking is
caused by combustion. The
burning of tobacco leaves creates
7,000 chemicals and compounds,
many of which are toxic.
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(Figure 1.3).

Tobacco is a priority issue for health practitioners and public health advocates who worry about noncommunicable diseases (NCDs). Tobacco somewhat uniquely affects the four leading NCDs that are
major threats to global public health: cardiovascular disease, diabetes, cancer, and chronic respiratory
disease. Table 1.2 shows that while other risk factors, such as unhealthy diets, lack of physical activity,
and harmful use of alcohol affect many of these leading NCDs, tobacco use is the only risk factor that
affects them all and exacerbates these conditions.

Table 1.2 Risk Factors for Non-Communicable Diseases
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Tobacco
Use

Unhealthy
Diets

Lack of
Physical
Activity

Harmful
Use of
Alcohol

Cardiovascular

☑︎

☑

☑

☑

Diabetes

☑

☑

☑

☑

Cancer

☑

☑

☑

☑

Chronic
Respiration

☑

The largest cause of death resulting from tobacco use is cancer. In the United States, smoking
accounts for 33% of all cancer deaths and 87% of lung cancer deaths. As demonstrated in Figure 1.4,
tobacco-related deaths will total more than six million in 2015.

Figure 1.4 Projected Tobacco-Caused Deaths, 2015

All causes 6.42 million deaths (totals may not sum due to rounding)
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Table 1.3 Top Cancer Killers
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Type of Cancer

Number of
Deaths

Lung

159,480

Colon

50,830

Breast

40,030

Pancreas

38,460

Prostate

29,720

TOTAL
(Colon, Breast,
Pancreas and
Prostate)

159,040

The American Cancer Society reported in 2013 that lung
cancer accounts for 159,480 deaths among men and
women in the U.S. As shown in Table 1.3, lung cancer
causes more deaths than the next four cancers
combined.

The American Cancer Society reported in 2013 that lung
cancer accounts for nearly 175,000 deaths a year in the
United States (Table 1.3). The latest data show that lung
cancer kills more people than the next four top cancers
combined.

An overwhelming amount of scientific evidence links smoking to deaths from lung cancer. But
smoking harms not only the lungs and the tissue along the smoking highway discussed above, but
also parts of the body that are not directly exposed to smoke. Smokers have an increased risk of
developing pancreatic or bladder cancer, to name just two examples. Table 1.4, excerpted from the
2004 U.S. Surgeon General’s Report, details the vast
number of diseases and other adverse health effects
of smoking.

Movie 1.3 Interactive Tour of the Tobacco
Body

In addition to lung cancer and respiratory diseases,
tobacco use contributes to cardiovascular disease, as
well as tuberculosis, diabetes, and digestive diseases.
The U.S. Surgeon General emphasizes that tobacco
affects nearly every organ system in the body.
Movie 1.3 includes an interactive tour of the harms of
tobacco on the body.

Key Takeaway
In 2013, an estimated 580,350 people will die from cancer.
Three out of ten will be from lung, bronchus, and esophageal
cancer – more than the next 4 cancers combined.
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Table 1.4 2004 U.S. Surgeon General Report Finds a Causal Relationship Between Smoking and Many Types of Cancer
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Disease

Highest level conclusion from previous Surgeon General
reports (year)

Conclusion from the 2004 Surgeon General report

Bladder cancer

“Smoking is a cause of bladder cancer; cessation reduces risk by about
50% after only a few years, in comparison with continued smoking.”
(1990, p. 10)

“The evidence is sufficient to infer a causal relationship between
smoking and...bladder cancer.”

Cervical cancer

“Smoking has been consistently associated with an increased risk for
cervical cancer.” (2001, p 224)

“The evidence is sufficient to infer a causal relationship between
smoking and cervical cancer.”

Esophageal cancer

“Cigarette smoking is a major cause of esophageal cancer in the
United States.” (1982, p. 7)

“The evidence is sufficient to infer a causal relationship between
smoking and cancers of the esophagus.”

Kidney cancer

“Cigarette smoking is a contributory factor in the development of kidney
cancer in the United States. The term ‘contributory factor’ by no means
excludes the possibility of a causal role for smoking of cancers of
this site.” (1982 p. 7)

“The evidence is sufficient to infer a causal relationship between
smoking and renal cell, [and] renal pelvis...cancers.”

Laryngeal cancer

“Cigarette smoking is causally associated with the lung larynx, oral
cavity, and esophagus in women as well as in men.” (1980, p. 128)

“The evidence is sufficient to infer a causal relationship
between smoking and the cancer of the larynx.”

Leukemia

“Leukemia has recently been implicated as a smoking-related
disease...but this observation has not been consistent.”
(1990, p. 176)

“The evidence is sufficient to infer a causal relationship
between smoking and acute myeloid leukemia.”

Lung cancer

“Additional epidemiological, pathological, and experimental data
not only confirm the conclusion of the Surgeon General’s 1964
Report regarding lung cancer in men but strengthen the causal
relationship of smoking to lung cancer in women.” (1967, p. 36)

“The evidence is sufficient to infer a causal relationship
between smoking and lung cancer.”

Oral cancer

“Cigarette smoking is a major cause of cancers of the oral cavity in
the United States.” (1982, p.6)

“The evidence is sufficient to infer a causal relationship
between smoking and cancers of the oral cavity
and pharynx.”

Chapter 1 - Harm From Tobacco Use and Secondhand Smoke
Section 2 - Causality is Established and Essential

It is important to be clear about the
soundness and the scientific rigor with
which the relationship between
smoking and disease has been
established. Scientific studies on
tobacco have made the case for
tobacco being deadly, and more
broadly, they have served as a basis for
modern epidemiology.
In the 1950s, when the medical and
scientific communities were attempting
to establish the relationship between
smoking and lung cancer, tobacco
companies were quick to respond, and
their response was one of denial. On
January 4, 1954, the major American
tobacco companies published a
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Figure 1.5 A Frank Statement to Cigarette Smokers

historic advertisement in more than 400
newspapers in the United States, titled “A

Movie 1.4 First Report of the Surgeon General’s
Advisory Committee on Smoking and Health

Frank Statement to Cigarette Smokers,” in
which they dismissed the scientific
evidence and attributed the link between
smoking and disease to faulty statistics
(Figure 1.5). They contended: “The
statistics purporting to link cigarette
smoking with the disease [lung cancer]
could apply with equal force to any one of
many other aspects of modern life. Indeed
the validity of the statistics themselves is questioned by numerous scientists.” They went on to say in
the ad: “We accept an interest in people’s health as a basic responsibility, paramount to every other
consideration in our business.” The history of the tobacco industry’s tactics over the 60 years following
this statement speaks for itself about whether or not the industry has upheld this responsibility.
In 1964, Luther L. Terry, Surgeon General of the U.S. Public Health Service, released the first report of
the Surgeon General’s Advisory Committee on Smoking and Health (Movie 1.4).
As part of the preparation for this landmark report, a group of scientists examining more than 7,000
articles on smoking and disease realized that there needed to be formal criteria to establish causal
relationships in the area of health. As they investigated the scientific evidence, they identified a set of
characteristics and criteria that would determine whether an observed relationship between a specific
factor (e.g., smoking) and a disease was causal or simply associative. These criteria, which include
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strength of association, consistency, specificity, and so on, became known as Hill’s Postulates (Table
1.5) after Austin Bradford Hill, the medical statistician who first presented them, and are now
considered a basic tenet of modern epidemiological research. Hill’s Postulates were applied for the
first time in developing the 1964 Surgeon General’s Report (Figure 1.6). This report is now considered
historic, as it represents the beginning of the decline of smoking in the United States. The concluding
remarks from the report are very clear about the relationship of smoking and disease: “Cigarette

Table 1.5 Hills Postulates (1965)
Postulate

Description

Strength

A strong association is more likely to be causal.

Consistency
Specificity
Temporality

When an exposure is associated with a specific outcome only, then it is more
likely to be causal.
The cause should precede the outcome.

Biological
Gradient

If the frequency or intensity of the outcome increases when an exposure is
more intense or lasts longer, then it is more likely that the association is causal.

Plausibility

An association is more likely to be causal when it is biologically plausible.

Coherence

A cause and effect interpretation of an association should not conflict with
what is known about the natural history and biology of the disease.

Experiment

If experimental evidence exists, then the association is more likely to be
causal.

Analogy
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An association is more likely to be causal when it is observed in different
population groups.

The existence of an analogy could strengthen the belief that an association is
causal.

smoking is causally related to lung cancer in men; the magnitude of the effect of cigarette smoking
far outweighs all other factors. The data for women, though less extensive, point in the same
direction.”
It is not only the medical and epidemiologic research communities that have accepted the causal
relationship between smoking and disease; courts of law have also found this relationship to be
established and substantial. In 1999, the U.S. Department of Justice sued several major tobacco

Figure 1.6 The First U.S. Surgeon General's Report on
Smoking was Release in 1964

companies (Philip Morris USA,
R.J. Reynolds Tobacco,
Lorillard, and Altria) for
fraudulent and unlawful
conduct and reimbursement
of tobacco-related medical
expenses. U.S. District Judge
Gladys Kessler found the
tobacco companies liable for
fraudulently covering up the
Key Takeaway
Hill’s Postulates were developed as
a set of criteria to determine
whether the observed relationship
between smoking and disease was
causal or simply associative. They
are now considered a basic tenet
of modern epidemiology.
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health risks associated with smoking and for marketing their products to children. She ordered the
tobacco companies to issue corrective statements that clearly state the harm caused by smoking.
Some of these statements are listed in Table 1.6.

Table 1.6 Corrective Statements for Adverse Health Effects of Smoking
A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria
deliberately deceived the American public about the health effects of smoking, and has ordered
those companies to make this statement.

Smoking kills, on average, 1200 Americans. Every day.
More people die every year from smoking than from murder, AIDS, suicide, drugs, car
crashes, and alcohol, combined.
Smoking causes heart disease, emphysema, acute myeloid leukemia, and cancer of the
mouth, esophagus, larynx, lung, stomach, kidney, bladder, and pancreas.
Smoking also causes reduced fertility, low birth weight in newborns, and cancer of the
cervix.
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Perhaps nothing can summarize the harms of smoking better than Figure 1.7, which shows a CAT scan
of a 72-year old patient who has emphysema (shown by the thick arrow) and a lung cancer tumor (thin
arrow). Simultaneously, the asterisk at the upper right-hand corner of the radiograph shows a pack of
cigarettes that
represents the
direct cause of
both his lung
cancer and
emphysema. So
rarely in one
picture do we see
the cause and
effect telling of
the tragic story of
tobacco and the
strength of
addiction.
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Figure 1.7 CAT Scan of a 72 Year Old Patient

Chapter 1 - Harm From Tobacco Use and Secondhand Smoke
Section 3 - Forced Smoking Harms and Kills

Now that we have discussed the harm caused by tobacco use, particularly cigarette smoking, let’s
turn to the harm caused by exposure to secondhand smoke.
Often referred to as forced smoking, secondhand smoke exposure occurs among people who are
involuntarily exposed to smoke from others’ cigarettes. These may be children or infants, or they may
be adolescents or adults who have
made the conscious decision not to
smoke themselves. We use the term

Figure 1.8 Global Deaths Resulting from Secondhand
Smoke in Nonsmokers

forced smoking or involuntary smoking
interchangeably to convey the reality
that secondhand smoke exposure is a
matter of being forced to inhale
smoke. Forced or involuntary smoking
has been shown to kill adults and harm
children.
Globally, 600,000 deaths occur
annually as a result of secondhand
smoke exposure. Though adult men
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Totals may not sum due to rounding.

smoke more than women, 75% of secondhand smoke deaths are among women and children (Figure
1.8).
Secondhand smoke consists of two components: mainstream smoke, which is smoke exhaled by a
smoker, and sidestream smoke, which is the smoke that comes from the lit end of a tobacco product.
Sidestream smoke contains higher concentrations of carcinogens than mainstream or exhaled smoke,
and there are smaller particles in sidestream smoke that are more likely to be inhaled into the lungs
and make their way to the body’s cells.
The harms of secondhand smoke exposure have been clear to tobacco
companies for a long time. In 1978, the tobacco industry commissioned a
report by the Roper Organization that identified the protection of non-

Key Takeaway
US and international
studies show that forced or
involuntary smoking kills
adults and harms children.

smokers’ rights as a major threat to the future existence of tobacco
companies—or, in their words, “the most dangerous development to the viability of the tobacco
industry that has yet occurred.” For this reason, tobacco companies have fought the evidence linking
secondhand smoke with disease and death, and they did so quite successfully until the mid-1980s
when a series of international reports was released documenting the causal relationship between
secondhand smoke exposure and cancer. This was followed by the 1986 U.S. Surgeon General’s
Report, which concluded that involuntary smoking is a cause of disease, including lung cancer, in
otherwise healthy non-smokers. It also concluded that the mere separation of smokers and nonsmokers while they continue to share the same airspace may reduce, but not eliminate, the exposure
of non-smokers to tobacco smoke in the environment. In 1992, the U.S. Environmental Protection
Agency concluded that secondhand smoke was a “Class A” (or known) human lung carcinogen.
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Table 1.7 specifies the

Table 1.7 Harm Caused by Secondhand Smoke

harms caused by
Sufficient Evidence

Suggestive Evidence

Adults

Coronary Artery Disease, Lung
Cancer

Stroke, Nasal Sinus Cancer, Breast
Cancer, Carotid Arterial Wall
Thickening, Chronic Obstructive
Pulmonary Disease, Pre-term
Delivery

Children

Middle-Ear Disease, Respiratory
Symptoms (cough, wheeze,
phlegm, breathlessness, impaired
lung function), Sudden Infant
Death Syndrome (SIDS), Lower
Respiratory Illness (including
infections), Low Birth Weight

Brain Tumors, Lymphoma,
Leukemia, Asthma

secondhand smoke
among adults and
children. There is
sufficient evidence that
among adults,
secondhand smoke
exposure causes heart
disease and lung
cancer. Additionally,
there is suggestive
evidence that it causes

stroke, chronic obstructive pulmonary disease (COPD), pre-term delivery, and other problems. Among
children, there is sufficient evidence that secondhand smoke exposure causes middle-ear disease,
respiratory symptoms, and impaired lung function, among other illnesses. In Europe, it is responsible for
24% - 32% of all cases of Sudden Infant Death Syndrome. Moreover, suggestive evidence points to
serious conditions such as brain tumors, lymphoma, leukemia and asthma.
Certainly, exposure to secondhand smoke is less deadly than active smoking. For every ten people killed
by active smoking, approximately one person dies from exposure to secondhand smoke. However, while
it is true that fewer people die from forced smoking than active smoking, it is important to remember that
those exposed to secondhand smoke had no choice in their exposure (Figure 1.9). They have an
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increased risk of developing a deadly disease as a
result of someone else’s decision to smoke.
Around the world, it is estimated that 40% of children
and 33% of non-smoking adults are exposed to
secondhand smoke. The region with the greatest level
of exposure is the Western Pacific region, which
includes China. Over 50% of the people living in this
region are exposed to secondhand smoke. The
largest number of deaths caused by secondhand
smoke exposure can be found in Europe, followed
closely by the Southeast Asian region.
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Figure 1.9 A Tip about Secondhand
Smoke

Table 1.8 provides a closer look
at secondhand smoke exposure among

Table 1.8 Secondhand Smoke Exposure Among
Youth

children throughout the world. This table
uses data collected by the Global Youth
Tobacco Survey (for more information on
GYTS, see Chapter 3) and shows the
countries in which more than 75% of
adolescents 13-15 years old are exposed
to secondhand smoke at home. As you can
see, the majority of these countries are
found in Eastern Europe, perhaps
accounting for the high level of
secondhand smoke deaths we saw above.
In Cyprus and Romania, for example, over
90% of children are exposed to
secondhand smoke at home.
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Country Name

Region

Total
(%)

Cyprus

EURO

96.1

Romania

EURO

90.4

Armenia

EURO

89.8

Greece

EURO

89.8

Turkey

EURO

89.3

Poland

EURO

86.7

Albania

EURO

84.8

Bosnia and
Herzegovina

EURO

77.3

Serbia

EURO

76.9

Montenegro

EURO

76.8

Tuvalu

WPRO

76.6

Russian
Federation

EURO

76.4

Belarus

EURO

75.3

Figure 1.10 Regional Deaths from Exposure to Secondhand Smoke, 2004
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Figure 1.11 Exposure to Secondhand Smoke by Age, Ethnicity and
Poverty Level

Looking at Figure 1.10,
deaths from secondhand
smoke in the Americas is
less common than in
other regions of the
world. However, any
exposure is too much,
and the amount of
exposure varies greatly
depending on one's
demographics.
As Figure 1.11 shows,
more than 50% of
children ages 3-11 are
exposed to secondhand
smoke in the U.S., with

most exposure occurring in the home. The chart shows that black Americans are much more likely to
be exposed to secondhand smoke than whites, children are more likely to be exposed than adults,
and those who live below the poverty level are more likely to be exposed than those who live at or
above the poverty level.
Moreover, there is a threefold variation in adult exposure to secondhand smoke in the home among
different states based on a CDC survey of 11 states in 2008 (Table 1.9).

29

The formal criteria used to establish a causal relationship between smoking and disease in the 1964
U.S. Surgeon General’s Report has since been applied towards establishing causality with regard to
exposure to secondhand smoke. Building on the
1986 U.S. Surgeon General’s Report, the report
issued in 2006 established that there was a

Table 1.9 Secondhand Smoke Exposure by
State

20-30% increased risk of lung cancer for a
nonsmoker who lives with a smoker. The 2010

State

U.S. Nonsmoking
Adults Exposed to
Secondhand Smoke in
the Home (%)

West Virginia

10.6

Mississippi

10.1

Tennessee

9.7

Louisiana

9

Indiana

8.9

North Carolina

7.8

New Jersey

5.8

Virginia

5.7

Connecticut

5

Kansas

4.5

Arizona

3.2

Report went further by looking at both the
biologic and behavioral mechanisms of how
disease is caused by smoking.
As we have seen in the case of active smoking,
the data linking secondhand smoke with disease
have been reviewed not only by medical
practitioners and epidemiological researchers,
but also by courts of law. In her 2006 ruling,
Judge Kessler concluded that tobacco
companies had made false and misleading
public statements, denying the grave threat
posed by secondhand smoke, even while their
own internal documents showed that the tobacco
companies were aware of the hazards of
secondhand smoke exposure (Table 1.10).
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Judge Kessler required the tobacco companies to issue corrective statements to provide the truth
about the negative health effects of secondhand smoke. As with the required corrected statements
for active smoking, these statements have not yet taken effect as of early 2016 even though the terms
of these statements were agreed upon in January 2014.

Table 1.10 Corrective Statements for Adverse Health Effects of Exposure to
Secondhand Smoke
A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and
Altria deliberately deceived the American public about the health effects of secondhand
smoke, and has ordered those companies to make this statement.
Here is the truth:

Secondhand smoke kills over 38,000 Americans each year.
Secondhand smoke causes lung cancer and coronary heart disease in adults who do
not smoke.
Children exposed to secondhand smoke are at an increased risk for sudden infant
death syndrome (SIDS), acute respiratory infections, ear problems, severe asthma, and
reduced lung function.
There is no safe level of exposure to secondhand smoke.
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Chapter 1 - Harm From Tobacco Use and Secondhand Smoke
Section 4 - Other Tobacco Products Also Kill

So far, we have discussed combustion, the predominant way that tobacco is consumed around the
world. Combustion is the most efficient way to deliver nicotine to the brain, a major reason why
manufactured cigarettes are the most commonly consumed tobacco product globally. Over 90% of
tobacco is consumed through cigarettes, but as we will see in this section, there are other ways that
tobacco is used.
As we begin this discussion, it is important to note that there exists no safe form of tobacco. Whether
it is smoked, or rubbed on the cheeks, or chewed, or sucked, or inhaled through the nose, tobacco is
harmful to health.
Figure 1.12 shows images of the variety of tobacco products that are available for smoking. Besides
traditional manufactured cigarettes, there are other tobacco products available
which are similarly combusted and smoke-inhaled (Table 1.11). For instance,

Key Takeaway

there are roll-your-own cigarettes, which are hand-rolled by a smoker rather than

There is no safe
form of tobacco.

by a machine. These are particularly common in Europe and New Zealand. Bidis,
popular in Southeast Asia, are made of tobacco wrapped in leaves with no filter.

Kreteks, which contain tobacco flavored by cloves, are common in Indonesia. The cloves tend to have
an anesthetic effect, allowing for smoke to be inhaled more deeply. Water pipes, which are
traditionally found in the Mediterranean region and are now becoming more common in Europe and
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Figure 1.12 Smoking Tobacco Products Available for Sale

the U.S., provide a way
to burn tobacco in a
bowl and cool the
smoke with water
before it is inhaled
through a pipe.
Though the smoke is
cooled with water and
thus easier to inhale, it
is no less harmful than
the smoke from any
other type of
combusted tobacco
product.
Presented in Figure
1.13 are tobacco
products that are not
combusted but rather
are placed in the

mouth or nose to provide access to nicotine. Chewing tobacco is placed in the mouth and either
chewed or sucked. In India, where chewing tobacco is very popular, we see a dramatic increase in oral
cancer compared to the rest of the world. In addition to chewing tobacco, there are two different
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kinds of snuff: moist
snuff, the most

Figure 1.13 Smokeless Tobacco Products Available for Sale

common, is ground
tobacco that is put in
the mouth between
the cheeks and
gums, and dry snuff
is powdered
tobacco that is
inhaled through the
nose (Table 1.12).
Most recently,
tobacco companies
have introduced
“dissolvables,” which
may take the form of
strips that dissolve in the mouth or a pellet that is sucked on. There are other varieties of dissolvables,
but they all share in common the quality of not having to be spit out. The risks of these new products
are at this point unknown.
India provides an interesting case study for smokeless tobacco use. It is estimated that 35-40% of all
tobacco consumed in India is in smokeless form. Table 1.13 shows the variety of smokeless tobacco
products that are consumed in India; it includes products that are chewed, sucked, or applied to the
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Table 1.11 Combusted Tobacco Products and their Global Use

Product

Roll your own
cigarette

Region of Primary Use

Europe/New Zealand

Description

Dangers of
Consumption
Compared to
Cigarettes

Increased risk of oral
Hand rolled by smoker
and upper
respiratory cancers
Increased exposure
to tar and carbon
monoxide

Bidis

South Asia

Tobacco wrapped in
dry leaves

Kreteks

Indonesia

Clove-flavored
cigarettes

Users inhale smoke
more deeply

North Africa,
Mediterranean, Asia

Flavored tobacco is
burned in a smoking
bowl and the smoke is
inhaled through a pipe

Increased exposure
to toxins may result
depending on how
smoke is inhaled

Water Pipes

teeth and gums. As you can see, the majority of men either smoke or use smokeless tobacco or do a
combination of both. Looking at the data for women, you can see that though there are relatively few
smokers in many areas, smokeless tobacco use ranges up to 57%, making for a very high rate of
combined tobacco use among women in India—perhaps unparalleled anywhere else in the world.
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To summarize, there is still no safe way of using tobacco. According to the American Cancer Society,
“Use of any smokeless tobacco product is not considered a safe substitute for quitting.” Smokeless
tobacco products cause oral, esophageal, and pancreatic cancers; precancerous lesions of the
mouth; gum recession; and bone loss around the teeth. They also lead to nicotine addiction.

Table 1.12 Non-combusted Tobacco Products and their Global Use
Region of
Primary Use

Description

Dangers of
Consumption
Compared to
Cigarettes

Chewing
Tobacco

Worldwide,
India

Oral, smokeless
tobacco used in the
mouth, cheek or lip
and sucked or
chewed

Increased risk of
oral cancer

Moist Snuff

Scandinavia,
U.S.

Ground tobacco
held between
cheeks or gums

Increased risk of
oral cancer

Dry Snuff

Europe

Powdered tobacco
inhaled nasally

Increased risk of
oral and nasal
cancer

Dissolvables

High-income
countries

Dissolve in the
mouth without
expectoration

Novel products
with unknown
risks of use

Product
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Table 1.13 Use of Tobacco in Seven Areas of India
Area
Mainpuri, Uttar Pradesh
Bhavnagar, Gujarat
Ernakulam, Kerala
Srikakulam, Andhra Pradesh
Singbhum, Bihar
Darbhanga, Bihar
Pune, Maharashtra
Goa
Mumbai (urban), Maharashtra
Trivandrum (urban), Kerala

* Prevalence <0.5%; nr=not reported
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Sex

Chew or
apply (%)

Smoke (%)

Mixed (%)

Total Users (%)

Male

21

41

20

82

Female

9

11

1

21

Male

9

56

6

71

Female

15

*

*

15

Male

14

45

22

81

Female

38

1

1

39

Male

4

70

7

81

Female

3

64

*

67

Male

17

50

14

81

Female

26

5

2

33

Male

28

24

26

78

Female

7

41

4

51

Male

53

6

2

62

Female

49

*

*

49

Male

3

61

5

69

Female

23

24

2

49

Male

46

14

10

69

Female

57

*

*

57.5

Male

27

56

nr

83

Female

26

2

nr
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Chapter 1 Discussion Questions
1. If the cigarette is “the only consumer product that kills when used as directed,” as stated by
Robert Proctor, why does it continue to be legal in the United States?
2. Should there be more aggressive laws protecting minors from exposure to secondhand
smoke?
3. What do you predict will happen to the curves in Figure 1.1 given the increased use of
smokeless tobacco products?
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Chapter 2

Adult Tobacco Use
Behaviors

Chapter Objectives
1. Explain gender differences in tobacco use.
2. Interpret the importance of smoking prevalence differences
in low- and middle-income countries.
3. Hypothesize the shift over time in U.S. tobacco smoking
rates among adults.
4. Recognize smoking behavior variations by population
characteristics (gender, race, SES, special populations).
5. Demonstrate an understanding of various tobacco
surveillance systems.

Chapter 2 - Adult Tobacco Use Behaviors
Section 1 - U.S. Adult Tobacco Use

In this chapter, we will examine adult tobacco use behaviors, first by looking at trends in the United
States and then by examining global trends.
The United States has numerous surveillance systems that monitor tobacco use. Some of these
systems, such as the Monitoring the Future Surveillance System and the Youth Risk Behavior
Surveillance System, examine tobacco use by young people and will be discussed in the next chapter.
The focus for this chapter will be on surveillance systems that monitor adult tobacco use (Table 2.1).
These include the Behavioral Risk Factor Surveillance System, which provides state-specific estimates
on smoking and other types of tobacco use, as well as the National Health Interview Survey, which
presents trend data for adult smoking rates in the U.S. going back to the 1960s. The most recently
developed system is the National Survey on Drug Use and Health, which is sponsored by the
Substance Abuse and Mental Health Services Administration (SAMHSA) and provides data on both
youth and adults and has the unique benefit of estimating smoking initiation rates.
We can examine tobacco use within a given population in two ways. One way is to look at tobacco
use in terms of consumption, which means investigating the number of cigarettes smoked per capita.
Another way is to measure tobacco use in terms of the rate or proportion of the population
characterized as current smokers, former smokers, or never-smokers. As Table 2.1 demonstrates,
there is some variation in the way that the different monitoring systems define a current smoker.
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Table 2.1 Comparison of Tobacco Surveillance Systems in the U.S.
Survey Name

Monitoring the Future

Youth Risk Behavior
Surveillance Survey

Behavioral Risk Factor
Surveillance System

National Health
Interview Survey

National Survey on
Drug Use and Health
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Sponsor

NIH

CDC

CDC

CDC

SAMHSA

Sample
Size

50,000

15,000

500,000

87,500

70,000

Population
Surveyed

Survey Method

Definition of “Current
Smoker”

Written
Questionnaire

None. (Respondents are
asked if they have ever
smoked cigarettes, and how
frequently they have smoked
during the past 30 days).

Written
Questionnaire

Smoked cigarettes on at least
1 day during the 30 days
before the survey (20 of 30
days for “current frequent”
smoker).

Adults

Phone

Smoked at least 100 cigarettes
in their lifetime and now
smoke every day or most days.

Adults

Computer
Assisted Personal
Interview

Smoked at least 100
cigarettes in their lifetime and
now smoke daily or some
days.

8th, 10th, & 12th
Grade Students

High School
Students

Ages 12+

Computer
Smoked cigarettes on at least 1
Assisted Personal day during the 30 days before
Interview
the survey.

Key Takeaway

For example, the CDC defines current smokers as those who have

Tobacco surveillance systems may
measure tobacco use in terms of
consumption (the number of cigarettes
smoked per capita) or in terms of
prevalence (the proportion of the
population characterized as smokers).

smoked at least 100 cigarettes in their lifetime and currently
smoke daily or some days. In this chapter, we will discuss both
consumption patterns and rates (also known as prevalence rates
or simply prevalence) of tobacco use.

Figure 2.1 represents one of the most important overviews of tobacco consumption in the U.S. and
the developments that have resulted from tobacco control efforts in the 20th century. It shows the
number of cigarettes smoked per capita across the span of the last century.
Figure 2.1 shows a
rapid increase in
cigarette consumption
during the period
between the First and
Second World Wars,
which may be
associated with the
inclusion of cigarettes
in rations provided to
soldiers fighting the
war overseas. Cigarette
use reached its peak
during the 1960s, and
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Figure 2.1 Adult (18 and over) per capita Cigarette Consumption
and Major Smoking and Health Events, U.S. 1900-2012

then declined quite rapidly from then until the present. This decline in per
capita consumption of cigarettes has been attributed to the release of
various Surgeon General’s Reports, the advent of nonsmokers’ rights
beginning in the 1980s, and increases in the price of cigarettes. Since the
first Surgeon General’s Report in 1964, when over 50% of men and nearly

Key Takeaway
While cigarette
consumption has declined
since 2000, there has
been a gradual increase in
the use of alternative
tobacco products.

40% of women smoked, prevalence rates have decreased by more than half.
However, because of the population increases during this period, the total number of smokers in the
U.S. is the same today as it was fifty years ago, even though smoking has become less common.
As we mentioned in the previous chapter, over 90% of all tobacco consumed in the U.S. is smoked in
the form of cigarettes. The
most recent data, from 2013,
indicate that about 18% of
U.S. adults smoke cigarettes.
There has been a rapid
decline in the total number of
cigarettes smoked each year
in the U.S.—from 435.6 billion
in 2000 to 292.8 billion in
2011 (representing a 32.8 %
decrease). For this period,
annual per capita cigarette
consumption also declined
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Figure 2.2 Trends in per capita Consumption of Various Tobacco
Products, U.S., 1880-2001

from 2,076 to 1,232 cigarettes, a 40.7% decrease.
Looking now at tobacco use patterns spanning from 1880 to 2000 (Figure 2.2), we can see that
towards the end of the 19th century, the most commonly used tobacco products were chewing
tobacco, pipe tobacco and cigars. A rapid increase in cigarette consumption occurred between 1900
and 1960, a phenomenon partly caused by the introduction of mass manufacturing capabilities for
cigarettes, as well as increasingly sophisticated marketing and distribution systems. Today, most
tobacco is consumed in the form of cigarettes with fairly minor use of cigars and pipe tobacco.
However, starting in 2000, while there has been an impressive decline in cigarette consumption,
there has simultaneously been a gradual increase in the use of alternative tobacco products,
especially the various forms of oral tobacco. We will be exploring
this pattern in more detail later in this chapter, as well as in
Chapter 4.
In addition to monitoring and understanding smoking rates, it is
also important to use the available data to set goals for reducing
prevalence. Healthy People 2020 provides a framework for achieving specific science-based national
objectives to improve the health of Americans. Launched in December 2010, the framework
establishes a 10-year agenda and provides benchmarks with the aim of achieving national health
goals by the year 2020. Under the “Framework for Ending the Tobacco Use Epidemic,” Healthy
People 2020 has set the ambitious goal of reducing cigarette smoking by adults to 12% by 2020
(Table 2.2)

51

Healthy People 2020 includes the following objectives with regard to tobacco:
•Tobacco Use Prevalence – Implementing policies to reduce tobacco use and initiation among
youth and adults.
•Health System Changes – Adopting policies and strategies to increase access, affordability, and
use of smoking cessation services and treatments.
•Social and Environmental Changes – Establishing policies to reduce exposure to secondhand
smoke, increase the cost of tobacco, restrict tobacco advertising, and reduce illegal sales to
minors.

Table 2.2 Healthy People 2020: Tobacco Use Objectives

Tobacco Use (TU) -1: Reduce tobacco
use by adults

52

Prevalence as of
2008

2020 Prevalence
Goal

TU-1.1

Reduce cigarette smoking by
adults

20.6%

12.0%

TU-1.2

Reduce use of smokeless
tobacco products by adults

2.3%

0.3%

TU-1.3

Reduce use of cigars by adults

2.2%

0.2%

While the U.S. has

Figure 2.3 Prevalence of Current Smoking Among Adults (18 and
over), U.S., 1997-2012

experienced a decline in
smoking over the last 15
years, the change has been
gradual, and the country is
still far from its objective of
a 12% smoking rate ( Figure
2.3).
Smoking prevalence rates
in the United States vary in
ways that are not
necessarily typical for other
major public health risk

factors. These variations are explored in the following pages.
Gender
Race/Ethnicity
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Men are more likely than women to smoke.
Some groups smoke more or less than others.

Age

Most U.S. smokers are between the ages of 25 and
44.

Socioeconomic
status

Lower-educated individuals and those living below
the poverty level tend to smoke more.

In 1965, male smoking rates were at a higher level than female smoking rates,
and the rate of male smoking has declined more in the latter part of the
century. Today, men continue to smoke at a slightly higher rate than women,
but in the U.S., the difference in smoking rates by gender is not very dramatic
(Figure 2.4). Global smoking trends, discussed later in this chapter, will offer a

Key Takeaway
In the U.S., the
difference between
male and female
smoking rates is
relatively small.

marked contrast, demonstrating large variations in smoking prevalence for men
versus women.

Figure 2.4 Trends in Cigarette Smoking, Adults 18 and Older,
U.S., 1965-2011
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Figure 2.5 examines the
differences in smoking

Figure 2.5 Current Cigarette Smoking Among Adults Age 18 and
Over

rates by race and ethnicity.
There is a rather large
difference in smoking
rates in 1965 based on
gender and ethnicity, with
the highest rates being
found among AfricanAmerican men, followed
by white men—both with
rates above 50%. For both
white women and African-American women, smoking rates were between 30% and 35% in 1965. We
see a dramatically different pattern in 2011. Here, there is very little difference between white and
African-American men, and likewise a small difference between white and African-American women.
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Looking now at smoking with regard to different age categories (Figure 2.6) we can see that people
between the ages of 25 and 44 experience the highest prevalence rate of any age group in the U.S.
While smoking rates for most age groups hover somewhere between 18 and 25% during the time
period shown here (2005-2011), Americans who are 65 years of age or older are much less likely to
smoke, with smoking rates falling below 10%. This remarkable difference may be attributed to some
extent to the fact that many smokers die before they reach the age of 65.
So far, we have seen
gender differences in
smoking rates as well as
differences in race,
ethnicity, and age. In
Figure 2.7, we can see
the most dramatic
discrepancies in smoking
rates as we look at some
of the indicators of
having a lower
socioeconomic status—in
this graph focusing on
the varying education
levels of smokers. The
group of individuals who
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Figure 2.6 Percentage of Adults (18 and over) who were Current
Smokers, by Age Group, U.S., 2005-2011

Figure 2.7 Age-adjusted Prevalence of Current Cigarette Smoking
Among Adults (25 and over), by Education Level, U.S.

have completed a
Bachelor’s degree or
higher had a
smoking rate of less
than 10% in 2011,
whereas those with
only a high school
diploma or GED or
who have dropped
out of high school
had smoking rates of
nearly 35%. This

threefold difference in smoking rates between the most educated and the least educated tells an
important story about smoking in America today: individuals who have lower socioeconomic status
and less education suffer the most from the burden of tobacco use.
To further illustrate smoking rates as a function of poverty, Figure 2.8 compares adult male smoking
rates by levels of income. The yellow line represents individuals who are living below the poverty line
in the U.S. and clearly, this group consistently has the highest smoking
rates. The wealthiest Americans, represented by the red line, are those who
have an income at least four times as much as the poverty line, and also
have the lowest smoking rates.
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Key Takeaway
Individuals who have lower
socioeconomic status and
less education suffer the
most from the burden of
tobacco used.

To summarize briefly, there is a persistent connection between lower socioeconomic status and
smoking. In 2011, 29% of American adults who were current smokers lived below the poverty level. In
the same year, among those living at or above the poverty level, only 17.9% were current smokers.
As mentioned above, the overall smoking prevalence for adults in the U.S. is approximately 18%. But
the situation is much more complex than that simple percentage might suggest. To further deepen

Figure 2.8 Male Adult (18 and over) Current Cigarette Smoking, by
Percent of Poverty Level, U.S.
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our understanding of some of the nuances of
smoking prevalence in the U.S., Table 2.3 provides
prevalence data on various populations.

Population

Smoking
Prevalence

Drug use

74%-88%

Bipolar disorder

69%

higher than the national average. Between 74% and

Alcohol abuse/dependence

68%

88% of drug users are current smokers, as are more

Schizophrenia

64%-74%

Generalized anxiety disorder

55%

Depression

34%-60%

Homeless

70%-78%

HIV/AIDS

47%-65%

Certain populations are at an increased risk of using
tobacco. As Table 2.3 shows, many of these
populations experience smoking rates that are much

than two-thirds of those who suffer from mental
illnesses such as schizophrenia and bipolar disorder.
Homelessness, educational attainment, disability
and sexual orientation are important factors
associated with higher smoking rates.
Public health advocates seeking to design
intervention programs for tobacco users need to
understand how these specific factors are related to
smoking. Communications and intervention
programs should be directed at populations that
have a higher risk of smoking and thus tobaccorelated illnesses.
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Table 2.3 Smoking Prevalence Among
Special Populations, U.S.

General Education
Development (GED)

46%

Young adults with cancer

43%

Military

34%

Men who have sex with men

33%

Mobility impaired

33%

Native Americans

32%

Below poverty level

31%

In addition to higher smoking prevalence rates, many special populations suffer a disproportionate
burden of disease for a variety of reasons. For example, many of them do not have access to effective
cessation treatments. They may be less likely to see a physician or to be advised to quit by their
doctors. For some, tobacco use may interact with other risks that cause them to be vulnerable, which
means that the effects of smoking are often compounded by other factors associated with having
lower socioeconomic status such as poverty, education level, and occupation type.
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Besides prevalence rates, another important aspect to consider when looking at tobacco use is the
number of cigarettes smoked per day. Figure 2.9 shows changes in the proportion of smokers in the
U.S. from 2005 to 2011 in terms of the number of cigarettes smoked per day. The most notable
change is a decrease in persons we would consider to be heavy smokers—those who smoke 30 or
more cigarettes per day, represented by the solid blue line. This is accompanied by an increase in
light smokers—those who smoked 1-9 cigarettes per day as represented by the dashed line. The
decrease in heavy smokers and increase in light or occasional smokers is an optimistic trend because
there is a clear relationship between the number of cigarettes smoked per day and the risk of disease.

Figure 2.9 Percentage of Daily Smokers (18 and over), by Number of Cigarettes
Smoked Daily, U.S., 2005-2011
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The number of cigarettes smoked by an individual is a good predictor of the risk of disease that
individual will experience. Christopher Haiman et al. studied the relationship between a person’s level
of smoking and likelihood of disease. Table 2.4 shows the risk of smoking-related lung cancer among
current and former smokers, and differentiates among the groups by race and ethnicity, as well as by
their levels of smoking. The first row shows the relative risk of getting lung cancer for those who
smoke 10 or fewer cigarettes per day. With African Americans serving as the reference group (1.00
relative risk), the relative risk of getting lung cancer is .88 for Native Hawaiians – a difference from
African Americans not considered statistically significant. But for Latinos who smoke 10 or fewer

Table 2.4 Relative Risks of Smoking-Related Lung Cancer Among Current and Former
Students, by Level of Smoking
AfricanAmerican

Native
Hawaiian

Latino

Japanese
American

White

≤10 Cigarettes/day
Relative Risk (95% CI)

1.00

0.88
(0.60-1.29)

0.21
(0.14-0.31)

0.25
(0.18-0.36)

0.45
(0.34-0.60)

11-20 Cigarettes/Day
Relative Risk (95% CI)

1.00

0.90
(0.74-1.12)

0.36
(0.29-0.44)

0.39
(0.32-0.47)

0.57
(0.49-0.68)

21-30 Cigarettes/Day
Relative Risk (95% CI)

1.00

0.93
(0.72-1.21)

0.61
(0.46-0.79)

0.61
(0.46-0.74)

0.73
(0.61-0.88)

≥31 Cigarettes/Day
Relative Risk (95% CI)

1.00

0.95
(0.66-1.35)

0.79
(0.55-1.13)

0.75
(0.57-1.00)

0.82
(0.64-1.05)

Smoking Level

Relative risks were adjusted for the duration of smoking, sex, and the time since quitting. African Americans served as
the reference group. CI denotes confidence interval.
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cigarettes per day, the relative risk of getting lung cancer is 0.21; for Japanese Americans it is 0.25;
and for white Americans it is 0.45. Thus, we see that race and ethnicity play a role in determining the
relative risk of getting lung cancer for light smokers: African Americans and Native Hawaiians who
smoke 10 cigarettes or fewer every day are at much greater risk of developing lung cancer than
Latinos, Japanese Americans and whites who smoke the same amount.
The next row, showing data for people who smoke 11-20 cigarettes per day, follows a very similar
pattern, with African Americans and Native Hawaiians experiencing the highest risk.
However, the relationship changes as we look at heavy smokers—those who smoke 31 or more
cigarettes per day. Again, African Americans are the reference group (1.00 relative risk), and Native
Hawaiians are still at high risk (0.95). But in this row, we can see that Latinos, Japanese Americans and
whites have relative risks with confidence intervals that surround 1.00, meaning that in the case of
heavy smokers, these groups are no longer protected by their race or ethnicity as they were in the
other smoking levels. In other words, whatever protective effect race and ethnicity may have had for
light or moderate smokers is clearly negated by those who smoke at least a pack and a half per day.
In the U.S., the decline in consumption of combustible tobacco products in the last decade or so has
been accompanied by a rise in alternative tobacco products, including combustible non-cigarette
products, such as cigars, cigarillos, and roll-your-own tobacco. Smokeless tobacco products, such as
Skoal, Copenhagen, and Snus, which are put in the mouth and either chewed or sucked on, are
increasing in popularity. Although cigarette use is declining, the use of smokeless tobacco products is
increasing in the U.S., and alarmingly, they are most prevalent among young adults. Individuals aged
18-25 use these products at higher rates (5.4%) than their younger (2.1%) or older (3.0%)

63

counterparts. In 2011, approximately 3.2% of U.S. citizens aged 12 and over were current smokeless
tobacco users. Males use smokeless tobacco at higher rates than females (6.2% vs. 0.4%).
Likewise, novel nicotine products such as e-cigarettes continue to grow in popularity. In 2009, 16% of
the U.S. population were aware of e-cigarettes and less than 1% had tried them. Just a few years later
in 2015, just over 87% of the U.S. population were aware of e-cigarettes and 17% had tried them.
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Chapter 2 - Adult Tobacco Use Behaviors
Section 2 - Global Adult Tobacco Use

In the first part of this chapter, we examined the surveillance systems that provide useful information
on tobacco use in the United States. Now, we will discuss similar systems that exist on a more global
level.
There are a number of very exciting developments with respect to global tobacco surveillance
systems. The Global Adult Tobacco Survey (GATS), primarily funded by Bloomberg Philanthropies,
provides standardized and comparable data on adult smoking. GATS was originally implemented in
15 countries that were considered priority countries by Bloomberg, and has since continued to
expand and include more countries.
The World Health Organization (WHO) assembles data using different country-specific survey
methods in order to construct their country profiles, which contain prevalence data. In addition, there
are global as well as continent-specific surveillance systems that are focused on tobacco use among
youth.
In this section, we will examine some of the important data on global adult tobacco use gathered
through these surveys (Table 2.5).
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Table 2.5 Comparison of Global Tobacco Surveillance Systems
Survey

Sponsor

Global Adult
Tobacco Survey
(GATS)

WHO, CDC,
Bloomberg
School of Public
Heatlh

Global Youth
Tobacco Survey
(GYTS)

Canadian Public
Health
Association, NCI,
UN Children
Emergency Fund,
and WHO

WHO TFI
Country Profiles

WHO

Global School
Based Health
Survey

WHO, UNICEF,
UNESCO,
UNAIDS

Health Behavior
in School Aged
Children Survey
(HBSC)
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WHO Europe

Sample Size

2,000 - 40,000
per site

1,875 - 24,375
per site

Population

Method

Definition of a
current smoker

Adults 15+

Computer
Assisted
Personal
Interview

Daily or occasional
smoking during the
30 days before the
survey

Written
Questionnaire

Smoked cigarettes
on at least 1 day
during the 30 days
before the survey

Students
13-15

Prevalence data for these reports is provided from country specific
surveys that vary in methodology, therefore sample sizes, population,
method, and definition of current smoker vary considerably by country.

Varies by site

Student
13-17

Written
Questionnaire

Smoked cigarettes
on at least 1 day
during the 30 days
before the survey

~1,500 per site

Students 11,
13, and 15

Written
Questionnaire

Students that
report smoking
once per week

Figure 2.10 shows a pattern for global cigarette consumption in the 20th century that is not too
different from the pattern we observed for U.S. consumption. At the start of the century, we see very
low rates of smoking, followed by a very rapid increase beginning around the 1920s. In 2009, nearly
six trillion cigarettes were consumed around the world. It is still unknown whether these numbers will
begin to fall, continue to increase, or plateau.
While it is helpful to
look at this graph and
see how many
cigarettes are smoked
globally, it is important
to keep in mind that it
measures overall total
consumption and is not
adjusted for
population size. As the
global population
grows, it is likely that
cigarette consumption
will increase simply
because the number of
smokers in the world
has increased.
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Figure 2.10 Global Cigarette Consumption Increased More Than 100
Times in a Century

Cigarette consumption varies
greatly in the different regions
of the world (Figure 2.11).
Nearly half of all cigarettes are
consumed in the Western
Pacific region (one of the six
regions of WHO). Between
1990 and 2009, consumption
of cigarettes dropped
dramatically in certain regions
—for example, Western
Europe saw a decline of 26%—
while increasing in other
parts, particularly Africa and
the Middle East (57%
increase).
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Figure 2.11 Regional Cigarette Consumption, 2009

It may be surprising to observe in Figure 2.12 that
five countries smoked more than half of all the
cigarettes in the world: China, Russia, the U.S.,
Indonesia, and Japan. In fact, nearly 40% of all
cigarettes in the world are smoked in China alone.
There are an estimated 1 billion adult smokers
worldwide. Eighty percent of male and 50% of
female smokers live in low- and middle-income
countries.
A report published in the The Lancet, a leading
medical journal, highlighted data collected using
the Global Adult Tobacco Survey (GATS) from 14
developing nations. Take a look at the findings,
which show disproportionate smoking rates in men
vs. women (41% men vs. 5% women) and a large
variation in smoking prevalence rates among the
14 countries included in the survey.
As we mentioned in our discussion of U.S. tobacco
use in the previous section, smoking rates vary by
gender, region, and socioeconomic status. This is
also true when we look at global smoking rates.
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Figure 2.12 The World's Top CigaretteConsuming Countries, 2009

Figure 2.13 Percent of Males Who Smoke Cigarettes

First, let’s examine male
smoking around the world.
Figure 2.13 shows global male
smoking rates, with the darker
colors showing the highest
rates of smoking. As you can
see, male smoking rates vary
considerably around the world.
Nine countries have male
smoking rates over 50% (TimorLeste, Indonesia, Kiribati, Nauru,
Armenia, Lao PDR, Papua New
Guinea, Russian Federation and
Tuvalu).
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Table 2.6 Average Adult Male
Smoking Prevalence by
Region

In Table 2.6, we examine male smoking rates in each of the WHO
regions, and see that adult male smoking prevalence varies by
region and country income category.

WHO Region

Average

AFRO

16.8%

EMRO

29.2%

EURO

39.1%

PAHO

24.9%

•The African region (AFRO) has the lowest average male

SEARO

32.2%

smoking prevalence in both low- and middle-income countries.

WPRO

40.8%

Global Average

30.6%

•The average male smoking prevalence rate is 30% in highincome countries, 33.5% in middle-income countries and 21% in
low-income countries.

•The South-East Asian region (SEARO) is the only region in
which high-income countries have a higher smoking prevalence
than middle- or low-income countries.
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Table 2.7 shows 18 countries with reported male
smoking prevalence rates at 50% or greater, and
the majority of these countries are in the
European and Western Pacific regions.
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Table 2.7 Countries With Highest Male
Smoking Prevalence Rates
Country Name

Prevalence

Kiribati

71.0%

Greece

63.0%

Albania

60.1%

Russian Federation

58.6%

Samoa

58.0%

Papua New Guinea

57.7%

Indonesia

57.2%

Georgia

56.6%

Tunisia

52.7%

Armenia

50.9%

Tuvalu

50.8%

China

50.4%

Latvia

50.1%

Ukraine

50.0%

Now turning our

Figure 2.14 Percent of Females Who Smoke Cigarettes

attention to smoking
rates among women,
we see a different
picture than the one we
saw with men. Of the 1
billion adult smokers in
the world, 200 million
are women. There are
nearly 50 countries in
which men’s smoking
rates are at least ten
times as high as
women’s smoking rates.
The lower prevalence
rates for women show
that we have the chance to prevent smoking initiation among women in many areas of the world, and
thus avoid unnecessary addiction, illness and death.
On the map in Figure 2.14, the darkest colors show the highest smoking rates—this time for women.
Immediately, you can see that the highest female smoking rates in the world are found mostly in
Eastern Europe, including Russia, with some high rates scattered around South America. There are 99
countries with female smoking prevalence rates below 5%. Most of those countries are found in the
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African and Eastern Mediterranean regions are classified as low- or middle-income. It is also
interesting to note that some of the lowest female smoking rates are found in Southeast Asia, most
notably China.

Table 2.8 Average Adult Female
Smoking Prevalence by Region

As we previously observed in prevalence rates among
men, female smoking rates vary greatly by region and
country income category (Table 2.8).

WHO Region

Average

AFRO

1.6%

EMRO

4.3%

EURO

20.6%

•The average female smoking prevalence rate is 18% in
high-income countries, 10.1% in middle-income countries
and 2.6% in low-income countries.
•The European region (EURO) has the highest average
female smoking prevalence with the highest smoking
countries falling into the high- and middle-income

PAHO

11.1%

SEARO

6.1%

WPRO

14%

categories.
•The South-East Asian region (SEARO) is the only region in
which low-income countries have a higher smoking
prevalence than high- or middle-income countries.

Global Average

11.2%

•The African region (AFRO) has the lowest average
smoking prevalence for females in both low- and middleincome categories.
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In general, adult males smoke more
than adult females and gender

Table 2.9 Countries with Substantial Differences in Male
and Female Smoking Prevalence

disparities are common in many
Country

Male Current
Prevalence

Female
Current
Prevalence

Difference

countries, in which male prevalence

Indonesia

57.2%

3.7%

53.5%

is dramatically different from female

Georgia

56.6%

5.7%

50.9%

prevalence. Interestingly, there are

Tunisia

52.7%

3.6%

49.1%

two countries (Sweden and Nauru)

Armenia

50.9%

2.1%

48.8%

China

50.4%

2.1%

48.3%

men. The smoking differences

LAO PDR

46.8%

2.9%

44%

between males and females often

Malaysia

45.6%

1.9%

43.8%

portrays an opportunity for public

Kyrgyzstan

44.8%

1.9%

42.9%

health best practices that have the

Rep. Korea

49.3%

6.6%

42.7%

potential to keep female smoking

Mongolia

48.2%

5.9%

42.3%

rates low in many countries.

Thailand

45%

2.7%

42.3%

Unfortunately, even if smoking rates

Albania

60.1%

19.4%

40.7%

remain low among women, women

Libyan Arab
Jamahiriya

41.6%

1%

40.6%

Azerbaijan

41.2%

0.6%

40.6%

Belarus

48.9%

8.8%

40.1%

countries (Table 2.9). The greatest
differences are seen in these 15

where more women smoke than

are still victims of secondhand
smoke from male smokers.
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Figure 2.15 Patterns of Adult Smokeless Tobacco Use

Smokeless tobacco use, which is found throughout the world, is particularly common in a few specific
countries. In Figure 2.15, the darkest colors represent the countries with the highest prevalence of
adult smokeless tobacco use. The map shows that these products are very heavily used in South Asia,
particularly in India and Bangladesh, as well as in some Scandinavian countries where oral tobacco is
quite common.
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Besides the intrinsic harmfulness of smokeless tobacco products, an additional concern is the fact that
they are often used in conjunction with cigarette smoking. We use the term “dual use” to refer to use

Figure 2.16 Patterns of Smokeless and Smoking Dual Tobacco Use

of both cigarettes and another form of tobacco, such as smokeless tobacco. Figure 2.16 shows the
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variations in the prevalence of dual use in select countries. In India, for example, we can see that
about 60% of current tobacco users consume only smokeless tobacco, approximately 25% use only
cigarettes, and 15% use a combination of both. Dual users are at a higher risk for tobacco-related
diseases.
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There is much work still to be done
to minimize or eliminate the harms of
tobacco globally. The good news is
that smoking prevalence has been
decreasing in many countries, such
as Japan, the United Kingdom, and
the U.S., thanks to tobacco control
efforts, evidence-based practices
and general education and
awareness about the impacts and
harms caused from smoking (Figure
2.17).
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Figure 2.17 Male and Female Smoking Trends

Chapter 2 Discussion Questions:
1. What steps should the U.S. take to meet the Healthy People 2020 Prevalence Goals? How likely
are we to meet these goals?
2. What do you think accounts for the disparities in race and gender for the United States outlined
in this chapter?
3. What public health interventions should be taken to address the smoking disparities observed in
special populations, such as those with minority sexual orientations or mental illness?
4. Why do you think higher smoking prevalence rates are found in low- and middle-income
countries? What interventions can the public health field take to address this growing trend?
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Kolonel, L. N., Henderson, B. E., & Le Marchand, L. (2006). Ethnic

World Lung Foundation.

and racial differences in the smoking-related risk of lung cancer.
The New England Journal of Medicine, 354(4), 333–342. doi:

Figure 2.13: Percent of Males Who Smoke Cigarettes

10.1056/NEJMoa033250.

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.
Fifth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Table 2.5: Comparison of Global Tobacco Surveillance Systems

World Lung Foundation.

Source: CDC and WHO
Table 2.6: Average Adult Male Smoking Prevalence by Region
Figure 2.10: Global Cigarette Consumption Increased More

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Than 100 Times in a Century

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

World Lung Foundation.

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:
World Lung Foundation.
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Table 2.7: Countries With Highest Male Smoking Prevalence

Figure 2.15: Patterns of Adult Smokeless Tobacco Use

Rates

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Fifth Ed. Atlanta, GA: American Cancer Society; New York, NY:

World Lung Foundation.

World Lung Foundation.
Figure 2.16: Patterns of Smokeless and Smoking Dual Tobacco
Figure 2.14: Percent of Females Who Smoke Cigarettes

Use

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

World Lung Foundation.

World Lung Foundation.

Table 2.8: Average Adult Female Smoking Prevalence by Region

Figure 2.17: Male and Female Smoking Trends

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

World Lung Foundation.

World Lung Foundation.

Table 2.9: Countries With Substantial Differences in Male and
Female Smoking Prevalence
Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.
Fifth Ed. Atlanta, GA: American Cancer Society; New York, NY:
World Lung Foundation.
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Chapter 3

Youth Tobacco Use
Behaviors

Chapter Objectives
1. Infer the implications of adolescents making life-long
decisions related to smoking during youth.
2. Understand the importance of curbing youth smoking
globally.
3. Analyze the Global Youth Tobacco Survey as a model for
global risk-factor surveillance.
4. Hypothesize the impact on global smoking rates if youth
smoking rates increase globally.

Chapter 3 - Youth Tobacco Use Behaviors
Section 1 - U.S. Youth Tobacco Use

It is important to know as much as possible about teenage smoking
patterns and attributes. Today’s teenager is tomorrow’s potential regular
customer, and the overwhelming majority of smokers first begin to
smoke while still in their teens . . . The smoking patterns of teenagers are
particularly important to Philip Morris.
- Philip Morris USA, 1981
In the United States, 88% of adults who smoke every day started smoking before the age of 18. Youth
cigarette initiation is a
major concern—indeed, it
is the root of the problem
of smoking-related
mortality in the U.S. and
globally. Starting smoking
at an early age is
associated with longer
duration of smoking and a
higher risk of tobaccorelated disease (Figure
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Figure 3.1 FDA Infographics Show Youth Smoking Is A Major
Concern

3.1). In the U.S., we estimate that 3,600 young people smoke their first cigarette every day.
“Kids who see others smoking are more likely to take up the habit
because they don’t perceive cigarettes as unhealthy.”
- Simon Racicot, Concordia University, U.S., 2011
In this 2011 ABC segment, several teens
are interviewed about why they smoke

Movie 3.1 ABC News: “Quit to Live: Why Teens
Smoke?”

and what it would take to get them to
quit (Movie 3.1).
The U.S. has a number of surveillance
systems that monitor tobacco use
among youth. These include the
Monitoring the Future study sponsored
by the National Institutes of Health
(NIH), the Youth Risk Behavior
Surveillance Survey by the Centers for
Disease Control and Prevention (CDC), and the National Survey on Drug Use and Health sponsored
by the Substance Abuse and Mental Health Services Administration (SAMHSA). These surveillance
systems provide useful data that help to direct national tobacco control efforts.
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Table 3.1 Youth Smoking
Youth smoking is
associated with:

know that certain factors put some youth at an increased risk of
smoking (Table 3.1). Various Surgeon General’s reports have

Low socioeconomic status

documented that youth smoking is associated with having a lower

Use and approval of tobacco
use by peers or siblings

socioeconomic status. Moreover, young people are more likely to

Exposure to smoking in
movies
Lack of skills to resist
influences to tobacco use
Smoking by parents or
guardians and/or lack of
parental support or
involvement
Accessibility, availability and
price of tobacco products
A perception that tobacco
use is the norm
Low levels of academic
achievement
Low self-image or self-esteem
Exposure to tobacco
advertising
Aggressive behavior (e.g.,
fighting, carrying weapons)
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Based on data collected through these surveillance systems, we

smoke if others around them smoke, especially their peers and
siblings. Exposure to tobacco marketing and smoking in movies also
contribute to youth
smoking, as well as
the ready availability
of tobacco products
and the cultural
perception that
tobacco use is the
norm. Youth who
have low self-esteem
or low levels of
academic
achievement are also
more likely to smoke
(Figure 3.2).

Figure 3.2 Peer Pressure as One
Reason for Youth Smoking Initiation

Figure 3.3 Past Month Smokers of One or More Packs of Cigarettes
per Day among Daily Smokers, by Age Group: U.S., 2002-2011

SAMHSA’s National
Survey on Drug Use and
Health provides the data
for Figure 3.3, which
shows the increase in the
number of people who
smoke one or more
packs of cigarettes per
day as people get older.
Cigarette initiation occurs
in youth and the amount
smoked increases
throughout adulthood.
Looking at the data from
2011 as an example, we
see that nearly 15% of
young people (12-17

years old) smoke at least a pack a day, and that this is true for 26% of 18- to 25-year olds and 47% of
people aged 26 or older. This offers a strong indication of the addictiveness of smoking and the
difficulty of quitting once a person starts smoking at a young age.
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Fact:

Key Takeaway

one out of every 13 American children under age 18 alive today (around 5.6

Youth cigarette initiation
is at the root of the
problem of smokingrelated mortality.

Although youth smoking rates in the United States halved during 1997-2011,
million children) will die prematurely from smoking-related diseases unless
current smoking rates further drop.

Dating back to 1976, the Monitoring the Future (MTF) study tracks the use of cigarettes, smokeless
tobacco, and other substances among high school seniors. Using data from MTF, Figure 3.4
demonstrates clearly that

Figure 3.4 Cigarette Use Among High School Seniors, by
Gender

smoking rates among high
school seniors has decreased
substantially since 1976.
Smoking prevalence among
male high school seniors
decreased from around 27%
in 1976 to just over 20% in
2011, and among females
from 33% to 15% in the same
period. Note that in the
1970s, females were more
likely to smoke than males,
and today the opposite is the
case.
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In addition to the change

Figure 3.5 Cigarette Use Among High School Seniors, by
Race

between 1976 and 2011, it is
particularly interesting to note
the rapid increase in smoking
that occurs just after 1990. You
can see that smoking prevalence
increased from under 30% to
nearly 35% between 1990 and
1995. CDC’s Office on Smoking
and Health attributes a large part
of this steep increase to the Joe
Camel advertising campaign,
which used a cool, stylish cartoon
figure that young people found
particularly attractive. Tobacco marketing, with specific reference to the Joe Camel campaign, is
discussed in greater detail in Chapter 7.
Figure 3.5 shows how smoking rates vary by race. Comparing cigarette use among white and AfricanAmerican high school seniors, we see that for the entire period between 1976 and 2011, whites
smoked more than African Americans. This difference becomes particularly pronounced when
considering the intersection of race and gender differences, and female African-American high
school seniors have the lowest smoking rates of these demographic groups.
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Figure 3.6 Prevalence of Cigarette Smoking Among Men, Women,
Boys, and Girls, 1975-2012

Now, let’s compare youth smoking rates, which we’ve just been examining, with smoking rates among
adults. Figure 3.6 overlays adult and teen smoking rates by gender. This allows us to see that in 1974
men had the highest smoking rates and teenage girls the second highest. Over the course of the last
few decades, adult smoking rates have gradually but steadily declined.
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Figure 3.7 Cigarettes and Cigarillos are
Attractive to Youth

In contrast, youth smoking rates appear to be much
more volatile. In the same period, they have
experienced increases and decreases, and these
fluctuations are often a function of marketing and
promotional efforts by the tobacco industry and the
introduction of new products. Even though youth
smoking rates are much lower today than they were a
few decades ago, experience shows that they can
increase again very rapidly. Public health advocates
need to be constantly vigilant about teen smoking
rates because of this demonstrated volatility.

Another source of concern are studies which show that the use of nontraditional tobacco products is
increasing among youth, even though cigarette use is in decline. These nontraditional products
include small cigars and cigarillos, pictured in Figure 3.7, which are experiencing an increase in sales
in the U.S. These products are most commonly used by young adults, a phenomenon at least partly
explained by the fact that although the U.S. Food and Drug Administration has banned flavors in
cigarettes, flavoring is not at all regulated in small cigars and cigarillos. Additionally, these products
can be sold in smaller packages or individually and are taxed at rates lower than cigarettes. Thus,
these products can have chocolate and other candylike flavors, making them more attractive to young
people. As you can see, their packaging also often makes them look more like candy than the deadly
products that they are.

97

Another type of tobacco which is growing in popularity among youth is hookah, also known as
waterpipes or “hubbly bubbly,” pictured in Figure 3.8. A study of 951 adolescents conducted by
researchers at Georgia State University found that 58.5% of adolescents had used hookah, and that
30.2% had used it within 30 days prior to the study. Most hookah users were male, and the most
concerning aspect of the study is the evidence that many of the youth who participated reported dual
use— a term which means that they use cigarettes and another form of tobacco, such as small cigars,
cigarillos or hookah, on the same day. In Chapter 2, we discussed
the Healthy People 2020 goals for tobacco use among adults. This
framework also sets tobacco prevalence goals for youth. The
overall goal is to bring tobacco use of all types down from 26% of
youth (the rate in 2008) to 21% by 2020.
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Figure 3.8 Hookah Smoking
Is Popular Among Youth

Based on the trends shown in Table
3.2, we can hypothesize whether or
not the U.S. will meet the Healthy

Table 3.2 Healthy People 2020 - 2008 Values and 2020
Goals for Tobacco Use Among Adolescents

People 2020 objectives for youth
tobacco use. There has been a
significant decline in the use of all

TU-2 Reduce
tobacco use by
adolescents

As of
2008

2020
Goal

TU-2.1

Reduce use of tobacco
products by adolescents
(past month)

26%

21%

TU-2.2

Reduce use of cigarettes
by adolescents (past
month)

19.5%

16%

TU-2.3

Reduce use of
smokeless tobacco
products by adolescents
(past month)

8.9%

6.9%

TU-2.4

Reduce use of cigars by
adolescents (past
month)

14%

8%

tobacco products in the last two
decades, and we are not too far
from the 2020 goal of 21%
prevalence. For users of cigarettes,
the pattern is similar—a steep
decline, indicating that the 2020
target is within reach. However, we
see a slightly different pattern for
cigars. There is a marked difference
between the trends in cigar use
among adolescents and the 2020
target. Moreover, it must be noted
that although Figure 3.9 makes it
appear that the 2020 goal for
smokeless tobacco product use has
already been met, we must remain
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vigilant as there is increasing emphasis on the marketing of smokeless tobacco products, as well as
other nicotine products that are newly introduced to the market.

Figure 3.9 The Proportion of Students in Grades 9–12 Who Used Tobacco Products in the Past
30 Days Decreased by 46% Between 1997 and 2011
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Chapter 3 - Youth Tobacco Use Behaviors
Section 2 - Global Youth Tobacco Use

Preventing youth tobacco use needs to be a
high priority for all nations. Most adult
smokers started smoking before the age of
18, and we estimate that about a third of
youth who start smoking will eventually die
from the addictive habit of smoking that they
began while young.
So far in this chapter, we’ve discussed some
of the different youth surveillance systems in the United States. To give us important insights into
global youth smoking patterns, we will now look at data from the Global Youth Tobacco Survey (GYTS)
—the world’s leading tobacco surveillance system. GYTS has been conducted since 1998, and is part
of the Global Tobacco Surveillance System (GTSS) operated jointly by WHO, CDC, and a number of
important global partners.
GYTS is one of the largest public health surveillance systems in

Key Takeaway

existence. It has been conducted in 168 WHO member states

Most smokers begin smoking before the
age of 18 and one-third of smokers who
start in their youth will die because of the
habit.

and 15 WHO non-member states, collecting data on millions of
children between the ages of 13 and 15 years and providing
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invaluable information on youth tobacco
use around the world.

Movie 3.2 Hear from the Experts: Samira Asma

Dr. Samira Asma is the Chief of Global
Tobacco Control at the CDC and has
played a lead role in conceptualizing and
implementing the GTSS to monitor and
track tobacco use and key tobacco control
measures among youth and adults. She
provides her expert view on GYTS in
Movie 3.2.
As Dr. Asma mentioned, GYTS is conducted among 13to 15-year olds in school settings. Based on data from
GYTS, we are able to assess which countries have the
highest smoking rates for boys and for girls.
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Key Takeaway
The Global Youth Tobacco Survey (GYTS)
provides invaluable information on youth
tobacco use around the worldwide.

There are 12 countries in which the current smoking prevalence rate for boys is above 30%. Most of
these are middle-income countries, many of them in Eastern Europe or in the Western Pacific region
(Table 3.3).
There are 12 countries in which the current smoking prevalence for girls is above 25%. All of these are
middle- and high-income countries (Table 3.4).
In the previous chapter, we learned that gender is an important factor in global smoking rates among
adults. Gender differences between adult males and adult females are fairly significant with males
smoking more. In fact, there are nearly 50 countries in which men smoke ten times as much as women
do.
For teens, gender differences do not appear to be as important. In other words, we see similar rates
among boys and girls in different regions of the world.
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Table 3.3 Countries in Which the Current
Smoking Prevalence for Boys is Above 30%

104

Country

WHO
Region

World
Bank
Income
Group

Papua New
Guinea

WPRO

Middle

Boys'
Current
Cigarette
Use
52.1%

Table 3.4 Countries in Which the Current
Smoking Prevalence for Girls is Above 25%
Country

WHO
Region

World
Bank
Income
Group

Girls'
Current
Cigarette
Use

Chile

AMRO

Middle

39.9%

Papua New
Guinea

WPRO

Middle

35.8%

EURO

High

32.7%

Timor–
Leste

SEARO

Tonga

WPRO

Middle

37.5%

Czech
Republic

Micronesia

WPRO

Middle

36.9%

Bulgaria

EURO

Middle

31.6%

Latvia

EURO

Middle

36.3%

Colombia

AMRO

Middle

30.7%

Malaysia

WPRO

Middle

36.3%

Latvia

EURO

Middle

30.2%

Switzerland

EURO

High

35.7%

Switzerland

EURO

High

29.6%

Lithuania

EURO

Middle

33.8%

Argentina

AMRO

Middle

27.3%

Tuvalu

WPRO

Middle

33.2%

Mexico

AMRO

Middle

27.1%

Belarus

EURO

Middle

31.2%

Estonia

EURO

High

26.2%

Palau

WPRO

Middle

31%

Lithuania

EURO

Middle

25.9%

Madagascar

AFRO

Low

30.7%

Croatia

EURO

High

25.6%

Middle

50.6%

Table 3.5 shows the similarity in boys’ and girls’ smoking rates in a number of countries. Of particular
interest in this table are places in which substantially more girls smoke than boys, indicating a likely
increase in adult female smokers globally in the coming years.
Besides being implemented in 168
countries, the GYTS has the important
feature of being used repeatedly in 124

Country

Region

Girls (%)

Boys (%)

Difference

Chile
(Santiago)

PAHO

39.9

28

11.9

over time, looking at both cigarette use

Sweden

EURO

13

5

8

as well as the use of other tobacco

Slovenia

EURO

23

15.2

7.8

Bulgaria

EURO

31.6

24.4

7.2

Uruguay

PAHO

22.9

16.4

6.5

Argentina

PAHO

27.3

21.1

6.2

New
Zealand

WPRO

20.6

14.5

6.1

Cuba

PAHO

13.1

8.7

4.4

Brazil
(Sao Paulo)

PAHO

13.2

9.2

4

of those countries. This allows us to
track changes in youth tobacco use

products.
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Table 3.5 Countries Where More Girls Than Boys
Smoke

Let’s take a look at some case studies
to see how GYTS can provide a picture
of what’s happening over time in
countries around the world. Table 3.6
shows data from South Africa, where
GYTS has been administered four
different times between 1999 and
2011. There has been a regular and
sustained reduction in teen smoking

Table 3.6 Percentage of Students Who Smoked
Cigarettes on At Least 1 Day During the Month
Preceding the Survey: South Africa - National (GYTS)
Year

Total

Boy

Girl

1999

17.6%

20%

15.3%

2002

14.8%

21%

10.6%

2008

13.6%

17.9%

10.6%

2011

12.7%

15%

10.8%

rates, from 17.6% overall in 1999 to
12.7% in 2011. Looking at these rates by gender, it is evident that there have been substantial drops
for both boys and girls; however, it is concerning to see that the drop in girls’ cigarette smoking rates
has appeared to subside since 2002, with rates remaining just above 10% for the last ten years.
Table 3.7 gives us a peek into Lebanon,
in the Eastern Mediterranean region of
WHO. Lebanon administered the GYTS
three times between 2001 and 2011,
and we can see an increase in cigarette
smoking during that period—up from
7.5% at the time of the first survey to
11.3% after ten years. This increase is
primarily seen among boys, while the
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Table 3.7 Percentage of Students Who Smoked
Cigarettes on At Least 1 Day During the Month
Preceding the Survey: Lebanon - National (GYTS)
Year

Total

Boy

Girl

2001

7.5%

10.4%

5.3%

2005

8.6%

11.8%

5.6%

2011

11.3%

17.7%

6%

prevalence for girls has remained quite steady between 5% and 6%.
This data from GYTS points out the inadequacy of tobacco control efforts, particularly the partial
tobacco legislation put into effect in Lebanon in 1996. To address the evident need for further action,
Lebanon passed a comprehensive tobacco law in 2011, making it a completely smoke-free country.
The new law includes a
comprehensive advertising ban
and mandates that health
warnings cover 40% of both the
front and the back of cigarette
packs. Continued surveillance will
allow us to see the impact of this
law on reducing tobacco use,
particularly among boys.
In the Czech Republic, part of the
European region of WHO, the
GYTS results shown in Figure 3.10
are somewhat mixed and not very
encouraging. Between 2002 and
2011, there is a very modest
reduction in overall smoking
among 13- to 15-year olds, and
the Czech Republic still has the
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Figure 3.10 Currently Smoked Cigarettes: Czech Republic National (GYTS)

Table 3.8 GYTS: Case Study:
Argentina (AMRO)
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third highest smoking prevalence among the European
countries that administered the survey. Of great concern is
the fact that boys and girls smoke at very similar rates;

Country
Name

Year

Indicator

Argentina

2007

24.5

smokers. Not presented here, but also of great concern, is a

Uruguay

2007

20.2

dramatic increase in the use of other forms of tobacco

Jamaica

2010

17.8

among youth, rising from 8.5% in 2002 to 17.3% in 2011.

Peru

2007

15.7

Effective tobacco control interventions are clearly needed to

Mexico

2011

14.6

counter the tobacco use occurring in the Czech Republic.

Saint
Vincent
and the
Grenadines

2011

Suriname

2009

12.1

Dominican
Republic

2009

11.6

Barbados

2007

11.6

Guatemala

2008

11.4

Saint Lucia

2011

10.7

Cuba

2010

10.6

12.8

approximately one third of both boys and girls are current

From the WHO region of the Americas, let’s take Argentina
as a sample case study, illustrated in Table 3.8. Argentina
has the highest teen smoking rate of any of the countries in
this region at 24.5%. GYTS has been administered only once
in this country, in 2007, and since then Argentina has passed
comprehensive tobacco control legislation. Ongoing GYTS
administration will allow us to measure the effect of this
legislation on youth tobacco use.

In the Southeast Asian region of WHO, Sri Lanka
provides an interesting case study, shown in
Table 3.9. Sri Lanka’s cigarette smoking
prevalence is the lowest in Southeast Asia at
1.5%. However, we see high rates of use of other
tobacco products; GYTS data from 1999 to 2011
shows an increase in the use of tobacco
products other than cigarettes from 7.2% to
10%. This rise occurs mostly among boys, for
whom rates went up from 9.2% to 14.6%. The
changes among girls were minimal in this
period.
For our final case study, Figure 3.11 represents
the Philippines in the Western Pacific region of
WHO. Once again, we have a country in which
the GYTS has been administered four times,
between 2000 and 2011. Here, we see dramatic
reductions in cigarette smoking, going from
18.2% in 2000 to 8.9% in 2011. In other words,
cigarette smoking prevalence among youth
halved in a period of 11 years. This decrease can
be seen among both boys and girls.
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Table 3.9 GYTS Case Study: Sri Lanka
(SEARO) - Percentage of Students Who Used
Tobacco Products Other than Cigarettes on
At Least 1 Day During the Month Preceding
the Survey
Year

Total

Boy

Girl

1999

7.2%

9.2%

5%

2003

7%

5.8%

7.9%

2007

8.6%

11.6%

5.6%

2011

10%

14.6%

5.4%

Figure 3.11 GYTS Case Study: Philippines
(WPRO)

Following the 2000 GYTS, the Philippines identified the need for stricter tobacco regulations and
passed the Tobacco Regulation Act of 2003. Figure 3.12 shows the impressive results of strict tobacco
control and demonstrates the dramatic decline in individuals being offered free cigarettes following
tobacco regulations in the Philippines.
This is one example of how GYTS provides invaluable data to help us further understand why people
begin to use tobacco products and why they quit. These data provide information needed to evaluate
and justify the continuation of tobacco control efforts in countries like the Philippines.
To conclude our discussion of global youth tobacco use, let’s see how youth smoking prevalence
rates compare with adult rates. Table 3.10
shows smoking prevalence for youth and
adults by WHO region. The first row displays
prevalence rates for the WHO regional
office in Africa: 13% for boys, 5.8% for girls.
The ratio between boys and girls is 2.2:1,
which means that boys smoke more than
twice as much as girls smoke in this region.
Looking at adult rates, we see that 20.8% of
males smoke, versus only 3.6% of females.
The ratio between males and females is
5.8:1—that is to say, men smoke almost six
times as much as women.
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Figure 3.12 Ever Offered a Free Cigarette by a
Tobacco Company Representative: Philippines National (GYTS)

Table 3.10 Cigarette Smoking Prevalence in WHO Regions

This pattern, showing similar rates for boys and girls and quite different rates between men and
women, is common to all of the WHO regions. Looking at the totals on the bottom row of this table,
you can see that the overall smoking ratio between boys and girls is 1.6:1, indicating that boys are
only somewhat more likely to smoke than girls. In contrast, the ratio between adult male and female
smokers is 4.4:1, suggesting that men are four times more likely to smoke than women.
It is concerning to see the parity between boy and girl smoking rates, as it could be a sign of what will
occur in the future. If girls continue to smoke at rates similar to boys, we may be looking at increasing
prevalence rates among adult women in the coming years, which could result in an even greater
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burden of tobacco-related disease in the future. While it is impossible to

Key Takeaway

make a prediction based on current data, it is important to continue to

If girls continue to smoke at
rates similar to boys, we may
be looking at increasing
prevalence rates among adult
women in the coming years,
which could result in an even
greater burden of tobaccorelated disease in the future.

monitor global smoking rates and use the data we have to put
appropriate interventions into place.

Chapter 3 Discussion Questions:
1. Are U.S. governments and civil society doing enough to regulate cigarettes and new innovative
tobacco products targeted to youth? What steps should they take to aggressively protect the
young in the future?
2. Global Youth Tobacco Surveys are conducted in school settings. Would the survey results be
different if taken at home or other settings? Why or why not?
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Chapter 4

Novel Nicotine Products
and Harm Reduction

Chapter Objectives
1. Recognize the importance of nicotine in tobacco.
2. Discuss historical attempts by cigarette companies to
produce a “safer cigarette.”
3. Examine the marketing of “light” cigarettes by tobacco
companies and how it deceived users.
4. Contrast the first novel nicotine products and today’s
products.
5. Analyze the concept of harm reduction from a public health
perspective.

Chapter 4 - Novel Nicotine Products and Harm Reduction
Section 1 - It’s All About Nicotine

"[N]icotine is addictive. We are, then, in the business of selling nicotine,
an addictive drug effective in the release of stress mechanisms."
- Addison Yeaman, General Counsel/Vice President, Brown & Williamson (a
subsidiary of British American Tobacco), 1963

In order to fully understand the global problem of tobacco use, we must recognize the importance of
nicotine and its impact on public health.
Nicotine is an extremely addictive nitrogen-containing alkaloid that occurs naturally in plants, but can
also be produced synthetically (Figure 4.1). Nicotine is
considered a stimulant. Consuming this chemical can
help people feel more relaxed; it brings feelings of
pleasure and reduces feelings of stress, anger and
depression.
The most efficient way of delivering nicotine to the
brain is through inhalation into the lungs— the chemical
reaches the brain within seven seconds of inhalation. So
far, this has typically meant burning tobacco and
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Figure 4.1 Nicotine Chemical
Compound

inhaling the nicotine that is contained in

Figure 4.2 Nicotine Occurs Naturally in Tobacco Plants

tobacco smoke. This process, called
combustion, is also the most harmful way
of consuming nicotine because of the tars
and toxins in smoke. As Professor Michael
Russell wrote in the British Medical
Journal, “People smoke for the nicotine
but they die from the tar.”
Nicotine is key to the very existence and
viability of the tobacco industry (Figure
4.2). Tobacco companies have been
aware of the importance of nicotine for a long time,
and as much as possible they emphasize the
pleasurable effects of the chemical. Sir Charles Ellis, a

Key Takeaway
Nicotine is highly addictive. The most
efficient way of delivering nicotine to the
brain is through inhalation.

tobacco industry scientist, asserts in a 1962 statement,
“It is my conviction that nicotine is a very remarkable beneficent drug that both helps the body to
resist external stress and also can as a result show a pronounced tranquilizing effect.”
As you can see from the statement in Figure 4.3, the tobacco industry has promoted the
psychological benefits of nicotine for decades, while obfuscating its highly addictive properties. They
also understate the problems inherent in the act of smoking, which is still considered the optimal way
of delivering this so-called “beneficent” drug to the body.
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Figure 4.3 1962 Statement on Nicotine by Sir Charles Ellis, a
tobacco industry scientist

Today, tobacco companies still focus on the pleasurable and tranquilizing effects of nicotine while
downplaying the harmful effects of smoke. In 2013, David O’Reilly, the Scientific Director for British
American Tobacco, claimed:
The world would be a poorer place without nicotine. It has helped
people through world wars, the stress of everyday life, and it is helpful for
people suffering from Parkinson’s and dementia. It’s a wonderful drug
but it’s only in the last few years that it has been used in a dangerous
way.
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Certainly, the tobacco industry’s attitude toward nicotine has changed very little in the last fifty years.
Nicotine is still the drug of choice for tobacco companies. In fact, the tobacco industry has made
alterations to cigarettes in order to facilitate the absorption of nicotine into the body. As we just
learned, smoking is the optimal way of delivering nicotine to the bloodstream and then to the brain;
however, as you might imagine, inhaling smoke is not a natural act and it can feel irritating to the
bronchial passages when a person tries smoking for the first time. Tobacco companies realized that
they could manipulate the smoke from cigarettes to make it easier to inhale, for example by adding
ammonia to cigarettes during the manufacturing process. Ammonia, the same chemical found in
many commercial cleaning products like bleach, alters the pH levels of smoke, making it “smoother”
and easier to inhale, thus helping the absorption of nicotine into the bloodstream to occur more
rapidly. The more nicotine a smoker inhales, the more quickly he or she can become addicted to
cigarettes.
By now, we know about the harms of smoke—but is nicotine by itself harmful or benign? Besides its
addictive properties, nicotine has been shown to have adverse effects on the nervous system and the
heart. It can cause decreased appetite, mood elevation, increased heart rate, increased blood
pressure, nausea and diarrhea.
Nicotine is often compared with caffeine, and both are widely considered to be benign drugs.
However, studies show that nicotine is much more likely to cause dependence (i.e., is more addictive),
has been shown in animal models to help cancer tumors to grow, and is considered lethal at a much
smaller dose than caffeine (Table 4.1).
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Table 4.1 Comparing the Effects of Nicotine and Caffeine
Topic

Nicotine

Caffeine

Withdrawal Symptoms

Nicotine withdrawal caused a
more intensive degree of
irritability, restlessness and
difficulty concentrating compared
with caffeine.

In groups that had used caffeine,
alcohol, and nicotine in the past
year, 28% showed dependence to
caffeine, compared to 50% to
alcohol, and 80% to nicotine.

Psychological Effect

Nicotine produces a
psychoactive, stimulant effect.
Nicotine increases the speed of
sensory information processing,
and induces a feeling of
relaxation and reduced stress.

Caffeine is a stimulant. It induces
alertness, elevates mood,
facilitates thinking, and increases
feelings of motivation.

Possible Effects on Cancer

In cell and animal studies,
nicotine helps cancer grow and
spread and may inhibit
chemotherapy.

In cell and animal studies,
caffeine prevents some events
that may help cancer grow.

Lethal Dose

50-60 mg

10 grams

In so far as nicotine addiction is commonly associated with smoking, it has deadly consequences.
Thanks in large part to tobacco control measures that have been put in place since the first U.S.
Surgeon General’s Report was released in 1964, the dangers of having a nicotine addiction are much
more widely known. Unfortunately, the knowledge that cigarette use results in death for one half of its
lifetime users has prompted tobacco companies to direct their efforts not to stopping the
manufacture and sale of these deadly products, but rather to developing new products that are either
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potentially less harmful (but harmful still), or that appear to be less harmful. In the following sections,
we examine the wide variety of these alternative products in greater depth. These products are often
referred to as novel nicotine products or electronic nicotine delivery systems (ENDS), alternative
nicotine delivery systems (ANDS) or potentially reduced exposure products (PREPs), and we will use
these terms interchangeably.
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Chapter 4 - Novel Nicotine Products and Harm Reduction
Section 2 - Tobacco Companies Respond to Smoking’s Harm

Cigarettes are on the decline in the United States. The dangers of cigarette smoking have been
apparent since the 1950s, and tobacco companies have recognized for a long time that they need to
develop new ways of providing nicotine to their customers.
When articles began to be published in the 1950s linking smoking with lung cancer, the major
tobacco companies in the U.S. banded together and made a concerted effort to devise a strategy to
continue to sell their product. In December 1953, a number of tobacco executives met at the Plaza
Hotel in New York City to find a way to deal with emerging scientific data confirming the hazards of
smoking. They needed a strategy that would allow them to preserve their customer base as well as
their public image.
They considered two different approaches. One approach was to be candid about what they knew
about the harms of smoking and to make the commitment to reduce these harms by whatever means
necessary. The second approach was to deny the scientific evidence showing that smoking was
harmful and to pursue a concentrated public relations campaign through which they would reassure
the American public that smoking was not a problem.
They chose the second approach and in 1954, the “Frank Statement to Cigarette Smokers” was
published in over 400 newspapers in the U.S. (also Chapter 1: Harm from Tobacco Use and
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Secondhand Smoke). In their statement, the tobacco companies

Key Takeaway

assured Americans, “We believe the products we make are not

Starting in the 1950’s, tobacco companies
responded to the mounting evidence
about the harms of smoking by
developing novel nicotine products that
were less harmful (but harmful still) or
that appeared to be less harmful.

injurious to health.” They dismissed the science that had been
conducted on cigarette smoking so far, and they also promised
to “cooperate closely with those whose task it is to safeguard the
public health.”

However, evidence continued to mount on the causal

Figure 4.4 The Kent Micronite
Filter, made with asbestos, was
advertised as “the greatest
health protection in cigarette
history”

relationship of smoking and lung cancer, and the tobacco
industry knew it had to respond with products that were safer
or at least appeared to be safer. Their first effort in this regard
was the addition of filters to cigarettes in the 1950s (Figure
4.4). The industry claimed that filters removed the tar
resulting from combustion, and thus made cigarettes safer to
smoke. One kind that became widely used was the Kent
Micronite filter, advertised as “the greatest health protection
in cigarette history.” As it turns out, the primary ingredient in
these filters was asbestos, so now smokers were inhaling
deadly asbestos in addition to the thousands of chemicals in
smoke (Figure 4.5).
Among the worst examples of the tobacco industry’s
response to the known harms of smoking were so-called
light cigarettes, introduced in the 1970s and still marketed to
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Figure 4.5 Example of Cigarette Advertisements Promoting
Health Protection

Key Takeaway
Most smokers believe that so-called
light cigarettes are safer, but lights
contain just as much tar and nicotine
as regular full-flavored cigarettes.

this day. Smokers, particularly
women, had become
increasingly concerned about
the risks associated with
smoking. Tobacco companies
sought to develop a product
that would be seen as less
harmful. They figured out that
they could modify the tar and
nicotine levels that the Federal Trade Commission (FTC) required to be reported for each brand of
cigarettes. The level of tar and nicotine that is displayed on all cigarette packs is measured by
cigarette-smoking machines that have standardized protocols around frequency of breathing and
depth of inhalation. Tobacco companies realized that by putting ventilation holes in the filter of the
cigarettes, they could make it look like the tar and nicotine levels were lower than what they were in
reality.
Theoretically, the small holes in the filter would dilute the smoke with clean air, thus resulting in a
lower concentration of smoke being inhaled by the smoker. The holes in light cigarettes are located
on the filter in front of where the cigarette would be attached to the smoking machine, so they
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register as having lower tar and nicotine yields than regular cigarettes. However, when a person
smokes a so-called light cigarette, without being conscious of it, he or she actually compensates for
these ventilation holes by holding the fingers or lips over the holes while inhaling. Often, smokers also
subconsciously inhale more frequently or more deeply in order to receive more nicotine. Thus, while
the smoke from a light cigarette is diluted when measured by a smoking machine, when people
smoke it they get just as much tar and nicotine as they would out of a full-flavored cigarette.
Unfortunately, however, because of the way light cigarettes are advertised by the tobacco companies,
most smokers believe that they are safer than regular cigarettes.
Products such as light cigarettes (and others

Figure 4.6 Advertisements For So-Called
Light Cigarettes Were Geared Towards
Assuaging Smokers’ Guilt for Continuing to
Smoke

we discuss subsequently) are sometimes
referred to as potential reduced exposure
products, or PREPs (Figure 4.6). In the 1970s,
as the dangers of smoking became more
widely known, many smokers switched to
lights rather than quit smoking altogether.
Light cigarettes were a way for tobacco
companies to provide health reassurance to
concerned smokers so that they would not
lose their market share. Their intent was to
assuage the guilt of smokers for continuing
to smoke, even though the tobacco
companies knew that the products were
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Figure 4.7 Proposed Corrective Statements for Addictiveness of Smoking and Nicotine
A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and
Altria deliberately deceived the American public about the addictiveness of smoking and
nicotine, and has ordered those companies to make this statement. Here is the truth:
• Smoking is highly addictive. Nicotine is the addictive drug in tobacco.
• Cigarette companies intentionally designed cigarettes with enough nicotine to create
and sustain addiction.
• It's not easy to quit.
• When you smoke, the nicotine actually changes the brain - that's why quitting is so
hard.

harmful. Lights were targeted especially to women, the market segment that was most concerned
about the negative health consequences of smoking.
Fast forward to 2006 and, based on the judicial findings of Judge Gladys Kessler, tobacco companies
are now required to make a series of corrective statements to compensate for deceiving the American
public. These statements are based on a review of scientific evidence and internal documents from
the tobacco industry (Figure 4.7). As we mentioned in Chapter 1, these corrective statements are still
pending based on the outcome of litigation by tobacco companies. Among these, there are
corrective statements that specifically address the false marketing of low-tar and light cigarettes
(Figure 4.8).
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Judge Kessler also weighed in on cigarette design and how these products were made to optimize
nicotine delivery with the intention of making them more addictive (Figure 4.9). She is requiring
tobacco companies to state at point of purchase, on television and the Internet, and in newspapers
and magazines that cigarettes are designed to addict people and keep them addicted. It is hoped
that these legal judicial statements based on scientific evidence will become public.

Figure 4.8 Proposed Corrective Statements About Lack of Significant Health Benefit from
Smoking “Low Tar,” “Light,” “Ultra Light,” “Mild,” and “Natural” Cigarettes
A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria
deliberately deceived the American public by falsely selling and advertising low tar and light
cigarettes as less harmful than regular cigarettes, and has ordered those companies to make this
statement. Here is the truth:
• Many smokers switch to low tar and light cigarettes rather than quitting because they think
low tar and light cigarettes are less harmful. They are not.
• “Low tar” and filtered cigarette smokers inhale essentially the same amount of tar and
nicotine as they would from regular cigarettes.
• All cigarettes cause cancer, lung disease, heart attacks, and premature death - lights, low tar,
ultra lights, and naturals. There is no safe cigarette.
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Figure 4.9 Proposed Corrective Statements for Manipulation of Cigarette Design and
Composition to Ensure Optimum Nicotine Delivery

A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria
deliberately deceived the American public about designing cigarettes to enhance the delivery of
nicotine, and has ordered those companies to make this statement. Here is the truth:
• Philip Morris USA, R.J. Reynolds Tobacco, Lorillard, and Altria intentionally designed
cigarettes to make them more addictive.
• Cigarette companies control the impact and delivery of nicotine in many ways, including
designing filters and selecting cigarette paper to maximize the ingestion of nicotine, adding
ammonia to make the cigarette taste less harsh, and controlling the physical and chemical
make-up of the tobacco blend.
• When you smoke, the nicotine actually changes the brain - that’s why quitting is so hard.
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Chapter 4 - Novel Nicotine Products and Harm Reduction
Section 3 - Novel Nicotine Products and Harm Reduction: A Cloud
of Controversy
As we have seen, tobacco companies have sought different strategies to continue selling their
products even as more and more evidence about the harms of smoking was brought to light. As the
public became increasingly aware that cigarettes were deadly and addictive, tobacco companies
began to develop alternatives that would at least appear to be safer or less harmful, so as to assuage
smokers’ guilt and make them less likely to quit.
The tobacco industry also developed innovative products, some of which did not involve
combustion. Over the last twenty years, there has been substantial effort to introduce electronic
cigarettes and other devices that heat either tobacco or liquid nicotine, but do not burn tobacco in
the traditional sense. Early versions of these products—Accord, Premier, and Eclipse—were marketed
as alternatives to cigarettes providing decreased toxin exposure. Hundreds of millions of dollars were
invested in these products over the years, but they were unable to capture a significant market share
until quite recently. For the remainder of this chapter, we will examine these alternative products in
greater depth.
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As you learn about the evolution of electronic cigarettes and their explosion into the market in the
last few years, it is helpful to keep in mind the words of Claude Teague, Jr., a scientist for Philip
Morris (1972):
The tobacco industry may be thought of as being a specialized, highly
ritualized and stylized segment of the pharmaceutical industry. Tobacco
products uniquely contain and deliver nicotine, a potent drug with a
variety of physiological effects.
All of the efforts invested by the tobacco companies toward developing cigarette alternatives reflect
their desire to continue to provide nicotine efficiently and, often, in a manner that maintains addiction.
An important precursor to today’s electronic cigarette was Eclipse, developed by R.J. Reynolds
Tobacco Company and first
tested with consumers in
1994. Dubbed a “nicotine
delivery system,” Eclipse
had a reservoir in which
shredded tobacco paper
was heated to emit nicotine
vapor (Figure 4.10). The
product was advertised in
such a way as to suggest a
lower risk of cancer
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Figure 4.10 Eclipse - One of the First Electronic Cigarettes

compared to traditional cigarettes, as well as producing less inflammation in the respiratory system,
which implies a lower risk of chronic bronchitis as well as emphysema. It also purported to reduce
secondhand smoke by 80%.
One of the first electronic cigarettes to hit the market, Eclipse ultimately failed to garner much market
share. Today, the picture looks very different for the PREPs market. Tobacco companies now admit that
smoking is risky (Figure 4.11 and Figure 4.12). Alongside these disclosures, the tobacco companies
have embraced PREPs into their product lines and invested hundreds of millions of dollars in creating
new products.

Figure 4.11 Health Warnings From R.J. Reynolds Tobacco Company
As stated on the R.J.R. website, “Cigarette smoking significantly increases the risk of developing lung cancer,
heart disease, chronic bronchitis, emphysema and other serious diseases and adverse health conditions.”

Figure 4.12 JTI Statement on Cigarettes
As stated on the JTI website, “JTI recognizes that cigarettes are a legal but controversial product. People
smoke for pleasure but there are real risks that come with that pleasure. Accordingly JTI believes that tobacco
products should be appropriately regulated.”

Following, we will review some of the novel products that have been developed over the last few
years. One of the early offerings was Ariva (Figure 4.13), a small dissolvable tablet containing 1.5 mg
of nicotine that came out in 2001. It was marketed as a product that could be used when a person
couldn’t smoke. That is, rather than being a quit aid, these tablets were presented as an alternative for
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situations in which
smoking was not allowed.

Figure 4.13 Ariva (Dissolvable Nicotine Tablet) Advertised for Use
When Unable to Smoke

When Ariva was released,
people responded to the
novelty of the product and
were curious about it, but
there was strong concern
about using these
products since they were
unregulated by the FDA.
Alternately, there are
pharmaceuticals, such as
nicotine replacement therapy patches and gums, that have met FDA standards and are proven to
help people quit.
A wide variety of products have entered the market to provide nicotine in non-combustible forms.
Snus is a product originating from Sweden that provides tobacco in a small sachet placed in the
mouth so that nicotine can be absorbed (Figure 4.14). There are sticks that resemble toothpicks, strips
that dissolve when placed on the tongue, and “orbs” which look like small candies; all of these
products deliver nicotine without burning tobacco and purport to have fewer toxins.
Corresponding to increasing regulations prohibiting smoking in public places, the marketing for
these products has also increased and is completely unregulated. They are marketed as alternatives
that can be used in places such as offices and restaurants where smoking is not allowed. As such, they
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lead to many public health concerns, including dual use (using them in addition to cigarette-smoking,
resulting in addiction to higher levels of nicotine) as well as possibly delaying cessation. Moreover,
because these products are often offered in a variety of candy-like flavors and packaged in ways that
attract young people, there are concerns around youth initiation to nicotine products that could
subsequently lead to cigarette smoking.
While the products we’ve looked at so far—Snus, orbs, strips, and sticks—do provide nicotine without
the harmful smoke, it is important to note that there are ways of obtaining nicotine that have secured
approval from the Food and Drug Administration (FDA) while these products have not. Nicotine
replacement therapy (NRT), in the form of gum and patches, has been provided by pharmaceutical
companies since the 1970s in the U.S. Originally sold by prescription only, they are now generally
available over the counter. NRT undergoes rigorous pre-market

Figure 4.14 Camel Snus
Originates from Sweden

approval to ensure the safety and efficacy of the product, and
they are proven to be effective in helping people to quit smoking.
NRT use has been shown to increase the chances of smoking
cessation. In this way, they are different from PREPs; the
manufacturers of PREPs are not permitted to make claims about
aiding in smoking cessation because they have not been
scientifically proven to do so.
Table 4.2 outlines the different methods available for obtaining
nicotine. We can compare these examples of the major sources of
nicotine and determine the level of nicotine in each source. Most
of the products listed here are currently unregulated by the FDA.
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Key Takeaway
Nicotine replacement therapy (NRT)
products undergo a rigorous pre-market
approval process with the FDA before
they can be sold. In contrast, potential
reduced exposure products (PREPs) are
sold without FDA approval and have not
been proven to aid in smoking cessation.

As you can see, nicotine levels vary by product type and
exposure to nicotine is based on how each product is used as
well as the frequency of use. As consumers of nicotine make
decisions about which products to use, they should consider
the risks associated with each kind and whether they are
regulated or unregulated.

In the past, we at R&D [research and development] have said that we're
not in the cigarette business, we're in the smoke business. It might be
more pointed to observe that the cigarette is the vehicle of smoke,
smoke is the vehicle of nicotine and nicotine is the agent of a
pleasurable body response.
-- William Dunn, VP of Research and Development, Philip Morris, 1969

By now, you’ve heard about electronic cigarettes, or e-cigarettes, and have likely even seen
advertisements for them on television or on the Internet. E-cigarettes and vaping products are
currently the most popular novel nicotine product on the market.
Typically, a traditional e-cigarette has a cartridge containing liquid nicotine and flavorings, illustrated
in Figure 4.15. The cartridge is heated by a battery to create vapor that is then inhaled. It is important
to fully understand why the introduction of e-cigarettes has been so significant—and a lot of it has to
do with smoke. Even in 1969, Philip Morris was aware of the importance of nicotine and understood
that smoke was the most efficient way to deliver nicotine to the body. But, as we have seen, smoke is
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the agent that results in the enormous burden of disease suffered by smokers. If there is a way to get
rid of the smoke, nicotine can be received by the body in a less harmful way.

Table 4.2 Comparing Nicotine Exposure By Product Type
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Product

Amount of Nicotine per
Unit

Daily Usage
(Example)

Daily Nicotine
Exposure (Example)

Cigarettes
Ex. Marlboro Red

1.2 mg per cigarette

1 pack (20 cigarettes)

24 mg

E-Cigarettes
Ex. blu disposables

24 mg per disposable
e-cigarette

1 disposable e-cigarette

24 mg

Smokeless Tobacco
Ex. Copenhagen Original
Long Cut

13.9 mg per gram

Half can (17 g)

236.3 mg

Snus
Ex. General Classic (0.9 g
pouches)

7.2 mg per pouch

12 pouches

86.4 mg

Dissolvables
Ex. Camel Orbs

1.0 mg per orb

1 package (12 orbs)

12 mg

Nicotine Replacement
Therapy - Patch
Ex. Nicoderm CQ

7, 14, 21 mg doses

1 patch per day

7-21 mg

Nicotine Replacement
Therapy – Gum
Ex. Nicorette Gum

2, 4 mg doses

9 pieces per day

18-36 mg

The question that we need to ask as we go forward in this discussion is the following: Are e-cigarettes
an effective and safe way of delivering nicotine? In the U.S., current estimates value the e-cigarette
and vaping industry at a few billion dollars. In comparison, the cigarette market is estimated at around
$75 billion in the U.S. and $500 billion globally. Thus, the market for e-cigarettes, while significant, is
still small compared to traditional cigarettes. It is, however, growing very rapidly at a time when
traditional cigarette sales are declining in many countries. Responding to this trend, all major tobacco
companies have now invested in the e-cigarette business.
Projections of how the e-cigarette market will look in the future are widely varied. Some suggest that
e-cigarettes will overtake the sale of traditional combusted cigarettes within a decade. Others
estimate that by 2050, e-cigarettes will be worth approximately 4% of the total value of all tobacco
products (including cigarettes and other tobacco products).
While these predictions paint very different possible scenarios, it is certainly the case that e-cigarettes
have penetrated contemporary culture very rapidly. As you can see in Table 4.3, awareness of ecigarettes among adults in the U.S. has increased from 16.4% in 2009 to 87.7% in 2015. At the same
time, awareness of other
products, such as Snus and
dissolvables, grew at a
considerably smaller rate. It
appears that e-cigarettes have
changed the market dynamics in
tobacco alternatives in terms of
popularity and awareness.
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Figure 4.15 How an E-Cigarette Works

Similarly, looking at the percentage of adults in the U.S. who have ever tried e-cigarettes, you can see
in Table 4.4 that less than 1% had tried them in 2009 and by 2015 over 17% had tried them, a
substantial increase for a consumer product over a relatively short period. Simultaneously, there is a
slight decline in the proportion of the population that have tried Snus and a very small percent of the
population have tired dissolvables.
A survey conducted on a nationally representative sample of adults in the U.S. has shown that 38% of
smokers have tried an alternative nicotine product, the most common of these being e-cigarettes.
Individuals thinking about quitting were significantly more likely to have tried one of these
alternatives. As of today, however, there is only limited evidence that the use of these products
increases success in quitting, and there are several population-level concerns around their use and
policy (Table 4.5). Specifically, we must have more scientific research to determine if e-cigarettes are
effective in helping smokers quit smoking, being used by youth, create situations of dual use,

Table 4.3 Awareness of Novel Nicotine Products Among U.S. Adults, 2009-2015
Awareness of
Product

2009

2010

2011

2012

2014

2015

Electronic
Cigarette

16.4%

39.7%

57.9%

67.2%

91.9%

87.7%

Snus

44.2%

33.3%

59.7%

10.4%

7.0%

40.6%

Dissolvables
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promote the return to smoking among former smokers, contribute to the renormalization of smoking,
and results in increased nicotine poisoning or other drug use.
Recent surveys have also examined novel nicotine product use globally. In 2010 and 2011, the
International Tobacco Control Four-Country Survey collected data on users of Electronic Nicotine
Delivery Systems (ENDS) in the U.S., U.K., Canada and Australia and found data that were similar to
those reported above for the U.S. According to the survey, 46% of respondents were aware of ENDS
and 7.6% had tried them. Of those who used ENDS, 79.8% perceived them as less harmful than
regular cigarettes, 75.4% used them to reduce cigarette smoking, and 85.1% used them as a means
to try to quit.

Table 4.4 Proportion of U.S. Adults Who Have Ever Tried Novel Products, 2009-2015
Ever Use of
Product

2009

2010

2011

2012

2014

2015

Electronic
Cigarette

0.6%

2.7%

6.2%

8.1%

14.9%

17.1%

Snus

5.4%

4.6%

4.0%

0.5%

0.5%

1.1%

Dissolvables

While there is much enthusiasm about the potential of e-cigarettes to possibly reduce the burden of
disease caused by smoking, there is also great uncertainty as to whether and how people’s smoking
behaviors will really change as a result of these relatively new devices.
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Governments should consider regulating e-cigs as drug delivery devices, or even as drugs (like
nicotine replacement therapy), to allow for possible future health claims. There should be appropriate
regulation to have the optimal public health benefits, if any for these products. Regulation should

Movie 4.1 E-Cigarette Advertisements
Commonly Use Celebrity Spokespeople

allow for them to be used if they are shown to be
beneficial to public health.
In May 2016, the FDA deemed their existing authority
over a variety of novel tobacco products, including ecigarettes, hookah, little cigars, cigarillos, and
premium cigars. The significance of the 2016
regulation is that it gives FDA the authority to
regulate these products, which only previously existed

for traditional cigarettes and smokeless tobacco. FDA now has the authority to regulate these
products in the future, which could include advertising and marketing (including use of ads on TV),
and limiting flavors. While these types of regulations may be established in the future, they were not
part of the May 2016 deeming ruling. Instead, the 2016 deeming ruling set the minimum age of
purchase at 18, required health warnings on packaging, and established a number of reporting and
registration requirements.
While bans on advertising for traditional cigarettes have existed for decades (since 1971), advertising
for e-cigarettes has been unregulated so they can be marketed on television and radio, in
newspapers and magazines, and on the Internet. Take a look at Movie 4.1, a commercial for blu ecigarettes featuring Jenny McCarthy, a popular and controversial celebrity. From a public health
perspective, it is concerning that cigarette-like behavior is once again being advertised on television.
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Some varieties, such as NutriCigs (Figure 4.16), are advertised as providing supplements that will help
consumers to sleep better, or have more energy, or eat less. At the very least, marketing nicotine-

Table 4.5 Even the Limited E-Cigarette Research that is Available has Policy
Implications
Issues/Concerns Evidence to Date
Youth - Initiation

Doubled in one year.

Policy Implications
Implement minimum age of purchase laws.

Most users continue to smoke,
Current Smokers although some may quit
Discourage long-term dual use.
Dual Use
completely.
Ex-Smokers Relapse

Non-Smokers Clean Indoor Air

Nicotine
Poisoning

Drug Delivery
Devices

145

Returning to “safe” nicotine
may be attractive to former
smokers.

Restrict marketing targeted at ex-smokers
(e.g. Welcome Back campaign).

Companies are advocating ecigs be used anywhere to
increase their acceptance and
use.

Regulate vaping in indoor areas so that it
does not undermine existing clean indoor
air laws.

Upsurge in calls to poison
control centers for children
under 6 years from liquid
nicotine poisoning.

Require child-proof packaging and
appropriate labelling of liquid nicotine.

Consider regulating e-cigs as drug delivery
E-cigs are being used for other devices, or even as drugs (like nicotine
drugs, particularly hash oil.
replacement therapy), to allow for possible
future health claims.

containing products that deliver
supplements with unproven benefits is a

Figure 4.16 NutriCigs Promise Better Sleep,
Increased Energy and Weight Loss

matter of questionable ethics. In fact, the
European Union has recently banned the
marketing of e-cigarettes containing
supplements.
Perhaps the most controversial aspect of
e-cigarettes is their potential as a harm
reduction method. The ultimate goal of harm reduction is to provide nicotine to consumers without
the smoke and its deadly effects (Figure 4.17). It may seem obvious, then, that harm reduction is a
goal that everyone can agree upon, yet many tobacco control advocates remain skeptical. While
eliminating or at least minimizing smoke is certainly a good thing, public health advocates must
consider the following:
1. Do they help people quit? Figure 4.18 shows the position of several medical and health-related
organizations in the U.S. regarding e-cigarettes as cessation tools.
2. Are there unintended consequences, such as unknown harms, youth initiation, dual use of multiple
tobacco products or delayed cessation?
3. What is the net benefit of e-cigarette use? FDA must balance the individual benefit, if any, with the
population benefit, if any, in establishing rules regulating the use of e-cigarettes and other novel
tobacco products.
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Figure 4.17 Snus Ad

In 2001, the Institute of Medicine published a report titled
“Clearing the Smoke: The Science Base for Tobacco Harm
Reduction.” The study drew some major conclusions with
important implications for harm reduction products. First,
according to the report, it is impossible to assess the harm
reduction potential of any product, though it is conceivable
that exposure reduction could be assessed. In other words,

This advertisement for Camel Snus

the report concluded that it is impossible to know if these

states, “If you’ve decided to quit

products will actually reduce harm; thus, rather than calling

tobacco use, we support you. But

them “harm reduction products,” it introduced the term

if you’re looking for smoke-free,

“potential reduced-exposure product.” The report advocated

spit-free, drama-free tobacco

for the need to understand how individuals will use these

pleasure, Camel Snus is your

products and what the long-term health effects will be. It also

answer.”

called for a rigorous scientific study of biomarkers that can
help provide

more proximal data regarding the long-term impact of
PREPs; the surveillance and evaluation of product use;
and regulation of claims that can be made by
manufacturers of PREPs.
We conclude this chapter with a video from Dr. Michael
Siegel (Movie 4.2). A physician and epidemiologist by
training, Dr. Siegel works in the area of tobacco control,
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Movie 4.2 Hear from the Experts:
Michael Siegel, MD, MPH

focusing on the health effects of smoking and exposure to secondhand smoke, the marketing
practices of the tobacco industry and their effects on youth, and tobacco control policies and their
impact on youth and adult smoking behavior.

Figure 4.18 Position Statements About E-Cigarettes as Cessation Tools
American Medical Association, 2015
Supports regulations that …”prohibit claims that electronic cigarettes are effective tobacco cessation
tools.”
Journal of the American Medical Association, 2015
“Despite the increased interest in these products as part of strategies to reduce or eliminate smoking,
counseling patients to use e-cigarettes is a practice that is currently not supported by evidence. Thus, it
should be considered off-label advice. Although the priority is to get tobacco users to completely stop
using combusted tobacco, clinicians should also consider treating people who use e-cigarettes with
nicotine replacement therapies that have been approved by the FDA.”
American Lung Association, 2015
“Until and unless the FDA approves a specific electronic nicotine delivery system or e-cigarette as safe
and effective for use as a tobacco cessation aid, the Lung Association does not support using them for
cessation, nor does it support any direct or implied claims that e-cigarettes help smokers quit.”
American Heart Association, 2014
“There is not yet enough evidence for clinicians to counsel their patients who are using combustible
tobacco products to use e-cigarettes as a primary cessation aid. The efficacy of e-cigarettes as a primary
smoking cessation aid has not been established as being better than other cessation modalities.”
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Chapter 4 Discussion Questions:
1. Is there a regulatory system in place requiring tobacco companies to present rigorous evidence
of harm reduction before placing a product on the market? Should there be one?
2. Do you think e-cigarettes are safer for your health? Are there circumstances under which they
should be promoted?
3. Given the continued development and marketing of innovative tobacco products by
manufacturers, should the U.S. pass regulations intended to inform and protect consumers that
would be applicable to all current and future tobacco-related products?
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Chapter 5

Tobacco Enterprise: Costs
and Implications

Chapter Objectives
1. Analyze the pros and cons of the global tobacco industry
with regard to farming of tobacco and manufacturing of
cigarettes.
2. Examine China’s unique role as a major tobacco-growing
country, manufacturer, and corporation.
3. Explain the consolidation of tobacco farming and
companies over time in the U.S.
4. Contrast the human and monetary costs of smoking to the
profits received by tobacco companies.

Chapter 5 - Tobacco Enterprise: Costs and Implications
Section 1 - The Tobacco Business: Big, Legal, and Deadly

In this chapter, we will examine the devastating global tobacco epidemic and how the tobacco
industry works to get new users addicted, especially youth.
Tobacco is a highly profitable business concentrated in a few global companies. The global tobacco
enterprise is estimated at nearly half a trillion dollars a year with over $30 billion in annual profits
(Movie 5.1). The enormous magnitude of the industry has much to do with why tobacco control is
such a challenge. Tobacco companies strive to maintain the status quo—a culture in which smoking is
an acceptable activity (even, in some cases, an activity that suggests an elevated social status), and
they want to continue to sell their products and be as profitable as possible. They protect their
existing franchise while also preparing for
future challenges in the market by developing
new nicotine products such as e-cigarettes.
In 2012, revenues of the top tobacco
companies exceeded that of Coca-Cola, Walt
Disney, General Mills, Home Depot, Amazon,
Google, McDonald’s, and Starbucks combined
(Table 5.1). Recall Figure 2.10 from Chapter 2,
which showed global cigarette consumption
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Movie 5.1 “The Truth About Tobacco: How
Much Is a Life Worth?”

going up to nearly six trillion cigarettes
in 2009. The dramatic increase of

Table 5.1 2012 Revenues for Top Tobacco Companies
Tobacco Company

2012 Gross Revenue
(Billions USD)

scope and influence of the tobacco

Altria

$24.62

industry and its successful penetration

BAT

$71.27

Imperial

$44.39

JTI

$24.72

Philip Morris
International

$77.39

China National Tobacco
Corporation*

$95.2

cigarette consumption in the last
century provides a clear sign of the

into U.S. and global culture.
While cigarettes dominated the
tobacco industry, there are other
tobacco products that play an
important role in maintaining and
increasing the industry’s market share.

*2012 data not available,
2011 estimate used
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$337.59

The proportions shown in Figure 5.1 are likely to change given the relatively recent success of ecigarettes and novel nicotine products. As we discussed in the previous chapter, it is highly likely that
these proportions will look very different in just ten years.

Figure 5.1 Value of Global Tobacco Industry Production (measured at retail sales
prices), 2010
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Figure 5.2 shows a 60% increase in
smokeless tobacco sales over the last

Figure 5.2 Global Smokeless Tobacco Sales Volume
Increases 60% in a Decade
Sheet 1

decade, giving a sense of just how
700K

cigarette consumption declines, public

600K

health advocates must remain vigilant to
ensure that smokers do not simply
transition to other nicotine products that
are still harmful to health.

Tons of Tobacco Sold

rapidly the market can change. As

500K
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China presents an important case study
for our discussion of the magnitude and

100K
0K
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influence of the tobacco business. The

2005

2010

2015

Year
The plot of sum of Number of Sales for Year.

China National Tobacco Corporation (CNTC) is a government monopoly that is also the world’s
largest producer of cigarettes (Figure 5.3). CNTC is the fourth largest company in China,
manufacturing 2.3 trillion cigarettes in 2009—a number that accounts for 40% of all cigarettes
manufactured in the world. Cheng Li, the director of the John L. Thornton China Center at the
Brookings Institute, noted in 2012, “China’s production is roughly equivalent to the combined
production of the next seven largest tobacco-producing countries.” CNTC contributes somewhere
Key Takeaway
The China National Tobacco
Corporation is a government
monopoly and the world’s largest
producer of cigarettes.
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between 7 and 10% of the entire governmental revenue of China.
The tobacco business is likewise thriving in the United States, in
spite of having more restrictions on tobacco than China. More than
303 billion cigarettes were purchased in the U.S. in 2010, with three

Figure 5.3 CNTC Annual Cigarette Revenues, 1990-2005
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companies selling nearly 85% of them (Table 5.2). By far, Philip Morris USA, the manufacturer of
Marlboro, Basic, and Virginia Slims, is the largest company selling cigarettes in the U.S. with nearly
50% of the market share.

Table 5.2 U.S. Cigarette Manufacturers and Market Share
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Company Name

Brand Examples

Market %

Cigarettes Sold

Philip Morris USA

Marlboro, Basic, Virginia Slims

46.4%

140.8 billion

Reynolds American, Inc.

Camel, Doral, Winston, Kool

25.5%

77.5 billion

Lorillard

Newport, Maverick, Kent

12.3%

37.4 billion

All other companies

USA Gold, Sonoma, Montclair

15.8%

47.9 billion

Table 5.3 shows a similar pattern for smokeless tobacco, with three companies controlling a huge
proportion of the market—in this case, about 90%. United States Tobacco, the manufacturer of
Copenhagen and Skoal, has 44.3% of the market; American Snuff 27.9%; and Swedish Match 17.7%. It
is particularly interesting to note the recent purchase of United States Tobacco by Altria, and
American Snuff by Reynolds American. In the last few years, the trend has been for the large cigarette
companies to acquire smokeless tobacco manufacturers, no doubt because of the growth of
smokeless tobacco sales.

Table 5.3 U.S. Smokeless Tobacco Manufacturers and Market Share
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Company Name

Brand Examples

Market %

Pounds Sold

United States Tobacco

Copenhagen, Skoal

44.3%

54.3 million

American Snuff

Grizzly, Kodiak

27.9%

34.2 million

Swedish Match

Timber Wolf, Red Man

17.7%

21.7 million

All other companies

Redwood, Kayak, Beech-Nut

10.5%

12.4 million

The market for cigars presents quite a different picture (Table 5.4). While a large majority of the
market share was dominated by three companies in the case of cigarettes and smokeless tobacco, for
cigars most of the market is dominated by a variety of companies and the three largest companies
have less than half of the market. The cigar market is fundamentally different from the cigarette and
smokeless tobacco markets, and perhaps not surprisingly, cigarette manufacturers have not been as
eager to buy into the cigar market as they have been for smokeless products.

Table 5.4 U.S. Cigar Manufacturers and Market Share
Company Name

Brand Examples

Market %

Cigars Sold

Swisher
International

Swisher Sweets,
Universal

21.0% (little cigars and cigarillos)
57.8% (little cigars)

2.6 billion
575 million

Cheyenne
International, LLC

Cheyenne, Derringer,
Bodyshot

14.7% (little cigars and cigarillos)
3.0% (little cigars)

1.8 billion
30 million

Altadis USA

Dutch Masters, Phillies

12.4% (little cigars and cigarillos)
11.1% (little cigars)

1.5 billion
280 million

51.9% (little cigars and cigarillos)
28.1% (little cigars)

6.4 billion
280 million

All other companies
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Chapter 5 - Tobacco Enterprise: Costs and Implications
Section 2 -Growing and Manufacturing Tobacco

While tobacco is considered a major cash crop, it is grown with little benefit to farmers. In 2011,
tobacco was grown in more than 124 countries—i.e., over 63% of the world’s countries—covering 4.3
million hectares (1 hectare equals 2.47 acres). To put this in perspective, the amount of tobacco
grown in the world exceeds the number of tonnes of artichokes, blueberries, cinnamon, cranberries,
figs, hops, pistachios, raspberries, string beans, and vanilla combined. And in contrast to these crops,
tobacco provides no nutritional value and does nothing to help with issues of food scarcity or
eliminating hunger in any of the countries in which it is grown. In 2011, six of the top ten tobaccogrowing countries had undernourishment rates between 11% and 39%. In place of tobacco, other
crops could be grown that not only provide nutrition to a country’s population but also yield more
profit to the farmers who grow them.
The top five tobacco-growing countries are China, Brazil, India, the U.S., and Indonesia (Figure 5.4). In
1965, there was very little difference in terms of tobacco production among these five countries, and
it is striking to note the incredible growth that has occurred in China over the last forty years. China
now leads the world in tobacco farming, surpassing the other four top countries combined in tobacco
leaf production. In 2012, China produced more than 3.2 million tonnes of tobacco - more than 42% of
all tobacco grown in the world.
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Figure 5.4 Production Quantity in
Million Metric Tonnes for Selected
Countries, 1965-2009

Growing tobacco benefits farmers in only minor ways
(Figure 5.5). It requires an enormous input of labor
and is not as profitable to farmers as many other
crops. Often, tobacco companies supply the needed
equipment to help farmers get started, but they do so
at above-market prices and on credit terms that are
not favorable to the farmers.
In the U.S., there has been a sharp reduction in the
number of acres devoted to growing tobacco since
1994. According to Table 5.5, the acres of tobacco
harvested was reduced by more than 50% between
1994 and 2011. In this period, tobacco production

Figure 5.5 Tobacco is Grown in More
Than 124 Countries

was reduced by almost two-thirds, yet the price of a
pound of tobacco remained about the same. Thus,
the economic value of tobacco to U.S. farmers has
decreased substantially, now totaling only a little over
$1 billion per year.
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Table 5.5 U.S. Tobacco Farming Over Time
1994

2000

2006

2011

Acres harvested

671,065

485,730

339,000

325,040

Tobacco production
(thousands of pounds)

1,582,896

1,099,884

727,897

598,320

Price per pound

$1.76

$1.87

$1.67

$1.82

Economic value to farmers
(in 1,000)

$2,779,056

$2,056,316

$1,211,885

$1,084,039

One of the major reasons for the dramatic change in tobacco farming in the U.S. is the Tobacco
Transition Payment Program (TTPP). Part of the Fair and Equitable Tobacco Reform Act of 2004, the
TTPP is a tobacco buy-out program that ended the federal quota program for tobacco established
during the Depression Era. Before TTPP, the federal government in the U.S. guaranteed a minimum
price for tobacco products and issued quotas
both to tobacco farmers and to individual
quota holders (who may not be growing
tobacco themselves). In 2004, this quota
system was seen as interfering with free
market principles. TTPP was thus established,
providing annual transitional payments for
ten years to eligible tobacco quota holders
and producers. Payments are funded through
assessments of approximately $10 billion on
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Figure 5.6 Acres of Tobacco Harvested by Year,
U.S.

Figure 5.7 Number of Tobacco Farms by County

tobacco product
manufacturers and
importers. As a result of this
buy-out of the quota system,
many farmers gave up
growing tobacco, illustrated
in Figure 5.6. The tobacco
farms that had previously
existed became
corporatized and increased
in size, and the price of
tobacco has declined.
Currently, tobacco growing
in the U.S. is concentrated in
the Southeast (Figure 5.7).
Kentucky has the highest
concentration of tobacco

farming and has found it the most difficult of all the states to transition to alternative crops.
Historically, North Carolina and Virginia had been the largest producers of tobacco, but their
economies have diversified and become less reliant on tobacco. Of note, the states in the Southeast
not only have the highest concentrations of tobacco growing but also tend to have weaker tobacco
control measures in place and higher rates of tobacco-related disease.
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In the U.S., tobacco farmers earn a penny from every dollar spent on tobacco (Figure 5.8). The lion’s
share of the tobacco dollar goes to tobacco manufacturers, who receive 58%. The rest go towards
excise taxes, local sales taxes, and wholesale, retail, and transportation costs. In other words, farmers
who provide the raw material—the tobacco itself—receive the smallest portion, only 1%, of the entire
amount spent on tobacco.
More problematic still, farmers often become indebted to tobacco companies from having to buy
special

Figure 5.8 Tobacco Farmers Earn a Penny From Each Dollar Spent on
Tobacco

equipment
from them to
grow tobacco.
For example,
whereas
farmers of other
crops need
refrigeration to
keep their
products from
spoiling,
tobacco
farmers need
curing barns to
heat tobacco
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after harvest. Once they have invested in these expensive pieces of

Key Takeaway

specialized equipment, it is much more difficult for farmers to stop

Tobacco is grown with little
benefit to farmers. Tobacco
farmers earn only 1% of every
dollar spent on tobacco, in
contrast to tobacco
manufacturers, who earn 58%
of the tobacco dollar.

growing tobacco and transition to alternative crops. The sale of tobacco
brings in minimal profits and farmers can make more money from
alternative crops; however, the transition from tobacco to other crops
involves changing their overall infrastructure and is very difficult to do
without support from the government.

One aspect of tobacco growing that has recently received much attention in the media involves the
health hazards of growing and harvesting tobacco leaves (Movie 5.2). Green Tobacco Sickness (GTS)
is a common illness that affects tobacco harvesters, resulting when nicotine from the tobacco leaves—
particularly when the leaves are wet—is absorbed into the skin. The symptoms of GTS include
weakness, headaches, nausea,
vomiting, dizziness, abdominal
cramps, difficulty breathing, diarrhea,
chills, and irregular fluctuations in
blood pressure or heart rate. The
costs of this illness to tobacco
harvesters are great: high
hospitalization costs are incurred by
nearly ¼ of those who seek medical
treatments, in addition to lost wages
during the time it takes to recover
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Movie 5.2 Human Rights Watch Report Exposes Dangers
in Tobacco Cultivation Among Child Workers.

from GTS, which is typically one to three days. While the illness can be prevented by protecting the
skin from direct contact with tobacco leaves, protective clothing is often not provided and must be
obtained at the expense of farm workers.
Given all the issues associated with growing tobacco—the health burden to consumers caused by the
final product, the amount of labor involved in the growing process, the increasing corporatization of
tobacco farms, and Green Tobacco Sickness—there has been an increasing emphasis on alternative
crop initiatives in tobacco-growing nations (Table 5.6). Much research and education are still needed
to help farmers make the transition from tobacco to crops that not only are safer for farmers and
consumers but also provide a nutritional benefit to the region or nation in which they are grown.

Table 5.6 Examples of Alternative Crop Production in Five Different Countries
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Country

Successful alternative crops

Bangladesh

Potato, maize, lentil, and coriander

Brazil

Organic food crops, bananas

China

Ingredients for traditional Chinese medicine

India

Sugarcane, onion, maize, groundnut, and soybean

Kenya

Sugarcane, bamboo, cotton, oranges, pineapples, bananas, cassava,
and maize

Figure 5.9 Bamboo Utilization
Workshop in Kenya as Part of
Growing Alternative Crops

While there are still relatively few countries currently
participating in alternative crop initiatives, successful
transitions have occurred in Bangladesh, Brazil, China, India,
and Kenya (Figure 5.9). In these countries, crop transitions
are encouraged by incentives such as loans and federal
assistance.
Just as the majority of countries in the world grow tobacco,
most countries manufacture cigarettes. An estimated 111
countries
manufacture
cigarettes, and there
are over 500
cigarette factories
worldwide,
producing six trillion
cigarettes each year
(Figure 5.10). As is
the case with
growing tobacco,
China leads the
world in cigarette
manufacturing: an
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Figure 5.10 Images of Cigarette
Manufacturing

Table 5.7 Top Cigarette
Manufacturing Countries,
2010
Percentage of
Cigarettes
Manufactured

astounding 41% of cigarettes are made in Chinese factories
(Table 5.7). This percentage, it should be noted, is very
disproportionate to the size of China’s population. Even though
China is the largest country in the world, its population only
makes up approximately 15% of the world’s population, yet it
grows and manufactures over 40% of the world's cigarettes.

China

41%

Russia

7%

U.S.

6%

5.3. Cigarettes are made through a highly engineered process

Germany

4%

that involves the creation of reconstituted sheets containing

Indonesia

3%

tobacco and hundreds of chemical additives, which are meant to

Manufacturing is a highly complicated process that involves far
more than just rolling tobacco in paper as you can see in Movie

alter the effects of the cigarette on the smoker. These additives
affect the ease with which the smoke can be
inhaled and nicotine can be absorbed into the
bloodstream, giving cigarettes an optimal level
of addictiveness.
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Movie 5.3 “What’s In A Cigarette?”

Chapter 5 - Tobacco Enterprise: Costs and Implications
Section 3 - The Costs of Smoking to Society Far Outweigh the Benefits to
Tobacco Companies
Measuring the economic impact of smoking is a complicated matter. Certainly, getting people to quit
smoking or not to start smoking at all has a direct impact on healthcare costs because such efforts
result in fewer people requiring treatment for smoking-caused illnesses such as lung cancer and heart
disease. However, direct healthcare costs are only a portion of the total cost of tobacco to society.
Often, the dollars that are saved from prevented medical expenses are spent on a longer life
expectancy and the use of pensions that accrue to non-smokers and ex-smokers; thus, money is not
necessarily saved and it may be pointed out that from a financial standpoint, the net effect of tobacco
control is a wash. However, while it may be true that successful efforts in tobacco prevention do not
result in saving money in the
long run, they do
unquestionably result in longer
and healthier lives for people,
which is the ultimate goal of
advocates of public health.
In trying to quantify the
economic impact of tobacco, we
have to look not only at the
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Figure 5.11 Comparing Direct and Indirect Tobacco Costs

Figure 5.12 Direct Costs of Smoking in China

direct medical costs incurred as a result of
smoking, but also the indirect costs of lost
productivity and absenteeism resulting from
smoking-related illnesses. Figure 5.11 shows
the example of three countries—Switzerland,
South Africa, and the United States—in which
indirect tobacco-related costs actually outweigh
the direct costs of treating tobacco-related
diseases.
In China, the direct costs of smoking more than

quadrupled in less than a decade, from US $7.2 billion in 2000 to US $28.9 billion in 2008 (Figure
5.12). Here, as in many other countries, it is difficult to put cost estimates on treating diseases in
general, but especially those specifically caused by smoking.
For the U.S., the Smoking-Attributable Mortality, Morbidity, and Economic Costs (SAMMEC) is an
online application available from the Centers for Disease Control and Prevention that generates
estimates on the health and health-related economic consequences of smoking to adults and infants.
The latest figures indicate that cigarette smoking is responsible for $193 billion in annual healthrelated economic losses in the U.S. Of this amount, almost $96 billion
are spent on direct medical costs, while lost productivity accounts for
$97 billion. Combined with the over 400,000 deaths each year
caused by smoking, these economic costs result in 5.1 million years
of potential life lost in the U.S. annually due to cigarette smoking.
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Key Takeaway
Measuring the economic impact of
tobacco requires looking at both
direct and indirect costs incurred as
a result of tobacco use and
exposure to secondhand smoke.

Smoking is expensive not just for smokers; secondhand smoke is also costly in terms of dollars and
lives. It is estimated that at least $5 billion in direct medical expenses and $5 billion in indirect costs
for lost productivity accrue each year in the U.S. from exposure to secondhand smoke. This translates
to an economic loss of about $150 per year for every nonsmoker in the U.S. exposed to smoke at
home and at work.
Secondhand smoke deaths result in nearly 600,000 years of potential life lost in the U.S., or 14.2 years
per death. More recent estimates of the
indirect expenses associated with
exposure to secondhand smoke indicate
$6.6 billion of lost productivity each year,
or $158,000 per death (Table 5.8). The
value of lost productivity per death was
highest among blacks ($238,000) and
Hispanics ($193,000), partially due to the
fact that they are susceptible to higher
levels of exposure to secondhand smoke,
especially in the workplace.

Table 5.8 Annual Cost of Lost Wages, Benefits and
Medical Services for Certain Conditions Caused by
Secondhand Smoke (excludes infants)
Lung cancer

$468 million

Low birth weight babies

$174 million

SIDS

$131 million

Annual Total:

$773 million

Employers should worry about smoking
not only for the sake of their employees’ health, but also for the sake of their bottom line. Employees
that smoke cost their employers money as a result of absenteeism, smoking breaks, and excess
healthcare expenditures (Table 5.9).
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It is beyond question that smoking has a real and substantial cost to individuals and to society as a
whole. From a macroeconomic standpoint, the cost of smoking may be counterbalanced by the fact
that non-smokers and ex-smokers live longer and the money saved from reduced medical
expenditures is often spent on pensions and social security benefits that accrue during their extended
lives. Rather than trying to hide this fact, tobacco control advocates should take it as a sign of success

Table 5.9 Total Annual Excess Cost of a Smoking Employee to a Private Employer
Category

Best estimate,
annual costs

High range

Low range

Excess absenteeism

$517

$576

$179

Presenteeism

$462

$1,848

$462

Smoking breaks

$3,077

$4,103

$1,641

Excess health care costs

$2,056

$3,598

$899

Pension benefit

($296)*

0

-$296

Total costs

$5,816

$10,125

$2,885

* For employees with denied-benefit pension plans.
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that unnecessary expenses for the treatment of tobacco-related disease can instead be spent for
individuals to enjoy a healthier life and a full retirement. While tobacco control may not save money in
the long run, it helps to reallocate financial resources in such a way as to optimize the benefits to
individuals over their lifetime.
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Chapter 5 - Tobacco Enterprise: Costs and Implications

Section D: The Illicit Cigarette Trade May Involve Organized Crime
As part of this chapter on the tobacco enterprise, it is important to discuss the problem of illicit
tobacco. An estimated 10% of cigarettes purchased around the world are sold illegally—that is, they
are either counterfeit or smuggled. Illicit cigarette trade undermines public health efforts by allowing
consumers to avoid age verification and cigarette taxes, resulting in billions of dollars in lost tax
revenues.
In the U.S., tax avoidance from illicit tobacco is a problem primarily because there are great
differences in excise tax rates from state to state (Chapter 10: Taxes and Funding Tobacco Control).
Cigarettes can be purchased in a state that imposes lower taxes on cigarettes and resold in states
with higher taxes for a substantial profit. It is estimated that a single truckload of cigarettes smuggled
from Virginia, a state with a low tobacco tax, to a high-tax state like New York can net $2 million in
profit. Similarly, tobacco products bought on Native American territory, where taxes are not collected,
can be resold elsewhere for big profits.

180

Illicit cigarette trade is not just a problem in the U.S. but worldwide. The greatest numbers of illicit
cigarettes come from China, Eastern European countries such as Poland, Belarus, and Ukraine. Figure
5.13 also shows countries in which there have been seizures of over 20 million illicit cigarettes; many
of these countries are located in Western Europe and around the Mediterranean Sea.
While it is true that the illicit tobacco trade is a serious problem, there is a tendency for tobacco
companies to exaggerate its scope in order to use it as an argument against tobacco control
measures.
Their position
is that greater
restrictions on
tobacco—
including
packaging and
labeling
requirements
as well as tax
increases—spur
on illicit trade.
However, the
facts show
otherwise.
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Figure 5.13 Global Illicit Market Share

Figure 5.14 compares
estimates of illicit trade
from the tobacco industry

Figure 5.14 Estimates of Illicit Cigarette Trade from the Tobacco
Industry vs. the Estimates from Academic Studies

with estimates from
academic studies.
Objective research
suggests that the amount
of illicit trade that occurs,
whether in the U.K., in
South Africa, or in Poland,
is about half of what the
industry claims it is. In
Australia, tobacco companies are now using this strategy of overestimating the amount of illicit trade
to try to undercut the plain packaging rules that were recently put in place there. The available data
simply does not support their assertions that strict tobacco control measures result in high levels of
illicit trade.
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Figure 5.15 Contrary to Tobacco Industry Claims, the
Increase in Retail Price has not Led to Any
Corresponding Increase in Illicit Trade

To take another example, in the U.K.,
there has actually been a decline in
the illicit cigarette market from 2005
to 2009 (Figure 5.15). This decline
occurs at the same time as sharp
increases in the average retail price
of a pack of cigarettes, suggesting
that the price increase has not led to
any corresponding increase in illicit
trade, contrary to tobacco industry
claims.

Key Takeaway
Tobacco companies claim that
greater restrictions on tobacco—
including packaging and labeling
requirements and tax increases—
spur on illicit trade, but the facts
show otherwise.
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Chapter 5 - Tobacco Enterprise: Costs and Implications
Section 5 - Cigarettes are Becoming More Affordable

Hana Ross is formerly the
Managing Director of
International Tobacco Research
at the American Cancer Society.
In Movie 5.4, she comments on
the increasing affordability of
tobacco products, a somewhat
surprising phenomenon given
the fact that taxes are increasing
in many countries around the
world.
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Movie 5.4 Hear from the Experts: Hana Ross

Figure 5.16 shows changes in the affordability of cigarettes from 2000 to 2010. It highlights the trends
mentioned by Dr. Ross, with cigarettes becoming less affordable during this period in high-income
countries as a result of substantial tax and price measures, while on the other hand, becoming more
affordable in low- and middle-income countries which tend to lag behind in tax and price policies.

Figure 5.16 Affordability of Cigarettes, 2000-2010

In this chapter,
we discussed the
scope and
magnitude of the
tobacco
enterprise. We
examined the
different aspects
of the tobacco
business, from
growing to
manufacturing
and sales. In the

next chapter, we will take a close look at the tobacco industry behavior, with a focus on business
practices used by the industry to undermine tobacco control.
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Chapter 5 Discussion Questions:
1. What is the relationship between cigarette affordability and consumption?
2. Should the U.S. offer subsidies or initiatives for tobacco farmers to switch to alternative crops?
What challenges or barriers do you perceive?
3. How can the U.S. reduce illicit cigarette trades?
4. Given the expected population growth and food shortage in China, discuss the implications of
China’s investment in tobacco growing and manufacturing rather than food crops.
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Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.

in Retail Price has not Led to Any Corresponding Increase in Illicit

Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Trade

World Lung Foundation.

Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.
Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:

Table 5.8: Annual Cost of Lost Wages, Benefits and Medical

World Lung Foundation.

Services for Certain Conditions Caused by Secondhand Smoke
(excludes infants)
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Movie 5.4: Hear from the Experts: Hana Ross

Figure 5.16: Affordability of Cigarettes, 2000-2010
Source: Eriksen M., Mackay J., Ross H. (2012). The Tobacco Atlas.
Fourth Ed. Atlanta, GA: American Cancer Society; New York, NY:
World Lung Foundation.
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Chapter 6

Tobacco Industry
Behavior

Chapter Objectives
1. Examine the ways in which the tobacco industry historically
deceived the U.S. public.
2. Demonstrate ways in which the tobacco industry influences
politics in the U.S.
3. Analyze the tobacco industry’s use of corporate social
responsibility as a means of improving their public image.
4. Contrast the tobacco industry’s behavior and means of
influence in the U.S. and in foreign countries.

Chapter 6 - Tobacco Industry Behavior
Section 1 - The Tobacco Industry as an Opponent to Public Health

“The cigarette industry is peddling a deadly weapon. It is dealing in
people’s lives for financial gain… The industry we seek to regulate is
powerful and resourceful. Each new effort to regulate will bring new ways
to evade… Still, we must be equal to the task. For the stakes involved are
nothing less than the lives and health of millions all over the world. But
this is a battle which can be won… I know it is a battle which must be
won.”
~ U.S. Senator Robert Kennedy, at the First World Conference on
Smoking and Health, 12 September 1967, New York, NY
In trying to understand the harm caused by tobacco use, we must look not only at the behavior of
individuals who smoke but also at the behavior of the tobacco industry. One way of investigating
tobacco companies involves looking at them as a disease vector. In medical terms, a vector is typically
an organism that transmits a pathogen; for example, a deer tick may act as a vector for Lyme disease,
transmitting the infection to humans. It is common for public health researchers to try to understand
the transmission of disease by examining the vector. In terms of smoking-related diseases, we say that
the diseases are caused by an agent—the tobacco products themselves. But the spread of tobacco
products is facilitated by a vector: this is the tobacco industry, which spreads the disease agent to a
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large number of people. Tobacco companies as a disease vector try to get their products in the hands
of as many people as possible so that the industry cannot just survive, but thrive.
Figure 6.1 illustrates the epidemiology of tobacco-related harms in terms of a traditional public health
model, commonly known as the HAVE model. HAVE is an acronym that stands for host, agent, vector,
and environment; the
model provides a
helpful way of visualizing
the context in which
tobacco use is spread
through the efforts of
the tobacco industry,
which acts as a vector.
This way of
conceptualizing the
problem of tobacco use
shows the interrelated
roles of the host
(smokers), the disease
agents (cigarettes), and
environment (the
political and
socioeconomic forces
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Figure 6.1 The Epidemiologic Triad of Tobacco-Related Disease
With Tobacco Companies as Disease Vectors

that allow the vector to purposely spread the agent). The HAVE
model makes clear the central position of the tobacco industry in
spreading tobacco-related disease in contemporary society.
In previous chapters, we have discussed the ways in which the
tobacco companies have responded historically to public concerns

Figure 6.2 In December
1952, Reader's Digest
Published "Cancer by the
Carton," Alerting Readers to
the Link Between Smoking
and Lung Cancer

about the harm of smoking. When the link between smoking and
lung cancer began to emerge through scientific research in the
1950s, tobacco companies responded by denying the causality of
harm. In the highly-publicized “Frank Statement to Cigarette
Smokers” (Chapter 1: Harm from Tobacco Use and Secondhand
Smoke), the major U.S. tobacco companies challenged the medical
research showing cigarette smoking to be a direct cause of lung
cancer. As demonstrated in Figure 6.2, the harms caused by
smoking began to be communicated to the general public in the
mid-1950s.
The tobacco companies asserted in the “Frank Statement” that they believed there to be “no proof
that cigarette smoking is one of the causes” of lung cancer. However, we now know that the industry
knew far more about the harm of smoking in 1954, when the statement was published, than it
revealed. In the mid-1950s, the tobacco industry not only knew of the dangers of smoking but also
the types of changes they needed to make. A research chemist for R.J. Reynolds stated at the time:
“Since it is now well-established that cigarette smoke does contain several polycyclic aromatic
hydrocarbons, and considering the potential and actual carcinogenic activity of a number of these
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compounds, a method of either complete removal or almost complete removal of these compounds
from smoke is required.” (cited in Dirty Business, 1988).
The tobacco industry attempted to delay the recognition of the harm caused by smoking. Internal
documents give evidence of the industry’s intentional strategy to conceal the harm of tobacco from
the public. A scientist at British American Tobacco stated in 1980:
A demand for scientific proof is always a formula for inaction and delay and usually the first
reaction of the guilty . . .in fact scientific proof has never been, is not and should not be the
basis for political and legal action.
In 1953, an employee of Hill and Knowlton, the public relations company hired by the tobacco
industry to counteract scientific findings linking smoking to lung cancer, stated:
We have one essential job – which can be simply said: Stop public panic. . . There is only
one problem – confidence, and how to establish it; public assurance, and how to create
it. . . And, most important, how to free millions of Americans from the guilty fear that is
going to arise deep in their biological depths – regardless of any pooh-poohing logic –
every time they light a cigarette.”
But even as tobacco companies chose a deliberate path of denial and obfuscation, their own internal
documents reveal concerns among their employees. Alan Rodgman, a research chemist with R.J.
Reynolds, wrote in 1962 that the company was publicly denying a link between smoking and cancer,
even while the company’s own research showed a link. Somewhat prophetically, Rodgman saw the
inevitability of litigation in the future as he recognized the problem inherent in smoking:
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What would be the effect on this company of not publishing these data now, but being
required at some future date to disclose such data, possibly in the unfavorable
atmosphere of a lawsuit? . . . It is recommended that the Company’s management
recognize that many members of its Research Department are intensely concerned
about the cigarette smoke-health problem and eager to participate in its study and
solution.
By the 1990s, evidence of the harms of smoking could
no longer be disputed. Tobacco companies thus tried a

Movie 6.1 “Nicotine Is Not Addictive”

different strategy—this time, challenging the
addictiveness of smoking. In 1994, the Chief Executive
Officers of the seven largest tobacco companies in the
U.S. were called to testify before Congress about the
addictiveness of smoking in what are now known as the
Waxman Hearings, named after Rep. Henry Waxman,
who chaired the hearings. One by one, the CEOs
testified under oath that they believed nicotine was not addictive (Movie 6.1).
Key Takeaway

As a result of the Waxman Hearings and increased efforts by the FDA to

Internal documents from the
tobacco industry reveal a
deliberate strategy to
conceal the harm of tobacco
from the public.

regulate nicotine and tobacco starting the same year, a number of
lawsuits were brought against the tobacco companies. Industry
documents that had previously been confidential were revealed during
the litigation, providing tremendous insight into the behavior of tobacco
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companies, their true knowledge of the harms of

Figure 6.3 Cartoon by Dan
Wasserman, Los Angeles Times
Syndicate

smoking, and what they did to hide their knowledge
from the public (Figure 6.3).
Exposing the tobacco industry documents has been
truly invaluable in advancing tobacco control efforts in
the United States and globally. In 1998, the Legacy
Tobacco Documents Library (LTDL) was created as a
result of the Master Settlement Agreement between 46
State Attorneys General and the major tobacco
companies in the U.S. The LTDL houses more than 40
million pages of internal documents from the tobacco
industry. Additional documentation has since been

released to the public following successful litigation by the U.S. Department of Justice against the
tobacco companies in 2006. Under the federal Racketeer Influenced and Corrupt Organizations Act
(RICO), the tobacco companies are required to make publicly available any documents produced for
litigation on smoking and health until the year 2021. The LTDL acquires all of these documents from
the industry websites on which they are posted, as well as other avenues, and makes them available
to the public (Figure 6.4).
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The tobacco industry documents are extremely useful for advancing
tobacco control efforts. They are accessible on the Web at the Legacy
Tobacco Documents Library, as well as on the websites of the major U.S.
tobacco companies.
The types of behavior we have reviewed in the context of the tobacco industry in the United States
are certainly not limited to this country. These are, in fact, a global strategy. To take one example,
tobacco industry interference is a serious problem in the country of Indonesia. Patricia Waagstein, an
advisor for the Campaign for Tobacco-Free Kids describes the situation in 2003:
In Indonesia, one of the biggest tobacco-producing countries in the world, industry
interference is the most important challenge to tobacco control. The tobacco industry
attempts to interfere in the legislative process by hindering or diluting any bill on
tobacco control and failing this, tries to thwart or slow its implementation. The industry
uses different strategies to achieve this, ranging from influencing the legislative process
to litigation.
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Similarly, the tobacco industry’s
influence upon policy makers is
a concern in Pakistan and
Russia. “The biggest challenge
to effective tobacco control in
Pakistan,” states Khurram
Hashmi, national coordinator of
the Coalition for Tobacco
Control in that country, “is the
tobacco industry’s constant
influencing of policy makers
and relevant stakeholders in an
effort to hamper the
government’s overall
enforcement efforts. Tobacco
control advocates have to be
alert all the time as the industry
finds new ways to violate
tobacco control laws in the
country, especially through
tobacco advertising, promotion
and sponsorship or in the name
of corporate social
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Figure 6.4 Selected Quotations From U.S. Tobacco Industry
Internal Documents Which Were Revealed Through
Litigation

Figure 6.5 Tobacco Billboard in
Indonesia Says "Don't Quit"

responsibility” (Figure 6.5). Similarly, Viktor Zykov, a legal expert
working with the Russian Anti-Tobacco Coalition, asserts: “The
tobacco industry will continue to seek ways around the new
tobacco control law passed this year, including using lawsuits.
The law will need to be strengthened to close any gaps and
loopholes for the tobacco industry, and to include strong
penalties and fines for violations.”
The collective efforts of the tobacco industry to influence the
policies of countries around the world was best captured by the
World Health
Organization
(WHO) in a
2012 video
that highlights

tobacco industry interference in various countries.
WHO encourages all to stand shoulder to shoulder
in fighting “Big Tobacco” (Movie 6.2).
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Movie 6.2 WHO Countries Stand Shoulder
to Shoulder Fighting Big Tobacco

Chapter 6 - Tobacco Industry Behavior
Section 2 - The Tobacco Industry Influences Politics

The tobacco industry has a long history of making political contributions with the purpose of
influencing the outcomes of elections. During the 2012 U.S. Presidential election, the tobacco
industry donated almost $54 million. The vast majority (87%) of these funds came from four
manufacturers: Philip Morris USA, Reynolds American, U.S. Smokeless Tobacco Company, and Altria.
A large portion—$51 million (or 95% of the total)—was used to influence the presidential election in
five states: California, Florida, Missouri, Virginia, and Illinois.
Why these five states in particular? Table 6.1 reveals that the majority of tobacco industry funds in
2011-2012 were spent on ballot measures, particularly in California, where the contributions
amounted to over $46 million to defeat a proposition that would have increased cigarette taxes. An
increase in cigarette taxes has historically been shown to be correlated to a decrease in consumption;
moreover, a tobacco tax increase in California could become a harbinger of additional increases
throughout the rest of the United States and thus pose a serious threat to the tobacco industry.
In Florida, funds were more targeted at political party committees. Missouri received a sizable
contribution, likely because legislation was proposed around this time that would have increased
tobacco taxes. In Virginia, where legislation was proposed to stop smuggling of tobacco (and
eventually passed) and a bill was passed to create a working group to study cigarette tax
administration, the tobacco industry gave almost equally to Democrats and Republicans.
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Table 6.1 Top Recipient States of Tobacco Industry Contributions, U.S., 2011-2012
State

Ballot Measures

Political Parties

Candidates

Total

California

$46,336,664

$441,354

$462,606

$47,240,624

Florida

$250

$1,460,840

$204,718

$1,665,808

Missouri

$825,812

$40,750

$231,037

$1,097,599

$0

$149,671

$378,926

$528,597

$0

$79,000

$320,950

$399,950

$47,162,726

$2,171,615

$1,598,237

$50,932,578

Virginia

Illinois

TOTAL

Looking at all the states, we see similar patterns: the tobacco industry’s largest investments are
directed at defeating tobacco control measures. In the same election cycle, out of the industry’s total
$53.7 million contributions, $47 million went to help defeat ballot measures that would have raised
taxes on tobacco products (Figure 6.6). State-level candidates received $3.5 million, and $3 million
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was given to party committees, with
76% of this amount going to

Figure 6.6 Tobacco Industry Contributions by
Recipient Type, 2011-2012

Republican candidates and
committees.
In addition to their contributions to
both sides of the party line, the
tobacco industry also influences
politics through lobbying and Political
Action Committee (PAC)
contributions to federal candidates
(Figure 6.7 and Table 6.2). Figure 6.7
shows the annual number of clients
lobbying on behalf of tobacco and
how this number has changed over
time. The elevated number of lobbyists
in 1998 coincides with the discussion
and passage of the Master Settlement
Agreement in the same year.
Key Takeaway
The tobacco industry has a long history
of making political contributions with
the purpose of influencing the
outcomes of elections.
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In

Figure 6.7 Annual Number of Clients Lobbying on
Tobacco

2012, Altria contributed over $965,000 to PACs,
more than any other tobacco company in the
United States. Reynolds American was the
second highest contributor to PACs, giving over
$373,000. As a point of comparison, while
cigarette companies contributed hundreds of
thousands of dollars to PACs in 2012, cigar and
other tobacco companies gave significantly less:
Swisher International gave $57,000; Swedish
Match $54,509; and General Cigar Company

Table 6.2 Political Action Committee (PAC)
Contributions to Federal Candidates, 2012
Total Amount:

$1,907,759

Total to
Democrats:

$375,605

(20%)

Total to
Republicans:

$1,532,154

(80%)

Number of
PACs making
contributions:

11

$5,750. Tobacco lobbying is lucrative in the U.S.
While it has decreased over time, millions of
political dollars are still spent each year in an
effort to defeat political tobacco control measures
and to promote candidates that have a pro-tobacco
stance (Figure 6.8).
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Figure 6.8 Lobbying is an Major Part of
Tobacco Industry Tactics

Chapter 6 - Tobacco Industry Behavior
Section 3 - The Truth About Corporate Social Responsibility

In theory, corporate social responsibility (CSR) is a phrase that denotes a form of self-regulation that
businesses may adopt. CSR expresses the belief that a company should be responsible for its actions
—socially, ethically, and environmentally. Programs implemented under a CSR-based ethic can benefit
constituents, the environment, and organizations.
In 2011, 57% of the Fortune 500 companies reported on the environmental, social, and governance
impacts they made through CSR programs and charitable giving. Taking a critical approach to CSR,
especially in the context of the tobacco industry, is necessary since history has shown that the real
motives behind CSR may not always be openly or sincerely expressed, and CSR is sometimes used as
a distraction from other issues.
The World Health Organization takes a critical approach. In a 2009 document, WHO describes the
true meaning of CSR for tobacco:
‘Corporate social responsibility’ is crucial to the tobacco industry for restoring its
damaged reputation, improving employee morale and maintaining and increasing the
value of company stock. In the words of a British American Tobacco executive, it can
provide important “air cover” to distract governments and the community from the
industry’s core business.
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It is true that tobacco industry philanthropy does good in
many ways. Charitable donations may go to legitimate
organizations in support of important causes: they may, for
example, fund battered women’s shelters, finance efforts to
reduce homelessness, or provide resources to arts
programs. But we must also be aware of how these
donations may be used in self-promoting ways, such as an
Indonesian health center being sponsored by a tobacco
company (Figure 6.9).
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Figure 6.9 Indonesian Health
Center Sponsored by a Tobacco
Company

Table 6.3 shows Philip Morris International’s CSR donations from 2009-2012 in the Association of
Southeast Asian Network (ASEAN) region. PMI has funded more than a hundred projects in Indonesia,
Malaysia, the Philippines, Thailand and Vietnam, with donations supporting education, community
development, disaster relief, and environmental protection.

Table 6.3 Number of CSR Grants Given by PMI in ASEAN Region, 2009-2012
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Country

Education,
School Bldg.,
Scholarships

Poor People,
Community
Development

Disaster
Relief

Environmental
Protection

Total

Indonesia

12

17

7

10

46

Malaysia

8

5

5

18

Philippines

8

6

6

2

22

Thailand

8

8

7

4

27

Vietnam

5

3

1

Total

41

39

21

--

--

9
21
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Increasingly, tobacco companies are investing in scholarships for students. Pictured in Figure 6.10 are
Indonesian students receiving scholarships from Beswan Djarum, as well as Malaysian students
funded by British American Tobacco.
Certainly, the
tobacco

Figure 6.10 Examples of Tobacco Companies Funding Student
Scholarships

industry’s efforts
to be seen as
socially
responsible can
and does do
some good. But
looking at the
broader picture,
CSR is ultimately
a way that
tobacco
companies
attempt to buy good publicity for themselves, and at relatively little cost. Charitable donations amount
to a small percentage of the profits made by tobacco companies. For instance, in 2012, PMI donated
$38 million to charitable causes, out of their $9.2 billion profit—a donation amounting to less than
0.5% of what they netted that year, but yielding a significant amount of goodwill and good publicity
for the company.
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"I never use the word corporate philanthropy. That implies that you do something without any regard
to yourself...I don't see any corporation giving money without a reason.”
- George Knox, Philip Morris Executive, 1993
A discussion on corporate social responsibility must
weigh the answers to a serious question: Does CSR
negate the global harm caused by tobacco? The
matter is a complicated one. Figure 6.11 shows a
photograph of a school that was rebuilt by tobacco

Figure 6.11 A Sign Outside a
Tobacco-Sponsored School in China
Reads, “Genius Comes From Hard
Work. Tobacco Helps You to Be
Successful.”

companies following a severe earthquake in central
China. At one point, more than 100 primary schools
in China were sponsored by tobacco companies, and
many of them include messages like this on the
exterior of the school building: roughly translated, it
states, “Genius comes from hard work. Tobacco helps
you to be successful.” This sign was visible on an
elementary school in China in 2009, and it has since
Key Takeaway
While tobacco industry
philanthropy does good in many
ways, corporate social
responsibility is ultimately a way
for the industry to buy good
publicity.
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been removed. Throughout the world, tobacco control advocates
must be wary of tobacco companies engaging in corporate social
responsibility activities that have a direct link to youth audiences.

Chapter 6 - Tobacco Industry Behavior
Section 4 - Tobacco Front Groups as a Diversionary Tactic

Another tactic used by the tobacco industry involves funding front groups. A front group is defined as
“an organization that purports to represent one agenda, while in reality it
serves some other party of interest whose sponsorship is hidden or rarely
mentioned.” -Tobacco Tactics, 2012
Tobacco companies fund front groups and allies to help keep pro-tobacco issues visible while the
tobacco companies themselves remain in the shadows. They commonly partner with the hospitality
industry, national and state restaurant associations, licensed beverage associations, farmer
associations and gambling associations with the aim of maintaining the status quo which allows the
tobacco companies to sell their products to consumers. Recently, tobacco companies have used front
groups to undermine excise tax increases, as well as to bolster efforts to defeat tobacco control
measures, such as packaging regulations.
In 1994, when the FDA began to consider regulating tobacco products in the United States, R.J.
Reynolds secretly backed a campaign to diminish government control. The program, called Get
Government Off Our Back (GGOOB), was not only tobacco-related, but the timing of its launch was
designed to counteract FDA-proposed tobacco regulations. Campaign materials published in
magazines and newspapers around the country included slogans such as the one shown in Figure
6.12, which reads: “I’m one of American’s 45 millions smokers. I’m not a moaner or a whiner. But I’m
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getting fed up. I’d like to get the government off my back.” GGOOB
was active for two years and successful in influencing politics,
gaining attention for pro-tobacco issues and derailing multiple antitobacco proposed laws.

Figure 6.12 A Slogan
from Get Government Off
Our Back, a Tobacco Front
Group

Mike Daube is a professor of health policy at Curtin University in
Australia. He also serves as the Director of the Public Health
Advocacy Institute, and was Western Australia’s first Director General
of Health (2001-2005). Professor Daube is internationally known for
his efforts to understand industry behavior for both tobacco and
alcohol companies. In Movie 6.3, he talks about tobacco interference
in Australia with regard to tobacco companies’ efforts to defeat plain
packaging rules and the concept of the “Nanny State.”
Unfortunately, front groups are far from being a thing of the past.
Australia provides just one example of how tobacco companies use
front groups to undermine tobacco control efforts. Reacting to the
Australian government’s push to establish plain
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Key Takeaway

packaging, Philip Morris, Imperial Tobacco, and

Tobacco companies
fund front groups and
allies to help keep
pro-tobacco issues
visible while the
tobacco companies
themselves remain in
the shadows.

British American Tobacco created an entity
called the Alliance of Australian Retailers (AAR)
(Movie 6.4). While funded almost exclusively
by tobacco companies, AAR claims to
represent “the owners of your local corner

Movie 6.3 Mike Daube on
tobacco industry
interference in Australia

stores, milk bars, newsagents and service stations.” AAR, together with its member associations,
further claims to “represent around 15,000 individual retailers around the country.”
To further undermine efforts to establish plain packaging in Australia, Imperial Tobacco launched the
“No Nanny State” campaign in 2011 (Movie 6.5 & Figure 6.13). In
their annual report for 2012, the company describes the effect they
wished to have on packaging regulations using this campaign: “Last

Movie 6.4 AAR
Commercial Opposing
Australian Plain Packaging

year we worked closely with our trade customers during the plain
packaging consultation and our ‘No Nanny State’ advertising
campaign. This helped us to further strengthen these key
relationships.”
In spite of these advertising campaigns and other efforts by the
tobacco industry, via front groups, to oppose plain packaging,
Australia was successful in passing and establishing the Tobacco

Movie 6.5 No Nanny State
Commercial From Imperial
Tobacco Front Group

Plain Packaging Act of 2011. An excerpt from the law states, “From 1
December 2012, if you buy, sell, offer for sale or otherwise supply
tobacco products in Australia that do not comply with the plain
packaging or new health warning requirements, significant criminal
or civil penalties may apply.” Australia’s success in eliminating promotional imagery and branding
from tobacco packaging is historic, and other countries, such as the United Kingdom, Ireland and
France are in the process of implementing plain packaging. In response, the tobacco industry
continues to pour efforts into undermining such regulations elsewhere. While unsuccessful in

216

Australia, tobacco companies are proceeding with aggressive
efforts in other countries that are trying to protect the public
through plain packaging laws.

Figure 6.13 Example of the
No Nanny State Ad
Campaign

The International Tobacco Growers Association (ITGA) is yet
another example of the industry using a front group, in this case
to mobilize tobacco farmers in opposing tobacco control. ITGA
was formed in 1984, and included farmers from Argentina, Brazil,
Canada, Malawi, and the United States. It claims to be a “nonprofit organization . . . with the objective of presenting the cause
of millions of tobacco farmers around the world.” It is hardly
surprising that funding for ITGA comes from tobacco companies
such as Philip Morris and British American Tobacco (BAT). The
organization acts as a front group for lobbying activities against
WHO around the world.
A BAT memo from 1988 describes how the industry wanted the
organization to function:
Manufacturers . . . ‘control’ the primary funding of the organization, and
would thus be able to ensure that it stuck to politics. . . . The ITGA could
‘front’ for our Third World lobby activities at the World Health
Organization, and gain support from nations hostile to multinational
corporations. The ITGA (pushed by us) could activate regional agriculture
lobbies which are at present very weak and resistant to industry pressure.
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It is clear that tobacco companies have established or manipulated groups to advocate for their
interests, and they continue to do so to this day. The use of front groups is just one manifestation of
tobacco industry behavior that has spanned 50 years, with an emphasis on delay and obfuscation and
a net effect of tens of millions of lives lost globally.

Chapter 6 Discussion Questions:
1. How can tobacco companies’ influence on politics be reduced? Other industries also influence
politics in the U.S. Is there any justification for singling out the tobacco industry for legislation
requiring transparency in campaign contribution and use of front groups?
2. Is it possible for tobacco companies to practice true CSR given the nature of the product they
market?
3. Tobacco companies use CSR to advertise to vulnerable communities such as students and
women in shelters. Should this form of advertisement be regulated?
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Figures and Tables

Figure 6.1: The Epidemiologic Triad of Tobacco-Related Disease With
Tobacco Companies as Disease Vectors
Source: Lee, S., Ling, P. M., & Glantz, S. A. (2012). The vector of the tobacco
epidemic: tobacco industry practices in low and middle-income countries.
Cancer causes & control: CCC, 23(0 1), 117–129. doi:10.1007/
s10552-012-9914-0.
Figure 6.2: In December 1952, Reader's Digest Published "Cancer by the
Carton," Alerting Readers to the Link Between Smoking and Lung Cancer
Source: Readers Digest. (2013). How we started a revolution. Retrieved
from: http://www.readersdigest.co.uk/magazine/readersdigestmain/how-we-started-a-revolution.
Movie 6.1: “Nicotine Is Not Addictive”
Figure 6.3: Cartoon by Dan Wasserman, Los Angeles Times Syndicate
Source: Action on Smoking and Health (ASH) (1998). Tobacco explained The truth about the tobacco industry...in its own words. Retrieved from:
http://www.ash.org.uk/files/documents/ASH_599.pdf.

219

Figure 6.4: Selected Quotations From U.S. Tobacco Industry

Figure 6.8: Lobbying is an Major Part of Tobacco Industry Tactics

Internal Documents Which Were Revealed Through Litigation

Source: Kevin McCoy, 2009

Source: No Smoke, 2005
Table 6.2: Political Action Committee (PAC) contributions to
Figure 6.5: Tobacco Billboard in Indonesia Says "Don't Quit"

federal candidates, 2012

Source: Campaign For Tobacco-Free Kids, 2013

Source: Center for Responsive Politics, 2013

Movie 6.2: WHO Countries Stand Shoulder to Shoulder

Figure 6.9: Indonesian Health Center Sponsored by a Tobacco

Fighting Big Tobacco

Company
Source: SEATCA, 2013, CSR Handout

Table 6.1: Top Recipient States of Tobacco Industry
Contributions, U.S., 2011-2012

Table 6.3: Number of CSR Grants Given by PMI in ASEAN

Source: Parkinson, R. (2013). Big Tobacco Wins Tax Battles.

Region, 2009-2012

National Institute On Money In State Politics.

Source: SEATCA, 2013, CSR Handout

Figure 6.6: Tobacco Industry Contributions by Recipient Type,

Figure 6.10: Examples of Tobacco Companies Funding Student

2011-2012

Scholarships

Source: Parkinson, R. (2013). Big Tobacco Wins Tax Battles.

Source: SEATCA, 2013, CSR Handout

National Institute On Money In State Politics.
Figure 6.11: A Sign Outside a Tobacco-Sponsored School in
Figure 6.7: Annual Number of Clients Lobbying on Tobacco

China Reads, “Genius Comes From Hard Work. Tobacco Helps

Source: Center for Responsive Politics, 2015

You to Be Successful.”
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Figure 6.12: A Slogan from Get Government Off Our Back, a
Tobacco Front Group
Source: Apollonio, D. E., & Bero, L. A. (2007). The creation of
Industry front groups: The tobacco industry and “get
government off our back.” American Journal of Public Health,
97(3), 419–427. doi:10.2105/AJPH.2005.081117.
Movie 6.3: Hear from the Experts: Mike Daube on Tobacco
Industry Interference in Australia
Movie 6.4: AAR Commercial Opposing Australian Plain
Packaging
Movie 6.5: No Nanny State Commercial From Imperial Tobacco
Front Group
Figure 6.13: Example of the No Nanny State Ad Campaign
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Chapter 7

Tobacco Marketing

Chapter Objectives
1. Examine the reasons why tobacco companies advertise
their products.
2. Compare and contrast the historical and modern
advertising methods.
3. Analyze marketing strategies for specific populations, such
as women and youth.
4. Examine marketing tactics in foreign countries.
5. Classify the types of U.S. marketing expenditures.

Chapter 7 - Tobacco Marketing
Section 1 - Marketing a Deadly Product—Why Advertise?

Smoking is not a natural activity. Often, when people try their first cigarette, they feel dizzy and
nauseated and find the taste of burned tobacco leaves unpleasant. Demand for smoking has to be
created, and in this chapter, we will examine how this occurs. Understanding the marketing tactics
used by tobacco companies is essential, since these tactics have enabled the tobacco industry to
create a demand that resonates with their customers’ deepest psychological needs and desires.
Philip Morris explains their reasons for advertising their products in the following way:
We design our marketing programs to enhance brand awareness,
recognition and loyalty among adult smokers. We want adult smokers of
our brands to purchase our brands consistently; and we compete to
grow our market share by attracting adult smokers of competitor brands
to switch to our brands. - Philip Morris USA, 2013
That is to say, according to the industry, tobacco products are only advertised to adults who already
smoke—to keep them smoking their brand of cigarettes or to get them to switch from competing
brands. However, we shall see clear evidence that in fact, tobacco companies target children and
young adults. They seek to influence young people to start smoking, creating new generations of
smokers with a lifelong addiction to nicotine. In the U.S. Department of Justice litigation against the
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tobacco companies, Judge Gladys Kessler made a clear pronouncement of the

Key Takeaway

industry’s intent after examining the evidence:

Tobacco companies
claim they only market
to adults who already
smoke, but there is
clear evidence that in
fact, they target
children and young
adults. The tobacco
industry seeks to create
new generations of
smokers with a lifelong
addiction to nicotine.

[Tobacco companies’] marketing activities are intended to bring
in new, young, and hopefully long-lived smokers into the market
to replace those who die (largely from tobacco-caused illnesses)
or quit. - U.S. Department of Justice. United States of America vs.
Philip Morris USA, Inc. et al., Civil Action No. 99-2496
During the 1950s, cigarette marketing was unregulated and ubiquitous in the
media. Tobacco companies often made unfounded claims and used popular

Movie 7.1 Winston Cigarettes Advertised
in The Flintstones Cartoon

imagery to sell their product. Athletes, physicians,
babies, and even Santa Claus figured in cigarette
advertisements as tobacco companies reached out
to audiences both old and young.
Cigarette companies sponsored many of the most
popular television shows: The Ed Sullivan Show, I
Love Lucy with Lucille Ball, and the Flintstones
(Movie 7.1), to name a few examples.
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After the release of the First Surgeon General’s Report in 1964, and because of increasing scientific
evidence on the harmful effects of smoking, cigarette advertising in the media began to be more
closely scrutinized. Tobacco companies were criticized for their tactics. In response to that criticism,
and in anticipation of inevitable legislation, the industry voluntarily adopted a code of advertising
conduct that included the following provisions:

Figure 7.1 Voluntary Cigarette Advertising Code Adopted by Tobacco
Industry
a) Natural persons depicted as smokers in cigarette advertising shall
be at least twenty-five years of age and shall not be dressed or
otherwise made to appear to be less than twenty-five years of age.
Fictitious persons so depicted in the form of drawings, sketches, or
any other manner shall appear to be at least twenty-five years of age
in dress and otherwise.

b) Cigarette advertising shall not depict as a smoker any person
participating in, or obviously having just participated in, physical
activity requiring stamina or athletic conditioning beyond that of
normal recreation.

c) Cigarette advertising shall not represent that cigarette smoking is
essential to social prominence, distinction, success, or sexual
attraction.
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Figure 7.2 shows images of
advertising used by tobacco
companies since developing
the provisions outlined in
Figure 7.1. Reviewing these
provisions alongside their
advertisements gives ample
evidence that, in spite of the
code of conduct that the
industry itself developed and
publicized, the tobacco
industry has used images of
young people and athletes, as
well as strong suggestions of
social desirability and sexual
attraction, to sell cigarettes.
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Figure 7.2 Examples of Advertising Following the Voluntary
Cigarette Advertising Code

Figure 7.3 Examples of Tobacco Advertisements Making Smoking
Look Desirable

Tobacco companies use
advertising to make
smoking look
glamorous and sexy,
and they do so in order
to attract new smokers
and to keep them
smoking (Figure 7.3). As
stated in an internal
report from Philip
Morris in 1999, “The

ability to attract new smokers and develop them into a young adult franchise is key to brand
development.” What’s at stake is not only brand development, but indeed the very survival of tobacco
companies, since longitudinal research has shown that the first brand that teenagers smoke tends to
be their lifetime brand of choice. Thus, targeting young people with their advertising is a way to
secure long-term brand loyalty.
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Figure 7.4 The Joe Camel Campaign was a Huge Success for
Camel Cigarettes

Key Takeaway
The Joe Camel
campaign was a
carefully orchestrated
effort to attract young
people, involving
detailed research into
the personalities and
aspirations of the
campaign’s target
audience.

One of the most recognizable cigarette campaigns was the Joe Camel campaign that began in the
early 1990s. Depicting a cartoon camel in a variety of glamorous settings, the campaign was aimed at
youth who were attracted by the bold colors of the cartoons and Joe Camel’s “cool” demeanor
(Figure 7.4).
The tobacco industry’s internal documents, many of which were made public as a result of the Master
Settlement Agreement of 1998, provide remarkable insight into the tactics that tobacco companies
have used to understand the motivations of their target audience and how they could be
manipulated. The tobacco industry has spent billions of dollars in market research. For instance,
Figure 7.5 shows an excerpt from a Philip Morris document summarizing the key elements in one of

232

Figure 7.5 1994 Philip Morris Document
Summarizing Key Elements of Young Adult
Male Smokers

their studies of young adult male smokers in
1994. Far more than an analysis of their
cigarette preferences, the document
evaluated the attitudes, activities, aspirations,
and social groups of young adults. Young
male smokers were divided into five
categories: Hollow Followers, Regular Guys,
Progressives, Macho Materialists and Solid
Suitors.

So how did Philip Morris use this
information about the population of
young male smokers in the 1990s?
The company took the key
characteristics of each segment and
mapped them along two axes
(Figure 7.6). At the opposite
extremes of the horizontal axis were
those who were driven by the desire
for security, and on the other side
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Figure 7.6 Philip Morris Classification of Young Adult
Smoker Lifestyle and Attitude Segmentation

Hollow Followers
20%

Regular Guys 18%

Progressives 19%

Macho Materialists
17%

Solid Suitors
20%

Self described
"followers" drawn to
downscale glamour want to fit in

Have a positive self
image - "good looking,
cool/hip, creative,
popular"

See themselves as
unique individualists Value authenticity,
creativity, and
imagination

See themselves as
tough, rugged, macho
partyers

Responsible, hard
working, honest

Brands and fashion seen
as the way to peer
acceptance

Brand and fashion
conscious

Reject materialism Don't seek to be
"popular" or "cool/hip"

Value money, a flashy
lifestyle and popularity
as measures of success

Value intelligence,
independence

Low on independence,
authentic, hardworking,
and unique

Prefer "old fashioned"
gender roles and
relationships
Not career or future
oriented

Active and outgoing

Socialness balanced by
self image as "serious,”
"reliable" looking to get
ahead and become
successful leaders

Not concerned with
Key goal to be satisfied
relationships or long
Future oriented with their lives - Do what
term goals – looking out working and saving for
they want, not what they
for number one in the
long term goals
"should" do
here and now
Crave excitement,
travel, cultural and
intellectual stimulation

Key segment for African Region 2, some college
Americans - form 38%
but not employed
of the cluster

Like to hang out with
friends, party and work
on their cars

See women as equals
socially and
professionally
Want a secure family life
but not an “old
fashioned marriage”

were those motivated by a desire for excitement. Meanwhile, the vertical axis portrayed
independence as a motivation at the bottom and acceptance at the top. Mapping each of the five
segments onto this graph, the market researchers at Philip Morris then determined which population
Marlboro cigarettes would be most likely to attract. Figure 7.6 shows that Marlboro’s strongest market
was determined to be among youth who placed a high importance on being accepted by their peers
and who also wanted a life of excitement. These were qualities that corresponded to the segments
described as the Hollow Followers and the Macho Materialists. Thus, much of the market research
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Figure 7.7 Project SCUM by R.J.
Reynolds Targeted Gay and
Homeless People in the Mid-1990s

subsequently done by Philip Morris focused on these two
groups, seeking information about their lifestyle (How do
they get their information? What television programs do
they watch? What radio stations do they listen to? What
do they read?) in order to better target them with
advertisements.
This way of mapping
consumers and potential
consumers has been

Movie 7.2 CounterMarketing Commercial Titled
“What if Big Tobacco Spoke
to You the Way they Speak
About You?

very effective for Philip
Morris in terms of
helping them to reach their target audience effectively. Another
example of a closely researched and extremely targeted marketing
campaign was one that was done by R.J. Reynolds in the
mid-1990s, called Project SCUM. The letters stood for Sub-Culture
Urban Marketing and the campaign was a strategic effort by R.J.
Reynolds to introduce a brand of cigarettes called Red Kamel into
the San Francisco area, with a focus on gay and homeless people.
Project SCUM was later used in an effective counter-marketing
campaign created by the American Legacy Foundation to expose
the truth about how tobacco companies regard their customer
base and how they operate (Movie 7.2 and Figure 7.8).
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Figure 7.8 CounterMarketing Advertisement
Titled “What if Big Tobacco
Spoke to You the Way they
Speak About You?”

Chapter 7 - Tobacco Marketing
Section 2 -Selected Case Studies of Tobacco Marketing

At the beginning of the twentieth
century, it was regarded as socially
unacceptable for women to smoke.
Female smoking was considered a sign
of loose morals and a tendency towards
promiscuous behavior. As late as 1908,
a woman was arrested in New York City
for smoking in public.
Realizing that cultural norms
discouraged smoking for roughly half
the world’s population, tobacco
companies sought ways to promote
smoking among women. The American
Tobacco Company hired Edward
Bernays to create a campaign that
would expel the taboo against female
smoking (Figure 7.9). The nephew of
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Figure 7.9 Early Marlboro Advertisement Aimed at
Women

Movie 7.3 Edward Bernays Attracts a
New Audience to Tobacco Through
"Torches of Freedom" March

Sigmund Freud and dubbed the “father of public
relations,” Bernays is credited with associating smoking
with the fight for women’s liberation. Movie 7.3 is
Bernays’s firsthand account of how he came up with the
idea of making cigarettes “torches of freedom”—symbols
of protest against “man’s inhumanity to women.” Figure
7.10 shows a woman smoking a "torch of freedom"
during a march and an advertisement letting women
know the stigma around female smoking is changing
Around the same time that Bernays was

Figure 7.10 Woman Smoking a "Torch of
Freedom"

associating smoking with women’s freedom and
the right to vote, other marketing campaigns
targeted women by associating smoking with
weight control. Figure 7.11, for example, shows
advertisements for Lucky Strike that claim
“reach[ing] for a Lucky instead of a sweet” helps
keeps a slender figure.
These overt associations of smoking with
freedom, empowerment, and weight control may
seem outrageous to us now—not something that

would be tolerated in contemporary society—but in truth, tobacco advertisements still continue to
appeal to these same aspirations. They portray images of women with an elevated social status,
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sexual allure, and vitality
(Figure 7.12 and Figure
7.13).

Key Takeaway
Tobacco advertising
associates smoking
with freedom,
independence, and
empowerment to
appeal to women.
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Figure 7.11 Lucky Strike Advertisements Associate Smoking With
Weight Control

Figure 7.12 Recent Tobacco Advertisements Still Target Women
This 2010 Lucky Strikes advertisement from American
Tobacco was geared towards women. The Stanford
Research Into the Impact of Tobacco Advertising
group provides the following commentary about this
particular advertisement and the likely intent and
meaning behind the elements in the ad:
“In this recent advertisement, billiards is used as a
mode for conveying sex appeal. The woman leans
over the pool table, making a thrusting action with
her cue toward the man, who leans against the table,
his erect cigarette at about waist level, pointing
directly toward the woman. The woman's bent knee is
angled toward the hole in the pool table, igniting
additional subliminal associations between smoking
and penetration. Her leather pants, and the light cast
upon them, accentuate her rear as she leans forward,
while the Lucky Strike Filters bull's-eye sign on the
wall - the only bit of color in the ad - is positioned
directly above her rear, further implying a connection
between sex appeal and Lucky Strike cigarettes.”
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Figure 7.13 2010
Advertisement for USA
Gold Cigarettes

Another important case study of tobacco marketing tactics involves
the introduction of light cigarettes in the 1970s. As discussed in
Chapter 4, light cigarettes are no less harmful than full-flavored
cigarettes, yet tobacco companies market them as a safer option for
smokers. As the public became increasingly concerned about the
harms of smoking, tobacco companies realized that they needed to
provide “health reassurance to the concerned smoker” or risk losing
their market share. Light cigarettes were created to “assuage smokers’
guilt” for continuing to smoke, and were particularly targeted toward
women, the market segment that was most concerned about the
negative health consequences
of smoking (Figure 7.14).

The concept of light cigarettes goes beyond simply calling a
cigarette “light;” it extended to the way cigarettes were
packaged, the colors used in advertisements, and the way the
cigarettes themselves looked. For example, a Philip Morris Vice
President of Marketing was quoted as saying that the company
used a “lighter, more white background” and a “white filter as
opposed to a cork colored filter” to communicate to consumers
that the cigarettes are low-tar, even though in reality, these
cigarettes are no less harmful than the traditional full-flavored
variety (Figure 7.15).
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Figure 7.14 Light Cigarette Ad
Intended to Assuage Guilt

Yet another case study of tobacco marketing tactics focuses on the industry’s efforts to get young
people to start smoking. As we learned in Chapter 3, the vast majority of adults who smoke every day
started smoking before they were 18
years old. In other words, a person who
does not smoke by the age of 18 is far
less likely to ever become a smoker.
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Figure 7.15 Examples of “Light” Cigarette
Packaging

Figure 7.16 Advertising
for Little Cigars was Still
Legal in the U.S. in 2014

Figure 7.17 Joe Camel
Advertisement from
1990

Tobacco companies thus know the
importance of making smoking
attractive to youth. Moreover, as we
learned earlier in this chapter, the first
brand that teenagers smoke tends to
be their brand of choice for their
lifetime. Therefore, tobacco companies
have made considerable effort to get

young people to smoke their particular brand, in spite of their
statements to the contrary. The tobacco industry still claims that
the purpose of their advertising is strictly to influence the
behavior of adults who already smoke. The ads shown in Figures
7.16, Figure 7.17, and Figure7.18 tell a very different story.
The advertisements featured above are brightly colored,
reminiscent of candy and sweets, and are clearly directed at a
younger market. Industry documents have revealed that tobacco
companies worked with candy makers to create sweets that
mimic cigarette pack designs (Figure 7.19). Indeed, the industry’s
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Figure 7.18 2012 Russian Kiss
Cigarette Ad Translated as "If
you're not allowed it, but you
really want it, then you can
have it!"

Figure 7.19 Candy Cigarettes
Strongly Resemble the Real Thing

efforts to get young people to see smoking as an
appealing activity is vitally important to the success of
tobacco.
The 1994 Surgeon General’s Report concluded:
“Cigarette advertising uses images rather than
information to portray the attractiveness and function of
smoking. Human models and cartoon characters in
cigarette advertising convey independence,
healthfulness, adventure-seeking, and youthful activities
—themes correlated with psychosocial factors that
appeal to young people.”
Cigarette advertising continues today in the United
States, and tobacco companies continue to target
young people (Figure 7.21). Between January 1993 and
May 2003, Philip Morris USA spent a total of

$133,727,300 on cigarette brand advertising in Sports Illustrated and other magazines popular
among youth. According to magazine industry data, each issue in this time
frame was read by an estimated 4.7 million readers aged 12-17 years.
If further proof is needed that cigarette advertisements are designed
specifically to appeal to youth, it is worth taking a look at the Joe Camel
campaign that was developed in the 1980s (Figure 7.20). Among the
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Key Takeaway
The tobacco industry uses
cartoons, sweet flavors, and
tried-and-true images of
peer acceptance and sex
appeal to target youth.

Figure 7.20 The Joe Camel Campaign by
R.J. Reynolds Was Incredibly Successful

tobacco industry’s internal documents is a focus
group report from 1985 that states: “Due to the
growing importance of young adult smokers, Camel
has developed a campaign which is directed solely
towards this group.” Further, an R.J. Reynolds
document from the following year reveals: “Overall,
Camel advertising will be directed toward using
peer acceptance/influence to provide the motivation
for target smokers to select Camel.” The document
goes on to state that Camel advertising would create
“the perception that Camel smokers are nonconformist, self-confident and project a cool
attitude, which is admired by their

Figure 7.21 Lil’ Wayne’s Brand of Cigars,
Bogey Cigars, Could Be Appealing to Youth
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peers. . .Aspiration to be perceived as a cool member of the in-group is one of the strongest
influences affecting the behavior of young adult smokers.”
The Joe Camel campaign was extraordinarily successful. Prior to 1988, when the campaign was
launched, Camel’s market share had progressively fallen to only 3.2%. Camel’s share of adult smokers
only increased from 2.7% to 4% between 1988 and 1993. However, Camel’s share of the teenage
market grew to 13% by 1993. Since the start of the campaign, studies have shown that young people
ages 10-17 could recognize Joe Camel and associate the character with smoking cigarettes just as
they associated the Keebler elves with cookies. The proportion of youth who recognized Joe Camel
was higher than the proportion who knew that Ronald McDonald advertised McDonald’s fast food
chain (Figure 7.22). Clearly, the Joe Camel campaign was remarkably successful in terms of increasing
visibility and recognition among younger audiences and accomplishing the strategic objectives of
R.J. Reynolds, which centered around capturing a young adult market share for Camel.

Figure 7.22 Young People Recognize Joe Camel More Than Other Popular Figures
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Michael Eriksen, who served as
the director of the CDC’s
Office on Smoking and Health
from 1992 to 2000, comments
on his experience of serving as
an expert witness in litigation
brought by the states against
the tobacco companies in
Movie 7.4.
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Movie 7.4 Hear from the Experts: Michael Eriksen, ScD

Chapter 7 - Tobacco Marketing
Section 3 -Today’s Tobacco Marketing

In the United States, some restrictions have been placed on tobacco marketing over the last twenty
years largely due to litigation brought against the tobacco companies. These restrictions include:
•Bans on outdoor advertising within 1,000 feet of schools and playgrounds.
•Bans on brand sponsorships of sports and entertainment events.
•Bans on free giveaways of any non-tobacco items with the purchase of a product.
•Bans on free samples.
•Limits to outdoor and point-of-sale advertising.
•Restrictions on vending machines to adult-only facilities.
•Establishment of 18 as a federal nationwide minimum age for legal tobacco sales with strong
federal penalties.
•Requirement for retailers to verify age for all over-the-counter sales and provides for federal
enforcement and penalties against retailers who sell to minors.
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While advertising in newspapers and magazines has
declined due to restrictions, tobacco companies still
take advantage of the lack of federal regulations to

Figure 7.23 Camel Crush Bold
Advertisement Seen in Magazines
Commonly Read by Youth

target young people through print media. For
instance, undeterred by existing restrictions, Camel
Crush ran ads in several magazines with a high youth
readership in 2013, including Entertainment Weekly,
ESPN the Magazine, Sports Illustrated, Rolling Stone,
People, Glamour, InStyle, Us Weekly, and Vogue. In
addition, young people are increasingly exposed to
tobacco advertising through in-store ads and the
Internet.
A prominent feature of the ad shown in Figure 7.23 is the invitation to “Get your coupons and try it
out.” In addition to traditional marketing, which we tend to equate with print or online advertising,
tobacco companies use price discounts and other efforts that lower the price of tobacco products
and make them more affordable. This is of particular concern with regard to the youth market,
because research has shown that young people are more sensitive to price increases than other age
groups. That is, as cigarette prices go down, youth become more likely to use cigarettes, while price
increases significantly discourage their use. Tobacco companies thus employ various tactics, such as
coupons or in-store promotions like “buy one, get one free,” as seen in Figure 7.25, to make tobacco
products as affordable as possible.
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Another way that the tobacco companies appeal to young people to try their products is by adding
flavors that mask the harsh taste of tobacco (Figure 7.24). In 2009, the Food and Drug Administration
(FDA) banned the sale of flavored cigarettes based on studies that show “that 17-year-old smokers
are three times
as likely to use

Figure 7.24 Examples of Advertisements Promoting Flavors

flavored
cigarettes as
smokers over
the age of 25.”
However, the
ban does not
cover menthol
products, cigars,

Figure 7.25 Tobacco Companies Promote Discounts

cigarillos, or smokeless tobacco.
These products are still marketed in
flavors such as vanilla, strawberry,
and cotton candy, which are
attractive to youth.
In addition to price discounts and
flavorings, tobacco companies
continue to rely on the tried-and-true
method of using sex appeal and social desirability in advertising. Cigarettes ads associate smoking
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Figure 7.26 Cigarette Advertisements
Focused on Sex Appeal and Happiness

with aspirations that people have to be attractive,
glamorous, sexy, successful, and happy (Figure 7.26).
The tobacco industry also has a history of sponsoring
sporting events such as tennis matches, auto races,
and football games as in Figure 7.27. To give an
example of the reach of this kind of marketing, the
estimated value of R.J. Reynolds’s Winston exposure
in 2002 during televised racing events was $1.2
billion, with the advertisements reaching over 533
million viewers. While their ability to sponsor sports
has been severely limited, tobacco companies are
still allowed to have one major sponsorship event
per year.

Figure 7.27 Examples of Advertisements for Sports
Sponsorships

Today, we not only have to
contend with the marketing of
traditional tobacco products
but also the aggressive
marketing of e-cigarettes,
pictured in Figure 7.28. As we
discussed in Chapter 4, there is
still much work to be done in
order to determine whether e-
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Figure 7.28 Today's E-Cigarette Advertisements

cigarettes will help smokers to quit or actually reinforce nicotine addiction. What we do know is that
while traditional cigarettes have not been allowed to be advertised on
television since 1971, e-cigarette advertising is allowed and they have
become ubiquitous on television, in newspapers and magazines, on the
Internet, and at point of purchase.
Tobacco companies advertise e-cigarettes using many of the same
marketing tactics that were banned in the 1970s for cigarettes (Figure 7.29,
Figure 7.30, and Figure 7.31).
Increasingly, e-cigarettes are marketed as an alternative option for smokers
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Key Takeaway
Tobacco companies now
advertise e-cigarettes
using many of the
marketing tactics that
were banned for
cigarettes in the1970s.
People who were born
within the last 40 years in
the United States can now
see advertisements from
the tobacco industry on
television for the first time
in their lives.

Figure 7.29 Sex Appeal
(1974 vs. 2014)

when they are in places where they are not allowed to smoke. Of
particular concern, many ads for e-cigarettes encourage exsmokers to enjoy smoking again. In other words, rather than
helping people to quit smoking, the marketing for e-cigarettes
actually presents the product as a way to obtain even more
nicotine or as a way for ex-smokers to return to nicotine (Figure
7.32). E-cigarette marketing has a strong potential to undermine
much of the progress made so far in tobacco control. FDA now

Figure 7.30 Nightlife (1973
vs. 2013)

has the authority to regulate
all tobacco products,
including e-cigarettes, and
how they are marketed. Until
this authority is put to use
and regulations are enacted,
tobacco control advocates

Figure 7.31 Tough Guys
(1983 vs. 2013)

must be wary of the
potential population-level
consequences use of these
products might create.
Directing our focus on
tobacco marketing around
the world, we find that
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Figure 7.32 Some E-Cigarette
Ads May Encourage Former
Smokers to Return to the Habit
of Using Nicotine

many countries have even more extensive bans on
tobacco marketing than the United States.

Japan: JTI sponsors women’s volleyball

However, less than 10% of the world’s population

In late 2011, JTI earned the unusual

live in countries covered by a complete ban on all

dishonor of being crticized by name by

types of advertising, promotion, and sponsorship.

WHO. This occurred after the Japanese

Tobacco advertising is still alive and strong in

national team player Risa Shinnabe, a star

much of the world, especially in low- and middle-

volleyball player whose picture is

income countries.

doubtless on the bedroom walls of

The Global Adult Tobacco Survey (GATS)

thousands of teenage Japanese girls, was

measures the varying levels of exposure to

pictured wearing a JTI logo as she waved

tobacco ads on different media around the world.

to adoring fans after her team beat U.S.

Table 7.1 shows the results of the survey from

opponents in Tokyo. JTI's logo was

2008-2010.

reportedly emblazoned not only on team

In low- and middle-income countries, sponsoring
sporting events remains a leading tobacco

around the volleyball court, on television

marketing tactic. To give a recent example, in

advertisements and gift packs handed to

2012, Japan Tobacco International (JTI) sponsored

schoolgirls, mothers and children entering

the Volleyball World Cup, an event that has been

the Yoyogi National Stadium and other

hosted annually in Japan since 1997 (Figure 7.34).

arenas across Japan during the Volleyball

JTI placed its logo on national team uniforms,
courtside digital billboards, and gave away “gift
packages” to spectators.
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uniforms, but also on digital billboards

Figure 7.33 E-Cigarettes
Displayed Adjacent to Candy

Figure 7.34 JTI Sponsored the 2011 Volleyball World Cup
with Extensive Advertisements, Including Uniforms with the
JTI Logo

A spokesman for WHO's Tobacco Free Initiative said WHO was
contacting the international governing body of volleyball to convey WHO's disappointment and to
remind it that in 2002 it publicly committed to making volleyball a tobacco free sport. WHO hoped JTI
would soon abide by its international commitments to the FCTC.
In responding to widespread criticism over the sponsorship, JTI claimed to abide by all laws and
voluntary codes in Japan. “Nowhere in our corporate sponsorship of volleyball games do we
advertise our cigarette brands or products,” a spokesman said. A sports journalist added that JTI was
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Table 7.1 Direct and Indirect Marketing Data in Select Countries

a sponsor “in the beverage category” because it also had a division selling tea, coffee and other
drinks.
Manabu Sakuta, a Tokyo doctor and head of Japan's society for tobacco control, said, “This is
complete nonsense. It seems that they are not a national team, but a Japan Tobacco team.” Other
observers voiced the fear that Japan risked losing its bid to host the 2020 Olympic Games because of
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Figure 7.35 Billboard
Advertisement for Concert
Sponsored by L.A. Lights

growing local and international opposition to JTI's sponsorship of
World Cup volleyball.
Tobacco sponsorship extends not only to sporting events but also to
music concerts and cultural functions. However, with efforts from
public health advocates, these tactics can sometimes backfire on
tobacco companies. For instance, in 2010, American Idol winner Kelly
Clarkson was set to perform a concert in Indonesia that was
sponsored by L.A. Lights, pictured in Figure 7.35. Public health
advocates called on Clarkson to pull the cigarette sponsorship, and
fans added more pressure by posting hundreds of Facebook
messages and sending over 1,300 emails to her management.
Clarkson ultimately cancelled the sponsorship, ended her association

with L.A. Lights, and continued with the concert.
Tobacco companies still use marketing to associate
smoking with sex appeal, as the international ads in
Figure 7.36 demonstrate.
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Figure 7.36 Cigarette Ads Using Sex
Appeal

Figure 7.37 shows an especially egregious ad for Kiss Cigarettes, released in Russia in 2011, just prior
to an anticipated ban on cigarette advertising in that country. The caption over the image of a rather
young girl states, “I love everything new, delicious and round!”

Figure 7.37 Russian Kiss Advertisement
Clearly Targeted at Young Women
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Chapter 7 - Tobacco Marketing
Section 4 - Marketing Expenditures and Tactics

In the United States, the Federal Trade Commission (FTC) tracks expenditures on tobacco marketing,
including marketing for cigarettes and smokeless tobacco. The latest available figures are from 2013,
during which $8.95 billion was spent on cigarette advertising and promotion in the country, a
decrease from the $9.17 billion reported in 2012.

Table 7.2 2013 Cigarette Advertising and Promotional Expenses for the U.S.
CIGARETTE ADVERTISING AND PROMOTIONAL EXPENDITURES FOR 2013
(DOLLARS IN THOUSANDS)
Price Discounts
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7,642,441

85.4%

Promotional Allowances – Wholesalers

397,182

4.4%

Promotional Allowances – Retailers

291,334

3.3%

Coupons

248,833

2.8%

Public Entertainment – Adult-Only

104,647

1.2%

All Other: Point-of-sale, outdoor, magazines, specialty item
distribution, direct mail, company website, Internet, etc.

263,773

2.9%

Table 7.2 reveals that most of the tobacco
marketing dollars are spent on price discounts.
This category includes coupons, two-for-one

Figure 7.38 Virginia Slims Direct-Mail
Advertising and Coupons Closely Associated
with Fashion

promotions, and other investments made by
tobacco companies to make smoking more
affordable and to nullify the impact of tax
increases that occur in various states. Since
marketing by other means is more strictly
regulated, the tobacco industry takes advantage
of the insufficient regulation around price
discounts to make their products cheaper for
customers.
The FTC breaks down the term “promotional
allowances” into four subcategories:
•Price discounts – manufacturers’ reductions
in the prices paid by retailers and/or wholesalers for tobacco products, who in turn reduce the
prices to consumers (such as buy-downs and voluntary price reductions) (Figure 7.38).
Key Takeaway
Since marketing by other means is more strictly regulated
in the United States, the tobacco industry takes
advantage of the insufficient regulation around price
discounts to make their products cheaper for customers.
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•Allowances paid to retailers – payments from
manufacturers to retailers to promote increased
sales volume or secure preferred placement of their
brands, such as volume rebates and other

payments for stocking, shelving, displaying, and merchandising brands in a certain manner.
•Allowances paid to wholesalers – payments from manufactures to wholesalers, including volume
rebates, incentive payments and fees for performing services related to retail value-added
promotions.
•“Other” allowances – payments made to others (besides retailers and wholesalers) involved in
the cigarette distribution and sales process, to promote the sale or placement of the
manufacturer’s brand.
The FTC reports are especially helpful not only in defining different kinds of marketing expenditures,
but also in making it possible to track changes in tobacco marketing over time. For instance, the
reports can be used to examine the shift from direct media marketing to price discounts in the last
few decades.
Figure 7.39 and Figure 7.40
illustrate trend data from the
FTC reports from 1970 to
2011. The amount spent on
price discounts and
promotional allowances to
retailers and wholesalers
has increased in both dollar
amount and as a proportion
of total advertising
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Figure 7.39 Trends in Promotional Advertising from 1970-2011
(Price Discounts and Promotional Allowances)

expenses, resulting in more affordable
cigarettes for consumers.
Again from FTC data, Figure 7.41 shows

Figure 7.40 Trends in Promotional Advertising from
1970-2011 (Spending on Price Discounts and
Promotional Allowances as a Percent of Total
Advertising Expenses)

the combined marketing expenditures for
both cigarettes and smokeless tobacco
products from 1998 to 2011. While this
graph illustrates important changes in
tobacco marketing over this period, it
does not tell the deeper story that
tobacco companies spent nearly $500
million marketing smokeless tobacco in
2011—three times the amount they spent
in 1998, the year of the Master Settlement

Figure 7.41 Marketing Expenditures for Cigarettes
and Smokeless Tobacco

Agreement. This provides some indication
of how tobacco companies are shifting
their efforts away from traditional
cigarettes towards alternative products
such as smokeless tobacco.
Tobacco products are dependent on
successful marketing campaigns. In the last century, tobacco companies developed very
sophisticated and effective marketing strategies to sell their products in the United States and around
the world. In some countries, many of the outlets for marketing and promotions have been restricted
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or banned. However, the current trend is the use of social media and the Internet to communicate
about tobacco products. The Internet is currently unregulated by the Federal Communications
Commission, and so cigarette and smokeless tobacco advertising can be done online and tobacco
companies are rapidly increasing their expenditures for websites and marketing on the Internet.
Going forward, tobacco control advocates must be attentive to the industry’s efforts to make tobacco
use appear commonplace and desirable in these unregulated venues, as well as keep a close watch
on novel products, including e-cigarettes, which are currently outside the realm of traditional
marketing restrictions.

Chapter 7 Discussion Questions:
1. How has tobacco advertising changed in the last twenty years? Is it less or more effective in
getting products sold?
2. Are tobacco companies using the Internet to advertise to youth? How can this reach be
regulated in the future?
3. It is clear that advertising techniques used by tobacco companies are effective. Should public
health more aggressively counter-market tobacco products at sporting events, on the Internet,
and other venues currently utilized by tobacco companies?
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Chapter 8

Tobacco Control
Frameworks

Chapter Objectives
1. Examine tobacco control interventions to determine if they
are clinical or population-based.
2. Demonstrate how the social-ecological model relates to
tobacco control.
3. Hypothesize how the role of changing social norms has
impacted tobacco control and how this can be furthered as
a tobacco control method.
4. Compare and contrast global frameworks for tobacco
control.
5. Examine how tobacco control methods work differently in
various locations and venues.
6. Contrast the pros and cons of the role of government in
tobacco control.

Chapter 8 - Tobacco Control Frameworks
Section 1 - Clinical vs. Population Approaches to Tobacco Control

The early history of tobacco control reveals an inclination to try to address the problem of tobacco
use by developing smoking cessation interventions at the individual level. Such approaches
emphasize one-on-one treatment delivered by healthcare providers and are often called clinical
interventions. The following are different types of clinical interventions that are implemented today:
•

Healthcare Provider Interventions – Formal and informal advice and information can influence

the smoking habits of patients.
•

Individual Cessation Behavior - Most smokers quit through self-quitting measures and there

are many reasons why people may or may not quit smoking (role of addiction, weight gain, fear of
withdrawal).
•

Pharmacotherapy - Pharmacotherapy includes Nicotine Replacement Therapy (transdermal
patches, gum, inhalers, lozenges, nasal spray) and medications that do not include nicotine
(varenicline and bupropion).

•

Healthcare Systems - Healthcare providers and clinicians are effective at screening individuals

to determine smoking status and offering cessation advice. Health systems must support and
enhance the work of clinicians.
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During the 1980s, the focus of tobacco control efforts changed, under the leadership of Joseph
Cullen, who served as Deputy Director of the National Cancer Institute from 1982-1989. Cullen
emphasized a purposeful transformation of the field by shifting tobacco control efforts from a
clinical orientation towards a population-based approach. Population-based interventions affect
large numbers of people and are much less costly than individual approaches. Because of their
effectiveness, population-based interventions have become more of the norm in tobacco control
and are now being studied for other areas of public health, such as obesity and violence. The
following are population-based approaches to tobacco control:
•

Tax Increases - As price increases, consumption decreases.

•

Smoke-Free Policies and Laws – Making smoking socially unacceptable can impact smoking

and cessation rates.
•

Graphic Warning Labels and Plain Packaging – The cigarette package is integral to the

marketing strategy of tobacco companies.
•

Marketing Restrictions and Counter Marketing Campaigns – Restrict the glamorization of

smoking and tell the truth about tobacco.
•

Quitlines and Technology-Based Interventions – Efficiently and effectively provide cessation

support to large numbers of people.
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The shift from a clinical focus to a
population focus can be attributed in
large part to what is known as the Rose

The Rose hypothesis:

hypothesis. Put forward by the eminent

Since diseases are rare, most

epidemiologist Geoffrey Rose in 1992,

individuals who adopt a behaviour

the Rose hypothesis suggests that
greater population benefits can be

designed to lower their risk of disease

achieved through small changes in many

will not benefit directly, although a few

people than by large changes in a few
people. Put more concretely, smoking

individuals may benefit enormously. For

cessation for a few individuals is

example, any one person’s decision to

important for those individuals, but large-

lose weight may only have a small

scale population interventions that affect
entire communities (sometimes entire

impact on that person’s risk of disease

nations) are more efficient and yield a

in the near future, but if many people

much larger public health benefit.

each lose a little weight, this may have a
substantial impact on the community’s

Key Takeaway
Population-based interventions affect large
numbers of people and are much less costly than
individual approaches. Because of their
effectiveness, population-based interventions
have become more of the norm in tobacco
control and are now being studied for other areas
of public health, such as obesity and violence.
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obesity-related disorders.

Not only are population-based interventions less costly than individual interventions, in some cases
they actually raise money. Tax increases are a case in point. As we saw in the last chapter, the tobacco
industry uses coupons and price discounts to manipulate the price of cigarettes because they know
that making the product more affordable increases consumption. Correspondingly, studies have
shown that raising the price of cigarettes with the addition of excise taxes is the most effective way of
decreasing consumption, so taxes have become a very important population-based tobacco
intervention (Chapter 10).
Another example of a population-based approach to tobacco control that has been very effective is
implementing smoke-free policies and laws, which involves establishing clean indoor air regulations
in private settings or in public venues (Chapter 9). In the United States, indoor smoking bans have
been increasingly implemented and now cover almost the entire nation.
A third major type of population-based tobacco intervention is the implementation of graphic
warning labels and plain packaging laws (Chapter 13, Section 3). In Australia, all tobacco products are
required by law to be sold in plain packaging — no brand logos — and health warnings cover 75 per
cent of the front of most tobacco packaging, 90 per cent of the back of cigarette packaging and 75
per cent of the back of most other tobacco product packaging (Figure 8.1). Knowing how important
brand recognition is in tobacco companies’ attempts to communicate a link between smoking their
products and a certain kind of lifestyle or status, the cigarette package is integral to the industry’s
marketing efforts. Further, graphic warning labels on cigarette packs can have large population
impact as the harms of smoking are disclosed to every smoker in a powerfully visual way with every
pack of cigarettes he or she picks up.
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Figure 8.1 Example of Australian Plain Packaging
Images used with permission of the Australian Government

Fourth, restrictions on marketing and
the use of counter-marketing
campaigns have large population
impacts (Chapter 11). As discussed
in the last chapter, marketing of
tobacco products is essential for the
industry’s commercial success, and
studies have shown that countermarketing campaigns are very
effective in deterring use,
particularly among youth.

Finally, quitlines and technology-based interventions provide cessation support to large numbers of
people. Located somewhat at the border between individual- and population-based approaches to
tobacco control, quitlines are being implemented at the state and national levels to provide support
for smokers who want to quit. In the future, public health practitioners will likely harness smartphone
technology to effectively reach smokers with messages to support their cessation efforts.
In addition to understanding the importance of population-based approaches, we must also keep in
mind the need for a theoretical framework within which to understand behavior change and ways to
sustain that change to benefit the public health. Currently, the CDC uses a four-level social-ecological
model for understanding tobacco control from a theoretical perspective (Figure 8.2). Developed by
Albert Bandura at Stanford University, the social-ecological model presents a comprehensive way of
observing and sustaining change that involves both physical factors such as biological and genetic
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Figure 8.2 The Social-Ecological Model

characteristics as well as behavioral factors. The model accounts for a person’s relationships with his
or her family and peer groups; the community setting in which these relationships exist and whether
laws encourage or discourage certain behaviors; and the societal milieu in which normative factors
come into play, creating a climate in which specific behaviors are either encouraged or discouraged.
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Having this broad, theoretical perspective helps to ground interventions and makes for a more
comprehensive and more effective treatment package.
A look at the history of tobacco control in China provides a good example of the far-reaching impact
of population-based approaches. There are currently 300 million smokers in China, most of them
male. The country has very low rates of cessation: only 10% of ever-smokers (persons who have
smoked at least one hundred cigarettes and cigars) in China have quit. If China reached the current
quit rate in the United States, which is about 50% of ever-smokers, there would be 150 million former
Chinese smokers. There is, thus, a great opportunity for large-scale smoking cessation and the
question rests on how this can be achieved by tobacco control. Reaching this vast number of people
would be very difficult, if not impossible, using clinical cessation measures, treating one smoker at a
time. It is far more efficient to achieve cessation through population-based measures such as tax
increases, smoke-free laws, and other efforts that discourage smoking, build self-efficacy, and make
smoking no longer socially acceptable.
The literature on tobacco control is replete with examples of the great impact of population
interventions. With regard to tax increases, it is generally shown that a 10% increase in the price of
tobacco results in a 3-5% increase in cessation rates. Clean indoor air laws not only protect
nonsmokers from hazardous exposure to secondhand smoke, but also
increase smokers’ quit rates by 12-38%. In comparison, the success rates of
individual or clinical approaches (such as nicotine replacement therapy or
physician counseling) are lower and reach fewer smokers. It is important to
note that most people who quit smoking (48%) do so “cold-turkey”—without
any intervention. Only about 5% quit with the use of nicotine patches, 2%
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Key Takeaway
The social-ecological
model provides a
theoretical framework for
tobacco control efforts.

with pharmaceuticals, and 1% with nicotine gum. So, while all of these efforts, both individual and
population-based, should be included in the armamentarium of tobacco control, the evidence is
increasingly showing that population-based efforts are more efficient, more cost-effective, and have a
greater impact on tobacco consumption than individual approaches.
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Chapter 8 - Tobacco Control Frameworks
Section 2 - The Importance of Social Norms

The Dictionary of Sociology (1998) defines social norm as a “shared expectation of behaviour that
connotes what is considered culturally desirable and appropriate.” Norms are similar to regulations or
rules in that they are prescriptive, but they lack the formal status of rules. If a person’s behavior differs
from the norm, it may be judged by others as “deviant.” Social norms function at both micro and
macro levels—i.e., they influence individuals as well as groups—and are therefore very important for
tobacco control.
We can take the example of secondhand smoke to further our understanding of the importance of
social norms. In the 1960s and 70s, as more and more people decided they did not want to be
exposed to secondhand smoke, social norms began to change, and ultimately policies and laws were
implemented. Smoke-free laws demonstrated a change in the social acceptability of smoking by: 1)
changing the everyday practices of smokers; 2) making smoking in public places more difficult; and
3) relocating smokers to designated areas, which were often marginal places. This change in social
norms resulted in an overall denormalization of smoking. In other words, though smoking was once
viewed as the norm—something that occurred everywhere and was even viewed favorably, thanks to
tobacco advertising—it came to be viewed increasingly as undesirable or at the very least,
inconvenient. This normative change has in turn resulted in reduced smoking.
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Figure 8.3 illustrates a conceptual model with which we can understand how social norms changed
for tobacco. The movement to create smoke-free laws to protect non-smokers was a reaction to what
we call a negative externality—a term borrowed from economics that denotes a person’s behavior that
affects someone else who did not choose the same behavior. Smoke was an example of a negative
externality, since nonsmokers had to smell and inhale the smoke from others’ cigarettes.

Figure 8.3 The Process of Changing Social Norms

The recognition of smoke as an inconvenience and as something unpleasant for nonsmokers
prompted action. Shortly thereafter, nonsmokers’ refusal to tolerate smoke was further intensified by
emerging evidence about the harm caused by secondhand smoke in multiple scientific reports in the
1980s, including Reports of the Surgeon General and studies done by the National Research Council.
The externality of being exposed to other people’s smoke combined with greater awareness of harm

281

led to social engagement: nonsmokers mobilized to prevent smoking in

Key Takeaway

shared spaces. As we will discuss in more detail, California was one of the first

The history of tobacco
control demonstrates
that formal laws
generally follow
changes in social
norms, rather than the
other way around.

states to put measures on the ballot to ban smoking in workplaces and public
places. Thus, social engagement facilitated changes in the social norms.
Smoking no longer occurred in workplaces, at dinner parties, and other
venues, and when people did smoke, they were seen as being deviant.

Smoking was no longer socially acceptable. Ultimately, as a result of this cascade of effects,
government and institutional policies began to change, codifying the demand from civil society that
emanated from negative externalities, increased awareness, and social engagement. Notably, rather
than the government leading the charge, it actually codified the protection of people only after citizen
engagement and the denormalization of smoking were already in motion.
The California Tobacco Control Program (CTCP) was the first to integrate a “social norm change”
approach as part of its core strategy for achieving goals, and its mission statement continues to
emphasize the promotion of “social norms that create a tobacco-free environment.” CTCP used the
social-ecological model to create systems-level changes in organizations, such as schools,
workplaces, government agencies, and entertainment venues, with the goal of “indirectly
influenc[ing] current and potential future tobacco users by creating a social milieu and legal climate in
which tobacco becomes less desirable, less acceptable and less accessible.”
California’s example has provided solid evidence that changing social norms is an effective tobacco
control method. A study published in 2006 quantified the relationship between the social
unacceptability of smoking and decreased cigarette consumption. Researchers found that effective
tobacco control campaigns could increase the perceived social acceptability of smoking, resulting in
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a 15% drop in cigarette consumption. This 15% drop was equivalent to what would be achieved by
raising the excise tax on cigarettes by $1.17. Changing social norms is thus a proven cost-effective
strategy for reducing tobacco consumption which, moreover, provides the ancillary benefit of
protecting nonsmokers from exposure to secondhand smoke.
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Chapter 8 - Tobacco Control Frameworks
Section 3 - Strong Evidence for the Effectiveness of Tobacco Control

In tobacco control, we have many reasons to be optimistic. Numerous interventions have been
scientifically proven to reduce the use of tobacco products. These interventions have been reflected
in a variety of channels, including Surgeon General’s Reports, Cochrane Reviews, guidance to
countries (MPOWER), and international treaties (WHO Framework Convention on Tobacco Control).
The latter two will be discussed in Chapter 13. These evidence-based interventions have been
established through rigorous research programs and reinforce the importance of scientific study and
evaluation to guide the development of tobacco control programs globally.
The first report of the Surgeon General, issued in 1964, identified smoking as a problem that required
appropriate remedial action. The Surgeon General’s Report in 2000 summarized the evidence from
thousands of articles and described how interventions could be broken down into clinical and
population approaches. This report, titled Reducing Tobacco Use, concluded that the approaches
with a smaller span of impact (i.e., educational and clinical approaches) are of greater importance in
helping individuals resist or abandon the use of tobacco; however, economic, regulatory, and
comprehensive approaches are likely to have the greatest long-term population impact.
In addition to the summaries provided by the Surgeon General’s Reports over the last fifty years, we
have benefited from having a number of thorough and well-funded systematic reviews that help
guide and summarize the evidence for the effectiveness of different types of tobacco control
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interventions. One of the most influential and rigorous systematic reviews is the Community Guide to
Preventive Services. Established in 1996 by the U.S. Department of Health and Human Services and
directed by the Task Force on Community Preventive Services, the guide reviews evidence regarding
specific aspects of tobacco control. Overall, it focuses on 22 topic areas of research within public
health, including tobacco. The Community Guide is a valuable resource for tobacco control programs,
reviewing 17 different interventions in this area.
Also very influential are Cochrane Reviews, the global systematic review of primary research in human
health care and health policy. These reviews meet the highest standards in evidence-based
healthcare. They are developed by the Cochrane Collaboration, a network of more than 31,000
reviewers from over 100 countries. Founded in 1993 and based in the United Kingdom, the
Collaboration has published over 5,000 reviews online in the Cochrane Database of Systematic
Reviews. As of December 2015, there are 91 reviews specifically focusing on tobacco, many with an
emphasis on clinical interventions, but also some investigating issues around counter-marketing and
the effect of advertising on tobacco use.
Unique among the other areas of public health, tobacco control has the benefit of an international
treaty that helps guide countries in their efforts to reduce the burden of tobacco use. The World
Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) and its guidelines
provide a foundation for countries to implement and manage tobacco control. The World Health
Assembly adopted the FCTC in May 2003 and as of early 2016, 180 parties (i.e., countries) have
ratified the treaty.
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The WHO FCTC embodies the evidence that has been scientifically proven through Reports of the
Surgeon General, Cochrane Reviews, and other rigorous evaluations. It takes what we know about
what works for reducing tobacco use and codifies this research into a treaty with numerous articles
pertaining to specific aspects of tobacco control. The entire text of the FCTC is available online, but
the following highlights some of the articles pertaining to protecting the public from the harms of
tobacco:
•

Article 5.3: Protection of public health policies with respect to tobacco control from

commercial and other vested interests of the tobacco industry.
•

Article 8: Protection from exposure to tobacco smoke.

•

Articles 9 and 10: Regulation of the contents of tobacco products and of tobacco product

disclosures.
•

Article 11: Packaging and labeling of tobacco products.

•

Article 12: Education, communication, training and awareness.

•

Article 13: Tobacco advertising, promotion and sponsorship.

•

Article 14: Demand reduction measures concerning tobacco dependence and cessation.

Dr. Douglas Bettcher is currently the Director of WHO’s Department for Prevention of
Noncommunicable Diseases based in Geneva, Switzerland. Dr. Bettcher is credited with promulgating
the WHO FCTC ,and in Movie 8.1 he talks about his experience in pushing forward this important
global health treaty.
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In addition to the proven strategies
we’ve discussed so far, we have what is
known as the MPOWER package for
reducing global tobacco use. To help
facilitate the goals of the who FCTC,
WHO introduced the MPOWER
measures. These measures are
“intended to assist in the country-level
implementation of effective
interventions to reduce the demand for
tobacco, contained in the WHO FCTC.”
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Movie 8.1 Hear from the Experts:
Dr. Douglas Bettcher

MPOWER stands for:
•

M: Monitor tobacco use and prevention policies

•

P: Protect people from tobacco smoke

•

O: Offer help to quit tobacco use

•

W: Warn about the dangers of tobacco

•

E: Enforce bans on tobacco advertising, promotion and sponsorship

•

R: Raise taxes on tobacco

Movie 8.2 Dr. Thomas Frieden on the Future of
Global Tobacco Control

Today, 2.3 billion people in the world are
covered by at least one MPOWER measure.
On April 14, 2011, Dr. Thomas Frieden,
Director of the Centers for Disease Control
and Prevention (CDC), offered his vision for
the future of global tobacco control efforts. In
Movie 8.2, he highlights the FCTC and
emphasizes the importance of populationbased tobacco control measures.
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Chapter 8 - Tobacco Control Frameworks
Section 4 - The Varying Levels of Tobacco Control

As we have learned so far, tobacco control interventions are implemented at different levels in a wide
variety of locations. Anti-tobacco efforts can occur at the local, state, or national level, and we have
even learned about global efforts such as the WHO FCTC. Each of these levels requires different
strategies and different expectations of outcomes.
Because of the importance of social norms, it is crucial to engage citizens at
the local level. Local settings include communities and schools, where people
can be directly reached and where the dialogue about changing the status quo
begins. Historically, smoke-free policies started at the local level with towns
and cities passing clean indoor air laws, as exemplified by several cities in
California in the early 1980s.

Key Takeaway
Anti-tobacco efforts
can occur at the local,
state, national, or
global level. Each of
these levels requires
different strategies and
different expectations
of outcomes.

National laws are comprehensive in nature, but there is little national legislation around tobacco in
the United States. Therefore, tobacco legislation falls under the authority of the individual states.
Additionally, the Master Settlement Agreement was made between the tobacco companies and the
states, thus giving states control over how the money from the settlement is spent. Some states are
more progressive than others in terms of tobacco control; for example, California, Massachusetts, and
Florida, have put strong tobacco control measures in place. States also have the authority to tax
tobacco products and many have done so very effectively.
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In some instances, however, states actually prohibit localities from enacting tobacco control laws that
are more stringent than state laws, which is known as preemption. Tobacco companies are
proponents of preemption, as it limits the ability of local jurisdictions from having rules, such as
smoke-free laws and advertising bans, that are more restrictive than the state laws. Preemption wrests
control from communities over problems they are concerned about and that can be effectively
addressed at the local level.
National initiatives are generally more focused on surveillance, research, regulation, and laws banning
advertising. In the United States, the Family Smoking Prevention and Tobacco Control Act, signed in
2009, gives the Food and Drug Administration (FDA) “authority to regulate the manufacture,
distribution, and marketing of tobacco products to protect public health.” We are optimistic that as
the FDA obtains the needed research and data in the coming years, it will make great advances in
nationally regulating tobacco products in a manner commensurate with the harm that they cause.
Lastly, there are international efforts to regulate tobacco. Because tobacco companies operate at the
global level, there must be global tobacco control strategies and initiatives in response. These are
best represented by the WHO FCTC and the MPOWER guidance discussed previously.
The social-ecological model suggests that each of the different levels of tobacco intervention plays an
important role in protecting public health and supporting healthy behaviors. Some interventions work
better at the societal level than at the individual level. For example, an advertising ban enacted at the
community level in metro Atlanta would have a very limited impact—the efforts would be immediately
negated by the ubiquity of national newspapers, magazines, and social media. However, a nationwide
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restriction or an international treaty that codifies marketing restrictions or standards can be very
effective.
The same is not true of all tobacco control measures, which is why it is so important to know what
works best in specific contexts. To give another example, in the U.S., the strongest smoking
restrictions have historically originated at the local level, with local jurisdictions first adopting
comprehensive smoke-free laws beginning in the 1980s. In fact, today there is still no national clean
indoor air law in the U.S., and we rely almost exclusively on local and state initiatives in this area.
Tobacco control laws starting at the local level, including smaller communities and municipalities, can
be very advantageous when preemption has not blocked tobacco control laws from being
implemented. Due to the sheer number of local jurisdictions, it is generally more difficult for the
tobacco industry to respond to measures enacted at this level. Even more important, efforts at this
level often result in engagement and dialogue, giving people an opportunity to express their
concerns and take action. For many communities, such efforts constitute a way of living democracy at
its best.
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Chapter 8 - Tobacco Control Frameworks

Section 5 - Anti-Government Sentiment Challenges Tobacco Control
In this chapter on tobacco control frameworks, we have emphasized that population strategies are
more effective than individual approaches in creating long-lasting change. Population strategies often
require government action; they rely on state- or nationwide enforcement of regulations, such as tax
increases or restrictions on where people can smoke. In the era of anti-government sentiment that we
live in, government intervention is unpopular, at best.
The issue of government involvement in public health has long been debated. Tom Frieden, Director
of the CDC, presents one side of the argument:
For some issues, government may be the only entity capable of
promoting the greater good by reconciling social and economic
interests. Limiting promotion of tobacco and alcohol helps individuals by
reducing consumption and benefits business by increasing workforce
productivity and reducing health care costs. Although increased use of
their products benefits tobacco and alcohol companies' employees and
shareholders, other companies and society bear increased medical,
economic, and social costs, as well as the illness and deaths caused by
use of these products.
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Government has a responsibility to implement effective public health
measures that increase the information available to the public and
decision makers, protect people from harm, promote health, and create
environments that support healthy behaviors.
The appropriate level of responsibility and reach assigned to government is far from straightforward,
however. A 2013 article by Chokshi and Stine in the Journal of the American Medical Association
provides a helpful gloss on the issue of government involvement:
A central dilemma in public health is reconciling the role of the individual
with the role of the government in promoting health. On the one hand,
governmental policy approaches—taxes, bans, and other regulations—are
seen as emblematic of “nanny state” overreach. In this view, public health
regulation is part of a slippery slope toward escalating government
intrusion on individual liberty. On the other hand, regulatory policy is
described as a fundamental instrument for a “savvy state” to combat the
conditions underlying an inexorable epidemic of chronic diseases.
The “nanny state” is a term that conveys the view that a government is unduly protective or interfering.
In Table 8.1, Choksi and Stine illustrate the contrasting perspectives of how a nanny state frames a
health issue versus a “savvy state.”
Antigovernment arguments are often used against tobacco control strategies. Smoke-free laws, taxes,
and other tobacco regulations are unpopular in some locales because they can be framed in such a
way so that they seem to oppose personal liberty. Many people miss the irony in the fact that these
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Table 8.1 Nanny-State Framing vs Savvy-State Framing
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Nanny State

Savvy State

Mandates affecting
behavior are a restriction
on individual liberty.

Some mandates (e.g., a ban on trans fat) deliver high
public benefit at low individual costs and are part of a
sensible regulatory design for healthy environments.

Taxes are heavy-handed
instruments of
government intervention.

In certain settings, taxes on unhealthy products encourage
healthier choices while generating needed public revenue.

Private markets facilitate
the exercise of free
customer choice, allowing
individuals to make
healthy choices for
themselves.

Unchecked private markets can lead to negative health
externalities such as harmful food environments in low
income communities (analogous to environmental
externalities such as industrial pollution).

The state can provide
information but not
regulate a person’s
decisions.

Poverty, geography, and disproportionate marketing of
unhealthy products limit a person’s decisions, and the state
has an interest in enabling individuals’ freedom to make
healthy choices.

Unhealthy behaviors are
nobody’s business but the
individual.

All pay for the health care costs associated with chronic
disease through government health spending and
opportunity costs of other social spending.

Key Takeaway
Tobacco laws can be
regarded as a way for
governments to limit personal
liberty; however, such laws
are designed to prevent
addiction—the very epitome
of the loss of freedom and
personal liberty.

government rules are aimed at preventing addiction—the very epitome of
the loss of freedom and personal liberty. Government involvement in
tobacco is always politically complicated because of entrenched
opposition to government regulation, and the tobacco industry exploits
anti-government sentiment. Thus, efforts to advance public health are
often denounced as nanny-state overreach.

Looking more closely, we find that this is more than an ideological issue about the proper role of
government in the lives of individuals. The tobacco industry, along with other industries, financially
support organizations that promote anti-government sentiment.
In Australia, the tobacco industry attacked the national plain packaging legislation by invoking nannystate overreach. In their advertising, tobacco companies promoted notions of personal freedom and
choice, while calling for decreased government
involvement. Movie 8.3 provides an example of the
advertisements used by the Australian tobacco
industry to attempt to defeat national plain
packaging laws.
To summarize this chapter on tobacco control
frameworks, there is substantial scientific evidence
on the effectiveness of tobacco control strategies.
This evidence is documented in the Surgeon
General Reports, the Cochrane Reports, systematic
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Movie 8.3 Australian Tobacco Industry
Advertisement Aimed at Defeating Plain
Packaging

reviews such as the Community Guide to Preventive Services, and global guidance such as the WHO
FCTC and MPOWER. In spite of all the documentation and codification of evidence about what works
in reducing the burden of tobacco use, it is often difficult to implement tobacco control largely
because of anti-government sentiment, which is inflamed by the tobacco industry. Tobacco control
advocates must be cognizant of the particular challenges posed by the industry’s concerted efforts to
maintain the status quo.

Chapter 8 Discussion Questions:
1. Describe the role the socio-ecological model played to promote or discourage tobacco use
among the youth in the U.S.
2. How can public health further promote change in norms to promote tobacco control?
3. What additional roles can private companies play in promoting tobacco control? i.e. drug/
pharmacy stores stopped selling tobacco, companies giving workers incentives to stop
smoking, etc.
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Defeating Plain Packaging
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Chapter 9

Smoke-Free Air Laws

Chapter Objectives
1. Classify the types of smoke-free air laws and regulations
and how they vary in the U.S. and internationally.
2. Analyze the reasons why smoke-free air laws have grown in
popularity.
3. Appraise the science behind smoke-free air laws and how
they work.
4. Discuss the future directions of smoke-free air laws,
including the impact of electronic cigarettes on smoke-free
policies.

Chapter 9 - Smoke-Free Air Laws
Section 1 - What are Smoke-Free Air Laws and Why are They Popular?

In the previous chapter, we discussed smoke-free air laws as an example of an effective populationbased tobacco control intervention. We will now look more closely at the different types of smokefree air laws, their evolution over time, the evidence that supports their growth, as well as future
directions and implications for novel nicotine products.
Smoke-free air (SFA) laws and regulations are enacted in order to protect the rights of nonsmokers to
breathe smoke-free air. The World Health Organization’s Tobacco Free Initiative includes
implementing protection from exposure to tobacco smoke under Article 8 of the Framework
Convention on Tobacco Control:
Each Party shall adopt and implement in areas of existing national
jurisdiction as determined by national law and actively promote at other
jurisdictional levels the adoption and implementation of effective
legislative, executive, administrative and/or other measures, providing
for protection from exposure to tobacco smoke in indoor workplaces,
public transport, indoor public places and, as appropriate, other public
places.
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Key Takeaway

While the impetus for the initial creation of smoke-free air laws was to protect

Smoke-free air laws and
regulations are enacted
in order to protect the
rights of nonsmokers to
breathe smoke-free air.

nonsmokers, the objectives for such laws have expanded and now impact
smokers themselves, as well as the norms associated with smoking.
As early as 1971, the United States Surgeon General’s Report mentioned the
hazards associated with involuntary exposure to smoke. In this report, then

Surgeon General Jesse Steinfeld states, “Nonsmokers have as much right to clean air and wholesome
air as smokers have to their so-called right to smoke, which I would define as a ‘right to pollute.’ It is
high time to ban smoking from all confined public places such as restaurants, theaters, airplanes,
trains and buses.” In spite of Steinfeld’s assessment, bans on smoking in public places still have not
uniformly occurred in the United States.
The tobacco industry likewise realized the harms of secondhand smoke exposure in the 1970s. In
1978, the Tobacco Institute commissioned the Roper Organization to prepare a report on the issue of
secondhand smoke and its implications for the tobacco industry. Based on a survey of public attitudes
toward environmental tobacco smoke, the Roper Report stated:
Nearly six out of ten believe that smoking is hazardous to the
nonsmoker's health, up sharply over the last four years. More than twothirds of nonsmokers believe it and nearly one half of all smokers believe
it. This we see as the most dangerous development to the viability of the
tobacco industry that has yet occurred.
Clearly, the tobacco companies knew that the public’s attitude toward secondhand smoke threatened
the survival of their industry and had to be taken very seriously. The Roper Report of 1978 has
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influenced the evolution and the spread of smoke-free air laws
throughout the country, and it also helps to explain why
tobacco companies have aggressively fought the
implementation of laws that are intended to protect

Figure 9.1 The 1986 Surgeon
General’s Report, The Health
Consequences of Involuntary
Smoking

nonsmokers from exposure to secondhand smoke.
An enormous body of scientific literature has documented the
harms associated with involuntary smoking. Following Surgeon
General Steinfeld’s 1971 Report and the Roper Report of 1978,
Surgeon General C. Everett Koop devoted the 1986 Surgeon
General’s Report exclusively to secondhand smoke, concluding
that exposure to it caused disease, including lung cancer, in
otherwise healthy nonsmokers (Figure 9.1). Moreover, the
report stated that mere separation of smokers and nonsmokers
within the same air space was inadequate to protect
nonsmokers. These conclusions were supported by other
reports, for example from the National Research Council, which
came out in the same year.
Adding to the scientific evidence of the harm caused by secondhand smoke, a 1992 report from the
Environmental Protection Agency (EPA) corroborated the Surgeon General’s Reports and classified
secondhand smoke as a Class A carcinogen. The EPA estimated that more people die from exposure
to secondhand smoke than from air pollution. Coming from a non-health organization, these findings
from the EPA made a huge impact.
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More recently, in 2006, evidence on the dangers of secondhand
smoke was updated in the second full Surgeon General’s Report
dedicated to the topic. The report, titled The Health Consequences
of Involuntary Exposure to Tobacco Smoke, summarized over a

Figure 9.2 2006 Surgeon
General's Report, The
Health Consequences of
Involuntary Exposure to
Tobacco

decade’s worth of findings (Figure 9.2):
•

Secondhand smoke is a U.S. EPA Class A carcinogen (1992).

•

Secondhand smoke is classified by the International Agency

on Research on Cancer (IARC) as a Group 1 carcinogen –
Carcinogenic to Humans (2004).
•

There is no risk-free level of exposure to secondhand smoke.

•

Eliminating smoking in indoor spaces fully protects

nonsmokers from exposure to secondhand smoke.
•

Separating smokers from nonsmokers, cleaning the air, and ventilating buildings cannot

eliminate exposures of nonsmokers to secondhand smoke.
A number of different organizations have reinforced several decades’ worth of scientific evidence
showing the harm caused by secondhand smoke. There is no longer any question about the harm of
involuntary smoking, and now the question has shifted to how to enact smoke-free air laws that are
effective.
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Implementing smoke-free air laws requires thoughtful planning. The Centers for Disease Control and
Prevention (CDC), American Cancer Society, and the World Health Organization (WHO) provide a
number of helpful documents giving guidance on how to implement such programs effectively.
Often, successful programs urge the constituents who will be affected by the new regulations to
become involved early on in the planning process. It is important to remember that smoke-free air
laws can be enacted at various levels of government— federal, state, or local. In the United States,
there is currently no nationwide smoke-free law (unlike Brazil, Canada, and Australia, for example).
However, there are more people in the United States protected from secondhand smoke exposure
than in any other country in the world as a result of state laws and local ordinances that prohibit
smoking. More than half of the U.S. population live in areas where smoking is completely prohibited
indoors. While there is strong local protection for the most part, those areas that do not enjoy such
protection still suffer, and the goal is to have uniform coverage through a national smoke-free law.
There is much guidance available on how to implement smoke-free air laws. WHO makes the
following recommendations for protection from secondhand smoke:
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•

100% smoke-free environments, not just ventilation.

•

Universal protection by law.

•

Proper implementation and adequate enforcement of the law.

•

Public education to reduce SHS exposure in the home.

Key Takeaway
Protecting the public
from smoke means 100%
smoke-free
environments, not just
ventilation.

These guidelines from WHO are further explained below:

Highlights from the WHO Policy
Recommendations for Protection from
Exposure to Secondhand Tobacco Smoke
Smoke-free environments should be mandated by law,
not by voluntary policies.
Legislation should be simple, clear and enforceable,
and comprehensive.
Consider which jurisdictional level(s) will afford the most
progress.
Anticipate the opposition.
Involve civil society.
Educate and consult to ensure smooth implementation.
Develop an implementation and enforcement plan and
ensure infrastructure for enforcement.
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Chapter 9 - Smoke-Free Air Laws
Section 2 - The Spread of Smoke-Free Air Laws

As mentioned earlier, the diffusion of smoke-free air laws started in California in the 1980s. The map
in Movie 9.1 shows how smoke-free air laws spread throughout the country. After California, Utah was
the second state to become entirely smoke-free, and then other jurisdictions as well as other states,
including New York and Florida, followed. The western United States rapidly became smoke-free,
along with the Northeast. The Southeastern United States has had the least coverage in terms of
statewide laws. It is no coincidence that
the states growing the most tobacco
are also the most unlikely to have
comprehensive smoke-free laws. Of
particular concern are reports showing
higher rates of lung cancer and heart
disease in the tobacco-growing states
of the Southeast than the rest of the
country.
The map in Figure 9.3 shows the level
of protection provided by each state
from secondhand smoke. The green
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Movie 9.1 U.S. Smoke-Free Laws

Figure 9.3 How Well Does Your State Protect the Public from Secondhand Smoke?
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states are those providing comprehensive
protection, while crimson states provide
the least. This map makes it obvious that

Figure 9.4 Number of Local 100% Smoke-Free
Laws in Workplaces, Restaurants and Bars, U.S., as
of July 2013

while much of the country is doing well
with implementing smoke-free air laws, the
Southeast lags far behind. It makes a
compelling argument in favor of enacting
a national law that provides all people
living in the U.S. with protection from
secondhand smoke.
Smoke-free laws have grown exponentially
over time in the U.S. A study done in July
2013 showed that 500 cities and towns
throughout the country mandate 100%
smoke-free workplaces, restaurants and
bars (Figure 9.4).
Currently, approximately 50% of the U.S.
population is covered by strong smoke-free air laws that prohibit smoking in workplaces, and
restaurants, and bars. Thirty states, plus the District of Columbia, Puerto Rico, and the U.S. Virgin
Islands require restaurants and bars to be 100% smoke-free.
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Of concern to tobacco control advocates, there is
an increasing number of states that have enacted

Movie 9.2 Hear from the Experts: Stanton
Glantz

preemptive legislation prohibiting localities from
creating laws that are more stringent than or that
vary from state law. Under preemption laws, many
of these states do not allow for 100% smoke-free
conditions in local jurisdictions. One of the
Healthy People 2020 objectives is to “eliminate
State laws that preempt stronger local tobacco
control laws on smoke free indoor air.”
Dr. Stanton Glantz, a Professor of Medicine at the
University of California, San Francisco and an American Legacy Foundation Distinguished Professor of
Tobacco Control, provides his insights on domestic tobacco control and the future of clean indoor air
laws in Movie 9.2,
Now, looking at the global picture for smoke-free laws, we estimate that just over 50% of the countries
in the world have some type of smoke-free policy in place (covering
Key Takeaway
Approximately 50% of
the world’s countries,
covering 16% of the
world’s population, have
some type of smoke-free
policy in place, ranging in
coverage from minimal to
complete.
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approximately 16% of the world’s population), ranging in coverage from
minimal to complete. Comprehensive bans on smoking in indoor areas and
strict enforcement are still not the norm.

Figure 9.5 Level of Protection Provided by National
Clean Indoor Air Laws, 2013

Figure 9.5 is a map of the world
prepared by WHO that shows the level
of protection provided by national clean
indoor air laws among the 193
countries. The U.S. shows up as having
the minimal level of national protection
because of the lack of a nationwide
smoke-free law. Other major countries
without a nationwide law include China
(Figure 9.6) and Russia.

Figure 9.6 Diners in a Beijing
Restaurant Smoking in Spite of
“No Smoking” Signs,
Demonstrating the
Uselessness of Smoking Laws
if Not Enforced
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Because of the proven effectiveness of smoke-free laws, there has been a rapid increase in smoking
bans worldwide in the last decade. Figure 9.7 is a map adapted from the fourth edition of The
Tobacco Atlas showing the increase in smoking bans in restaurants in just two years, from 2008 to
2010.

Figure 9.7 Smoking Bans in Restaurants are Increasing
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Chapter 9 - Smoke-Free Air Laws
Section 3 - Smoke-Free Air Laws Work

There is no longer any question that smoke-free air laws are effective in protecting non-smokers from
exposure to secondhand smoke. While protecting non-smokers is the primary purpose of such laws, it
has been demonstrated that they also benefit smokers in some cases.
The 2010 Cochrane Review provides an overview of
the effectiveness of smoke-free air laws.
Incorporating findings from 50 studies, the Review
concluded that legislative bans reduce exposure to
secondhand smoke. Moreover, contrary to the

Smoke-free air laws have
been shown to:
•

smoke.

hypothesis that such bans simply cause smokers to
smoke more at home, the evidence suggested that

•

studies that measured smoking prevalence and

Reduce health problems (e.g., fewer
heart attacks and ambulance calls).

there was actually no change in self-reported
secondhand smoke exposure in the home. Of the

Reduce exposure to secondhand

•

Not have a negative impact on
restaurants and bars.

behavior, a few reported the absence of change, but
the majority showed a net reduction in the number of cigarettes smoked by a smoker as a result of
smoke-free air laws. There is evidence emerging that smoke-free laws contribute to fewer children
starting to smoke and more smokers quitting. Studies also showed health improvement in individuals
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—for example, a decrease in heart attacks and emergency room utilization—in cities with a smoking
ban in place.
Figure 9.8 is a graphic representation of the dramatic reduction of secondhand smoke exposure
resulting from smoke-free air laws. Incorporating data from the National Health and Nutrition
Examination Surveys (NHANES) from the late 1980s through the early 2000s, the graph shows a
significant (at least two-thirds and up to three-fourths) reduction in levels of serum cotinine in the U.S.
population. Examining cotinine levels is a common and reliable way of measuring secondhand smoke
exposure because it uses biological data rather than self-reported surveys. The sharp reduction in
serum cotinine levels demonstrates that

Figure 9.8 Serum cotinine levels verify a decline in
exposure to secondhand smoke in the U.S

the implementation of clean indoor air
laws has not only resulted in self reports
of less exposure, but also biological
evidence of reduced exposure.
Following up on the data from NHANES,
an additional study examined the serum
cotinine levels of almost 6,000 nonsmoking adults from 57 survey locations
in areas classified as having extensive,
limited, or no coverage from a smokefree law. The results showed that nonsmoking adults had the following levels
of secondhand smoke (SHS) exposure
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based on coverage type:
•

Extensive smoke-free law coverage: 12.5% exposed to SHS.

•

Limited smoke-free law coverage: 35.1% exposed to SHS.

•

No smoke-free law coverage: 45.9% exposed to SHS.

Together with the results from NHANES, this study presents compelling evidence that smoke-free
laws effectively protect individuals from exposure to secondhand smoke.
For further evidence, we can examine examples of how clean indoor air laws have affected individuals
as well as businesses. In July 2003, New York implemented a comprehensive state law requiring most
indoor workplaces and public places (e.g., restaurants, bars, and other hospitality venues) to be
smoke-free. A report from the Centers for Disease Control and Prevention (CDC) assessed the
changes in indoor air quality that occurred in 20 hospitality venues in western New York where
smoking or indirect SHS exposure from an adjoining room was observed at baseline and post-ban.
On average, the levels of respirable suspended particles (a marker for SHS) decreased 84% following
the implementation of the law (Figure 9.9).
Recent studies show that people living and working in areas covered by clean indoor air laws have a
reduced prevalence of heart attacks—on average, smoke-free legislation reduced the risk of heart
attacks by 13% (Figure 9.10).
In 2013, researchers looked at the likelihood of a call for an ambulance coming from a facility before
and after the implementation of a smoke-free policy. A study done in Colorado County compared
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Figure 9.9 Indoor Air Quality in Hospitality
Venues Before and After Implementation of a
Clean Indoor Air Law - Western New York,
2003 (CDC)

ambulance calls originating in casinos and
those not originating in a casino for 2000 and
2012 (before and after a state-wide smoke-free
law that was later extended to include casinos).
When the smoke-free law went into effect,
there was a 22.8% drop in ambulance calls not
originating from a casino. During the initial
period when casinos were exempt from the
smoke-free law, there was no change in the
number of ambulance calls originating from
casinos. Later on, when the law was extended
to casinos, there was a 19.1% drop in
ambulance calls from casinos (and no change
in those originating outside of casinos).
The tobacco industry and their front groups

often purport to speak for the public, claiming that smoke-free air laws will harm businesses because
they are regarded unfavorably by most people. However, studies have shown that the public supports
laws banning smoking in restaurants, bars, and sports arenas and their support has actually increased
over time (Figure 9.11). Non-smoking has been established as the norm, even in locations typically
associated with “good times” and entertainment.
Furthermore, a study done in Hong Kong provides evidence that businesses, rather than being
harmed by smoke-free air laws, can actually experience the opposite. Figure 9.12 shows an increase
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Figure 9.10 Comprehensive Smoke-Free Legislation Associated with Significantly
Lower Rates of Hospital Admissions
Relative risk of hospital admissions for four disease categories after implementation of a smoke-free law
compared to before implementation of the law. 95% confidence intervals shown by error bars and numbers
appearing above horizontal axis show number of studies included in estimate. AMI= acute myocardial infarction,
ACS= acute coronary syndrome, ACE= acute coronary event, IHD= ischemic heart disease, CHD= coronary heart
disease, SCD= sudden cardiac death.

in restaurant receipts after a complete smoking ban was implemented in Hong Kong establishments.
Various studies have demonstrated the same impact in other parts of the world, with establishments
seeing an increase in business as they attract customers who wish to avoid smoke as they dine with
their family and friends.
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Figure 9.11 Percentage of Respondents
Supporting Smoking Bans in Public Places

In 2013, the CDC Foundation conducted a
study to determine the association between
local smoke-free air laws and economic
outcomes in bars and restaurants in states
without statewide laws. Among the states
evaluated were Alabama, Indiana, Kentucky,
Mississippi, Missouri, South Carolina, Texas,
West Virginia, and North Carolina (Movie 9.3).
The results showed that smoke-free laws did
not have an adverse economic impact on
restaurants or bars that became smoke-free in
these states (a small increase in business was
found in West Virginia). The CDC Foundation

Movie 9.3 South Carolina - Business Has Never
Been Healthier

concluded that statewide smoke-free air laws
would not have a negative economic impact
on these states.
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Key Takeaway

Figure 9.12 Smoking Bans Do Not Negatively
Effect Restaurant Sales

Contrary to the tobacco industry’s
claim that smoke-free rules harm
businesses, studies show that going
smoke-free does not have a negative
economic impact on restaurants, bars,
and other establishments.

We end this section on the effects of smoke-free air laws on individuals and on businesses with a
quote from the CDC Foundation, which presents the perspective of some restaurant and bar owners
as they relate their experience of going smoke-free.

321

“Restaurant and bar business owners in communities
throughout South Carolina were worried about nonsmoking ordinances affecting their businesses. Business
owners found that the ordinance was a positive thing as
food sales increased and customers realized how great the
food and atmosphere was without the smoke. Restaurant
and bar business owners in communities throughout South
Carolina were worried about non-smoking ordinances
affecting their businesses. Business owners found that the
ordinance was a positive thing as food sales increased and
customers realized how great the food and atmosphere
was without the smoke.”
~ CDC Foundation, 2013
Going smoke-free won’t hurt your bottom line

322

Chapter 9 - Smoke-Free Air Laws
Section 4 - What are the Future Directions of Smoke-Free Air Laws?

With the growing popularity of smoking bans, legislation is now being drafted in the United States to
cover more venues and populations, with varying levels of controversy. Smoke-free laws are now
being expanded to outdoor areas such as parks and beaches. Arguments against smoking bans for
outdoor venues usually question whether there is a proven health risk associated with exposure to
secondhand smoke when it is diffused into the outside environment. We are also seeing more and
more college campuses and health centers become completely smoke-free. In many instances,
campuses ban not only tobacco use but also the sale and marketing of tobacco products on their
premises. Moreover, we are seeing prisons increasingly becoming smoke-free, with onsite medical
facilities offering smoking cessation services and nicotine replacement products to inmates.
Additionally, there is increasing focus on making mental health facilities smoke-free. As we saw in
Chapter 2, people with mental illness use tobacco at a much higher rate than the national average,
and the compounded risk and exposure to cigarettes have a dramatically adverse effect on their
health. Indeed, a recent study found evidence suggesting that nearly half of the deaths of those with
mental illness are attributable to smoking. Going smoke-free is an important way that mental health
facilities can protect the health of their patients.
Yet another movement that has recently gained some ground is the push for smoke-free multi-family
housing, particularly public housing apartments and condominiums where the air may be shared

323

among different dwellings. Lastly, there has been a vigorous effort to ban smoking in cars and even in
private houses whenever children are present. Historically, tobacco control has steered away from
private property, but serious attention and discussion is warranted when the behavior of an adult is
having a deleterious effect on the health of a child (who usually has no choice but to be subject to the
harms caused by that behavior). In 2014, the United Kingdom passed a law that made it illegal to
smoke in a car if it is carrying children. More can be learned about this in the BBC News Article: “Car
smoking ban ‘will be brought in”.
So far, our discussion has focused on combustible or traditional cigarettes. Now, we turn briefly to
electronic cigarettes and consider what impact they may have with regard to smoke-free laws. Smokefree has become more of the norm because the harms of smoking and inhaling secondhand smoke
are well documented. On the other hand, because e-cigarettes are still relatively new on the market,
there is much that we do not know about their effects on health. An e-cigarette does not involve
combustion, so it does not emit smoke, only a vapor.
One of the risks presented by e-cigarettes is the potential to re-normalize smoking in public places,
undermining the progress that has been made in tobacco control over the last four decades. EKey Takeaway
Allowing e-cigarette use
in places where
cigarettes are banned, as
well as e-cigarette
advertising in the media,
may result in the renormalization of smoking
in our culture.
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cigarette manufacturers support allowing the use of e-cigarettes anywhere—in
hotels, restaurants, workplaces, even in airplanes. Moreover, in the United
States there is currently no ban on advertising for e-cigarettes as there is for
traditional cigarettes. It is becoming normal to see celebrities and models
using e-cigarettes in advertisements on television. A survey conducted by the
School of Public Health at Georgia State University in 2012 found that out of
more than 800 Georgia restaurant and bar managers and owners, 30% would

allow people to smoke e-cigarettes in their establishment. In another survey, Georgia State
researchers found that out of more than 4,000 individuals, 22% thought e-cigarettes should be
allowed in public areas where smoking was prohibited, whereas the majority, 41%, were not sure if
they should be allowed. This reflects the uncertainty that many people feel about the products.
We are at a crossroads in terms of deciding how to regulate the use and advertising of e-cigarettes.
There is a clear intent behind e-cigarettes, as stated by Olivier Girard, the Chief Executive Officer of

Figure 9.13 Smoke-Free sign at
AT&T Park

Smarty Q, an e-cigarette brand based in England: “We’re
trying to bring back the chic attitude, the sexiness in
smoking.” There have been proposals, in California for
example, to ban e-cigarettes wherever cigarettes are
banned. Prior to a decision from the government, some
locations have already banned e-cigarettes, such as the
AT&T Park where the San Francisco Giants play baseball
(Figure 9.14). More research is needed to understand the
health effects of secondhand exposure to e-cigarettes,
but even more, we need to understand the implications
of not restricting e-cigarette use and the risk of renormalizing smoking in our culture.
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Chapter 9 Discussion Questions:
1. Based on what you learned in this chapter, list the immediate and long-term benefits of smokefree laws.
2. Discuss the benefits and challenges of getting a law to ban smoking in private properties, such
as cars and houses, with children present?
3. Is there enough evidence to implement smoke-free laws to e-cigarettes? What additional
evidence would be helpful?
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Source: WHO. (2013). WHO Report on the Global Tobacco

After Implementation of a Clean Indoor Air Law - Western New

Epidemic, 2013: Enforcing bans on tobacco advertising,

York, 2003 (CDC)

promotion and sponsorship. WHO Document Production

Source: Centers for Disease Control and Prevention. (2004).

Services.

Indoor air quality in hospitality venues before and after
implementation of a clean indoor air law --- Western New York,

Figure 9.6: Diners in a Beijing Restaurant Smoking in Spite of

2003. Morbidity and Mortality Weekly Report (MMWR), 53(44),

“No Smoking” Signs, Demonstrating the Uselessness of Smoking

1038-1041.

Laws if Not Enforced
Source: Pamela Redmon, 2009
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Figure 9.10: Comprehensive Smoke-Free Legislation Associated
with Significantly Lower Rates of Hospital Admissions
Source: Stanton Glantz, 2016 Personal Communication and
Tan and Glantz, 2012, Circulation.
Figure 9.11: Percentage of Respondents Supporting Smoking
Bans in public Places
Source: Robert Wood Johnson Foundation. (2011). Social norms
and attitudes about smoking: 1991—2010.
Figure 9.12: Smoking Bans Do Not Negatively Effect Restaurant
Sales
Source: Eriksen, M., Mackay, J., Ross, H. (2012). The Tobacco
Atlas. American Cancer Society; New York, NY: World Lung
Foundation.
Movie 9.3: South Carolina – Business has Never Been Healthier
Figure 9.13: Smoke-Free Sign at AT&T Park
Source: Judd Winick, 2013

329

References

American Lung Association. (n.d.). Tobacco control legislation passed
during 2006—by state. Retrieved from: http://www.lung.org/assets/
documents/publications/slati/state-legislated-actions-on-2.pdf.
American Nonsmokers’ Rights Foundation. (2013). Chronological table of
U.S. population protected by 100% smoke-free state or local laws.
Retrieved from: http://www.no-smoke.org/pdf/
EffectivePopulationList.pdf.
American Nonsmokers’ Rights Foundation. (2013). Local 100% smoke-free
laws in all workplaces, restaurants, and bars: Effective by year. Retrieved
from: http://www.no-smoke.org/pdf/
current_smokefree_ordinances_by_year.pdf.
American Nonsmokers’ Rights Foundation. (2013). Summary of 100%
smokefree state laws and population protected by 100% U.S. smokefree laws. Retrieved from http://www.no-smoke.org/pdf/
SummaryUSPopList.pdf.
Callinan, J., Clarke, A., Doherty, K., & Kelleher, C. (2010). Legislative
smoking bans for reducing secondhand smoke exposure, smoking
prevalence and tobacco consumption. The Cochrane Database Of
Systematic Reviews, (4), CD005992. doi:
10.1002/14651858.CD005992.pub2.
Campaign for Tobacco-Free Kids. (2010). Only comprehensive smoke-free
laws are effective. Retrieved from: http://www.tobaccofreekids.org/
research/factsheets/pdf/0368.pdf.

330

CDC Foundation. (2013). Going smoke-free won’t hurt your
bottom line. Retrieved from: http://www.youtube.com/user/
smokefreebusiness/videos.

Eriksen, M. P., & Cerak, R. L. (2008). The diffusion and impact of
clean indoor air laws. Annual Review of Public Health, 29, 171
—185. doi: 10.1146/annurev.publhealth.29.020907.090920.

Centers for Disease Control and Prevention. (2004). Indoor air
quality in hospitality venues before and after implementation
of a clean indoor air law --- Western New York, 2003.
Morbidity and Mortality Weekly Report (MMWR), 53(44),
1038-1041. Retrieved from: http://www.cdc.gov/mmwr/
preview/mmwrhtml/mm5344a3.htm.

Eriksen, M., Mackay, J., Ross, H. (2012). The Tobacco Atlas.
American Cancer Society; New York, NY: World Lung
Foundation.

Centers for Disease Control and Prevention. (2010). State
preemption of local smoke-free laws in government work
sites, private work sites, and restaurants --- United States,
2005--2009. Morbidity and Mortality Weekly Report (MMWR).
Retrieved from: http://www.cdc.gov/mmwr/preview/
mmwrhtml/mm5904a4.htm.
Centers for Disease Control and Prevention. (2012).
Comprehensive smoke-free laws—50 largest U.S. cities, 2000
and 2012. Morbidity and Mortality Weekly Report (MMWR).
Retrieved from: http://www.cdc.gov/mmwr/preview/
mmwrhtml/mm6145a3.htm.
Collins, D., & Procter, A. (2011). Smoking's shrinking
geographies. Geography Compass, 5(12), 918-931. doi:
10.1111/j.1749-8198.2011.00463.x.

331

Glantz, S.A., Gibbs, E. (2013). Changes in ambulance calls
following implementation of a smoke-free law and its
extension to casinos. Circulation. Retrieved from: http://
circ.ahajournals.org/content/early/2013/08/02/
CIRCULATIONAHA.113.003455.abstract?
sid=8079496e-0e68-4ce9-ace0-200dd76ae675.
Kurutz, S. (2013). Confounding a smoking ban, and bouncers.
New York Times, August 7, 2013. Retrieved from: http://
www.nytimes.com/2013/08/08/fashion/smoking-is-backwithout-the-stigma.html?pagewanted=1&_r=0&hp.
Lin, H., Wang, H., Wu, W., Lang, L., Wang, Q.,Tian, L. (2013). The
effects of smoke-free legislation on acute myocardial
infarction: a systematic review and meta-analysis. BMC Public
Health, 13:529. Retrieved from: http://
www.biomedcentral.com/content/pdf/
1471-2458-13-529.pdf.
Loomis, B.R., Shafer, P.R., Van Hasselt, M. (2013). The economic
impact of smoke-free laws on restaurants and bars in 9 states.

Preventing Chronic Disease;10:120327. Retrieved from:
http://www.cdc.gov/pcd/issues/2013/12_0327.htm.
Nykiforuk, C.J., Eyles, J., & Campbell, H. (2008). Smoke-free
spaces over time: a policy diffusion study of bylaw
development in Alberta and Ontario, Canada. Health & Social
Care In The Community, 16(1), 64-74. doi:10.1111/j.
1365-2524.2007.00727.x.
Pickett, M.S., Schober, S.E., Brody, D.J., Curtin, L.R., Giovino, G.A.
(2006). Smoke-free laws and secondhand smoke exposure in
U.S. non-smoking adults, 1999–2002. Tobacco Control, 15(4),
302-307. doi:10.1136/tc.2005.015073. Retrieved from:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2563609/.
Poland, B., Frohlich, K., Haines, R. J., Mykhalovskiy, E., Rock, M.,
Sparks, R. (2006). The social context of smoking: The next
frontier in tobacco control? Tobacco Control, 15, 59—63. doi:
10.1136/tc.2004.009886.
Robert Wood Johnson Foundation. (2011). Social norms and
attitudes about smoking: 1991—2010. Retrieved from: http://
www.rwjf.org/content/dam/web-assets/2011/04/socialnorms-and-attitudes-about-smoking.
Reuters. (2013). France to ban electronic cigarettes in public.
Retrieved from: http://www.reuters.com/article/2013/05/31/
us-france-cigarettes-idUSBRE94U0QJ20130531.

332

Roper, O. (1978). A Study of Public Attitudes Toward Cigarette
Smoking and the Tobacco Industry in 1978. Vol. 1.
Washington, DC: Roper Organ. Bates No. 500070008/0060.
State of Tobacco Control. (2013). Smoke-free air laws. Retrieved
from: http://www.stateoftobaccocontrol.org/state-grades/
state-rankings/smokefree-air-laws.html.
Steinfeld, J.L. (1983). Women and children last? Attitudes toward
cigarette smoking and nonsmokers' rights, 1971. NY State J
Med. 1983;83:1257–1258.
Tan, C.E. and Glantz, S. (2012). Association Between Smoke-Free
Legislation and Hospitalizations for Cardiac, Cerebrovascular,
and Respiratory Diseases: A Meta-Analysis. Circulation. 2012;
126:2177-2183. Retrieved from: http://circ.ahajournals.org/
content/126/18/2177.
U.S. Department of Health and Human Services. (1986). The
health consequences of involuntary smoking: A report of the
Surgeon General. U.S. Department of Health and Human
Services, Centers for Disease Control and Prevention,
National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health.
U.S. Department of Health and Human Services. (2006). The
Health Consequences of Involuntary Exposure to Tobacco
Smoke: A Report of the Surgeon General. U.S. Department of
Health and Human Services, Centers for Disease Control and
Prevention, Coordinating Center for Health Promotion,

National Center for Chronic Disease Prevention and Health
Promotion, Office on Smoking and Health, Atlanta, GA, USA.
U.S. Department of Health and Human Services. (2012). 2020
topics and objectives: Tobacco use, TU-16.1. Retrieved from:
http://www.healthypeople.gov/2020/topicsobjectives2020/
objectiveslist.aspx?topicId=41.
WHO. (2003). WHO Framework Convention on Tobacco lContro.
Geneva, Switzerland: WHO Document Production Services.
Retrieved from: http://www.who.int/tobacco/control/
measures_art_8/en/index.html.
WHO. (2007). Protection from exposure to second-hand tobacco
smoke. Policy recommendations. Retrieved from: http://
whqlibdoc.who.int/publications/
2007/9789241563413_eng.pdf.
WHO. (2013). WHO Report on the Global Tobacco Epidemic,
2013: Enforcing bans on tobacco advertising, promotion and
sponsorship. WHO Document Production Services. Retrieved
from: http://apps.who.int/iris/bitstream/
10665/85380/1/9789241505871_eng.pdf.

333

Chapter 10

Taxes and Funding
Tobacco Control

Chapter Objectives
1. Examine how the economic concept of elasticity applies to
tobacco prices and taxes.
2. Explain how tobacco taxes vary throughout the U.S.
3. Critique the arguments used by the tobacco industry
against tobacco taxes.
4. Compare and contrast the various ways tobacco control is
funded around the world.

Chapter 10 - Taxes and Funding Tobacco Control
Section 1 - As Price Goes Up, Consumption Goes Down

The law of demand states that when all else is constant, the higher the price of a good or service, the
lower the quantity demanded of that good or service. And vice versa, the lower the price, the higher
the quantity demanded. The elasticity of a product indicates how responsive demand is to changes in
price.
Tobacco is considered to be relatively inelastic since the demand for these products varies based on
price and other factors. The first graph in Figure 10.1 shows how the interaction with supply
determines market price and consumption. The second graph in Figure 10.1 shows this concept in
relation to cigarette prices in the U.S. For example, per capita cigarette sales were much lower in
states with a higher cost per pack; and per capita cigarette sales were much higher in states with a
low cost per pack.
In high-income countries, like the U.S., the price elasticity of demand for tobacco products is
estimated to be -0.4 meaning that a 10% increase in price would result in a 4% decrease in
consumption. When prices go up, smokers quit, reduce the number of cigarettes smoked per day, or
youth never start smoking. Cigarettes and other tobacco products are relatively inelastic (that is, the
reduction in consumption is proportionally less than the increase in price) for two reasons: 1) there
are few substitute goods, and 2) the addictive nature of nicotine keeps some people smoking
regardless of the price of the product.
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Tobacco is considered to be relatively inelastic. In high-income countries, like the U.S., elasticity for
tobacco products is estimated to be -.4 meaning that a 10% increase in price would result in a 4%
decrease in consumption. When prices go up, smokers quit, reduce the number of cigarettes smoked
per day, or youth never start smoking. Cigarettes and other tobacco products are relatively inelastic
(that is, the reduction in consumption is proportionally less than the increase in price) for two reasons:
1) there are few substitute goods, and 2) the addictive nature of nicotine keeps some people smoking
regardless of the price of the product.

Figure 10.1 Demand Theory In Action – Graph 1: Interaction with Supply Determines
Market Prices and Consumption and Graph 2: U.S. Consumption and Pack Price Examples
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Key Takeaway

To really understand how cigarette consumption is impacted by price, look at

Tobacco is a relatively
inelastic product. As
tobacco prices go up,
consumption goes down;
however, the reduction in
consumption is
proportionally less than
the increase in price.

Figure 10.2. On this graph, the price of a pack of cigarettes has been
adjusted for inflation and the change in price over time has been overlaid
onto a graph of the number of cigarette packs sold (in millions). In this type of
ecologic comparison, it is important to remember that there may be other
factors that influence trends in consumption; however, when investigating the
relationship between price elasticity and tobacco consumption, researchers

typically control for other factors such as the presence of advertising bans or the implementation of

Figure 10.2 Cigarette Sales and Average Price per Pack, 1970-2014
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Table 10.1 Raising Cigarette Taxes Increases State Revenue and
Reduces Smoking

clean indoor air laws.
The data show that
significant increases in
tobacco taxes and
price are the most
effective intervention
for reducing tobacco
use, especially among
the young and poor.
In Chapter 9, we
discussed the Roper
Institute’s warning to
the tobacco
companies in 1978
that concerns about

secondhand smoke were the greatest threat to the viability of the tobacco industry. Since then, there
has been a similar concern within the industry about tobacco taxes. In 1985, a representative from
Philip Morris was quoted as saying:
Of all the concerns, there is one - taxation - that alarms us the most.
While marketing restrictions and public and passive smoking
[restrictions] do depress volume, in our experience taxation depresses it
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much more severely. Our concern for taxation is, therefore, central to our
thinking.
The known effect of taxes on their sales volume has driven the tobacco companies’ strategy for
pricing their products. They will at first try to prevent increased taxation from occurring, but if an
increase happens, the strategy shifts to offering discounts and coupons to reduce the price of
tobacco products and minimize the impact of the tax increase.
To abet their case, tobacco companies argue that increasing taxes will result in decreased revenue for
a state, since fewer people will continue to buy cigarettes at a higher price; but this is not true. Table
10.1 highlights the major tax increases on cigarettes between 2006 and 2010. All states that increased
their cigarette tax by at least $0.50 in this period saw their revenues increase, and at the same time,
almost all of them saw a decline in the number of
packs sold. This study clearly shows that raising the
tobacco tax by at least $0.50 increases state revenue
while at the same time discouraging people from
smoking.
How can there be an increase in revenue when there
are fewer smokers? Going back to the concept of
elasticity, tobacco is a relatively inelastic product. As
mentioned prevoiusly, a 10% increase in price would
result in only a 4% reduction in consumption, which
means that many people still continue to buy
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Figure 10.3 Increased Tobacco Taxes
Increase Tax Revenue, Poland, 2010

Figure 10.4 Cigarette Consumption Goes Down as
Tobacco Taxes Go Up, Israel

cigarettes even at the higher price, and
tax revenue continues to come in (and
even increases as a result of the higher
tax). This study demonstrates that raising
the tobacco tax discourages people from
smoking, but overall state revenue still
increases.
This phenomenon of increasing revenue
with tobacco tax increases has not only
been observed in every instance in the
United States, but has also been found

globally. Figure 10.3 illustrates an example from Poland. In 2000, excise taxes made up 42% of the
price of a pack of cigarettes, yielding 8.3 billion PLN in total tax revenue. By 2010, taxes made up 63%
of the pack price, and tobacco tax revenues had more than doubled.
For another example, Figure 10.4 illustrates the relationship between price and consumption of
cigarettes in Israel. Here, we can see a dramatic drop in per capita cigarette consumption—from
around 1,600 to 200 cigarettes per capita over a 20-year period—a change largely attributed to price
increases.
But there’s even more to the concept of elasticity. Some groups are more sensitive to changes in
tobacco prices than others. For instance, youth are two to three times more sensitive to tobacco
prices than adults. In Table 10.2, we can see that while elasticity for tobacco products among adults is
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Table 10.2 Certain Groups are More
Sensitive to Tobacco Prices than Others
Group

Estimated Elasticity

Adults – High Income
Countries

-0.4

Youth – High Income
Countries

-0.5 to -1.2

Low and Middle Income
Countries

-0.2 to -0.8

-0.4, it ranges from -0.5 to -1.2 among youth,
who tend to have less expendable money than
adults and are also less likely to be already
addicted to cigarettes. We also see different
levels of elasticity associated with high-income
countries as opposed to low- and middleincome countries.
Looking now at trend data for young people in
the U.S., we again see the relationship between

price and consumption in Figure 10.5. Even minimal tobacco price changes correspond to changes in
youth smoking rates. This graph is particularly interesting as we consider the federal cigarette tax
increase of 2009. That year, the tax on a pack of cigarettes went from $.39 to $1.01, and it is estimated
that in the 30 days following the increase, smoking rates among teenagers decreased by about 10%,
resulting in approximately a quarter of a million fewer smokers among middle and high school
students.

341

Figure 10.5 U.S. Youth Smoking Prevalence vs. Cigarette Pack Price, 1991-2011
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Chapter 10 - Taxes and Funding Tobacco Control
Section 2 - Tobacco Taxes Vary Widely Throughout the World

In this section, we turn our attention first to tobacco taxes in the U.S., and then examine them in the
global context. In the U.S., excise taxes have proven to be a win-win situation. Increasing taxes on
tobacco provides a steady revenue stream to state and federal governments, and at the same time
cigarette consumption decreases. The history of tobacco taxation in the U.S. goes back more than a
hundred years, with the first excise tax implemented in 1864. In 1951, the tax was set at $0.08 per
pack of cigarettes, and it took over three decades to double, up to $0.18 per pack in 1983. Almost
twenty years later, the tax was raised to $0.39 per pack in 2002. The largest increase in the federal
excise tax occurred in 2009, going up to $1.01 per pack (not including state or local taxes).
In addition to the federal excise tax, currently at $1.01, every state has a tobacco tax, ranging from a
low of $0.17 in Missouri to a high of $4.35 per pack in New York. Overall, the average state cigarette
tax is $1.60 per pack. We see a great deal of variation among the states, but it must be noted that the
average tobacco tax in states with major tobacco production and/or manufacturing is 48.5¢ per pack
—much lower than the national average. In non tobacco-producing and/or manufacturing states, the
average is $1.75.
Some counties and cities also levy their own tobacco taxes in addition to state and federal taxes. For
instance, New York City has a $1.50 tax on tobacco products; in Illinois, the city of Chicago has a
$1.18 tax and Cook County, in which Chicago is located, has an additional $3.00 tax on tobacco.
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Figure 10.6 State Tobacco Excise Tax Rates Throughout the U.S., 2015

Looking more closely at the variation in cigarette taxes in the U.S., we can make some interesting
comparisons (Figure 10.6). First, we can see that the lowest taxes are in the Southeast, the region that
has the most tobacco-growing states. The majority of states in this region have taxes less than $1.00
per pack. The states which are bolded have not increased their tobacco tax since 2005 or earlier.
There are 32 states that have a tax of $1.00 or more—15 of these have a tax of $2.00 or more, and
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Figure 10.7 Tobacco Excise Tax Revenue as
a Percentage of Total Tax Revenues,
Selected European Countries, 2008

seven states have a tax of $3.00 or more. New York
is the only state that has a tax higher than $4.00
per pack.
Cigarette taxes have the potential to create
significant revenue for federal and state
governments. As of 2014, combining federal and
tobacco taxes together, the retail price of a pack of
20 cigarettes ranged from a low of $5.05 in
Missouri to a high of $10.56 in New York. The
federal cigarette tax rate has been set at $1.01
since April 2009. In fiscal year 2014, federal
tobacco taxes grossed more than $13.4 billion in
tax revenue and states grossed more than $16.5
billion in tobacco taxes. Combined, this accounts
for over $30 billion in revenue from cigarette taxes
in 2014.

The World Health Organization recommends that excise taxes should make up at least 70% of the
retail price of a pack of cigarettes (Figure 10.7). So far, only five countries have achieved this
recommendation: Cuba, Egypt, the United Kingdom, Fiji, and San Marino. In many countries, excise
taxes make up less than half of the pack price.
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Figure 10.8 Percentage of Excise and Total Tax
Burden Relative to Retail Price on a Pack of
Cigarettes, 2010

In Figure10.8 we look at data from the
Southeast Asian region, comparing the
proportion of the price of a pack of
cigarettes attributable to taxes. The red
bars show the percentage of the price that
comes from taxes. In Thailand, taxes make
up almost 70% of the pack price, whereas
in Laos, they make up less than 20% of the
price. There can be great variation even
within one country, as we see in the
Philippines, where the proportion varies
depending on the brand of cigarettes.
Australia has been one of the boldest
countries in using excise taxes as a form of
tobacco control. In 2013, the Australian
Prime Minister raised tobacco taxes by
12.5% to increase revenue and to boost

the government’s economic credibility prior to elections. This
resulted in an increase in the price of cigarettes to nearly AU
$1.00 per stick, making the cost of a pack over AU $20.00. This
increase will generate an extra AU$5.3 billion (US$4.7 billion)
per year.
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China provides another noteworthy case study illustrating
the importance of price and revenue to tobacco control.
China National Tobacco Corporation is a governmentowned monopoly; in addition to receiving tobacco
revenue through taxes as in other countries, the Chinese
government uniquely receives revenue through profits
from tobacco. In 2012, for example, the government
collected 864.9 billion Yuan (US$137.7 billion) in tax
revenue, and 716.6 billion Yuan in profits. These amounts represent an increase of 15.7% and 19%,
respectively, over the previous year. It is estimated that 7-10% of the Chinese government’s entire
operating revenue comes from tobacco profit and taxes. The economic importance of tobacco to the
Chinese government is a key item to address in efforts to reduce smoking in China, which tobacco
control advocates must do in a way that optimizes both health and revenue.
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Chapter 10 - Taxes and Funding Tobacco Control
Section 3 - The Tobacco Industry Claims that Tobacco Taxes are
Regressive and Create Illicit Trade
Knowing the impact of tobacco prices on cigarette consumption, the tobacco industry works hard
and invests substantial resources to oppose tobacco taxes. There are two industry tactics or
arguments against taxation that have become fairly common: 1) they claim that tobacco taxes are
regressive and harm those who can least afford it; and 2) they claim that tobacco taxes lead to illicit
trade and tax avoidance. With these arguments, tobacco companies try to influence politics at the
state and federal level to prevent additional taxes on their products.
With regard to the first argument against taxes, let us first clarify what is meant by a regressive tax. In
contrast to a progressive tax, in which the tax rate increases as the amount subject to taxation
increases (as is the case with the U.S. federal income tax, for instance), a regressive tax is one in which
the tax rate decreases as the taxable amount increases, or the tax rate remains the same regardless of
the taxable amount. The latter is the case with the sales tax and tobacco tax in the U.S. Since the same
amount of sales tax is taken with every purchase, regardless of who the purchaser is, sales taxes hurt
those with a lower income proportionally more than those with a higher
income. The tobacco companies use this as an argument that the poor end
up shouldering a greater burden than the rich when it comes to tobacco
excise taxes.
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Key Takeaway
The tobacco industry
claims taxes impact those
who can least afford to
pay and lead to illicit
cigarette trade and tax
avoidance.

This view is expressed in the following quote from Altria:
[Excise taxes] are unfair to adult tobacco consumers. Revenues from
tobacco product excise taxes are often used to fund general government
spending that benefits many, while the economic burden of tobacco
taxation is placed solely on tobacco consumers. In addition, because
tobacco excise taxes are based on the product and not on income level,
tobacco excise taxes are highly regressive, adversely affecting lowincome tobacco consumers more than high-income tobacco consumers.
The following data from the U.S. Department of Labor show that indeed, the proportion of income
spent on tobacco products is much higher among those in the lower income brackets (Table 10.3).
For instance, people who make between $5,000 and $10,000 per year spend on average 3.79% of
their income on tobacco products, while people who make $70,000 or more spend only 0.25% of
their income on tobacco. Since the poor end up spending a disproportionate part of their income on
smoking, they have less money to spend on food, housing, education, health care, and other
necessities.
However, the truly regressive aspect in this situation is the fact that the harmful effects of tobacco use
are disproportionately experienced by lower-income populations. Figure 10.9 illustrates data from a
selection of countries showing that the risk of dying from smoking between the ages of 35 and 69
years is remarkably higher for people with a lower socioeconomic status. We know that people who
belong to a lower social class, who are less educated, and who make less income—the people that
tobacco companies claim to be concerned about and that they want to “protect” from regressive
excise taxes on tobacco—are already the ones who disproportionately suffer from greater levels of
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Table 10.3 Income Before Taxes (Average Annual Expenditures and Characteristics), 2011
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Income Brackets

Average Income
before taxes

Average Amount
Spent on Tobacco
Products

% of income

All

$63,685

$351

0.55%

Less than $5,000

-$1,393

$299

-21.46%

$5,000 to $9,999

$8,056

$305

3.79%

$10,000 to $14,999

$12,654

$332

2.62%

$15,000 to 19,999

$17,563

$328

1.87%

$20,000 to $29,999

$24,940

$361

1.45%

$30,000 to $39,999

$34,777

$379

1.09%

$40,000 to $49,999

$44,698

$416

0.93%

$50,000 to $69,999

$59,306

$392

0.66%

$70,000 and more

$130,588

$321

0.25%

Figure 10.9 Differential Health Outcomes Due to
Smoking

illness and early death from smoking. If the
tobacco tax disproportionately affects the
poor, advocates for tobacco taxation argue
that the poor also deserve to have a greater
motivation to stop using tobacco products
than other groups.
We know too that price more heavily impacts
the tobacco consumption of individuals with
lower socioeconomic status. Thus, while they
pay a larger proportion of their income for
tobacco products as the price increases, they
are also much more likely to quit than

Figure 10.10 Varying Levels of Tobacco
Taxation Across States
individuals with a higher income. In other words, a
significant price or tax increase would result in
proportionately more people with low income
reducing their consumption—thus improving their
health and financial situation. In the best-case
scenario, revenues from the tobacco tax would be
used to invest in programs that help the low-
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Figure 10.11 The Industry Tends to Exaggerate the Scope of Illicit
Trade as a Counterargument Against Tobacco Control Measures

income population to quit
smoking.
The second argument
commonly used by
tobacco companies
against tobacco taxes is
that they lead to illicit trade
and tax avoidance. This
matter is of real concern,
as there is in fact some

level of illicit trade and tax evasion that occurs when neighboring states and counties have widely
varying levels of taxation. For example, New York, as mentioned above, has a much higher tax on
tobacco than its neighboring states (Figure 10.10). In 2013, two individuals were arrested in New York
City for running a cigarette smuggling ring believed to have generated $22 million in just 17 months.
Smuggling and tax evasion are a reality; however, the tobacco industry vastly exaggerates the extent
of these violations. Where the emphasis should be on using resources to enforce the law, tobacco
companies instead argue that illicit trade is a reason not to levy additional
taxes on their products. As shown in Figure 10.11, they intentionally
overestimate the scope of illicit trade in order to promote their agenda. The
industry’s estimates of illicit trade is double that obtained from objective
academic studies in each of the examples—the U.K., South Africa, and
Poland. The inflated figures for illicit trade are used as a scare tactic to push
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Key Takeaway
The tobacco industry
exaggerates the scope of
illicit trade in order to
promote their argument
that tobacco control
measures lead to illicit trade
and tax avoidance.

back on tobacco control measures—not only against excise taxes on tobacco, but also against plain
packaging restrictions. They claim that if a package of cigarettes is not allowed to display a brand
name, they are easier to counterfeit and will thus lead to an increase in illicit trade.
However, the tobacco industry claims that taxes (as well as plain packaging) encourage illicit trade are
misleading. A 2013 research letter published in Tobacco Control discussed how most of the increase
in tobacco prices have been the result of tobacco companies themselves raising their prices, rather
than taxes. According to the authors, the tobacco industry’s claims about taxes leading to illicit trade,
are made despite evidence of the far more complex supply-side drivers
of the illicit tobacco trade (including tobacco industry involvement),
recent survey evidence showing that price was unrelated to levels of illicit
tobacco use across Europe, and data from her Majesty's Revenue and
Customs showing that levels of illicit cigarettes in the UK have declined
steadily to reach an estimated nine per cent by 2010-11.
- Gilmore and Reed, 2013
The argument that the price of tobacco is what drives illicit trade is disingenuous, and, moreover, illicit
trade has in fact declined even while tobacco taxes have increased over time.
Ultimately, even if smuggling and illicit trade were to increase as a result of a tax increase, the fact is
that higher taxes on tobacco still result in greater revenues for government and decreased
consumption of the product. Certainly, smuggling and illicit trade should be addressed.
Governments can do so by having strong tax administrators, increased enforcements, swift and severe
penalties for tax avoidance, and collaboration with neighboring regions to even out tax rates. The
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Figure 10.12 Tobacco Industry's Political Contributions by
Recipient Type, 2011-2012

illicit trade in tobacco
should not be accepted as
a reason not to levy taxes
on tobacco.
The real driving force for
the tobacco industry is
money. Tobacco
companies are willing to
accept increases in the
price of cigarettes if they
get to pocket the
additional profit, but price
increases from government

taxes are a different story. They invest an enormous amount of their resources to defeat efforts to raise
the tax on tobacco products (Figure 10.12). In 2011-2012, the four leading tobacco manufacturers—
Philip Morris USA, Reynolds American Inc., U.S. Smokeless Tobacco Company, and Altria—contributed
$47.4 million to defeat ballot measures that would increase taxes on tobacco.
The issue of tobacco tax increases has been very much politicized in recent years. Politicians are
encouraged to pledge not to increase taxes of any type. Since 1986, over 1,100 state office holders
have signed the Americans for Tax Reform pledge (Figure 10.14), which includes a promise to oppose
tobacco taxes. The tobacco industry has tended to latch onto conservative politicians who are
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typically opposed to tax increases, which has led to the politicization of a public health issue that
should otherwise be nonpartisan (Figure 10.13).
The Centers for Disease Control and Prevention (CDC) estimate that the health costs and productivity
losses caused by smoking equal $10.47 for every pack sold. To tax tobacco in a way that would be
commensurate with the harm it causes might mean taxing it by that amount—$10.47 per pack—in
every state and locality. We are still far from that scenario, and an important role for tobacco control
advocates is to depoliticize the issue of tobacco taxes and ensure that legislators and voters
understand the benefits of raising taxes on tobacco, which include the reduction of smoking as well
as the increase of resources that can be used to further advance the population’s health outcomes.

Figure 10.13 Tobacco Industry's Political
Contributions by Political Party, 2011-2012
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Figure 10.14 Taxpayer Protection Pledge, from the Americans
for Tax Reform
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Chapter 10 - Taxes and Funding Tobacco Control
Section 4 - Funding Tobacco Control Through Taxes and the
Master Settlement Agreement
In 1998, the largest civil litigation in U.S. history (at the time) came to an end with the signing of the
Master Settlement Agreement (MSA). This agreement between the four major tobacco companies, 46
states, the District of Columbia, and five U.S. territories requires the tobacco companies to pay the
states and territories billions of dollars in yearly installments to compensate them for taxpayer money
that has been spent in connection with tobacco-related diseases. An estimated $246 billion will be
paid out in the
first 25 years. At
the time of

Table 10.4 Fiscal Year 2015 Tobacco Money for Tobacco Prevention (in
billions)

signing, both

18.4

parties agreed
conceptually that
the funds would

CDC
Recommended

be used to
prevent future
harm from
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Annual Funding
for Tobacco

7.3

Prevention

tobacco, and in

Estimated

Estimated

particular to keep

Tobacco

Tobacco

youth from

Settlement

Tax

Revenues

Revenues

Actual
Tobacco

3.3

Prevention
Spending

0.46

smoking. However, the agreement provides no written restriction on how the states can use these
funds, since the allocation of funds is determined by legislatures rather than by legal agreements.
Figure 10.15 illustrates the disastrous result of the lack of restrictions on how MSA funds are to be
used. The total state tobacco revenue in fiscal year 2015 was $25.6 billion, taking into account
revenues from both state tobacco taxes and tobacco settlements. The CDC put forward an estimate of
$3.3 billion as the amount that states should spend annually to prevent and control tobacco use.
However, we can see that the actual amount spent on tobacco control efforts in the United States is
less than half a billion dollars.
Based on these figures, there are some who argue that overly aggressive efforts in reducing tobacco
use will ultimately reduce the billions of dollars in state revenue that are generated by the sale of
tobacco. But while some find this a worrying prospect, others would welcome such a reduction since
a decrease in tobacco consumption is the ultimate goal.
Table 10.5 shows the top ten states that spend the most money on tobacco control. Alaska is in the
lead, spending slightly more than the CDC recommended level. On the other end of the spectrum,
four states (New Hampshire, New Jersey, North Carolina, and Ohio) do not spend any money on
tobacco control. It is also important to note that several states spend less than 2% of the CDC’s
recommended levels for tobacco control. We can thus see a wide variation in the amount invested in
tobacco control programs by each state.
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Table 10.5 Top 10 U.S. States Spending the Most Money on Tobacco Control
State

FY2014 Current
Annual Funding
(millions)

CDC Annual
Recommendation
(millions)

FY2015 Percent
of CDC’s
Recommendation

Current
Rank

North Dakota

$9.5

$9.8

97.1%

1

Alaska

$9.7

$10.2

95.6%

2

Delaware

$8.7

$13.0

66.7%

3

Oklahoma

$23.6

$42.3

55.7%

4

Hawaii

$7.5

$13.7

55.0%

5

Wyoming

$4.6

$8.5

54.1%

6

Maine

$8.2

$15.9

51.4%

7

Arkansas

$17.5

$36.7

47.6%

8

Vermont

$3.9

$8.4

46.4%

9

Colorado

$23.1

$52.9

43.7%

10

Most of the funds coming from state excise taxes on tobacco and the MSA go into each state’s
general budget. They are not generally earmarked for any particular purpose, and are often used to

Figure 10.15 Health and Economic Impact of Tobacco Taxes, 2011 (ACS-CAN)
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balance the budget rather than to help deal with the problem of tobacco use. This means that
increases in excise taxes are more often prompted by budget shortfalls, rather than public health
concerns. If every state and the District of Columbia raised its tax by $1 per pack, they would gain
over $8.6 billion in new revenue and save over $1 billion in medical expenses that are avoided due to
decreased consumption (Figure 10.16).
Some states provide great examples of using tobacco revenues for tobacco control efforts. For
instance, Alaska spends 20% of its revenues from the MSA and some of its tax revenues for tobacco
control. California dedicates 20% of its excise tax revenue to fund its tobacco control program, which
is one of the most successful in the country. It is no coincidence that California has one of the lowest
smoking rates of any state in the country.
As mentioned above, most revenue from excise taxes and the MSA are not earmarked for any
particular purpose. One major exception to this is the $0.62 federal tax increase on tobacco in 2009
(which raised the tax from $0.39 to $1.01 per pack). The funds associated with this tax increase are
dedicated to expand the State Children’s Health Insurance Program (SCHIP). This program covers 8
million children in families with incomes that are too high to qualify for Medicaid but still can’t afford
private insurance coverage. This is a good example of using revenue for a public health purpose that
at least begins to balance out the harm caused by tobacco products.
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To summarize this chapter, we emphasize that tobacco tax increases are the single most effective
tobacco control strategy we have to reduce tobacco use. Currently, there is great variation from state
to state in terms of the rate of tobacco taxation, as well as the use of tobacco revenue. Going forward,
we can expect to see continued effort to raise the tax on tobacco products, and the use of funds
generated by tobacco sales and the MSA will continue to be an important public policy issue.

Chapter 10 Discussion Questions:
1. Compare the situation in China where the government has a monopoly on the tobacco industry
with the situation in the U.S. where tobacco companies fund candidates, parties, and ballot
measures committees? How are they similar or different?
2. Should revenues from tobacco tax and the MSA be restricted to tobacco control or public health
purposes?
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Chapter 11

Marketing Restrictions
and Counter-Marketing

Chapter Objectives
1. Explain why marketing restrictions are important in tobacco
control efforts.
2. Contrast the purpose and effectiveness of various tobacco
marketing restrictions and counter-marketing.
3. Examine the American Legacy Foundation’s countermarketing programs as an example of effective tobacco
control counter-marketing.
4. Analyze the concept of warning labels and plain packaging
and its potential impact on global tobacco control.

Chapter 11 - Marketing Restrictions and Counter-Marketing
Section 1 - Why Use Marketing Restrictions to Curb Tobacco

In the previous chapters, we discussed the importance of marketing to the survival of the tobacco
industry. We know that tobacco kills up to half of all lifetime users. Tobacco companies want to addict
new smokers and will do so by any means. We also know that tobacco marketing persuades
individuals to start smoking, especially youth. In this section, we will investigate how public health
advocates can use restrictions to limit people’s exposure to tobacco marketing and help to decrease
tobacco consumption. Our discussion will also cover graphic warning labels and counter-marketing
strategies that help inform the public about the hazardous effects of smoking and
secondhand smoke.
In spite of the claim by tobacco companies that they only market their products in order to get adults
who already smoke to either switch their cigarette brand or maintain their brand loyalty, the truth is
that tobacco advertising and sponsorships target young people, giving tobacco companies new
clients and lifetime addicts. There is no question that tobacco advertising, promotion, and
sponsorship are a substantial contributing factor to the initiation of tobacco use among teenagers.
Globally, 78% of youth 13 to 15 years of age report regular exposure to some form of tobacco
marketing. They are much more likely than adults to be offered free cigarettes by a representative of a
tobacco company. Further, in the United States 66% of movies rated PG-13 contain images
of smoking.
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Studies have shown that marketing restrictions are effective in reducing

Key Takeaway

people’s exposure to tobacco advertising and, in turn, reducing tobacco

Marketing restrictions
are effective in
reducing people’s
exposure to tobacco
advertising and, in
turn, reducing tobacco
consumption

consumption. A comprehensive ban on all tobacco advertising, promotion, and
sponsorship has the potential to decrease tobacco consumption by
approximately 7%, with some countries experiencing up to a 16% decline in
consumption. In accordance with its constitution and constitutional principles,

the WHO Framework Convention on Tobacco Control (WHO FCTC) requires its member parties to
implement a comprehensive ban on all tobacco advertising, promotion and sponsorship. However, so
far only 24 countries have met this requirement, representing only 10% of the world’s population.
Approximately one in three
countries has minimal or no
restrictions on tobacco
marketing.
Figure 11.1 is a graph from the
WHO Report on the Global
Tobacco Epidemic showing the
spread of different types of
advertising and marketing
restrictions for high-, middle-,
and low-income countries. It is
important to note that there are
a greater proportion of low-
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Figure 11.1 Global Bans on Advertising, Promotion and
Sponsorships, 2011

income countries banning all forms of direct and indirect advertising than high-income countries. In
many instances, the U.S. being one example, high-income countries feel limited in their ability to ban
all forms of marketing for constitutional reasons. Often, developing countries have greater ability to
incorporate such restrictions as laws are still becoming established.
The fight against tobacco marketing in the U.S. has an interesting history. As we have suggested
previously, tobacco companies were among the largest advertisers on television in the 1960s. The first
Report of the Surgeon General was published in 1964, concluding that cigarette smoking was
causally related to lung cancer, but even then, tobacco advertising continued to be aired on
television. At that time, the Federal Communications Commission (FCC) had a policy called the
Fairness Doctrine, which required broadcast stations to present issues of public importance in a
balanced manner. This meant that television stations, for example, could not show only one point of
view on a given issue or present a biased perspective; they had to present multiple perspectives and
be equitable in their production of television programming. A young attorney named John F. Banzhaf
III petitioned the FCC to apply the Fairness Doctrine to cigarette advertising, on the premise that
these advertisements were providing an unfair perspective on smoking and disregarding the harm
caused by smoking. The other side of the story needed to be told, and Banzhaf demanded equal
airtime for anti-smoking messages. To the surprise of many people, the FCC concurred with Banzhaf,
and announced on June 5, 1967, that the Fairness Doctrine applied to cigarette advertising. All the
television networks that were broadcasting cigarette ads were required to broadcast one antismoking commercial for every three cigarette ads that they aired (Movie 11.1).
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Movie 11.1 Example of Anti-Smoking
Commercial Broadcast Following
Fairness Doctrine, 1967

As a result of the application of the Fairness Doctrine to
cigarette advertising, smoking rates dropped between
1967 and 1970 more than they had in any previous
period. Tobacco companies, concerned that more
advertising would only result in more counteradvertising on television and radio, voluntarily removed
many of their ads from broadcast media. Then, in 1971,
the U.S. Congress banned broadcast advertising of
cigarettes altogether. Following the voluntary
agreement by tobacco companies and the subsequent
congressional ban, the focus of tobacco companies

shifted to print media advertising. Coverage of smoking and health in magazines carrying cigarette
advertisements fell in the post-ban period and cigarette ad revenues increased.
Since then, tobacco companies have spent billions of dollars each year on print and billboard
advertisements, with most of their efforts directed at attracting youth. The most egregious example
was the Joe Camel campaign (Chapter 7: Tobacco Marketing) in the late 1980s, developed by R.J.
Reynolds to get teenage boys to smoke Camel cigarettes. The company’s internal memos document
the use of extensive market research and focus groups to create a cartoon character that would
influence boys to smoke. Camel’s share of the teenage market more than quadrupled in just five years
as a result of this campaign.
Largely spurred on by the alarming ability of the Camel advertisements to influence young people,
the Federal Trade Commission (FTC) launched an investigation into the company’s marketing
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practices. The study confirmed that Joe Camel was a substantial contributing factor to the onset of
smoking among youth. At around the same time as the investigation, the Master Settlement
Agreement (MSA) was finalized between the tobacco companies and the state attorneys general. A
number of marketing restrictions were included in the MSA: it eliminated billboard and transit
advertising, and tobacco companies could no longer use cartoon characters to promote tobacco
products. Consequently, the FTC decided not
to proceed with further action against Joe

Movie 11.2 Ad for blu e-cigarette

Camel because the MSA, by banning cartoon
characters in tobacco advertising, had already
put in place the very remedy they were
seeking. In addition, the MSA restricted free
product distribution to only those venues that
do not permit children and limited event
sponsorships by tobacco companies.
The MSA represented a big step in restricting tobacco marketing in the United States, but the
restrictions were by no means comprehensive. Tobacco companies were still permitted to use human
images in their advertising—the Marlboro Man, for instance, could still be used to sell cigarettes.
Though billboards were restricted, outdoor advertising up to 14 square feet could still be used on
buildings or on the property of places where tobacco is sold (Figure 11.2). Tobacco advertising in
magazines and newspapers remained ubiquitous. Today, there are very few countries in the world
that remain as lenient on tobacco marketing as the United States.
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A very important debate is now occurring around the
marketing of e-cigarettes. As we mentioned, tobacco
advertising has been banned from television and

Figure 11.2 Despite MSA Marketing
Restrictions, Tobacco Advertising is Still
Visible, as in this L.A. example

radio since 1971. However, the existing laws
restricting tobacco advertising do not apply to ecigarettes. We can now see ads for e-cigarettes on
television, in spite of the fact that e-cigarettes are
legally considered tobacco products. Indeed, ecigarettes are not currently regulated by any agency
in the U.S., and for the first time, ads like the one
shown in Movie 11.2 are allowed to be shown on
television.
The most recent effort to curb tobacco use occurred
in June 2009, with the signing of the Family Smoking
Prevention and Tobacco Control Act by President
Barack Obama (Movie 11.3). This act, which went into
effect in 2010, gives the U.S. Food and Drug
Administration (FDA) comprehensive authority to
regulate the manufacturing, marketing and sale of
tobacco products. It includes a number of new
requirements related to the marketing (labeling,
advertising, and promotion) of tobacco products.
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Movie 11.3 President Obama Signs the
Family Smoking Prevention and Tobacco
Control Act into Law, 2009

The Family Smoking Prevention and Tobacco Control Act (FSPTCA):
•

Prohibits tobacco brand name sponsorship of any athletic, musical, or other social or cultural

event, or any team or entry in those events.
•

Requires that audio ads use only words with no music or sound effects.

•

Prohibits the sale or distribution of items, such as hats and t-shirts, with cigarette and smokeless

tobacco brands or logos.
It has been nearly five years since the law was passed, yet many of the restrictions associated with it
are still under legal consideration. If fully implemented, the FDA law will require graphic warning
labels on cigarette packages and restrict cigarette advertising to black-and-white text, removing color
and imagery from tobacco ads. Some steps have already been taken by the FDA to put these new
restrictions into action; however, many of the actions are still under litigation in a variety of courts
around the country. Tobacco companies have challenged the requirement of graphic warning labels
on the grounds that it violates the First Amendment. The graphic warning labels, pictured in Figure
11.3, were deemed unconstitutional in March 2012. The FDA decided not to appeal the ruling and is
now in the process of designing new graphic warning labels that comply with the 2009 FSPTCA. Most
recently in May 2016, FDA issued a final deeming ruling on e-cigarettes and other tobacco products,
such as premium cigars and hookah. The ruling gives FDA the authority to regulate these products in
the same manner it regulates traditional cigarettes and smokeless tobacco. Additionally, it establishes
several regulations related to the marketing and sale of these products. For example, e-cigarettes
cannot be sold to individuals under the age of 18, companies must show what is included in the
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products, and health warnings must appear on packaging and advertisements. The FDA is expected
to issue further marketing regulations in the future.

Figure 11.3 Revised U.S. Graphic Warning Labels
Were Defeated

Graphic warning labels in the U.S. were supposed to look like this as of September 2012:

This is how warning labels still look today:
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Chapter 11 - Marketing Restrictions and Counter-Marketing
Section 2 -Types of Campaigns and Guidelines

So far, we have discussed the important role of marketing in achieving the tobacco industry’s purpose
of keeping smokers addicted and attracting new smokers, especially among young people. The good
news is that marketing campaigns can also be used effectively by tobacco control advocates to
protect the public from the harm of tobacco use. Mass media campaigns can reduce tobacco
consumption by influencing norms, perceptions, and attitudes toward smoking. They can also be
used to protect nonsmokers from exposure to secondhand smoke by encouraging them to advocate
for smoke-free environments. They can convince young people to reject the tobacco industry’s
exploitative marketing efforts. Over half of the world’s population live in one of 37 countries that have
implemented at least one strong anti-tobacco mass media campaign within the last two years. Mass
media campaigns can be very cost-effective and can be implemented in a much shorter time than
other tobacco control initiatives, which often require legislation or litigation and take several years,
even decades, to accomplish.
The Community Preventive Services Task Force recommends using mass
media campaigns on the basis of strong evidence of their effectiveness in

Key Takeaway

reducing tobacco use among adolescents. These campaigns are especially

Anti-tobacco campaigns in
the mass media reduce
tobacco consumption by
influencing norms,
perceptions and attitudes
toward smoking.

effective when they are combined with other community interventions so
that people are exposed to a consistent message that tobacco is harmful
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Figure 11.4 World Lung Foundation’s Mass
Media Advertising Campaign Guide

and nonsmoking is the norm. Studies
conducted in the U.S., Norway, and Finland
showed that in follow-up periods ranging from
two to five years, self-reported tobacco use
was 2.4% lower in groups that were exposed
to a mass media campaign. To assist in
creating successful mass media advertising
campaigns, the World Lung Foundation
created a 360 degree process and planning
guide (Figure 11.4).
In the U.S., we have seen the launch of a
number of counter-marketing campaigns in
recent years. The American Legacy Foundation

(now known as Truth Initiative) started the truth® campaign in 2000, releasing several anti-tobacco ads
with the goal of reducing tobacco use.
Most recently, the FDA has started its own anti-tobacco campaign, under the authority granted in
2009 by President Obama. In February 2014, the “Real Cost” campaign was launched, focusing on
preventing youth tobacco use. Targeting young people ages 12 to 17 who have never smoked, the
campaign is a comprehensive effort that incorporates ads on television, radio, the Internet, and social
media to spread the message about the real cost of smoking (Movie 11.4).
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Movie 11.4 "The Real Cost"
Campaign

The Centers for Disease
Control and Prevention
(CDC) likewise launched
its own national anti-

“We know that early
intervention is critical,
with almost nine out of

smoking campaign

every ten regular adult

called “Tips from Former

smokers picking up their

Smokers” (Movie 11.5).

first cigarette by age 18.”

The campaign ran for

- FDA Commissioner Margaret A.

three months in 2012 and was re-launched in 2014, providing hard-

Hamburg, M.D.

hitting, emotionally evocative television ads that depict the smokingrelated suffering of real people. Upon thorough scientific evaluation of the 2012 campaign,
researchers found that it resulted in a 12% increase in quit attempts; that is, an estimated 1.64 million
additional smokers made a quit attempt after viewing the ads. In addition, the prevalence of people
talking with friends and family about the dangers of smoking rose, resulting in six million people
having conversations about smoking’s adverse
effects.
Though it is often difficult to determine the
effect on smoking and quit rates of any single
independent intervention (particularly with
ongoing developments around FDA regulation,
changes in the price of tobacco, additional
coverage of clean air laws, and so on), there is
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Movie 11.5 Tips from Former Smokers

no question that tobacco control interventions are collectively making a difference and will hopefully
accelerate the decline of tobacco use. We should, however, temper our optimism with this sobering
fact: tobacco control marketing campaigns are still dwarfed by tobacco industry marketing
expenditures (Figure 11.5). For instance, CDC’s Tips campaign cost $54 million and ran for three
months, making it the largest
national counter-marketing
campaign for adults to have

Figure 11.5 Comparing Marketing Expenditures of Tobacco
Companies vs. CDC Counter-Marketing Campaign

appeared in the U.S. In contrast,
the tobacco industry spends
$23 million each day on
tobacco advertising and
promotions. In other words,
tobacco companies spend
more than 150 times as much
on marketing their deadly and
addicting product than the CDC
spends on spreading antitobacco messaging.
In light of the enormous importance of marketing in the fight against tobacco, the CDC has
developed a resource called the Media Campaign Resource Center (MCRC), which provides access to
advertisements licensed by the CDC for use by tobacco-control organizations. The MCRC helps state
and local jurisdictions that wish to conduct their own counter-marketing efforts by providing tools to
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find, learn about, and order already existing tobacco counter-ads without incurring additional
expenses.
Based on the experience of a variety of locations in the U.S. and around the world with mass media
campaigns, there are eight characteristics that have been identified with successful anti-tobacco
programs. These include:
•

A strong and sustained presence over time, meaning the campaigns run over many years and

are refreshed periodically;
•

Adequate funding - the U.S. CDC recommends spending $1.36 - $3.90 per person, per year for

an effective media campaign in the U.S.;
•

Integrated communication components that complement each other;

•

The campaign is integral to a wider tobacco control program and mass media tools are

designed to enhance and improve the impact of other tobacco control interventions;
•

The campaign is part of a long-term strategic plan;

•

Strong creative material that motivates smokers to quit;

•

Cultural acceptability and tailoring of campaigns so they are appropriate for target audiences;

and
•
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Thorough pre- and post-campaign evaluation

Chapter 11 - Marketing Restrictions and Counter-Marketing
Section 3 - Case Study on Truth Initiative, formerly the American Legacy Foundation

Located in Washington, D.C., the American Legacy Foundation (which became Truth Initiative® in
2015) was created as a result of the November 1998 Master Settlement Agreement reached between
attorneys general from 46 states, five U.S. territories and the tobacco industry. A portion of the money
received by the states as a result of the settlement was used to establish and fund Truth Initiative, the
first national public health organization in the United States dedicated to tobacco control. Truth
Initiative envisions an America where tobacco is a thing of the past, where all youth and young adults
reject tobacco use. Truth Initiative’s public education programs, including truth® and EX®, have been
proven effective and nationally-recognized.

Movie 11.6 truth®: Visit truth
(www.thetruth.com) For Finish It Campaign
Videos and Promotional Material

Truth Initiative has created a variety of
groundbreaking tobacco counter-advertisements
on the Internet, in print, and on television to get its
message to young people. For example, the “Finish
It” campaign (Movie 11.6) focuses on declining
smoking rates among youth, encouraging them to
make the fight to end smoking for good. A very
marked decrease in teenage smoking between
1997 and 2002 has been attributed to Truth
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Initiative’s truth® campaign (Figure 11.6). During this period, rates of smoking among youth declined
from 28% to 18%. At least 22% of this change has been attributed to the truth® counter-marketing
campaign.

Figure 11.6 Changes in Current Smoking Prevalence Among U.S. Students Before and After the
Launch of the truth® Campaign in 2000: 1997-2002

Along with its youth prevention efforts, Truth Initiative has also invested substantially in programs to
help smokers quit. The EX Plan is a free quit-smoking program designed to show smokers a new way
to think about quitting. The “Become an EX” campaign was developed in consultation with exsmokers and scientific researchers from the Mayo Clinic who shared their experiences and knowledge
about effective ways to quit smoking and stay quit. Their insights have been incorporated into mass
media campaigns and free web resources.
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Chapter 11 - Marketing Restrictions and Counter-Marketing
Section 4 - The Ultimate Counter-Marketing – Warning Labels and Plain
Packaging
One of the most
controversial areas related to

Figure 11.7 Knowledge About Tobacco Harms is Higher in
Countries with Package Warnings, 2011

tobacco marketing and
counter-marketing strategies
in the U.S. involves warning
labels and plain packaging
for tobacco products.
Around the world, health
warning labels on cigarette
packages range from
minimal (text-only warnings),
to graphic warning labels
(pictorial warnings covering
the majority of the pack), to
plain packaging which takes away all color and logos from the product. According to WHO, the goal
of warning labels is to “shift the value of packaging away from marketing and towards public health
messaging.” We may forget the power of packaging, but just consider for a moment some of our
favorite products—think about the logo, the specific coloration of a package, the way the packaging
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Figure 11.8 U.S. Text-Only
Warnings are on the Side of
Tobacco Products

forms an integral part of the identity of the product—may give
an idea of the importance of packaging.
As Figure 11.7 demonstrates, people who live in countries
that require tobacco package warnings know more about the
risk for specific diseases and specific constituents of tobacco
smoke than those living in countries that don’t require such
warnings. At a minimum, warning labels are effective at
increasing knowledge about the harms of tobacco use.
In the U.S., tobacco products have text-only warning labels,
which minimally impact the appearance of the package
(Figure 11.8). The text labels found on the side of a pack of

Figure 11.9 U.K.'s Larger TextOnly Warnings are on the Front
of a Pack

cigarettes are not much different from how they were 40 years
ago. The health messages they portray are not very
noticeable and can thus be quite ineffective. Some countries,
like the U.K., have larger, more prominent text-only messages
on the front rather than, or sometimes in addition to, the side
of the pack (Figure 11.9).
More recently, the concept of warning labels has expanded
from text-only warnings to graphic pictorial warnings (Figure
11.10). Studies have shown that graphic pictorial warnings on
cigarette packages reduce the number of youth who start
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smoking as well as increase the number of current smokers who quit. They also significantly increase
people’s awareness of the harms of tobacco use. Currently, there are 30 countries (most of them lowor middle-income, and
representing 14% of the world’s
population) that meet best
practices for pictorial warnings.
Best practices for pictorial warnings
recommend warnings in the local
language covering at least half of
the front as well as the back of
cigarette packs.
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Figure 11.10 An Example From the WHO FCTC Health
Warnings Database

Figure 11.11 Comparison of Text vs. Graphic Warning
Labels

In 2012, researchers at the
University of Pennsylvania showed
that graphic warning labels improve
smokers’ recall of the warning and
health risks associated with
smoking, again confirming that
graphic warning labels are much
more powerful than text-only
warnings.
Figure 11.11 shows a side by side
comparison of a text-only label
compared to a graphic warning
label, showing aa child inhaling
secondhand cigarette smoke.
Researchers have found that

graphic warning labels are overwhelmingly supported by the public, often with levels of support at
85-90% or higher, and even most smokers support labeling requirements. Following the introduction
of graphic warning labels in Canada, there was a dramatic increase in smokers’ intention to quit
(Figure 11.12).
Key Takeaway
Graphic pictorial warnings on cigarette packages reduce the number of youth who start smoking as well as increase the
number of current smokers who quit. They also significantly increase people’s awareness of the harms of tobacco use.
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Figure 11.12 Intention to Quit Increased with
Canadian Pack Warnings, 2011

While graphic warning labels have
become standard practice in many
countries, the U.S. still lags behind in
implementing them to help reduce
tobacco use. In this country, there has
been an effort to include graphic warning
labels (they were part of the law signed by
President Obama in 2009), but the
tobacco companies have brought
litigation against the FDA and the courts
have mandated revisions to the warning
labels as they were originally designed.
Additional litigation is expected (and it is
likely that the case will ultimately be taken
to the Supreme Court) before the revised
warning labels can be implemented.

Pictorial health warnings on tobacco packages are a proven, cost-effective means of increasing public
awareness about the dangers of tobacco use. WHO collects tobacco package health warnings from
around the world in its WHO FCTC Health Warnings Database, with the aim of helping countries to
share effective pictorial health warnings and messages with one another. Article 11 of the WHO FCTC
specifies that member parties (i.e., countries that ratified the Convention) need to have warning labels

390

on the packaging of tobacco products and recommends
strongly that these warning labels should be graphic
(Figure 11.13).
The following is Philip Morris International’s (PMI) position
on warning labels and plain packaging:

Each Party shall, within a period
of three years after entry into

“Because smoking causes a number of

force of this Convention for that

diseases, we support laws that mandate that

Party, adopt and implement, in

health warnings rotate to allow for several

accordance with its national law,

different messages. . . However, we do not

effective measures to ensure that:

support excessive warning sizes. . . Our
distinctive trademarks, logos, and pack
designs are extremely valuable intellectual

package of tobacco products

property, and using warnings for the

and any outside packaging

purpose of debasing or overwhelming that

and labeling of such products

property as opposed to informing

also carry health warnings

consumers is inappropriate.”

describing the harmful effects

PMI acknowledges that smoking causes disease (in spite of

of tobacco use, and may

having denied this for decades), but uses the guise of

include other appropriate

protecting its “valuable intellectual property” to reject

messages.

prominent health messaging on cigarette packages.
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• Each unit packet and

Figure 11.13 Brazilian
Graphic Warning Label

Indeed, what companies like PMI fear most is the implementation of
plain packaging. Considered the gold standard of warning labels,
plain packaging is the standardization of cigarette packaging that
removes all product advertising, including colors, logos, and brand
imagery, and enforces restrictions on font size and type that can be
used on tobacco packages (Figure 11.14).
In 2012, Australia became the first country to pass plain packaging
legislation. Australia’s government has been extraordinarily
aggressive in trying to reduce tobacco use and the goal of the plain
packaging law was to prevent tobacco advertising and promotion on
tobacco product packaging in order to reduce their attractiveness
and appeal for consumers, especially youth (Figure 11.15). Plain
packaging also increases the noticeability and effectiveness of the

health warnings on the package. Overall,
the Australian tobacco packaging laws
reduce the ability of tobacco companies
to use the packaging of their products to
continue to mislead consumers about the
harm caused by smoking. These laws
contribute to the long-term objectives
and efforts of Australia’s comprehensive
program to reduce smoking rates.
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Figure 11.14 Plain Packaging - The Gold Standard of
Warning Labels
Images used with permission of the Australian Government

Following Australia’s example of implementing plain packaging, a number of
other countries have looked into passing similar legislation. Ireland is expected
to be the second country to pass plain packaging; Scotland and the U.K. are
also considering plain packaging.
The widespread implementation of plain packaging laws would be a huge step
for tobacco control. As expected, Australia’s announcement of plain packaging

Key Takeaway
Australia was the first
country to implement
plain packaging
legislation in 2012,
and several other
countries around the
world are now
considering the same.

generated an immediate reaction from the tobacco companies. Often, we can
tell the effectiveness of a particular tobacco control intervention by observing tobacco companies’
reactions to its implementation. The industry launched mass media campaigns, funded front groups,
funded their own research, sued the Australian government, and began to dispute plain packaging in
terms of existing trade
agreements through the
World Trade
Organization. These
reactions from the
tobacco industry
demonstrate just how
important the
packaging is for tobacco
and the extent to which
it is used as a means of
marketing and
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Figure 11.15 Example of Australian Plain Packaging
Images used with permission of the Australian Government
Health Warning Image © Professor Laurence J Walsh, The University of Queensland

Figure 11.16 Tobacco Packaging is a
Means of Marketing, and Plain Packaging
Disrupts this Marketing Avenue for
Tobacco Companies
Images used with the permission of the Australian
Government

maintaining a brand image (Figure 11.16).
Tobacco companies fear losing this last, mostly
unregulated marketing avenue.
Extremely concerned about the spread of plain
packaging laws around the world, the tobacco
companies are attacking the policy on two fronts.
First, they claim that generic packaging or plain
packaging has not been proven to be effective in
cutting rates of smoking—that there is no
evidence that it actually works as a tobacco
control measure. Second, they suggest that plain
packaging leads to illicit trade and criminal

behavior, as people would go across national borders to acquire cigarettes in their traditional packs.
Indeed, plain packaging has caused such panic among tobacco companies that we see PMI actually
pushing for governments to disregard this policy—on the grounds that it is as yet “untested,
speculative”—and instead “implement and reinforce proven, effective measures to reduce youth
smoking and address concerns about the harm caused by tobacco.” We know that these proven,
effective measures are tax increases, clean indoor air laws, and marketing restrictions—the very things
that the tobacco industry spends billions fighting against in other venues.
Ultimately, the tobacco industry may or may not be able to influence governments on the issue of
plain packaging. But there are challenges on other fronts as well. As already mentioned, because the
tobacco companies were unsuccessful in overturning the Australian decision, they have taken their
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Here is what Philip Morris
International says about
plain packaging:
“The scientific studies of generic
packaging conducted in the last decade
and a half have failed to produce
credible evidence supporting generic
packaging. These studies have not even
attempted to establish a meaningful link
between youth smoking uptake and
cigarette packaging.”
And further:
“In lieu of implementing generic
packaging—an untested, speculative
measure likely to backfire—governments
can implement and enforce proven,
effective measures to reduce youth
smoking and address concerns about
the harm caused by tobacco.”

complaints to the World Trade Organization
(WTO). Located in Geneva, Switzerland, the
WTO oversees 159 countries, ensuring that
member economies respect the rules of global
commerce. Indonesia, Ukraine, Honduras, the
Dominican Republic, and Cuba have
challenged Australia at WTO over plain
packaging. The plaintiff countries argue that
Australia’s law breaches international trade rules
and intellectual property rights to brands. The
complaints are still in process at WTO, but the
Australian government re-affirms its
commitment to tobacco plain packaging laws.
In the meantime, Australia is certainly free to
continue to enforce plain packaging within its
own borders—the complaints have to do only
with tobacco products traded and exported
outside of those borders. Other countries may
do well not to wait for the outcome of the WTO
proceedings, which may take several years, but
to establish their own plain packaging rules
within their sovereign boundaries. Interestingly,
in June 2015 Ukraine, the first of the five
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countries to challenge Australia’s plain packaging laws suspended its legal
proceedings against Australia. Leaders of Ukraine, a party to the WHO
FCTC, stated that the country intends to pursue a mutually agreed upon

Movie 11.7 Hear
from the Experts:
Simon Chapman

solution with Australia on the issue of plain packaging.
To conclude this chapter on marketing restrictions, we have an inspiring
video from Dr. Simon Chapman (Movie 11.7), who shares his experience
with plain packaging in Australia. Dr. Chapman is a Professor of Public
Health at the University of Sydney and has won many awards for his
leadership in tobacco control.

Chapter 11 Discussion Questions:
1. Are you surprised to learn that the U.S. has one of the least restrictive laws for tobacco
advertising? Why do you think this is the case even as compared to other democratic countries?
2. Present arguments for and against plain packaging laws keeping in mind the tobacco industry’s
claim of first amendment rights.
3. While the U.S. and other countries are working to implement plain packaging laws, brainstorm
other counter-marketing methods that can be pursued.
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Chapter 12

Tobacco Cessation

Chapter Objectives
1. Recognize that nicotine addiction is a chronic condition
often requiring multiple interventions and quit attempts.
2. Classify interventions as either population-based or clinical.
3. Analyze the effectiveness of population-based interventions
and their role in a comprehensive tobacco control program.
4. Contrast clinical-level cessation support and interventions.
5. Examine why special populations experience additional
challenges around cessation.

Chapter 12 - Tobacco Cessation
Section 1 - The Basics of Cessation

In the previous chapters, we learned about the harm of
tobacco use. We know that tobacco smoke contains a
deadly mix of more than 7,000 chemicals, of which
about 70 are known to cause cancer. There are more
deaths each year caused by tobacco use than deaths
from HIV, illegal drug use, alcohol use, motor vehicle
injuries, suicides, and murders combined. The adverse
health effects from cigarette smoking account for nearly
one in every five deaths each year in the United States,
making tobacco use the leading preventable cause of
death in this country. Those who stop smoking greatly
reduce their risk for disease and premature death, and
efforts to increase smoking cessation are among the
most important public health interventions.
Quitting smoking has many immediate as well as longterm results. One of the reasons why smokers have an
elevated risk of heart disease is that oxygen in the blood
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Figure 12.1 Smoking Cessation
Infographic from the U.S. Department
of Health and Human Services, 2012

is replaced by the carbon monoxide from smoke.
Within only 12 hours after quitting, carbon

Figure 12.2 Stopping Smoking: Lung
Cancer Mortality

monoxide levels in the blood return to normal.
After a year, the risk of coronary heart disease is
cut in half; after 5 years, the risk of some cancers
are likewise reduced by half; after 10 years, the risk
of death from lung cancer is reduced by half; and
after 15 years, the risk for coronary heart disease is
the same as that of a never-smoker (Figure 12.1).
Researchers from Oxford University conducted
studies on smoking-related deaths, collecting data
starting from 1950. Figure 12.2 provides a
compelling summation of the benefit of quitting,
and especially of quitting earlier rather than later.
For a never-smoker, the risk of dying from lung
cancer is close to 0%. Smokers who quit at the age
of 30 have significantly less risk of lung cancer
mortality than those who smoke until age 50 or
older.
Putting smoking cessation within the broader context of public health, Figure 12.3 comes from a
World Bank report that looks at projections of tobacco-caused deaths over the first half of the 21st
century. If there is no change in tobacco uptake and cessation rates, the number of deaths from
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Key Takeaway

tobacco will total approximately 520 million by the year 2050. But if we are

Unless current smokers
quit, tobacco deaths will
rise dramatically in the
next 50 years.

successful at cutting in half the proportion of young adults who take up
smoking, the number of tobacco deaths would be reduced to 500 million.
This would certainly be an achievement, but it is still a rather small impact on
mortality. This may be explained by the fact that deaths from tobacco

normally do not happen within 40 years of the initial uptake, which means that changes in youth
tobacco initiation rates would not be likely to affect overall tobacco mortality until after 2050. In order
to have a significant impact
on tobacco mortality before
2050, the consumption of
cigarettes by current adult
smokers must be reduced. If
the adult consumption rate
is halved by 2020, tobacco
mortality in 2050 would be
closer to 340 million rather
than the projected 520
million.
No one really disputes that
smoking cessation would
have a dramatic impact on
public health. However, it
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Figure 12.3 Estimated Cumulative Tobacco Deaths 1950-2050,
with Different Intervention Strategies

remains a daunting challenge because smoking is addictive and quitting can be very difficult.
According to the Centers for Disease Control and Prevention (CDC), almost 70% of U.S. adult smokers
want to quit smoking completely. About half (52.4%) of all smokers stop smoking for at least one day
each year because they are trying to quit. In the U.S., there are now more ex-smokers than there are
current smokers. In Figure 12.4, we can see that large proportions of smokers, from every age bracket
including high-schoolers, have tried to quit at some point.

Figure 12.4 Percentage of Smokers who Stopped Smoking for More Than One Day
in 2009 or 2010 Because They Were Trying to Quit
70
62.4
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Figure 12.5 Cessation Programmes Policies, by WHO Region, 2010

A couple of points should be made clear about cessation. The first is that nicotine dependence is a
chronic condition that requires repeated interventions and treatments. Most smokers quit multiple
times before they are able to quit permanently, and so it requires an ongoing effort to encourage and
reinforce cessation attempts and the knowledge that relapse can occur. Population-based
interventions have made a positive impact on cessation rates (Chapter 8: Tobacco Control
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Frameworks). Cost-effective and targeted at large groups of smokers at once, population-based
interventions include strategies such as smoke-free air laws, tax increases, marketing restrictions, and
graphic warning labels. Individual cessation programs are helpful in assisting individuals to quit and
include such treatments as nicotine replacement therapy, physician counseling, and behavioral
cessation therapies. Both population-based and individual interventions are necessary in order to
have a large collective effect on the prevalence of smoking.
The World Health Organization (WHO) estimates that over 85% of the world’s population do not have
access to comprehensive treatments for tobacco dependence, especially in developing countries
(Figure 12.5).
Taking a few member countries of the WHO Framework Convention on Tobacco Control as examples,
we can compare them in terms of the proportion of smokers who have attempted to quit or have
thought about quitting. Table 12.1 shows data collected from select countries using the Global Adult
Tobacco Survey. Of the countries included, Viet Nam had the highest proportion of smokers making
at least one quit attempt in the past 12 months (55.3%). We see extremely low rates of smokers who
are thinking about quitting in China and Viet Nam. The data also shows that in five out of these six
countries, less than half of those who smoke received a recommendation to quit smoking from their
health care provider.
China provides a particularly interesting case study for cessation. In China, there are 375 million “eversmokers”—a term used to refer to people who have smoked more than 100 cigarettes in their life. Of
these, 25 million (7%) have quit smoking, while 350 million (93%) continue to smoke. As a point of
comparison, the United States has 90.7 million ever-smokers. Of these, 47.3 million (52%) have quit,
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Table 12.1 Cessation Among WHO Member States
China

Brazil

India

Mexico

Viet Nam

Russia

Smokers who
made a quit
attempt in the
past 12 months
(%)

36.4

45.6

38.4

49.9

55.3

32.1

Current
smokers who
plan to or are
thinking about
quitting (%)

16.1

52.1

72.1

9.5

60.3

Smokers
advised to
quiet by a
health care
professional in
the past 12
months (%)

33.9

57.1

26.7

29.7

31.8

no data

46.3

and 43.4 (48%) million still smoke. In other words, the number of ex-smokers in the U.S. constitutes
the majority of ever-smokers, and quitting smoking is more of the norm. If the norms could be
similarly changed in China, so that about half of China’s smoking population quit, the result would be
an additional 160 million ex-smokers in the country. Such a change requires effective strategies to
help smokers in China quit their addiction to cigarettes.
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Chapter 12 - Tobacco Cessation
Section 2 - Population-Based Cessation

As mentioned previously, the proportion of ever-smokers in the U.S. who have quit has increased
dramatically over the last 50 years, thanks in large part to population-based interventions. In 1965,
only a little over 20% of ever-smokers had quit, whereas for the last ten years this proportion has been
at or above 50%.
Figure 12.6 is an apt illustration of the role of population-based interventions in the quitting process.
Smokers may contemplate quitting after hearing messages about the harm of smoking and the
importance of cessation from

Figure 12.6 Percentage of Adult Former Smokers,
1965-2009

their physician or the mass
media. This may lead to them
making an attempt to quit.
Some smokers will be
successful at quitting, but many
more will experience relapse.
Implementing telephone
hotlines can be an effective
strategy to help prevent
smoking relapse. For smokers
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Figure 12.7 Population-Based Smoking Cessation

to have a much
better chance of
quitting
permanently, it is
important to have a
network of
strategies in place
that all encourage
cessation, including
additional taxes to
increase the cost of
cigarettes,

restrictions on smoking in public places,
and pharmacological therapy.
Comprehensive tobacco control

Change in social norms

programs create an environment that

Smoke free air laws

reinforces people’s desire to quit as well

Taxes

as building their ability to do so (Figure

Marketing restrictions and counter marketing

12.7).

Packaging, warning labels and plain packaging

Population-based cessation interventions,
if successful, can cause dramatic changes
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Population-based Cessation Interventions

Quitlines
Other resources and technology

Figure 12.8 Percentage of Respondents Supporting Smoking Bans in Public Places

in social norms around smoking. In turn, changing social norms lead to changes in policies and
smoking behaviors. Indeed, social norms and attitudes toward smoking have played an important
role in making positive changes in tobacco control and smoking behavior during the latter half of the
20th century. In Figure 12.8, for example, we can see the change over time in the level of support for
smoking bans among the U.S. population. A 2015 Gallup Poll shows the majority of Americans (58%)
believe it should be illegal to smoke in all public places, a trend that has continued since 2011. To a
large extent, the desire for smoke-free public places is associated with increasing public awareness
and acceptance of the idea that all people have a right to live in a smoke-free environment. Social
norms have an interactive relationship with policy change, since policy-makers are sensitive to public
attitudes toward risky behaviors. In tobacco control, many of the changes in policy and legislation
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Figure 12.9 Smoke-Free Indoor Air Laws for Private Worksites,
Restaurants and Bars, U.S., 2010

were initially driven by
changes in social norms that
motivated citizens to push for
new laws at the state level. But
the relationship between
social norms and policy can
also be said to be
bidirectional, since instituting
even an unpopular policy can
decrease a risky behavior and,
in doing so, gradually alter
social norms and attitudes.
The impact of clean indoor air
laws cannot be
overestimated. While there is
currently no federal smoke-

free air law in the U.S., more than half of the population live in states covered by comprehensive laws
prohibiting smoking in worksites, restaurants, bars, and other public places (Figure 12.9). These state
laws have come about because citizens demanded smoke-free public areas. As clean indoor air laws
spread, they not only help nonsmokers to avoid secondhand smoke but also has the residual benefit
of helping smokers to successfully quit smoking by reinforcing smoke-free as the norm—and they do
so without costing businesses anything.
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Previous chapters have discussed different strategies to

Movie 12.1 A video from the “Dear
Me” campaign to promote the
Washington State Quitline

encourage smokers to quit, including tax increases,
marketing restrictions, counter-marketing campaigns,
warning labels and plain packaging. In addition to these,
technology-based cessation measures such as quitlines and
text messaging services have been proven to be effective. A
quitline is a tobacco cessation service available through a
toll-free telephone number (Figure 12.10). Callers receive

individualized counseling, support, and in some instances, pharmacologic assistance free of charge
over the telephone to help them to quit smoking. Though they resemble tobacco interventions at the
individual or clinical level, quitlines are considered a population-based approach; they are often more
feasible to implement in a cost-effective way to reach the entire population (Movie 12.1).

Figure 12.10 Tobacco Quitline Advertisement

The Community Preventive Services Task
Force recommends quitline interventions,
particularly those that offer follow-up
counseling calls. According to twelve trials
involving over 30,000 people, telephone
quitlines with call-back counseling increased
the relative success of quit attempts by
25-50%. Moreover, quitlines are cost-effective
at providing counseling and cessation
information and result in a median of $2,012
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Figure 12.11 NCI QuitPal iPhone
App

saved per quality-adjusted life year (QALY).
Increasingly, tobacco control advocates are turning to
smartphone technology to promote smoking cessation. For
example, the National Cancer Institute’s QuitPal app is a free
smartphone app that was developed to provide support to
smokers who are trying to quit (Figure 12.11). The app
allows users to set a quit date, financial goals, and
reminders; users can also track their daily smoking habit,
and graph the amount of money they have saved and the
number of packs not smoked. Through the app, users can
be connected to social media networks, allowing them to
give milestone updates and benefit from reinforcement and
support from their peers.
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In addition to quitlines and smartphone apps,
there are also text-messaging services

Figure 12.12 SmokefreeTXT Mobile TextMessaging Service

available. SmokefreeTXT is a mobile textmessaging service available 24/7 that provides
encouragement, advice, and tips to help
smokers quit smoking (Figure 12.12 and Movie
12.2).

Movie 12.2 Commercial for SmokefreeTXT
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Chapter 12 - Tobacco Cessation
Section 3 - Clinical or Individual-Level Cessation

We now turn our focus to clinical or
individual-level approaches to
cessation. As we suggested in the
previous section, cessation represents a
desired end result to what is usually a
lengthy, demanding, and often
frustrating undertaking. Although
millions of Americans say they want to

following advice for those who
want to quit smoking:
Don’t smoke any cigarettes. Even occasional
smoking is harmful.

quit smoking, studies suggest that only

Write down why you want to quit. Really

about 6% of individuals who try to quit

wanting to quit is important to success.

at any given time are successful for
more than one month. For most people,
it takes multiple attempts before they
Key Takeaway
Quitting smoking is
hard and most
individuals try
multiple times
before succeeding.
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The CDC provides the

can finally quit. It is
also important to

Know that it will take commitment and
effort to quit. Nicotine is very addictive, and
there are many ways to quit, including
nicotine replacement products.

note that most

Get help if you want it. Free assistance is

people who do

available through quitlines. Healthcare

succeed actually

providers are a good source of help.

quit “cold turkey”; they succeed because
they are ready, they have a strong desire

Movie 12.3 Hear from the Experts: Michael Fiore,
MD, MPH

to quit, and they are confident in their
ability to quit.
Dr. Michael Fiore is a nationally
recognized expert on tobacco, providing
perspectives on the subject to audiences
ranging from Good Morning America to
the United States Senate. He has written
numerous articles, chapters, and books on
how to quit smoking and was a co-author
and consulting editor of Reducing
Tobacco Use: A Report of the Surgeon General, 2000. In Movie 12.3, he discusses clinical approaches
to tobacco cessation.
In 2008, Dr. Fiore chaired a panel that produced the U.S. Public Health Service Clinical Practice
Guideline for treating tobacco use and dependence. The document included ten key guideline
recommendations, as follows:
1. Tobacco dependence is a chronic disease that often requires repeated intervention and
multiple attempts to quit.
2. It is essential that clinicians and health care delivery systems consistently identify and
document tobacco use status in a health care setting.
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3. Tobacco dependence treatments are effective across a broad range of populations.
4. Brief tobacco dependence treatment is effective.
5. Individual, group, and telephone counseling are effective, and their effectiveness increases
with treatment intensity.
6. Numerous effective medications are available for tobacco dependence, and clinicians
should encourage their use.
7. Clinicians should encourage all individuals making a quit attempt to use both counseling
and medication.
8. Telephone quitline counseling is effective with diverse populations and has broad reach.
9. If a tobacco user currently is unwilling to make a quit attempt, clinicians should use
motivational treatments.
10. Insurers and purchasers should ensure that all insurance plans include the counseling and
medication identified as effective in the Guideline as covered benefits.
Because of the difficulty of quitting, the role of healthcare providers is vitally important in encouraging
patients in their cessation efforts. Unfortunately, as we can see from Figure 12.13, the likelihood of
patients receiving advice to quit smoking from their healthcare provider actually decreased between
2000 and 2010, a decrease which warrants further study.
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There are many reasons
why brief counseling from
healthcare providers

Figure 12.13 Percentage of Current Smokers (Aged 18 or Older)
Who Received Health Care Provider Advice to Quit Smoking in the
Past Year

makes a difference in
cessation. The majority of
smokers, 70%, see a
physician and 50% see a
dentist every year.
Smokers view clinicians as
credible and persuasive,
and clinic visits represent
teachable moments when
health concerns are
salient. There are actually
higher levels of satisfaction among patients who receive tobacco advice and support from their
healthcare provider. Moreover, meta-analyses show that physician advice on cessation results in
modest, but consistent, positive effects. Compared with other medical services, brief cessation
counseling is highly cost-effective.
The U.S. Preventive Services Task Force (USPSTF) recommends counseling interventions for tobacco
cessation in adults and pregnant women. They developed the “5-A’s” Framework for counseling,
which is comprised of the following steps:
1. Ask about tobacco use.

422

2. Advise to quit through clear personalized messages.
3. Assess willingness to quit.
4. Assist to quit.
5. Arrange follow-up and support.
Again, there is an emphasis on follow-up counseling and support to increase the chances of success
in cessation.
In addition to counseling, medication can also play an important role in helping individuals to quit
smoking. FDA-approved pharmacotherapy includes nicotine replacement therapy (NRT), bupropion,
and varenicline.
NRT is a treatment that provides small,

Figure 12.14 Different Types of Nicotine Replacement
Therapy

steady doses of nicotine to help stop
cravings for those trying to quit
(Figure 12.14). Most commonly, NRT
comes in the form of a patch or gum,
which are approved by the FDA as
safe and effective methods for
quitting tobacco use. Formerly
prescription medications, NRT patches
and gum are now available over-thecounter. NRT is also available as an
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inhaler, nasal spray, or lozenges. In
all of these forms, NRT provides
nicotine to help lessen withdrawal

Table 12.2 Prescription Cessation Treatments: Bupropion
and Varenicline
Method

Description

Buproprion

Also known as Zyban®, helps reduce
nicotine withdrawal and the urge to smoke.

Vernicline

Also known as Chantix®, reduces
withdrawal symptoms and blocks the
effects of nicotine if the user starts
smoking again.

symptoms until individuals are able
to wean themselves. Not all NRT
products are FDA-approved,
however. Those sold by
pharmaceutical companies have
undergone premarket testing to
establish the safety and efficacy of the product, while those sold by tobacco companies have not
obtained FDA approval and are not necessarily proven to aid in cessation.
Additionally, prescription
cessation treatments are available
to help smokers to quit. Two of
the most common medications
are bupropion and varenicline,
both of which reduce nicotine
withdrawal symptoms and
cigarette cravings, without any
added nicotine (Table 12.2).
As we look at cessation efforts at
either the population or
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Figure 12.15 Relapse Curves for Self-Help, Single
Counseling, and Multiple Counseling

individual level, it is important to remember that cessation is a difficult process; relapse is common
and those who want to quit smoking should have a plan for what to do if they relapse. According to
Figure 12.15, between half and two-thirds of people who attempt to quit smoking relapse back to
smoking within the first 30 days following a quit attempt. The percentage varies depending upon the
type of assistance used by the smoker to quit smoking. Regardless of whether quit attempts are
supported by counseling, aided with pharmacotherapy, or occur unassisted, relapse is a major
concern and smokers must be educated so that they do not become discouraged about their relapse
patterns. Individuals can learn to identify what conditions and cues are associated with their relapse to
smoking so they can try to avoid those factors in future quit attempts. Cessation must be understood
as a process rather than a discrete event.
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Chapter 12 - Tobacco Cessation
Section 4 - Cessation Among Special Populations

There are certain populations that smoke at higher levels than the general population or
otherwise deserve special attention. They include people who participate in substance abuse or
who have been diagnosed with mental illness. Lesbian, gay, bisexual, and transgender (LGBT)
individuals experience higher smoking prevalence rates, as do minorities and people with low
socioeconomic status (SES). Pregnant women, while experiencing low smoking rates relative to
the general population, are a group that deserves special attention because of the adverse
health effects of smoking during pregnancy. In order to be effective among these populations,
smoking cessation efforts must be specifically tailored to meet the needs of these groups.
It is estimated that 40% of all cigarettes consumed in the U.S. are smoked by people with a
Table 12.3 Individuals with a Diagnosable Mental Illness Smoke at
Higher Rates
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mental illness or
addiction.
According to Table

Disorder

Percent of people with disorder who
are current or former smokers

Lifetime Depression

60%

people diagnosed

Bipolar Disorder

70%

with depression

Schizophrenia

88%

are smokers, as are

12.3, 60% of

Table 12.4 Tobacco-Related Mortality in People with Mental Illness
Disorder

Percent of total deaths due to
tobacco-related conditions

Standardized
Mortality Ratio (SMR)

Schizophrenia

53%

2.45
(95%CI = 2.41-2.48)

Bipolar Disorder

48%

1.57
(95% CI = 1.53-1.62)

Depression

50%

1.95
(95% CI = 1.93-1.98)

70% of those
diagnosed with
bipolar disorder
and 88% of those
diagnosed with
schizophrenia.
Many people
agree that there is

a level of self-medication associated with smoking among these populations, and that nicotine
may help with symptom management, particularly for those with schizophrenia. This has led to
some debates about implementing smoking cessation treatments while patients are recovering
from these illnesses. While some argue against recommending smoking cessation during
recovery, research shows that smoking cessation does not harm recovery and many substance
abuse and addiction treatment facilities have successfully become smoke-free.
Researchers have examined the implications of the increased rates of smoking among individuals
with mental illness and have found that tobacco-related mortality is also higher in people with
mental illness compared with the general public. The percentage of total deaths resulting directly
from smoking among individuals with schizophrenia, bipolar disorder, or depression hovers
around 50% (Table 12.4). The connection between tobacco-caused deaths and the presence of
mental illness is one that deserves urgent attention from the public health community.
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Another group that deserves special attention in terms of smoking

Key Takeaway

cessation is the LGBT population. According to the 2009-2010

Individuals with psychiatric
conditions have a smoking
prevalence 2-4 times greater
than the general population.

National Adult Tobacco Survey (NATS), the prevalence of tobacco use
among LGBT adults is higher in many categories compared to
heterosexual adults
(Table 12.5).
Factors that may

Table 12.5 LGBT Populations Smoke at Higher Rates
Tobacco Type

Prevalence for
LGBT adults

Prevalence for
Heterosexual adults

this increase

Any tobacco type

38.5%

23.3%

include social

Cigarette smoking

32.8%

19.5%

Cigars, cigarillos or small cigars

12.2%

6.5%

Water pipes

6.1%

6.5%

be associated with

stress, frequent
patronage of bars
and clubs, and
direct targeting of

LGBT consumers by the tobacco industry. This, too, is an area for additional research and is of
particular concern when considered alongside the disproportionate prevalence of HIV/AIDS
among the LGBT population. Due to the compromised pulmonary function and immunity
associated with smoking, individuals with HIV/AIDS experience much poorer health outcomes if
they smoke.
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Minorities and low-SES groups need special consideration for smoking cessation for a variety of
reasons. For decades, tobacco companies have specifically targeted minority communities with
intense advertising and promotional efforts. Research suggests that tobacco retailer density near
schools is higher in minority or low-income communities. It is estimated that 29% of adults who
are below the poverty level are smokers, compared with 18% of adults who are at or above the
poverty level. Fortunately, there are solutions available for addressing these disparities: for
instance, we know that low-SES smokers are more sensitive to changes in the price of tobacco,
so one of the best methods to prompt lower-income smokers to quit is through raising cigarette
taxes. However, those who are low-SES and continue to smoke are in even more need of
assistance to quit because they will end up spending a higher proportion of their income on
tobacco products. Thus, providing additional help through cessation resources and medications
is crucial in helping low-SES populations quit smoking for good.
Lastly, we must say a word about the importance of smoking cessation for pregnant women.
Smoking during pregnancy causes many health problems, including premature birth, birth
defects, and infant death. According to the 2010 Pregnancy Risk Assessment and Monitoring
Data (PRAMS) from the CDC, approximately 10.7% of women reported smoking during the last
three months of their pregnancy. Nicotine replacement therapy during pregnancy is controversial
because of concerns about the possible effects of nicotine on a developing fetus, and more
research is needed in this area.
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Smoking is not only harmful during pregnancy, it is also harmful before conception and after
delivery. Smoking can delay conception among females, and smoking near conception is
associated with cleft lip and cleft palate. After delivery, exposure to secondhand smoke increases
an infant’s risk for respiratory tract infections, ear infections, and Sudden Infant Death Syndrome
(SIDS). Thus, in addition to helping women who are pregnant to quit smoking, public health
advocates and healthcare practitioners must help all women of reproductive age to understand
the importance of smoking cessation prior to conception—for their health and the health of their
babies.
To conclude, smoking cessation is an important public health strategy, though it tends to be
undervalued in the U.S. Cessation efforts have the potential to make a dramatic impact on the
rates of preventable deaths in this country and around the world.

Chapter 12 Discussion Questions:
1. Brainstorm additional technology based population-based interventions for smoking cessation.
2. Propose funding mechanisms to increase population-based interventions for smoking cessation
in the United States.

430

Figures and Tables

Figure 12.1: Smoking Cessation Infographic from the U.S. Department of
Health and Human Services, 2012
Source: U.S. Department of Health and Human Services. (2012a). Get on a
path to a healthier you (quitting).
Figure 12.2: Stopping Smoking: Lung Cancer Mortality
Source: Richard Peto, Personal Communication
Figure 12.3: Estimated Cumulative Tobacco Deaths 1950-2050, with
Different Intervention Strategies
Source: Peto, Richard et al. (1994). Mortality from Smoking in Developed
Countries 1950-2000. Oxford University Press.
Figure 12.4: Most Smokers Want to Quit
Source: Centers for Disease Control and Prevention. (2013). Smoking and
tobacco use; Fact sheet; smoking cessation. Smoking and Tobacco Use.
Figure 12.5: Cessation Programmes Policies, by WHO Region, 2010
Source: World Health Organization. (2010). WHO Cessation programmes.
Table 12.1: Cessation Among WHO Member States

431

Figure 12.6: Percentage of Adult Former Smokers, 1965-2009

Figure 12.10: Tobacco Quitline Advertisement

Source: American Lung Association. (2011). Trends in tobacco
use.

Movie 12.1: A video from the “Dear Me” campaign to promote
the Washington State Quitline

Figure 12.7: Population-Based Smoking Cessation
Source: U.S. Department of Health and Human Services. Public

Figure 12.11: NCI QuitPal iPhone App

Health Service, National Institutes of Health, National Cancer
Institute. (2000). Monograph 12: Population Based Smoking

Figure 12.12: SmokefreeTXT Mobile Text-Messaging Service

Cessation: Proceedings of a Conference on What Works to

Source: U.S. Department of Health and Human Services. (2013).

Influence Cessation in the General Population.

SmokefreeTXT.

Figure 12.8: Percentage of Respondents Supporting Smoking

Movie 12.2: Commercial for SmokefreeTXT

Bans in Public Places
Source: Robert-Wood Johnson Foundation (RWJF). (2011).

Movie 12.3: Hear from the Experts: Michael Fiore, MD, MPH

RWJF Retrospective Series: Social Norms and Attitudes About
Smoking, 1991-2010.

Figure 12.13: Percentage of Current Smokers (Aged 18 or
Older) Who Received Health Care Provider Advice to Quit

Figure 12.9: Smoke-Free Indoor Air Laws for Private Worksites,

Smoking in the Past Year

Restaurants and Bars, U.S., 2010

Source: CDC, 2012

Source: Centers for Disease Control and Prevention. (2011).
State smoke-free laws for worksites, restaurants, and bars --United States, 2000--2010.

432

Figure 12.14: Different Types of Nicotine Replacement Therapy

Table 12.1: Prescription Cessation Treatments: Bupropion and

bipolar disorder, or depression. Journal of Psychiatric Research.

Varenicline

doi:10.1016/j.jpsychires.2013.09.014.

Source: U.S. Department of Health and Human Services. (2013).
Explore medications. Smokefree.gov.

Table 12.4: Tobacco-Related Mortality in People with Mental
Illness schizophrenia

Figure 12.15: Relapse Curves for Self-Help, Single Counseling,
and Multiple Counseling

Table 12.5: LGBT Populations Smoke at Higher Rates

Source: U.S. Department of Health and Human Services. Public

Source: Tobacco Fact Sheet: Lesbian, Gay, Bisexual, and

Health Service, National Institutes of Health, National Cancer

Transgender (LGBT) Communities and Smoking.

Institute. (2000). Monograph 12: Population Based Smoking
Cessation: Proceedings of a Conference on What Works to
Influence Cessation in the General Population.
Table 12.2: Prescription Cessation Treatments: Bupropion and
Varenicline
Source: Legacy. (2011). A Hidden Epidemic: Tobacco use and
mental illness.
Table 12.3: Individuals with a Diagnosable Mental Illness Smoke
at Higher Rates
Source: Callaghan, R. C., et al. (2013). Patterns of tobacco-related
mortality among individuals diagnosed with schizophrenia,
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Chapter 13

Laws, Litigation, and
Regulation

Chapter Objectives
1. Describe the variability of tobacco control laws in the U.S.
and globally.
2. Diagram the evolution of the three waves of tobacco
litigation in the U.S.
3. Contrast the results and outcomes of the major tobacco
control legal proceedings in the U.S. (including the Waxman
hearings, MSA, RICO ruling, and the 2009 FSPTCA).
4. Analyze the role the WHO FCTC has in supporting tobacco
control laws, litigation, and regulation.
5. Examine the ways in which the tobacco industry opposes
legal tobacco control measures globally.

Chapter 13 - Laws, Litigation, and Regulation
Section 1 - Laws

There are a myriad of ways in which different aspects of tobacco can
be controlled by laws at the local, state, and federal levels. The major
areas in which laws are used as tobacco control strategies are related
to clean indoor air, taxation, restriction of access for minors, and
restrictions on marketing of tobacco products.
To begin, we will review smoke-free laws, also known as clean indoor
air laws (also Chapter 9: Smoke-Free Air Laws). The smoke-free
movement started in California in the 1980s and has spread
throughout the United States. Smoke-free laws may be applied to
schools, restaurants, bars, government buildings, parks, and private cars (especially when children are
passengers). Though the U.S. has no federal clean indoor air law, most people in this country are
protected by local and state laws restricting where people are allowed to smoke. However, the
strength of smoke-free laws and policies varies widely from state to state. Figure 13.1 features a map
created by the American Lung Association that shows the distribution of comprehensive clean indoor
air laws throughout the U.S. in 2012. There are 28 states with comprehensive laws. Much of the South
and many of the states within the Appalachian region have the weakest restrictions. Unsurprisingly,
these areas also tend to have higher rates of smoking and smoking-caused mortality.
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Figure 13.1 The Strength of Smoke-Free Air Laws/Policies
Varies Widely Throughout the U.S.

In addition to clean indoor air
laws, states and federal
governments use laws to levy
taxes on tobacco products (also
Chapter 10: Taxes and Funding
Tobacco Control). Every state
collects a tobacco excise tax in
addition to the federal tax on
tobacco products. The amount
of tax varies from state to state,
with rates per pack ranging from
a high of $4.35 in New York to a
low of $0.17 in Missouri. The
national average is $1.49 per

pack of cigarettes. The variation in tax rates is somewhat problematic in that it encourages crossborder sales, as well as some level of smuggling and tax avoidance. Some have argued that the
greatly varying state excise taxes should be replaced by one uniform federal excise tax on tobacco—
covering not just cigarettes but all tobacco products.
Another way in which laws have been used as an effective tobacco control strategy is the restriction of
young people’s access to tobacco products. Here again, restrictions come in many different forms.
U.S. federal regulation sets the minimum age for purchasing cigarettes at 18 and requires vendors to
verify age if the customer appears to be under the age of 26. Four states—Alabama, Alaska, New
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Jersey, and Utah—have the minimum age of purchase set at 19, and in May 2014, New York City raised
the minimum age to 21. Under a provision known as the Synar Amendment, all states are required to
monitor the sale of cigarettes and other tobacco products to underage customers. They must also
perform random inspections of stores that sell tobacco products and report the extent of illegal sales
to the Substance Abuse and Mental Health Services Administration (SAMHSA). The Synar Amendment
has been associated with a significant drop in in the proportion of vendors selling cigarettes illegally
to minors—from over 60% to below 10% for many states. In addition to imposing a minimum age of
purchase, states also implement laws prohibiting the possession and use of tobacco products by
minors. They may use laws to regulate signage related to tobacco, the placement of tobacco
products, Internet sales of tobacco products, and photo identification requirements associated with
the purchase of tobacco products at retail outlets.
Additional laws have been implemented by the U.S. government and various states to further protect
youth from the harms of tobacco. Vendors were previously able to sell cigarettes individually or in
mini-packs of five cigarettes, making them more affordable for young people. Federal laws now set
the minimum at 20 cigarettes per pack. The law also prohibits free sampling of tobacco products (with
some exceptions), as well as the sale of cigarettes in vending machines except in establishments
where retailers have ensured that minors are not permitted. Two states, Idaho and Vermont,
completely prohibit the sale of tobacco products through vending machines.
As we have seen in previous chapters (especially Chapter 11: Marketing Restrictions), laws restrict the
advertising and promotion of tobacco products. The U.S. is somewhat unique in the world in terms of
having a specific protection of free speech written as the First Amendment to the Constitution.
Originally intended to protect the free speech of individuals, the First Amendment has been

441

Table 13.1 States Considering Smokers a Protected Class (and Protected from Discrimination)
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State

Year Passed

State

Year Passed

California

2005

New Jersey

1991

Colorado

1990

New Mexico

1991

Connecticut

2003

New York

1992

District of Columbia

1993

North Carolina

1991

Illinois

1987

North Dakota

1993

Indiana

2006

Oklahoma

1991

Kentucky

2010

Oregon

2005

Louisiana

1991

Rhode Island

2005

Maine

1991

South Carolina

1991

Minnesota

1992

South Dakota

1991

Mississippi

1994

Tennessee

1990

Missouri

1992

Virginia

1989

Montana

1993

West Virginia

1992

Nevada

1991

Wisconsin

1991

New Hampshire

1991

Wyoming

1992

increasingly invoked by corporations to protect commercial speech, making it more difficult to limit
the advertising and promotion of products. Efforts to enforce laws or judicial findings that call for such
restrictions are often thwarted by tobacco companies that sue for the protection of their First
Amendment rights (Table 13.1).
Other areas covered by law include licensing requirements for tobacco sellers, smoker protections,
products disclosure, tobacco industry liability, the use of tobacco settlement (specifically, Master

Figure 13.2 Examples of States with Preemption Clauses Prohibiting Cities and
Municipalities from Passing Stronger Tobacco Control Laws
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State

Issue Area
Where
Preemption
Exists

Specific Provisions Preempted

California

Youth Access

Only preempts the amount of fines localities may impose for violations
of certain youth access laws.

Connecticut

Smoking
Restrictions

Any stronger local laws/ordinances further restricting smoking enacted
after October 1, 1993 are not allowed under state law.

Delaware

Youth Access

Local laws/ordinances further restricting youth access to tobacco
products enacted after June 30, 1996 are not allowed under state law.

Florida

Smoking
Restrictions

State law supersedes any municipal or county ordinance on the subject
of the regulation of smoking.

Settlement Agreement) funds, preemption, tobacco control programs, fire

Key Takeaway

safety standards, and divestment. Laws are used to protect smokers against

Supporting state
preemption has been a
major strategy of the
tobacco industry over the
last three decades,
because tobacco
companies can lobby
much more effectively at
the state level than at the
local level.

discrimination: 29 states and the District of Columbia have passed laws
prohibiting employers from discriminating against smokers based on
concerns around increased health care costs. In other states, many
companies have instituted policies against hiring smokers, for both ethical
and economic reasons.
In the context of discussing laws that govern tobacco, it is important to also

include the issue of preemption. As we mentioned in Chapter 8, preemption is the restriction or
prohibition that one level of government imposes on a lower level regarding the enactment of
enforcement of more stringent laws (Figure 13.2). For example, if a state passes a relatively weak law
with respect to clean indoor air, they may, as part of that law, explicitly preempt local jurisdictions from
having laws that are stronger than the state standard. Supporting state preemption has been a major
strategy of the tobacco industry over the last three decades because tobacco companies can lobby
much more effectively at the state level rather than at the local level. For instance, in Oregon in 2001,
the tobacco industry supported a state law that would prohibit smoking in several public venues such
as restaurants. The reason for their support: the legislation preempted more comprehensive bans that
were already being put into effect in some municipalities, thus taking away the ability of Oregon’s
cities and towns to impose stronger smoke-free laws.
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CASE STUDY:
The Anti-Bloomberg Bill
During his tenure as mayor of New York City, Michael
Bloomberg was an active supporter of tobacco control
and other public health measures that were stronger
than those adopted by the rest of the state of New York.
These included higher excise taxes and comprehensive
clean indoor air laws, but also measures designed to
prevent and reverse obesity—bans of trans fats and,
more recently, an attempt to set the maximum size of
sugary drinks at 16 ounces. Responding to such efforts,
the state of Mississippi passed the “Anti-Bloomberg
Bill” in 2013, specifically to preempt local jurisdictions
from having any law stronger than the state law with
respect to limiting portion sizes of soda. According to
the law, only the state can regulate the sale and
marketing of food in Mississippi. Thus, the issue of
preemption not only applies to tobacco control but also
to other areas of public health, such as obesity
prevention (also Chapter 14: Lessons Learned).
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Federal tobacco control laws remain
relatively limited in the U.S. Until the
enactment of the Family Smoking
Prevention and Tobacco Control Act
(FSPTCA) of 2009, the U.S.
government was virtually inactive
with regard to nationwide tobacco
control efforts. Even today, there
continues to be no federal clean
indoor air law providing uniform
coverage throughout the country.
The government does tax tobacco
products, and there are continued
efforts to raise the tobacco excise
tax. The laws that are in place are
constantly challenged by tobacco
companies, whose strategies often
involves using litigation to
obfuscate the facts in order to gain
additional time to maintain the
status quo and addict more users.

Chapter 13 - Laws, Litigation, and Regulation
Section 2 - Litigation

Litigation has proven to be an extraordinarily effective tool for advancing
tobacco control. When one party sues another, both parties are required to
provide relevant documents in a process known as discovery. Litigation has
thus resulted in the discovery and subsequent publication of tobacco

Key Takeaway
Lawsuits have been filed
against tobacco companies
in three distinct waves
starting in 1954.

industry documents, and in this manner has served to dramatically
transform the public’s perception of the industry. For decades, tobacco companies pleaded
ignorance and resorted to outright denial of the harm caused by tobacco use and the addictiveness
of nicotine, but the internal documents that were exposed in the course of litigation proved that they
knew all along how false these claims were. After the publication of these documents, the public and
the media no longer regarded the industry as being truthful and responsible. The disclosure of these
documents also led the tobacco companies to realize they needed to engage in more responsible
language and behavior—at least in public. Litigation has also promoted tobacco control by prompting
substantial increases in the price of tobacco
products after the companies were found
guilty or agreed to a settlement.
Over the last 60 years, lawsuits have been filed against tobacco companies in three distinct waves.
The first wave, spanning the period from 1954 to 1983, began when scientific evidence linking
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smoking to cancer was first published. During this time, there were a number of lawsuits brought
against tobacco companies, but none of them were successful. The first tobacco lawsuit was filed in
1954 on behalf of a Missouri smoker who got lung cancer. After 13 years of litigation, the lung cancer
victim dropped the case. Over the next three decades, 150 cases were filed alleging that tobacco
manufacturers were liable for the medical expenses, lost wages, and pain and suffering caused by
their products. In every one of these cases, the tobacco industry successfully defended itself on the
grounds that the medical evidence of smoking-caused harm was still controversial.
During the second wave, from 1983 to 1992, there were an additional 200 personal injury cases filed
against the tobacco industry, whose defense tactic shifted from denying that there was sufficient
evidence about the relationship between smoking and harm to now saying that the harm caused by
smoking was common knowledge, and that smokers had “assumed the risk” of death and disease
knowingly. By this time, warning labels were printed on packs of cigarettes, providing tobacco
companies some protection from liability. Once again, as was the case in the first wave, the tobacco
industry won the second wave of litigation.
During this second wave, however, there was one case, Cipollone vs. Liggett Group, Inc., which
proved to be a harbinger of the later success of tobacco control. This was a personal injury case filed
in 1983 on behalf of New Jersey smoker and lung cancer victim Rose Cipollone and her husband
Tony (Figure 13.3). The case was unique in that it focused on gaining access to industry documents as
part of the litigation, and some of the requested documents were ultimately released. It was also the
first trial in 30 years in which the jury awarded the plaintiff $400,000 in damages, though this was later
overturned. Though it did not result in any payment to the plaintiff, it was nonetheless important
because it was the first case that was won by a plaintiff suing a tobacco company for the harm caused
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Figure 13.3 Rose Cipollone

by their product. The case was filed in 1983, lasted until 1985, was
appealed into the following decade, and was finally concluded in
1992 when the plaintiff’s attorney could no longer fund the efforts.
By then, we estimate the amount spent on the plaintiff’s attorney at
$3 million, whereas the tobacco companies spent an estimated $50$75 million defending themselves in trial.
The industry’s expenditure of this exorbitant amount is consistent
with the “scorched earth” strategy they used during this period to
combat litigation. This strategy involves using unlimited funds “to
make even the most straightforward case a grinding, exhausting,
and ultimately unsustainable, ordeal.” The attorney for R.J. Reynolds
was quoted as saying,

[T]he aggressive posture we have taken regarding depositions and
discovery in general continues to make these cases extremely
burdensome and expensive for plaintiffs’ lawyers, particularly sole
practitioners. To paraphrase General Patton, the way we won these cases
was not by spending all of [R.J. Reynolds’s] money, but by making that
other son of a bitch spend all of his.
The strategy of investing hundreds of millions of dollars in lawyers’ fees proved successful for the
tobacco industry—that is, until they came up against the government itself as the plaintiff.
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The litigation environment began to change a great deal in the 1990s as a result of documents that
were released by whistleblowers from within tobacco companies. Among the first was a paralegal
from Brown and Williamson (a subsidiary of British American Tobacco), who
leaked tobacco industry documents that were disseminated and analyzed in the
media from the Wall Street Journal to the Journal of the American Medical
Association. These documents led to subsequent disclosures, most famously by
Jeffrey Wigand, a former Brown and Williamson Research Director. As a result,
the Food and Drug Administration (FDA), under the direction of David Kessler,
began an inquiry into the addictiveness of nicotine and the ways in which the

Key Takeaway
The tobacco industry’s
litigation strategy
involves using
unlimited funds “to
make even the most
straightforward case a
grinding, exhausting,
and ultimately
unsustainable, ordeal.”

tobacco companies sought to manipulate the delivery of nicotine to the body to
make their products as addictive as possible. This investigation led, in turn, to what became known as
the Waxman Hearings—the congressional inquiry in 1994 that forever tainted the tobacco industry
(Chapter 6: Tobacco Industry Behavior).
The Waxman Hearings mark the beginning of the third wave of litigation, which still continues today.
More and more industry documents became available as a result of the congressional hearings and
the FDA inquiry. These documents were so powerful that it led the American Medical Association to
conclude:
[T]hese documents and the analyses merit . . . careful attention . . .
because they provide massive, detailed, and damning evidence of the
tactics of the tobacco industry. They show us how this industry has
managed to spread confusion by suppressing, manipulating, and
distorting the scientific record. They also make clear how the tobacco
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industry has been able to avoid paying a penny in damages and how it
has managed to remain hugely profitable from the sale of a substance
long known by scientists and physicians to be lethal.
With the disclosures of the whistleblowers and the new availability of industry documents, there was
mounting evidence not only of the addictiveness of tobacco but also of the tobacco companies’
deliberate efforts to target young people. Their statements about their customers’ “assumption of
risk” became less acceptable. Third parties, such as the government, began to place the responsibility
on the industry for significant health care costs they had incurred as a direct result of smoking.
Tobacco companies could no longer argue that these parties had voluntarily assumed the risks of
smoking and the resulting costly diseases.
All of these efforts culminated in the ultimate tobacco litigation, the result of which was the 1998
Master Settlement Agreement (MSA). This monumental undertaking was initiated by then Mississippi
Attorney General Michael Moore (Figure 13.4), who announced his plan to sue the tobacco
companies for the harm they had caused. At the time, tobacco companies had never paid a single
cent in damages to any plaintiff. Moore brought much passion to the issue, calling on other states to
join in the effort. It became an effort for all fifty states to use litigation to recoup the money spent on
treating diseases caused by smoking. For the first time in history, the tobacco companies settled
individually with four states: Mississippi, Florida, Texas, and Minnesota. The 46 remaining states
settled as a group in what we now know as the Master Settlement Agreement (MSA). Under the terms
of the settlement, the tobacco companies must provide $280 billion to the states over 25 years, and
the states agreed to drop their suits and never sue the tobacco companies again.
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In addition to the monetary compensation provided to the
states, there were a number of provisions included in the MSA

Figure 13.4 Mississippi Attorney
General Michael Moore

that were big advances for public health. The tobacco
companies agreed to no longer use billboards or cartoon
characters such as Joe Camel to market their products, and
they funded the American Legacy Foundation (now known as
Truth Initiative), an organization that was created to educate the
youth of America in order to prevent tobacco from becoming a
problem for future generations. The MSA also required the
various trade groups of the tobacco industry to dissolve and
prohibited them from reforming. These were the same trade
groups, or lobbying firms, that had organized the
misinformation campaigns to obscure and obfuscate the truth about tobacco and the industry’s
practices and delay any reasonable action against the industry. They were the Tobacco Institute, the
Council on Tobacco Research, and the Center for Indoor Air Research.
Collectively, the litigation efforts of the 1980s and 1990s resulted in billions of dollars being paid by
tobacco companies to individual plaintiffs as well as to state attorneys general, but perhaps even
more important is the disclosure of thousands of pages of documents from the tobacco companies.
These documents can now be freely accessed on a variety of websites paid for by the tobacco
industry, allowing us to study the industry’s behavior and thus improve our efforts to counter their
tactics.
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Thus far, we have discussed litigation brought against the tobacco companies by the states—but the
federal government also incurs expenses that are used to treat diseases caused by smoking. Indeed,
the expenses incurred by the federal government overshadows that of the states, as it covers
Medicaid, Medicare, the Veterans Administration, and the Indian Health Service. In January 1999,
during his final State of the Union Address, President Bill Clinton authorized U.S. Attorney General
Janet Reno to pursue litigation against the tobacco industry. In September of the same year, the U.S.
Department of Justice (DOJ) filed suit against the tobacco companies under the Racketeer Influenced
and Corrupt Organizations Act (RICO) on the grounds that they had engaged in a decades-long
conspiracy to:
•

Mislead the public about the risks of smoking;

•

Mislead the public about the danger of secondhand smoke;

•

Misrepresent the addictiveness of nicotine;

•

Manipulate cigarette design to increase nicotine addiction;

•

Deceptively market cigarettes characterized as “light” or “low tar,” while knowing that those

cigarettes were at least as hazardous as full-flavored cigarettes;
•

Target youth; and

•

Fail to produce safer cigarettes.

The litigation took six years, including nine months of trial, hundreds of depositions, and thousands of
exhibits. Judge Gladys Kessler presided over the case and in August 2006 she delivered her ruling
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that the tobacco companies were guilty of RICO violations and of defrauding the American public.
The following words from Judge Kessler capture the essence of the findings resulting from the sixyear effort:
[This case] is about an industry, and in
particular these Defendants, that
survives, and profits, from selling a
highly addictive product which causes
diseases that lead to a staggering
number of deaths per year, an
immeasurable amount of human
suffering and economic loss, and a
profound burden on our national health care system. Defendants have
known many of these facts for at least 50 years or more. Despite that
knowledge, they have consistently, repeatedly and with enormous skill
and sophistication, denied these facts to the public, the Government,
and to the public health community.
Judge Kessler ruled in favor of the government on all counts and ordered remedies to be
implemented. It was intended that the U.S. government would collect financial remedies in a manner
similar to the terms of the MSA, but ultimately, these remedies were denied since the RICO statute is
intended to prevent and restrain future conduct rather than punish past conduct. In other words, the
tobacco companies could not be ordered to pay financial penalties as a result of being found guilty.
The remedies that were approved were steps that would prevent future violations of RICO, and they
included a call for the release of corrective statements to disclose the truth about the harm of tobacco
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and the industry’s practices to the public. The final order also called for additional documents and the
disclosure of marketing data, which would give evidence of the relationship between the tobacco
industry’s marketing expenditures and the population’s smoking behaviors. This way, the tobacco
companies could no longer deny this direct relationship.
Unfortunately, the corrective statements ordered by Judge Kessler have yet to appear (Figure 13.5).
The tobacco companies have filed suit, invoking their First Amendment rights. Thus, even though the
tobacco companies were found guilty, they paid no money as a result of this litigation and as of now,
there is a stay on the remedies pending the results of their appeal. They are suing over the content of
the corrective statements, claiming that they are being compelled to engage in speech that is not in
their best interest. It is highly likely that the case will go to the Supreme Court, and the corrective
statements will not appear until 2016 or later. These actions are consistent with the tobacco industry’s
strategy of delaying remedies and changes to their business practices that have been stipulated by
courts of law or by Congress. By the time the corrective statements appear, a decade will have passed
since the official ruling.
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Figure 13.5 Corrective Statements for Adverse Health Effects of Smoking
A Federal Court has ruled that Philip Morris USA, R.J. Reynolds Tobacco, Lorillard,
and Altria deliberately deceived the American public about the health effects of
smoking, and has ordered those companies to make this statement. Here is the
truth:

• Smoking kills, on average, 1200 Americans. Every day.

• More people die every year from smoking than from murder, AIDS, suicide,
drugs, car crashes, and alcohol, combined.

• Smoking causes heart disease, emphysema, acute myeloid leukemia, and
cancer of the mouth, esophagus, larynx, lung, stomach, kidney, bladder, and
pancreas.

• Smoking also causes reduced fertility, low birth weight in newborns, and cancer
of the cervix.
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Chapter 13 - Laws, Litigation, and Regulation
Section 3 - Regulation

In 2009, President Barack Obama signed the Family Smoking Prevention and Tobacco Control Act
(FSPTCA), giving the FDA the authority to regulate the manufacturing, marketing, and sale of tobacco
products, including cigarettes, smokeless tobacco and roll-your-own tobacco. The road to get there
was a long one, and in this section we will look at some of the highlights in the complicated history of
the FDA and tobacco.
Throughout the 1960s and 70s, the FDA justified the lack of regulation around cigarettes by stating
that cigarettes were neither a food nor a drug—they were considered, rather, a “device of pleasure.” It
was not until 1994 that the FDA, under the leadership of David Kessler, began the process of
regulating tobacco products on the grounds that cigarettes were a means of manipulating the
delivery of nicotine, which was a drug and thus subject to FDA regulation. Within a short period,
regulations were put in place primarily around the marketing and sale of
tobacco products to young people. Immediately, the tobacco industry sued

Key Takeaway

the FDA, effectively putting a stay on regulatory action against their

In 2009, President Barack
Obama signed the Family
Smoking Prevention and
Tobacco Control Act
(FSPTCA), giving the FDA
the authority to regulate
the manufacturing,
marketing, and sale of
tobacco products.

products. The litigation went all the way to the Supreme Court, and in 2000,
the Supreme Court decided in a 5 to 4 vote that the regulation of tobacco
was needed, but that the FDA did not have the authority to do so. This
authority had to come from Congress, and it took another nine years after
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Figure 13.6 FSPTCA Infographic Section 1
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Figure 13.7 FSPTCA Infographic Section 2
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the Supreme Court ruling for Congress to approve the FSPTCA.
Since President Obama’s signing of the bill, the tobacco companies have challenged virtually all
aspects of the FDA’s action in courts of law, using litigation as an aggressive response to regulation
and as a strategy to delay the implementation of anti-tobacco measures. Some of the most
contentious issues are around menthol flavoring of cigarettes, warning labels, and, more recently, the
classification of novel tobacco products, including e-cigarettes. In this section, we will discuss the
different aspects of FSPTCA and the controversy that continues to be raised around them.
In Figure 13.6 developed by the FDA, the first section provides an overview of the harm caused by
smoking, and the bottom section details some of the key events and milestones in U.S. tobacco
regulation since the FSPTCA was signed in 2009, including the establishment of the Center for
Tobacco Products and efforts to begin to implement the various aspects of the law.
Figure 13.7 continues the timeline of key events and milestones in U.S. tobacco regulation. In June
2011, the Center for Tobacco Products published the final regulation requiring graphic warning labels
on cigarette packages. However, the FDA’s efforts to implement these warning labels have been
challenged by the tobacco industry and litigation continues to this day. During this same period, the
FDA has also submitted proposals to regulate menthol, a flavoring for cigarettes that is of concern in
terms of facilitating the initiation of smoking. The FDA has banned all flavorings in tobacco products
other than menthol and efforts are focused on including menthol in that ban.
The law gives the FDA extensive power to regulate tobacco products in ways that would reduce
tobacco consumption and prevent tobacco companies from engaging in practices that would
facilitate youth smoking initiation. The FDA can restrict tobacco advertising and promotion to black-
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and-white text-only messages—a measure that, again, has been disputed by the tobacco industry in
the courts under the First Amendment protecting the freedom of speech. The law also allows the FDA
to enforce the prohibition of illegal sales of tobacco products to minors, as well as health claims about
purported reduced risk products, where such claims are not scientifically proven or would cause net
public health harms (for example, by discouraging current tobacco users from quitting or
encouraging new users to start). Moreover, the FDA is given authority to require tobacco companies
to disclose the contents of tobacco products, any changes made to their products, and the results of
industry research on the health effects of their products.
The FSPTCA gives the FDA authority over tobacco products, namely cigarettes, smokeless tobacco
and roll-your-own tobacco. However, since 2009, a new world of novel products has emerged on the
market, including e-cigarettes, snus, and dissolvables (Chapter 4: Novel Nicotine Products). All of
these products fell outside of
FDA regulation because they
were introduced after the law
went into effect. In 2013, FDA
issued a notice of proposed
rule-making that would deem
certain tobacco products,
including e-cigarettes, to be
subject to the same regulation
outlined in the FSTCPA. In May
2016, this deeming rule was
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Figure 13.8 Tobacco Products Regulated by the FDA

finalized, and it
extends the FDA’s

Table 13.2 The Differences Between Regulation of Cigarettes and
E-Cigarettes Varies Significantly

authority to include
the regulation of
electronic nicotine
delivery systems
(such as e-cigarettes
and vape pens), all
cigars, hookah
(waterpipe) tobacco,
pipe tobacco and
nicotine gels (Figure
13.8).
Table 13.2 provides a
helpful comparison
of how traditional
combusted cigarettes
are regulated in the U.S. versus e-cigarettes. The FDA’s authority over the manufacturing, sales, and
marketing of traditional cigarettes is only beginning to be extended to e-cigarettes. While some
regulations in the May 2016 deeming ruling will go into effect in August 2016, these regulations are
just the beginning and do not provide the same level of regulation that traditional cigarettes receive.
While cigarette advertising has been banned on television and radio since 1971 as a result of
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Table 13.3 The Differences in the Regulation of Nicotine Products Varies Significantly in the
U.S. (bold lettering indicates the presence of regulation)

Product

ECigarettes

Cigarettes

Rx Drug
Delivery
Device
Rx
Cessation
Aids
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Evidence
on Safety
and
Premarket
Approval
None, but
less harmful
than
combusted
cigarettes

Excise
Taxes

Warning
Labels

Limits on
Where
Product
Can Be
Used

May 2016
regulation
will require
not to be
sold to ppl
under 18
years

None

May 2016
regulation
will require
warning
statements
on
packaging

None, any
regulation
in place
occurs at
the state
and local
level

18 years as
federal law;
Some
states/
localities
set as 21
years

Federal
and State
Taxes

Required

Yes

Ban on TV
Ads

Ban on
Flavors

Minimum
Age of
Purchase

First time
smoking is
seen on TV
in 40 years

Countless
flavors,
including
bubble
gum, fruit,
candy, etc.

Most deadly
tobacco
product
known

Banned

Menthol
allowed

Required

Extensive
broadcast
and print
ads

Yes

Yes

None

Required

None

Required

Allowed but
limited

Mint and
fruit flavors
allowed

Yes

None

Required

None

legislative action, there are no such marketing restrictions on e-cigarettes. Likewise, state and local
restrictions on where traditional cigarettes can be used generally do not apply to e-cigarettes; the
exceptions are New York City and Chicago, which treat e-cigarettes the same as tobacco products.
Nationwide, the minimum age of purchase for traditional cigarettes is 18 years, and the ruling has just
been made that e-cigarettes cannot be sold to individuals under age 18. Prior to the federal law, less
than half of the states had independently passed laws setting a minimum age for buying e-cigarettes.
Recently, Hawaii, California and hundreds of local jurisdictions have enacted legislation increasing the
minimum purchase age of traditional cigarettes to 21 years of age.
To expand our comparison, Table 13.3 describes regulation of traditional cigarettes and e-cigarettes
alongside prescription nicotine delivery devices and cessation aids. While scientific evidence on the
safety and effectiveness of prescription devices and nicotine replacement therapy is required before
they can be sold on the market, there is no such requirement for e-cigarettes—they can be
manufactured and sold by companies without having to do research or clinical trials to prove that they
are safe and effective when used as intended. The 2016 deeming regulation will require e-cigarette
companies to register with the government, report ingredients, and require premarket review of new
tobacco products. While this regulation is a start, we can see from the table that the current regulatory
status of nicotine products sold in the U.S. varies widely and is often shaped by the influence of
special interests. The regulation of nicotine products should be based not on special-interest
lobbying or historical precedent, but rather on the level of harm that they cause.
The 2009 FSPTCA Act bans all cigarettes that have a characterizing flavor, including all fruit and candy
flavors, other than tobacco flavor or menthol (Figure 13.9). The FDA has the power to ban menthol
and they have proposed a course of action that is now being considered within the administration.
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Figure 13.9 MentholFlavored Cigarettes

When the matter was opened for public comment in July 2013,
over 200,000 comments were received which are now being
read, evaluated, and documented so that they can help to inform
the ultimate regulation of menthol in tobacco products. The issue
is an important one, with 30% of adults and more than 40% of
youth smoking menthol cigarettes, as well as 70% of African
Americans; it should be regulated to the extent that it contributes
to the initiation and continuation of smoking.
Cigarettes used to come in all sorts of flavors. Camel, for instance,
carried a piña colada cigarette. While the FDA has banned all
flavors except menthol for cigarettes, flavors are still allowed for
e-cigarettes, little cigars, and cigarillos (Figure 13.10). These
products continue to be sold with a variety of flavors such as
strawberry, cotton candy, and licorice. This is particularly

concerning (as we noted in Chapter 4)
because these flavors are particularly
attractive to young people. The 2016
deeming regulation states the FDA’s
intent to issue a proposed product
standard relating to flavorings in the
future, but at this point in time,
flavorings remain unregulated.
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Figure 13.10 E-Cigarettes Come in Many Fruit and
Candy Flavors

Figure 13.11 Proposed FDA Cigarette Warning Labels

Additionally, the FSPTCA prohibits terms such as “light,” “mild,” and “low-tar” on tobacco product
packages and advertisements, while also authorizing the FDA to restrict additional terms in the future.
The 2016 deeming regulation will prohibit e-cigarettes to be sold as modifiable risk products or to
include the same “light,” “mild,” or “low” labeling.
Further, the 2009 law
requires bigger, more
prominent warning labels
on cigarettes and smokeless
tobacco products. Figure
13.11 shows examples of
the cigarette warning labels
that were proposed by the
FDA. These immediately
elicited litigation from R.J.
Reynolds, who found such
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Figure 13.12 The FDA and NIH Invest in Tobacco Centers of
Regulatory Science Across the Country

warnings to impede freedom of speech. With litigation happening in various courts, some judges
have ruled in favor of R.J. Reynolds, and some have ruled on behalf of the FDA. Regardless of the
outcomes of these individual cases, the FDA has withdrawn the graphic warning labels and has gone
back to attempt to develop new labels that correspond to U.S. case law, in addition to being accurate
and informative. Though graphic warning labels have become a common practice in other nations
throughout the world, and in spite of the 2009 act which calls for such labels to be implemented—not
to mention the fact that the labels depict real conditions caused by smoking—it will likely be many
years before they become part of cigarette packaging in the U.S. (Figure 13.11). The 2016 deeming
regulations will require e-cigarette packaging to carry health warnings, such as "WARNING: This
product contains nicotine. Nicotine is an addictive chemical,” or “This product is made from tobacco."
There are many challenges still to be met in implementing the FSPTCA and the 2016 deeming ruling.
But in spite of the limitations of the law and the litigation undertaken by the tobacco industry, it is
exciting to have a federal agency exerting regulatory authority over tobacco products. The FDA has
invested heavily in a number of Tobacco Centers of Regulatory Science (TCORS), which are intended
to provide the objective scientific evidence that will guide FDA rule-making in the years to come.
Under the TCORS program, researchers from 14 institutions around the country will focus on finding
evidence that will inform the FDA’s regulatory actions on tobacco (Figure 13.12).
Essentially, tobacco regulation can occur at every stage of the tobacco lifecycle, including the
production, display, purchase and use of tobacco products. As shown in Figure 13.13, adopting
regulations at each stage of the tobacco lifecycle is possible, and it has the potential to limit the harm
caused by these products.
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Figure 13.13 Regulations Can and Should Occur at all Stages of the Tobacco
Life Cycle
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Chapter 13 - Laws, Litigation, and Regulation
Section 4 - Global Effects

While this chapter so far has focused on the laws, litigation, and regulation around tobacco
products in the United States, it is important to also recognize the efforts being made in these
regards by other countries around the world. The WHO Framework Convention on Tobacco
Control is an important evidence-based treaty that has been ratified by 177 countries, which
obligates member countries to implement tobacco control measures, such as smoke-free
environments, advertising restrictions, and health warnings (also Chapter 8: Tobacco Control
Frameworks). In essence, it is a legal obligation to protect the population’s health against the
tobacco epidemic. The WHO FCTC has made an important difference in getting effective
tobacco control programs, laws, and regulations put into place.
Since 2005, more than 35 FCTC member parties have enacted or implemented strong smokefree legislation across the globe, including Australia and Canada. In Latin America, 14 countries
have passed strong smoke-free legislation. Among them is Brazil, the most populous country in
the world to enact 100% smoke-free legislation. More than 68 countries have enacted or
implemented graphic warning labels that cover at least 30% of tobacco packaging. At least 37
countries have enacted legislation that strengthens restrictions on tobacco advertising,
promotion and sponsorship.
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Key Takeaway

Needless to say, the tobacco companies have fought back against

Since the WHO FCTC holds
legal sway in countries that
ratified the treaty, courts of
law can use it to counter
the tobacco industry’s
claims.

smoke-free legislation in foreign countries. In more than 20 countries,
the courts have referred to the WHO FCTC when affirming the
government’s right to protect the health of citizens from tobacco. For a
specific example, we can look at the following case study from Canada.

In 2007, tobacco manufacturers complained that a law requiring graphic health warnings to cover
50% of pack labels infringed upon their right to freedom of expression under the Canadian
Charter of Rights and Freedoms. The Canadian court rejected their argument, referencing the
WHO FCTC and the work of other countries that had embraced similar laws in accordance with
the treaty. Since the WHO FCTC holds legal sway in countries that ratified the treaty, courts of
law can use it to counter the tobacco industry’s claims.
To take another example, a law prohibiting smoking in any enclosed space was challenged in
2010 by the Guatemalan Chamber of Commerce, which opposed “unreasonably restricting the
exercise of constitutional freedoms of industry and commerce on the basis that it would render
the manufacture, production, distribution or marketing of tobacco-based products ‘worthless.’”
The Constitutional Court upheld the law and concluded that the Guatemalan Constitution’s
“right to health” mandate entitled the government to implement these prohibitions to be
consistent with the WHO FCTC.
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A final recent example comes to us from South Africa, where, British American Tobacco
challenged a law banning tobacco advertising and promotion in 2012. The South African court
upheld the law on the basis that any limitation on the freedom of commercial speech was
justified, making it clear that by ratifying the WHO FCTC, the country had “accepted the link
between advertising and consumption as incontrovertible” and had a duty to “have regard to
international law when interpreting the Bill of Rights.” In these and many other ways, the WHO
FCTC has provided countries with the legal justification to oppose tobacco industry efforts to
undermine effective tobacco control measures.
We end this chapter with a few words from
Dr. Judith Mackay, a British medical doctor

Movie 13.1 Hear from the Experts: Judith
Mackay

living in Hong Kong who has focused much
of her work since 1984 on tobacco control in
developing countries (Movie 13.1). Dr.
Mackay serves as a Senior Advisor to the
World Lung Foundation. She has been
identified by the tobacco industry as one of
the three most dangerous people in the
world and has been counted among TIME Magazine’s 100 Most Influential People. Here, she
gives her perspective on the importance of law, legislation, and regulation for tobacco control.
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Chapter 13 Discussion Questions:
1. The U.S. is a party to the WHO Framework Convention on Tobacco Control but has not ratified or
entered the Framework into force. Hypothesize why it has not done so and what are the
ramifications of not ratifying or entering the Framework into force.
2. If the U.S. does ratify and enter the Framework into enforce, would it be helpful in rebutting the
tobacco industry’s First Amendment arguments? How?
3. Are there any other national situations where an industry has tried to manipulate the legal
system’s efforts at regulation for over 50 hears? Can or should the U.S. expedite the processes
for judicial and executive actions against the tobacco industry?
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Chapter 14

Lessons Learned

Chapter Objectives
1. Examine how the process of social change applies to
tobacco and other public health issues.
2. Compare and contrast tactics used by the tobacco industry
with those used by the food and alcohol industries.
3. Hypothesize how tobacco control methods, such as taxes
and marketing restrictions, can impact other public health
issues.
4. Analyze how the food industry can be a part of the battle
against obesity.

Chapter 14 - Lessons Learned
Section 1 - Understanding Externalities and Social Change

Since 1964, we have learned many lessons in the course of our efforts to control tobacco. The
tobacco industry’s motives and tactics have been exposed and, to an extent, the industry has been
held accountable for the damages caused by smoking. Today, evidence-based practices for tobacco
control and comprehensive tobacco control programs have become the norm in many countries. In
this chapter, we will explore how lessons learned from tobacco control can be applied to other public
health problems, such as obesity and alcohol abuse, with a particular emphasis on how the process of
social change can be accelerated to promote public health.
Tobacco control is widely considered to be a success story. The lives saved and healthy years
extended as a result of the movement is considered one of the most important public health victories
from the latter half of the 20th century and the beginning of the 21st. In 2014, the 50th anniversary
edition of the Surgeon General’s Report was published, lauding the remarkable progress in reducing
tobacco use in the United States (Figure 14.1). Since the first Surgeon General’s Report, smoking
prevalence among U.S. adults has been reduced by half; ex-smokers now outnumber current smokers
in this country. However, tobacco use remains the leading preventable cause of disease, disability,
and death in the U.S. The 2014 Surgeon General’s Report not only commemorates the progress that
has been made so far, but also calls for urgent action and accelerated progress to further reduce the
burden caused by tobacco use. If we are to prevent the hundreds and thousands of annual deaths
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Figure 14.1 Cover of the
50th Anniversary Edition of
the Surgeon General’s
Report on Smoking and
Health, 2014

that are projected globally, tobacco control must disrupt the status
quo. We can start by understanding how and why progress has
been achieved so far, the time and resources it has taken, and the
relevance of this progress for other public health problems.
One of the ways in which tobacco control is unique among other
areas of public health has to do with the issue of externalities. We
use the phrase negative externality to describe the costs to
society that are generated as a result of an individual’s decision to
engage in a certain type of behavior. In the case of smoking, there
are many known negative externalities: secondhand smoke can be
seen, smelled, and even tasted by those in close proximity to a
smoker; there is strong scientific evidence proving harm from
secondhand smoke; and nonsmokers experience health risks
caused by the decision made by others to smoke. These very
salient and palpable dimensions of exposure to secondhand

smoke spurred on local movements advocating for nonsmokers’ rights in the early 1980s, marking the
beginning of sweeping changes in public opinion regarding where smoking should and should not
be allowed, as well as paving the way for government intervention in the issue.
To a large extent, the reversal of social norms around tobacco use in the United States resulted from
the extraordinarily visible externalities associated with smoking; the question now lies in how we can
use our understanding of externalities to address other public health issues. Looking at problems
such as obesity, alcohol consumption, or even climate change, we can ask the following questions:
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• What behaviors do some people engage in that harm others?
• How can we make these externalities more real, immediate, and salient to the public?
• What strategies can be implemented to mitigate the harm caused by these externalities?
Recognizing the tobacco control movement’s success in changing social norms, public health
advocates are now putting much effort into understanding the process of social change. As shown in
Figure 14.2, the process involves several steps that must happen before policies become enacted at
the government or institutional level. In the case of tobacco, social change began with the recognition
of the negative externalities associated with smoking—for instance, the pervasive smell of smoke in

Figure 14.2 The Process of Social Change

Negative
Externalities
(e.g., involuntary
or forced
exposure to
costs, harm or
annoyance
among those
who decided
not to smoke)
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Awareness &
Scientific
Documentation
of Harm
(e.g., scientific
studies, Surgeon
General’s
Reports, etc. that
bolster evidence
on harm caused
by involuntary
exposure)

Social
Engagement
(e.g., citizen
action
demanding
protection from
secondhand
smoke through
legislation,
referendum, and
institutional
policies)

Changes in
Social Norms
(e.g., public
smoking no
longer the norm.
Smoking in
private and
public settings
discouraged, if
not prohibited)

Government
& Institutional
Action &
Policy
(e.g., in
response to
changing norms
and behaviors,
institutions
codify rules to
protect
nonsmokers
from negative
externalities)

public places was a very palpable externality, at the very least an annoyance to those who chose not
to smoke. Nonsmokers felt it was unfair to be exposed to smoke, and their decision to take action was
bolstered by increasing awareness and scientific documentation of the harm caused by long-term
exposure to secondhand smoke. An unprecedented level of social engagement around the issue
occurred as citizens demanded protection from involuntary exposure; advocacy groups put pressure
on institutions and local governments to create legislation or to put referendums on the ballot so that
citizens could have their voices heard on the issue. More and more rapidly, social norms around
smoking started to change; in just a matter of years, smoking was no longer considered a socially
acceptable activity. It developed the status of a deviant behavior, and one no longer seen in any
public indoor areas. This process of transformation reached its culmination as governments and
institutions codified, or formally put into law, the smoke-free policies that had emerged as a reaction
from citizens opposed to secondhand smoke exposure. The lesson here, of course, is that social
change did not start with government and institutional policies, but rather from citizen action to
address the negative externalities of smoking. Public health advocates working in other domains look
at the phases of social change in the context of tobacco control and attempt to answer the question:
How can the process of social change be initiated in the absence of large negative externalities?
Even without negative externalities to stimulate the process of social change, there are a number of
elements that can help push along needed changes in social norms. First, there must be a persuasive
scientific base documenting the threat to the public health. Such documentation is particularly helpful
if it also addresses the economic implications of the threat and if it can gain the support of mass
media channels. Strategic leadership is key—such movements especially benefit from a prominent and
highly visible champion; but equally important, there must be a diverse constituency of highly
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Key Takeaway

effective advocates bringing many different perspectives and serving a

Negative externalities
stimulate the process of
social change.

variety of roles in order to push the agenda in ways that government officials
cannot. Lastly, laws, regulations, and policies codify new norms and further
enable sweeping changes to take place.

Often, creating lasting social change requires
the government codifying the new norms in the
form of laws, regulations, and policies. Knowing

Movie 14.1 Imperial Tobacco's 2011 "No
Nanny State" Campaign Against Plain
Packaging

this, tobacco companies work aggressively to
question and undermine the role of government
in regulating public health matters. For instance,
the Imperial Tobacco Company sponsored a
campaign that was aired in Australia in 2011
(Movie 14.1), which was designed to provoke
fears of the “Nanny State.” The campaign was
part of an effort to defeat plain packaging legislation in that country. Organized efforts to severely
limit the role of government have become commonplace, and antigovernment sentiment is one of
the greatest challenges now facing advocates of public health.
New York City provides an interesting case study in terms of progressive public health action from the
government that was met with fierce opposition from commercial interests. Former Mayor Michael
Bloomberg put a number of proactive measures in place to reduce obesity as well as tobacco use,
which have been met with a strong backlash from affected industries. These efforts include restricting
the amount of sodium in prepared meals, requiring chain restaurants to include calorie counts on
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their menus, requiring health department grades to be posted by restaurants, limiting the use of
tobacco products, and regulating sugary drinks.
Among the public, there is ambivalence regarding the appropriateness and effectiveness of certain
interventions. Partly, this is stimulated by commercial interests advocating against the “Nanny State,”
but also by widespread concerns about frivolous lawsuits, the appropriate role of government, and an
increasing emphasis on personal responsibility for health behaviors. We don’t know all the answers,
and there is certainly no formula for stimulating social change, but we have learned much from the
last fifty years of tobacco control that can be applied to many other public health problems. Positive
change will require small steps sustained over time. As we learned from tobacco control, citizens led
the charge in changing social norms and only later were sweeping changes put in place in the form of
laws and regulations. Likewise, for issues like obesity and alcohol, we know that effective solutions will
require the involvement of all sectors of society.

483

Chapter 14 - Lessons Learned
Section 2 - Relating Tobacco and Obesity

In this section, we focus on how lessons learned from tobacco control can be applied to preventing
obesity. Tobacco and obesity share many similarities (Figure 14.3): they both cause illness and
disease and thus contribute to rising healthcare costs; tobacco and unhealthy foods that cause

Figure 14.3 Many Lessons From
Tobacco Control Can Be
Applied to the Obesity
Epidemic

obesity are marketed aggressively, with a special focus on
attracting youth; and they disproportionately affect low-income
individuals.
They are also very different from one another. Tobacco causes
disease and death when it is used as intended, and the same is
not true for unhealthy food products. Indeed, there is no single
food product that is as harmful as cigarettes. Moreover,
cigarettes are not necessary for life, whereas food must be
consumed daily. Still further, the adverse effects of obesity can
be ameliorated by other factors, such as physical exercise.
These differences set obesity prevention efforts quite apart
from tobacco control and lend more nuance to the issue.
In comparing the tobacco experience to obesity, it is important
to look at externalities, as we discussed previously. One of the
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first questions that we need to address is the following: Does a person’s poor food choices affect
another person in a way similar to secondhand smoke? Clearly, the externalities differ between the
two risk behaviors; the externalities associated with obesity have significantly less impact on others
compared with those associated with smoking. However, there are economic costs that are shared by
everyone. The estimated annual medical cost of obesity in the U.S. was $147 billion in 2008; medical
costs for people who are obese were $1,429 higher on average than those of normal weight.
We also find similarities in the way that the food industry and the tobacco companies conduct
business. As a matter of fact, the food industry has taken several tips from the tobacco industry,
employing many of the same arguments and tactics used in the tobacco wars. For instance, the food
industry ascribes the cause of the nation’s unhealthy diet to personal responsibility. It tries to raise
fears that government action impacts personal freedom, often using terms associated with freedom
and liberty to promote products that may actually be harmful. It vilifies critics by characterizing them
as totalitarian, leaders of a nanny state, food police, and even “food fascists.” The food industry also
criticizes studies that hurt its public image, dismissing them as “junk science.” Further, the industry
emphasizes physical activity over diet; it uses terms that imply health (for example, “all-natural”) but
are not consistently defined; the industry states that there are no good or bad foods; hence no food
or food type should be targeted. The tactic is to plant doubt whenever concerns are raised about the
industry—the same tactic used for decades by the tobacco companies.
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Key Takeaway

Given all these similarities, there are a number of strategies that have

The food industry uses many of
the same tactics used by
tobacco companies to promote
specific foods and brands.

worked for tobacco control that may have relevance for obesity
prevention. As in the fight against tobacco, advocates of obesity
prevention must have a good grasp of the information environment,

which includes marketing and advertising from the food industry, the use of counter-marketing and
media campaigns to improve risk perceptions and health behaviors, as well as the impact of warning
labels on products and the way ingredients are disclosed. Obesity prevention advocates should also
pay attention to the ease of access to certain foods in communities and schools. In the case of
tobacco, there are fairly stringent restrictions on who can access the products and where they can be
used, and there has been a push to restrict some foods in a similar manner (for example, removing
sugary drinks from schools or Mayor Bloomberg’s proposal to limit the size of sugary drinks to 16
ounces). Further, economic factors must be taken into account. For tobacco control, efforts to increase
the excise tax has proven to be an important strategy, given the inverse relationship between price
and consumption, and a parallel move for food products, particularly sweetened soft drinks, has been
much discussed recently. The legal and regulatory environment may also be key in obesity
prevention. As of yet, the food industry has not faced litigation from the states or the federal
government, unlike the tobacco industry, which has had to pay billions of dollars in payments to the
states as a result of the Master Settlement Agreement and being found guilty of fraud and misleading
the public. However, public health advocates are now seriously considering such efforts against the
food industry, particularly around the marketing of food products. Besides the potential of having
stricter regulations on food advertising, litigation could result in the disclosure of the food industry’s
internal documents through the discovery process at trial, just as it did for tobacco, exposing the
industry’s efforts to mislead consumers about its products. Lastly, obesity prevention strategies must
take into account the importance of social norms and how they change. As we discussed, the social
norms with respect to tobacco were turned upside down over a 50-year period, with smoking going
from being a socially acceptable activity to becoming a deviant behavior. Obesity is much less
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straightforward in this regard, and efforts to change the acceptability of obesity in our culture must be
careful to avoid stigmatizing those who are obese.
The five domains outlined in the box below cover the types of interventions that have been shown to
be successful in combating tobacco; whether they will also work for obesity prevention, and to what
extent, still remains to be seen. Looking

What public health
domains can we focus on
for obesity prevention?
The information environment: marketing &
advertising, media campaigns, warning labels,
ingredient disclosure
Access and opportunity: ease of access in
communities and schools
Economic factors: taxes, agriculture &
farming interests
Legal and regulatory environment: laws,
product liability, FDA & FTC regulation
Social environment: changing social
norms, education
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more closely at marketing, we know that
the tobacco companies have, for decades,
promulgated an advertising code whereby
they advocate for self-regulation of
tobacco product advertising. The food
industry has taken a similar approach,
putting forward a self-regulation policy for
their marketing. Unfortunately, as we have
found with tobacco, the food industry’s
advertising code does little to nothing in
terms of limiting the claims they make or
their targeting of children with their
marketing. A recent study examined quickserve restaurants (QSRs) and found that
self-regulation did not work: QSRs
advertised heavily to children (particularly
McDonald’s, Burger King, and Subway),

with the majority of these ads mentioning some type of toy giveaway. Movie tie-ins were present in
55% of children’s advertisements, compared with 14% in advertisements geared towards an adult
audience. Ads targeting children were also more likely to include strong branding: images of food
packaging were present in 88% of ads aimed at children, compared with 23% of ads targeting adults.
The marketing of food products to youth is the subject of a number of recent studies. A report from
the Kaiser Family Foundation examined data from 2005 and found that food was the most heavily
advertised product to youth, with ads for candy and snacks making up 34% of food ads. Ads for cereal
made up 28% and fast food 10%. There were no ads for fruits and vegetables. The same study
showed that preschoolers or children in early elementary school saw an average of about twelve ads
per day, adding up to thousands of ads seen over the course of a year (Table 14.1). Of note, a
separate study done in 2004 by the American Psychological Association found that children under the
age of eight were unable to critically interpret televised advertising messages. Unlike adults, children

Table 14.1 Children’s Exposure to Food Advertising on TV, On Average
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Age

Number of
Food Ads
Seen per Day

Number of
Food Ads
Seen per
Year

2-7

12

4,427

29:31

8-12

21

7,609

50:48

13-17

17

6,098

40:50

Hr:Min of Food
Ads Seen per Year

cannot differentiate fact from fiction and tend to believe what they were told by advertisements. Dr.
Brian Wilcox, who was among the psychologists who performed the study, concluded: “Because
younger children do not understand persuasive intent in advertising, they are easy targets for
commercial persuasion.” Along the same lines, the Institute of Medicine found that “[t]elevision
advertising influenced the food
preferences, purchase requests,
and diets, at least of children
under age 12 years, and is
associated with the increased
rates of obesity among children
and youth” (Figure 14.4). All told,
these studies provide a
compelling argument for
regulating advertising that
reaches young children to ensure
that they provide truthful and
non-distorted messages.
Labeling of foods is a food
industry marketing tactic that can
be controversial. In 2008 and
2009, the food companies Kraft,
Kellogg, and Unilever took part in
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Figure 14.4 Like Tobacco, Food Companies Use
Celebrities, Sponsorship and Giveaways to Attract Youth

Figure 14.5 Food Items that Feature the Smart Choices Label

the Smart Choices
program, which aimed to
offer consumers an easy
way to identify healthy
choices by placing a green
check mark on foods.
Among the products that
received the green check
mark were Fudgsicles and
Fruit Loops, pictured in
Figure 14.5. The Smart

Choices program was pulled after the FDA announced it would be analyzing misleading food labels
more closely.
Rep. Henry Waxman, who chaired the Congressional hearings that revealed the secret activities of the
tobacco industry to the public, has also held a hearing on restricting marketing from the food
industry. These hearings were highlighted in an HBO documentary titled The Weight of the Nation.
In addition to marketing and advertising, we know that economic factors play an important role in
people’s food choices just as they do in people’s decision to smoke or not to smoke. Many countries
and states are now looking at taxes as a way to regulate consumption of unhealthy foods. However,
levying taxes on certain foods is a much more complicated matter than taxing tobacco. Taxing
unhealthy foods requires first determining which foods are unhealthy or defining what constitutes a
“snack” food. Notwithstanding the complications of judging the health value of different foods, soda
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and sugar-sweetened beverages have emerged as ideal candidates for taxation
due to their lack of nutritional value, their ease of categorization, and empirical
association with added calories in children’s diets.
Mexico was the first country to levy a soda tax as part of an effort to reduce
obesity. Soda is taxed at one peso per liter, and researchers are monitoring and

Key Takeaway
Many countries and
states are now
looking at taxes as a
way to regulate
consumption of
unhealthy foods.

evaluating the program’s success in terms of reducing obesity in Mexico but also in terms of the
revenue that is collected as a result. Already, there has been extensive lobbying to try to defeat this
type of tax on sugar-sweetened beverages in the U.S., and it is expected that opposition from the
affected industries will continue to be strong.
Thus, the precedent set by tobacco control of using increased taxation to discourage the
consumption of harmful products is now being applied to unhealthy foods. The practice comes with
several advantages, and in some ways, it is easier to implement for food than for tobacco. Unlike
advertising, taxes are not covered under the First Amendment; while taxes are unpopular, there is no
constitutional protection against taxation and local, state, and federal jurisdictions can consider taxes
as a way of discouraging unhealthy behaviors when necessary and appropriate. The public more
readily accepts these types of taxes if revenues are used for public health programs like subsidizing
healthier options or providing better access to healthy foods particularly in impoverished areas.
Arguably, taxes on food are less regressive than tobacco taxes since food products are not addictive
like nicotine. It is easier for individuals to change their behavior as a response to increased taxes on
food. As with cigarettes and substitute products like cigarillos and chewing tobacco, taxing sodas may
not be enough. Taxing all sugar-sweetened beverages is important, including those disguised as
“healthy” options. While taxation can be complicated by the need to specify the exact types of food
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that will be affected, progress is
being made in implementing a taxing
strategy for food products in ways
that reduce the prevalence of
obesity.
In addition to the push for marketing
regulations and increased taxation,
restricting access to unhealthy foods
is yet another way in which the
obesity prevention movement has
followed the lead of tobacco control
in recent years. In 2010, the Healthy,
Hunger-Free Kids Act required the
U.S. Department of Agriculture
(USDA) to establish nutrition standards
for all foods served in schools—not just
the federally-supported meal programs.
Before the new standards, many of the
items available for purchase at school
were filled with empty calories, as shown
in Figure 14.6. Drawing on data from the
Institute of Medicine, the USDA
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Figure 14.6 Examples of Foods Served in Schools Before
and After the Hunger-Free Kids Act of 2010

established a set of standards governing the types of food that could be sold in schools.
The 2010 law provides snacks in schools that have fewer calories overall, and with a much lower
proportion of empty calories. Though the law allows schools to bend the rules a bit for special events
like bake sales and fundraisers, it has changed the ease of access to high-calorie, low-valued foods in
schools, in ways that will hopefully make a difference in preventing obesity.
More recently, the Food and Drug Administration (FDA) proposed a ban on trans fats in food. In
November 2013, the FDA made a preliminary determination that partially hydrogenated oils, or trans
fats, contained in processed foods are no longer “Generally Recognized as Safe” (“GRAS”), a
designation that a compound or chemical must have in order to be used in the U.S. food system. The
final determination was made in June 2015, and food manufacturers have three years to remove
partially hydrogenated oils from their products. The proposed restrictions on trans fats could prevent
20,000 heart attacks and 7,000 deaths per year. If the FDA makes a final determination that trans fats
are not safe, a company could not use them in food without special approval from the FDA.
To conclude our comparison of tobacco control and obesity prevention measures, we turn once more
to former New York City Mayor Bloomberg, who has successfully championed a number of public
health initiatives on both fronts. During his tenure, Mayor Bloomberg was able to ban smoking in
public places, increased the purchasing age for cigarettes to 21, and required posted calorie counts
in chain restaurants. However, some of his initiatives have failed to go through: limiting the size of
sugary drinks, implementing a sales tax on soda, and excluding sugar-sweetened beverages from
food stamps. These issues remain controversial, and though they failed to pass in New York City, they
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provide examples of the types of laws and policies that leaders can push in their jurisdictions to
advance the public health.
Indeed, Mayor Bloomberg’s efforts have been so controversial that the state of Mississippi—which has
one of the highest obesity rates in the country—passed a state law prohibiting cities and municipalities
from legislating the portion size of sodas. This link shows a clip from CNN discussing the role of
government and the appropriateness of putting policies in place that promote the
public health.
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Chapter 14 - Lessons Learned
Section 3 - Relating Tobacco and Alcohol

As was the case with tobacco and obesity, tobacco and alcohol share a number of similarities but also
have distinct differences. Both the tobacco and alcohol industries target youth, even though both
products are illegal for youth to consume. Both have negative impacts on the health of consumers,
and there are negative externalities associated with both products. They differ in that there is no safe
level of consumption for tobacco products, as there is for alcohol. That is, while tobacco consumption
is harmful whatever the amount, alcohol consumption can be safe and there is even some evidence
that moderate consumption may be beneficial.
Alcohol overuse is associated with a number of externalities, including illness, death, and harm to
others. Worldwide, 1.8 million deaths in 2000 were attributable to alcohol use, which caused 3.2% of
all deaths and contributed to 4% of the disease burden. In the U.S., there are approximately 80,000
deaths attributable to excessive alcohol consumption each year, which may be equated to about 2.3
million years of potential life lost. This number includes not just the lives of the drinkers themselves,
but also those killed in alcohol-related traffic accidents, falls, drownings, burns, and unintentional
firearm injuries. The externalities of alcohol overuse also extend to intimate partner violence and child
maltreatment, as well as a greater chance of engaging in risky sexual behaviors like having
unprotected sex or sex with multiple partners. Moreover, alcohol is the cause of Fetal
Alcohol Syndrome.
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As with obesity, it is important to understand the economic costs of alcohol use. It is estimated that
excessive alcohol consumption created an economic burden of $223.5 billion in the U.S. in 2006. The
cost varied widely from state to state, with a median of $2.9 billion, and ranging from a low of $420
million in North Dakota to a high of $32 billion in California. For each alcohol drink consumed, the
median cost to the state was about $1.91, and about $2.00 of every $5.00 in state costs were paid by
the government. Costs associated with excessive drinking largely resulted from losses in workplace
productivity, health care expenses, and other costs incurred from a combination of criminal justice
expenses, motor vehicle crash costs, and property damage.
Alcohol consumption among youth is a major concern (Movie 14.3). Youth who start drinking before
the age of 15 are five times more likely to develop alcohol dependence or abuse in their lifetime
compared to those who begin drinking at age 21 or later. Every day in the U.S., more than 4,750
children under 16 years of age have their first full drink of alcohol. Alcohol is the drug most used by
youth in this country. In a national study, 13.8% of eighth-graders reported having at least one drink in
the past 30 days, and 11.5% had been drunk at least once in the past year. Approximately 10 million
people ages 12 to 20 (26.3%) reported drinking alcohol in the past month, with 6.5 million (17.0%)
reporting themselves as binge drinkers and 2 million (5.1%) as heavy drinkers. Among college
students, almost half (48%) of all alcohol use is attributable to those who are underage.
Just like the tobacco companies, the alcohol industry tries to recruit young people to use their
products. Underage drinking is estimated to account for 11% to 20% of the U.S. alcohol market. The
lower estimate of 11% represents 3.6 billion drinks each year. Numerous studies have shown that
greater exposure to alcohol advertising contributes to an increase in drinking among youth. A study
published in January 2006 found that for each additional ad a young person saw (above the monthly
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Movie 14.2 “Close Encounters,” a Bud
Light Commercial using Humor and Sex
Appeal to Attract Young People

youth average of 23), he or she drank 1% more. And
for each additional dollar per capita spent on
alcohol advertising in a local market (above the
national average of $6.80 per capita), young people
drank 3% more. Conclusively, the more ads youth
see, the more likely they are to drink. Like cigarettes,
exposure to in-store displays, magazine advertising,
and other people drinking at public events all
contribute to an increased frequency of drinking
among youth.

Movie 14.2 illustrates an example of how the alcohol industry promotes their products in a way that is
particularly appealing to young people.
Restricting advertising for alcohol is a
complicated matter, just as it is for tobacco.
The Alcohol and Tobacco Tax and Trade
Bureau (a subgroup of the U.S. Department
of the Treasury) regulates some alcohol
advertising. The following are generally
prohibited:

497

•

Statements that are false or untrue;

•

Statements that are inconsistent with

Movie 14.3 Exposure to Alcohol and Marketing
Starts Young

approved product labels;
•

False or misleading statements that are disparaging of a competitor’s product;

•

Health-related statements that are false or misleading; and

•

Misleading guarantees (though money-back guarantees are not prohibited).

While there is some regulation of egregious advertising behaviors, the alcohol industry subtly implies
associations between drinking alcohol and sex, glamour, and elevated social status without
consequence.
Implementing legal restrictions on advertising for products like tobacco and alcohol is very difficult
because of the freedom of speech guaranteed by the First Amendment. Rather than trying to regulate
the alcohol industry using laws, the Institute of Medicine and the U.S. Surgeon General have called for
more self-regulation by the industry. The Surgeon General specifically recommends that the industry
should not portray alcohol as an appropriate rite of passage from childhood to adulthood or as an
essential element in achieving popularity, social success, or a fulfilling life. It also recommends that the
industry’s placement of alcohol advertising, promotion and other means of marketing do not
disproportionally expose youth to messages about alcohol. Products should not be designated to
disproportionately appeal to youth. And lastly, the content and design of industry websites and
alcohol advertising on the Internet should not especially attract or appeal to adolescents or others
under the legal drinking age.
The alcohol advertising environment is vastly different from that of tobacco. Alcohol advertising is
permitted on television, and the alcohol industry takes advantage of the lack of formal marketing
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restrictions by using sex appeal, sports, and celebrities to attract youth, just as the tobacco industry
did before these practices were prohibited for tobacco marketing. In 2008, the Federal Trade
Commission (FTC) reviewed the alcohol industry’s voluntary guidelines for advertising and marketing
to underage audiences and suggested that the industry’s efforts at self-regulation have been largely
effective. The alcohol industry’s voluntary measures have even at times exceeded accepted standards
of self-regulation, which includes guidelines around the placement and content of advertising and
limits on college marketing. Even so, the FTC did note room for improvement in the current
standards; their suggestions included reducing product placement in films, reducing access to
minors, and reducing sponsorship of events and ad placements in print and broadcast media.
Just as we have seen in the case of tobacco, self-regulation is often not effective in limiting the alcohol
industry’s ability to recruit young people to use its products. The industry provides a variety of
products, sometimes referred to as “starter” products, which introduce young people to alcohol. For
example, they offer many kinds of
“alcopops,” which are viewed by
many as a bridge between soda and
beer (Figure 14.7). Like flavored
cigarettes, these beverages mask the
taste of alcohol and are very popular
among youth. The newest fad,
powdered alcohol, raises additional
concerns. Data from Monitoring the
Future shows that 78% of 8th
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Figure 14.7 “Alcopops” Mask the Taste of Alcohol and
Are Popular Among Youth

graders, as opposed to 35% of 25 to 30 year olds, had consumed an alcopop in the past 30 days.
Classifying them as a malt beverage makes them more widely available to youth and also cheaper,
since beer is often taxed at lower rates than distilled spirits.
Like novel nicotine products, novel alcohol products target young people. Products such as Four Loko
are a combination of energy drink and alcoholic beverage. Each 23.5 ounce can contains 12%
alcohol, 660 calories, and the caffeine equivalent of two cups of coffee. The alcohol content is about
equivalent to five light beers, and a can costs only $2.50. The product has been extremely popular on
college campuses, where it is known among students as “Blackout In A Can.”
Clearly, the marketing and advertising environment of alcohol is quite different from that of tobacco.
But the differences can also be identified as opportunities to implement stricter measures and
legislation to keep the alcohol industry in check, as has been done with tobacco.
Another area in which tobacco control may have some relevant lessons for alcohol is in taxation. Just
like tobacco, alcohol is taxed at both the federal and state levels, with federal alcohol taxes varying as
a function of the type of alcohol and a product’s alcohol percentage. Table 14.2 illustrates the
differential tax rates for different types of products.
Tax rates for alcohol vary significantly by state as well as by product (beer, wine, or liquor), much the
same way that tax rates vary for cigarettes, smokeless tobacco, and so forth. Alcohol appears to be
more price sensitive than tobacco (or slightly more elastic). Whereas a 10% increase in the price of
cigarettes results in a 4% decrease in consumption (showing a -4% elasticity), an equivalent increase
in the price of beer results in a 7.7% decrease in consumption (-7.7% elasticity). This suggests that
increases in the price of alcoholic beverages are likely to have almost twice the impact on
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Table 14.2 Federal Alcohol Taxes Vary Depending on
Alcohol Type and Percentage
Product

Tax

Tax per Package

$18/
barrel

$0.05/ 12
oz. can

Wine (14%
alcohol or
less)

$1.07/
gallon

$0.21/ 750
mL bottle

Wine (21%
to 24%)

$3.15/
gallon

Beer

Naturally
Sparkling

consumption as an increase in
cigarette prices would have on
cigarette consumption.
The following three maps illustrate
the variation in alcohol tax rates
across the U.S. for beer, wine, and
distilled spirits. First, Figure 14.8
shows the state excise tax rates for
beer. Tennessee has the highest beer

$3.40/
gallon

$0.62/ 750
mL bottle
$0.67/ 750
mL bottle

tax in the country at $1.29 per gallon
(one gallon equals roughly 10 beers).
Looking at wine in Figure 14.9,
Kentucky has the highest wine excise
tax per gallon at $3.56. Figure 14.10

Hard Cider

Distilled
Spirits

$0.226/
gallon

$0.04/ 750
mL bottle

shows that Washington state has the

$13.50/
proof
gallon*

$2.14 (at 80
proof)

gallon. It is interesting to note the

* A proof gallon is a gallon of liquid that is 100 proof, or
50% alcohol. The tax is adjusted, depending on the alcohol
percentage of the product.
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highest tax on sprits at $35.22 per
wide disparity in excise rates among
these three alcohol types.

Across the board, the state

Figure 14.8 State Beer Excise Tax Rates (Dollars Per Gallon) as
of January 1, 2014

excise tax on beer, wine, and
spirits is much less than the
societal and health costs
associated with consuming
the same products. In 2014,
the CDC estimated that
excessive drinking cost
$223.5 billion in 2006, or
about $1.90 per drink. In
2011, state revenues from
alcohol taxes exceeded $6.2
billion. Similar to tobacco,
alcohol consumption results
in more societal and
monetary costs than it
provides in tax revenue.
Additionally, tax revenue for
tobacco and alcohol is not
necessarily used to prevent
harm from smoking and
alcohol-related accidents,
illness or injury.
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Studies show that higher alcohol prices or taxes were consistently related to fewer motor vehicle
crashes and fatalities, less alcohol-impaired driving, lower mortality from liver cirrhosis, and lower
mortality from all causes. Similar to tobacco, the importance of taxation on decreasing alcohol
consumption cannot be
overestimated. Understanding the
sensitivity of alcohol consumption
rates to price increases, we know
that it is an extremely important
public health strategy to reduce the
adverse effects associated with
overconsumption of alcohol.
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Figure 14.9 State Wine Excise Tax Rates (Dollars Per
Gallon) as of January 1, 2014

Figure 14.10 State Spirits Excise Tax Rates (Dollars Per Gallon) as of
January 1, 2015
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Chapter 14 - Lessons Learned
Section 4 - Other Public Health Issues Learned from Tobacco

We have seen how the lessons learned from tobacco control can be applied to the prevention of
obesity and alcohol overuse, but there are also other public health challenges that may benefit
from the tobacco experience. For instance, many parallels can be drawn between tobacco and
gun control. Like tobacco, the gun lobby is extremely powerful. The firearm industry successfully
put a 17-year ban on gun research by the CDC, which has had the effect of limiting progress in
gun control. Forty-four states have preempted cities from passing stricter gun control laws. The
tobacco and firearm industries both use the Bill of Rights as a means of maintaining the status
quo: for tobacco companies, the First Amendment is the touchstone protecting the freedom of
speech, which they have interpreted to mean avoiding interference in their advertising practices;
and for firearms, the Second Amendment assures the right to bear arms and is used as an
argument for stricter gun control laws. Given these similarities between tobacco and gun control,
there may well be opportunities to use liability lawsuits (similar to those used successfully against
tobacco) to counteract the firearm industry’s arguments for the constitutional right to bear arms.
Lessons from tobacco control may have relevance for other problems, too, such as tanning beds.
As with tobacco, tanning beds are a product that can harm the user, even when used as directed.
Moreover, a dose-response relationship is seen between tanning bed use and the risk of
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melanoma. Users of tanning beds even show signs of addictiveness, including withdrawal
symptoms. Like tobacco, the tanning bed industry uses front groups with deceptive names like
the Vitamin D Council to portray tanning as attractive and socially preferable while
simultaneously obfuscating the health concerns associated with the use of their product.
Some of the major tobacco control strategies, such as banning access, implementing taxes, and
restricting advertising, are also being applied to tanning beds. Many countries (Australia, France,
Germany, Canada, and the United Kingdom) as well as some states in the U.S. (New York,
California, and Vermont) ban tanning in tanning beds for people under the age of 18. The U.S.
government has passed a federal tanning tax of 10%, the effects of which as still being
investigated. It is likely that tanning salons have absorbed the additional cost from taxation,
without passing it on to their customers. The implementation of effective regulations to control
tanning bed advertising and promotion is still in its infancy, although the FTC has prosecuted
some companies for false advertising and misleading health claims.
Lastly, the tobacco control experience may be relevant for energy drinks. Currently unregulated,
energy drinks contain high levels of caffeine, a drug that is addictive and can be dangerous.
Energy drink makers are very effective at marketing their products to young people. Emergency
room visits involving energy drinks doubled to nearly 21,000 between 2007 and 2011, with
approximately 1,500 of these visits occurring among children ages 12 to 17. We end with a news
clip from CBS This Morning, which discusses parallels between tobacco control strategies and
efforts to regulate energy drinks.
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Chapter 14 Discussion Questions:
1. Has self-regulation proven effective in the context of controlling unhealthy foods or alcohol
promotion?
2. Will class action litigation be necessary to stop targeted unhealthy food promotion? If so, on
what basis (age, SES, etc.)?
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Chapter 15

Endgame

Chapter Objectives
1. Understand the relationship between smoking prevalence,
population growth and absolute number of smokers.
2. Analyze endgame targets and strategies in place around
the world.
3. Hypothesize how endgame strategies can further tobacco
control.
4. Determine whether endgame strategies should be stated in
terms of reduction in smoking or nicotine delivery.

Chapter 15 - Endgame
Section 1 - Global Tobacco Consumption Projections

In setting targets for tobacco control, public health professionals are faced with the question of
whether efforts should be focused on reducing prevalence—the proportion of smokers to nonsmokers
—or reducing the absolute
number of smokers. In the
United States, smoking
prevalence has been reduced
by more than half over the
past 50 years; however, the
absolute number of smokers
has decreased only slightly
because of population
growth (Figure 15.1).
In 1965, the adult population
of the U.S. was 131 million,
and smoking prevalence was
42.4%—which translates to 50
million adult smokers. By
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Figure 15.1 Trends in Cigarette Smoking, Adults 18 and Older,
U.S., 1965-2011

Figure 15.2 U.S. Adult Population Increasing Over Time

2012, adult smoking
prevalence had dropped to
18.1%, but the adult
population had grown to 240
million (Figure 15.2). Thus,
although smoking
prevalence has decreased
substantially since 1965,
tobacco companies are still
serving over 40 million adult
smokers in the U.S. It is
therefore important to
differentiate between

tobacco control targets that are expressed in terms of prevalence or in terms of the number of
smokers.
Preventing additional death from smoking requires understanding the
current situation (the status quo) and setting specific goals (Figure 15.3). We
know the harm caused by smoking, and we can project what future smoking
rates will be if conditions remain the same. The trend in many high-income
countries has been a decline in smoking rates. But in low- and middleincome countries, tobacco companies take advantage of lax marketing
restrictions and rapid population growth to increase their business. If the
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Key Takeaway
In the United States,
smoking prevalence has
been reduced by more
than half over the past 50
years; however, the
absolute number of
smokers has decreased
only slightly because of
population growth.

status quo is not changed in these countries, our goals of
decreasing smoking initiation and increasing cessation

Movie 15.1 Hear from the Experts:
Ken Warner, PhD

globally cannot be attained.
In this chapter, we will discuss how countries around the
world are setting creative endgame targets to decrease
global tobacco consumption. But first, we turn to Dr.
Kenneth Warner, who gives an important overview of the

Figure 15.3 Projections of Tobacco Prevalence Considering
the Status Quo and Prevalence Reductions (Billions of
Smokers)

problems we currently face in
tobacco control. Dr. Warner is
the Avedis Donabedian
Distinguished University
Professor of Public Health at the
University of Michigan. He
served as the Senior Scientific
Editor of the 25th anniversary
Surgeon General’s Report and is
a leader in the quantitative
estimation of smoking rates. In
Movie 15.1, he shares his
insights on the status quo for
tobacco, the importance of
decreasing smoking rates, and
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specific endgame strategies that work.
Reducing tobacco use worldwide will save millions of lives. If present trends continue, we estimate
520 million cumulative deaths will be caused by tobacco by 2050. However, if adult consumption is
halved by 2020, that number would be reduced to 340 million. The World Health Organization (WHO)
has set an endgame target of 30% relative reduction in tobacco use by the year 2025. For instance, if

Table 15.1 Effectiveness of MPOWER Policies on Initiation and Cessation Rates
Policy

Description

Effect of cessation (RR)

Effect of initiation (RR)

P (protect)

Clean air laws

1.11

0.926

O (offer help)

Cessation support

1.061

NA

W (warn)

Mass media and package
warnings

1.23

0.8

E (enforce)

Enforce ad bans

1.03

0.94

R (raise)

Raise taxes

Price elasticity of
prevalence = -0.20

Price elasticity = -0.7

a country has a current adult smoking prevalence of 30%, the goal is to reduce that figure by 30%,
which would bring it down to 21% by 2025.
As we think about endgame targets, it is essential to consider which strategies
and tactics will be the most effective in helping to achieve our goals. As we
learned in Chapter 8, the WHO Framework Convention on Tobacco Control
includes MPOWER measures that assist in country-level implementation of
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Key Takeaway
The World Health
Organization (WHO)
has set an endgame
target of 30%
relative reduction in
tobacco use by the
year 2025.

effective interventions to reduce the demand for tobacco. Researchers from the University of
Michigan looked at the different policies included under MPOWER and measured their impact on
rates of cessation and initiation. Table 15.1 shows their findings in terms of the relative risk of
cessation and initiation after the implementation of each policy. For instance, we can see that the
policy of protection, which refers mainly to implementing comprehensive clean indoor air laws,
increases the rate of cessation by 11% (represented by a relative risk estimate of 1.11). The same
policy reduces smoking initiation by 7.4%, as indicated by the relative risk estimate of 0.926. Likewise,
we can see impacts from the other MPOWER strategies, which include cessation support, mass media
and package warnings, enforcement of ad bans, and increased taxes.
Researchers from the
American Cancer
Society took the
relative risk estimates
from the above study
and applied them to
the six WHO regions.
The results of their
analysis are shown in
Table 15.2, which
projects smoking
prevalence in each of
the WHO regions for

520

Table 15.2 Projections of Smoking Prevalence by WHO Region

the years 2020 and 2030. With no additional policy interventions, the global smoking prevalence for
adults is expected to decrease slightly from its current standing at 23.7% to 22.7% in 2020, and 22.0%
in 2030. However, this small decrease in prevalence indicates that the absolute number of smokers in
the world will have increased because the population will have grown. Applying the MPOWER
interventions, global smoking prevalence is expected to decline to 15.0% in 2020, and 13.2% in 2030.
We see similar patterns in each of the WHO regions. In the absence of policy directions, we expect
slight decreases in prevalence for all regions except for Africa, where a large increase is anticipated
due to the low current baseline of smokers and the heavy marketing by tobacco companies in the
region.
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Chapter 15 - Endgame
Section 2 - Endgame Targets

The International Conference on Public Health Priorities in the 21st Century was held in New Delhi,
India in September 2013 (Figure 15.4). Titled “The Endgame for Tobacco,” the conference called on
governments, WHO, and United Nations agencies to advance the actions under the WHO Framework
Convention on Tobacco Control to realize the vision of a world free from tobacco within this century.
Dr. Margaret Chan, Director-General of WHO, delivered the keynote address at the conference. She
stated:
Disease eradication is one clear opportunity for a definitive end to a
health threat. A tobacco endgame is another. Both have tremendous
appeal. They promise to improve the world in a permanent way, offering
every future generation the perpetual gift of freedom from major
diseases.
Her speech alludes to the typical division of global health approaches to diseases and conditions into
three categories. The first category is control, in which public health advocates try to lessen the
problem caused by a specific organism or behavior—most relevant, of course, to tobacco control. The
second category involves elimination, in which we try to eliminate the organism or behavior
associated with a disease, and the third is eradication, the ultimate public health approach in which
we try to eradicate a disease from the face of the earth. Dr. Chan equates a tobacco endgame with
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Figure 15.4 Objectives of the Endgame for
Tobacco Conference in New Delhi

disease eradication in terms of the impact it
would have on the public health if
successfully achieved.
While elimination or eradication of tobaccocaused diseases would be ideal, most people
realize that the most likely outcome is control.
Much effort is currently directed at trying to
better understand what we can consider a
realistic endgame for tobacco. A series of
meetings have been convened with this goal
in mind, one of which was a meeting led by
Kenneth Warner in June 2012, with support
from the Robert Wood Johnson Foundation
and the American Legacy Foundation. The
meeting was attended by forty top tobacco

control advocates, who came to discuss endgame strategies. Such strategies included a policy that
would require manufacturers to reduce nicotine content, as well as a “sinking lid” strategy for quotas
on sales and imports of tobacco. A “tobacco free generation” policy was also proposed, which would
prevent the sale of tobacco to those born after a given year. These and other proposals were also
included in a series of articles discussing various endgame strategies released by the international
peer-reviewed journal Tobacco Control in May 2013 (Figure 15.5).
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“There is a newfound interest in discussing the idea of an endgame strategy.
The fact that we can talk about it openly reflects a sea of change.”
- Dr. Ken Warner
Reducing tobacco-related deaths requires bold

Figure 15.5 Cover of the Tobacco Control
Edition Titled “The Tobacco Endgame,”
2013

endgame targets. Researchers are very much
concerned with finding innovative ways to
accelerate our progress in lessening the harm of
tobacco. The absence of specific goals and
targets has been a challenge for tobacco control,
and we are faced with assembling existing
strategies while also investigating new methods.
Many of the major tobacco control strategies that
have been proven effective are embodied in the
WHO Framework Convention on Tobacco Control
(WHO FCTC). Being the first global health treaty,
the WHO FCTC is a landmark achievement in
public health; however, the treaty did not include
any specific targets for reducing tobacco use to a
certain level within a specific amount of time. This
lack of specificity made it more difficult to
measure performance and accomplishments in a
meaningful way. Therefore, as a means of
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addressing this, and in an effort to set measurable targets for advancing non-communicable disease
goals, WHO adopted a target of a 30% relative reduction in tobacco use prevalence in member
countries by the year 2025. In the U.S., for example, where the current adult smoking prevalence is
18%, the goal is to reduce the smoking rate to about 12% by 2025.
Of the six WHO regions, the Western Pacific Region (WPRO) has the greatest number of smokers, the
highest rates of male smoking prevalence, and the fastest increase in tobacco uptake by women and
young people. In fact, one in three cigarettes consumed globally is smoked in the Western Pacific
Region, which includes a total of 37 countries, including China, Japan, Malaysia, the Philippines,
Australia, and New Zealand. Even before the WHO target of 30% relative reduction was set, WPRO
put in place the very ambitious endgame target of 5% prevalence or less by 2025. In the past five
years, significant progress has taken place in the countries that are part of the WPRO region; through
measures such as tax increases, national smoke-free laws, plain packaging in Australia and pictorial
health warnings on tobacco packaging in many of its member countries. As a result, smoking rates in
the region have been dramatically reduced.
Setting an example of endgame targets at the national level, Ireland has proposed a new tobacco
policy which aims to make the country tobacco free by 2025 (Figure 15.6). Dr. James Reilly, Ireland’s
Minister for Health, stated in 2013, “To make Ireland tobacco free in twelve years is an extraordinary
challenge, but if we work together to denormalize smoking for young people we can do it.” As part of
the efforts to meet this goal, Ireland became the first country to make bars and pubs smoke-free,
setting an important example that resulted in a global effort to make all indoor areas smoke-free.
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Another leader in tobacco control is Australia, where endgame strategies include a number of
aspirational targets by which the government aims to end the commercial sale of tobacco and reduce
its use to near zero. One of the policies being considered is a birth year cutout to create a smoke-free
generation, which would prohibit retailers from selling tobacco to anyone born after a specified year.
Also under consideration is a smoker licensing program that would permit only persons with a license
to purchase tobacco products. Additionally, Australia is looking at measures that would reduce the
appeal of tobacco by prohibiting flavorings and additives, reducing nicotine, and eliminating vented
filters (so-called “light” cigarettes). More generally, Australia aims to reduce the availability of tobacco
products by raising the price of a pack of cigarettes to AU$20, or by ending the commercial sale of
cigarettes altogether.
Singapore is also a leader in setting tobacco endgame targets, with a goal to deny access to tobacco
for all citizens born after 2000.
Approximately 70% of Singaporeans
who were surveyed support the
proposal, including many smokers. The
country was also the first to ban tobacco
advertising in 1971.
As a final example, New Zealand (Figure
15.7) has proposed a number of
strategies to eradicate smoking by 2025,
which include:
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Figure 15.6 Today's Youth in Ireland May See a
Smoke-Free Country

• Smoke-free cars

• Tax hikes

• Slashing supply

• Mass media shock tactics

• Plain packs

• Smoke-free communities
• Cutting duty-free tobacco

• Removing all flavor
enhancers
• Booting out tobacco
lobbyists
• Quitting support

As evidenced by the few examples included here, countries have adopted different approaches to
tobacco control, some of them using the MPOWER strategies with their proven effectiveness and
specific impact estimates, and others providing bold new approaches, the true effects of which are
still largely unknown. The leading countries combine
both proven strategies and innovative measures as they
take on the challenge of changing the status quo and
substantially lessening the projected burden of disease
and death from tobacco use in the 21st century.
To provide a contrast to the previous examples, which
have set ambitious endgame strategies and targets for
the future, we look at China, a country which needs such
strategies but currently faces many challenges in trying
to put them in place. As previously mentioned, China is
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Figure 15.7 New Zealand Plans to be
Smoke Free in 2025

unique in that the tobacco company in China, the China National Tobacco Corporation (CNTC), is a
monopoly owned by the Chinese government. As a result, the Chinese government collects tax
revenue from the sale of tobacco products (similar to other countries) but also profits from selling
tobacco products in the way that private corporations do in other countries. Together, the taxes and
profits from the sale of cigarettes in China provides approximately 7% of the entire Chinese
government’s revenue, making tobacco a major force in China—and one that regularly impedes the
progress in tobacco control which is critically needed in the country. Over 50% of men and about 5%
of women smoke in China, equating to over 300 million smokers. In addition to consuming one third
of the world’s cigarettes, China also grows one third of the world’s tobacco. CNTC produced 1.7
trillion cigarettes in 2005, generating $30 billion in tobacco taxes and profit. The problem of tobacco
in China is thus complicated by the government’s ownership of the tobacco monopoly; endgame
strategizing is rendered much more difficult because of the government’s reliance on tobacco
revenues.
There is, however, reason for optimism in China. In 2005, China ratified the WHO FCTC, which will
provide incentives for the Chinese government to implement tobacco control provisions. Since then,
China has put a number of regulations in place that have helped to change social norms and create
smoke-free indoor venues. For instance, all medical facilities and schools are now smoke-free. A
national law now bans tobacco advertising in movies, television, radio, newspapers, and magazines;
other types of promotion and sponsorship are also restricted. There are packaging and labeling
requirements for tobacco; however, the current warning labels are text-only, use small type, feature
the same background color as the rest of the pack, and do not spell out the specific health harms of
smoking. Considering the significance of tobacco use, as well as the extent of tobacco growing and
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manufacturing in China, it will be very interesting to track the country’s progress in the coming years.
China has the potential to use its one-party system to make a very significant change in tobacco use
and improve the health of millions of citizens.
The WHO African Region (AFRO) is also unique, in ways very different from China. Africa had the
lowest smoking prevalence of all the WHO Regions in 2010, at 15.8%. Unfortunately, this proportion is
increasing as tobacco companies target the region with billboard advertisements and easily
accessible products. From 2007-2011, 59.1% of youth (ages 13-15) in the African Region saw
cigarette advertisements on billboards, and 68.9% bought cigarettes in a store and were not refused
purchase because of their age. If no additional policies are implemented in Africa, the smoking
prevalence is expected to increase to about 21.9% by 2030; in contrast, all other WHO regions expect
a slight decrease in smoking prevalence if no new tobacco policies are implemented. There is a great
potential to make Africa the only place on earth in which the tobacco epidemic is prevented from
ever occurring, but much work is needed to put the necessary protections in place.
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Figure 15.8 Projected Number of Adult Smokers in Africa, 2010-2100

Figure 15.8 shows that there are currently less than one hundred million smokers in Africa, but the
number is expected to grow as smoking prevalence and the population both increase in the course of
this century. The graph compares forecast numbers with and without the implementation of MPOWER
policies, and illustrates how vastly different the two scenarios can be for the African region. And there
is much reason to be optimistic: though tobacco companies have tried to take advantage of the
relatively weak regulations in many of the developing countries in Africa, several of these countries
have successfully assembled strong citizens’ movements against tobacco. In fact, Africa was one of
the leaders in passing the WHO FCTC, a role which has helped the region to counterbalance the
tobacco industry’s efforts to recruit and maintain smokers.
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Before we end our discussion on setting endgame targets, we turn our attention to the United States.
Since the 1980s, the U.S. has focused on establishing health objectives for the nation, not only for
smoking but for many other health risks and diseases as well. In a regularly updated process of goalsetting that has come to be known as the Healthy People objectives, the U.S. has set explicit health
targets every ten years. In 2012, the U.S. Department of Health and Human Services issued a strategic
action plan titled Ending the Tobacco Epidemic, which charts a framework designed to achieve four
central tobacco-related objectives from Healthy People 2020:
•

Reduce tobacco use by adults and adolescents.

•

Reduce the initiation of tobacco use among children, adolescents, and young adults.

•

Increase smoking cessation by adult smokers.

•

Reduce the proportion of nonsmokers exposed to secondhand smoke.

As we discussed in Chapter 2, the U.S. Healthy People 2020 Objectives include specific targets
related to reducing tobacco use. For instance, the objective for adult smoking prevalence is 12% by
the year 2020 (currently at approximately 18%). For adolescents, the objective is to reduce tobacco
use prevalence to 21%. Healthy People 2020 also sets the goal of reducing initiation of tobacco
product use among children to 5.7%. Additionally, it sets the following goals around smoking
cessation:
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•

Increase smoking cessation attempts by adults to 80%.

•

Increase smoking cessation during pregnancy to 30%.

Figure 15.9 Cigarette Smoking, Adults, 1965-2011

•

Increase smoking

cessation attempts by
adolescent smokers to
64%.
Figure 15.9 illustrates
the decline in adult
smoking prevalence
since 1965. Much
progress has been
made and indeed the
decline of smoking in
the U.S. is one of the
major public health
success stories from the
twentieth century.
However, we are still far from our goal of 12% prevalence. The only way we can hope to achieve this
target by the year 2020 is by aggressively accelerating our efforts to increase cessation rates and
decrease initiation. Projections suggest that major disruptions to the status quo are needed as well as
significant changes to the way we conduct tobacco control if we are to meet the Healthy People 2020
Objectives.
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Chapter 15 - Endgame
Section 3 - Important Issues for the Future

In this final section, we summarize some of the key messages we have covered in the course of this
textbook and highlight topics of importance as we continue to think about the endgame for tobacco.
The health impact of tobacco use has been enormous, and in many cases the harm from tobacco use
occurring today will not manifest immediately but in decades to come. Even if every smoker were to
quit today, the harm from tobacco use will extend into the future. Tobacco caused 100 million deaths
during the 20th century, and we know that if current trends continue, approximately one billion
people will die in the 21st century from tobacco-caused diseases. Disruptive action is needed if we
are to change the trajectory of tobacco use and tobacco-related harms in this century.
Even if prevalence decreases, the number of smokers will likely continue to increase in the
foreseeable future as a result of population increases, particularly in low- and middle-income
countries. There is great urgency for public health advocates to design and implement bold measures
that will help current smokers to quit and decrease initiation among potential smokers, especially
young people. In developing endgame strategies for tobacco, we now have to consider not just
traditional tobacco products but also novel nicotine products that purport to reduce harm. Though
novel nicotine products are likely safer than combustible cigarettes, more research is needed before
we can truly understand their long-term impact. E-cigarettes will continue to have an important role in
discussions about the tobacco endgame, but currently, it remains to be seen whether e-cigarettes will
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prove to be a safe and effective solution for smokers who are attempting to quit, or just another
means for the tobacco companies to create even more nicotine addicts. All we know for now is that in
the future, tobacco control advocates will need to differentiate between endgame strategies that
address the use of combustible cigarettes and those that focus on nicotine addiction.
As we have suggested throughout this course, creating appropriate regulations requires a thorough
understanding of the behaviors not just of smokers but of the tobacco industry as well. We know that
the tobacco industry has a long track record of deceiving the public and deliberately obfuscating and
denying scientific evidence of the harms caused by their products. We must continue to expose the
industry’s behaviors, including its use of corporate social responsibility to rehabilitate its public image
and its manipulation of trade agreements to undermine government laws against tobacco. We must
be especially watchful over the tobacco companies’ expansion into the e-cigarette market; as we have
seen, all of the major tobacco companies have acquired their own e-cigarette brand, a fact which
raises important questions about what role the tobacco companies should be allowed to have in the
context of harm reduction.
Experience in tobacco control has shown the importance of legal and regulatory solutions to
reducing tobacco use. We will need to determine whether, and to what extent, new and existing
tobacco control policies apply to novel nicotine products. Ultimately, protecting the public health will
mean regulating all tobacco and nicotine products in a manner commensurate with the harm that
they cause. Lawmakers must ensure that these new products fulfill their potential to reduce harm,
rather than creating yet another generation of individuals addicted to nicotine.
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Being the world’s leading preventable cause of death, tobacco needs to be further regulated.
Evidence-based tobacco control methods exist and should be adopted and implemented worldwide
if we are to make real and substantial progress toward a world in which people are free from
addiction and free from the harms of tobacco use.

Chapter 15 Discussion Questions:
1. What can the United States learn from the countries leading the world in tobacco control
endgame strategies?
2. What tobacco control methods should be implemented in Africa to stop the increase of
prevalence in tobacco smokers? Would a proposal to tie aid funding to tobacco control
measures pose any perceived ethnical or legal issues?
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Addiction
Physiological or psychological dependence on a substance characterized by
neurochemical changes, compulsive drug-seeking behaviors, dose tolerance, withdrawal
symptoms, uncontrolled cravings, and self-destructive behaviors. Common addictive
drugs include alcohol, stimulants, cocaine, heroin, and nicotine
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Advertising
Any commercial effort to promote tobacco consumption, including the display of
trademarks, brand names, and manufacturer logos; marketing of tobacco products;
sponsorship of sports and other social and cultural activities; and other methods.
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Brand Stretching
A marketing approach by tobacco companies in which cigarette brand names are
attached to advertisements for non-tobacco products (such as clothing).
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Buproprion
An antidepressant pharmaceutical used as a smoking-cessation aid. Brand names include
Wellbutrin and Zyban.
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Cancer
A type of disease in which abnormal cells divide uncontrollably. Cancer cells can invade
nearby tissue and spread through the bloodstream and lymphatic system to other parts of
the body. Tobacco consumption significantly increases the risk of developing many types
of cancers, especially lung and oral cancers. Tobacco is also associated with cancers of the
pharynx, larynx, esophagus, pancreas, kidney, bladder, and other organs
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Carcinogen
A substance that causes cancer. Tobacco contains many potent chemical carcinogens,
including tobacco-specific nitrosamines (TSNs), polyaromatic hydrocarbons (PAHs), and
volatile organic compounds (VOCs).

Related Glossary Terms
Drag related terms here

Index

Find Term

Chapter 1 - Cigarettes are Instruments of Death
Chapter 1 - Forced Smoking Harms and Kills
Chapter 1 - Forced Smoking Harms and Kills
Chapter 6 - The Tobacco Industry as an Opponent to Public Health
Chapter 9 - What are Smoke-Free Air Laws and Why are They Popular?
Chapter 9 - What are Smoke-Free Air Laws and Why are They Popular?
Chapter 9 - What are Smoke-Free Air Laws and Why are They Popular?

Chronic Bronchitis
Inflammation of the bronchial mucus membrane over a long period of time, characterized
by cough, hypersecretion of mucus, and expectoration of sputum; associated with
increased vulnerability to bronchial infection.
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Chronic Obstructive Pulmonary Disease
A chronic lung disease, such as asthma or emphysema, in which breathing becomes
slowed or forced. See also Chronic bronchitis.
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Clinical interventions
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Combustion
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Consumption
Total cigarette consumption is the number of cigarettes sold annually in a country, usually
in millions of sticks. Total cigarette consumption is calculated by adding a country’s
cigarette production and imports and subtracting exports. Per adult cigarette
consumption is calculated by dividing total cigarette consumption by the total population
of those ages 15 years and older. Smuggling may account for inaccuracies in these
estimates.
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Coronary Artery Disease
The narrowing or blockage of the coronary arteries (blood vessels that carry blood and
oxygen to the heart) usually caused by atherosclerosis (a buildup of fatty material
[cholesterol] and plaque inside the coronary arteries). Also known as coronary heart
disease.
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Costs
Macroeconomic costs associated with tobacco use. Direct costs: Health costs related to
diseases caused by tobacco, including health-service costs, such as hospital services,
physician and outpatient services; prescription drugs; nursing home services; home
health care and allied health care; and changed expenditures due to increased utilization
of services. Indirect costs: Productivity costs caused by tobacco-related illness or
premature death; loss of productivity and earnings. Total costs: The sum of direct and
indirect tobacco-attributable costs to society.
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Cotinine
Nicotine’s major metabolite, which has a significantly longer half-life than nicotine.
Cotinine measurement is often used to estimate a smoker’s tobacco/nicotine usage prior
to quitting, and to confirm abstinence self-reports during follow-up. Also, cotinine is
commonly used as an indicator of exposure to secondhand smoke among nonsmokers.
Cotinine is commonly measured in blood serum, urine, and saliva.
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Counter-marketing
The use of commercial marketing tactics to reduce the prevalence of tobacco use.
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Dose-response relationship
a relationship in which the effect on an organism changes as a function of differing levels
of exposure to a stressor (also known as exposure-response relationship)
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Dual use
the concurrent use of cigarettes plus another tobacco product

Related Glossary Terms
Drag related terms here

Index

Find Term

Chapter 2 - Global Adult Tobacco Use
Chapter 2 - Global Adult Tobacco Use
Chapter 2 - Global Adult Tobacco Use
Chapter 3 - U.S. Youth Tobacco Use
Chapter 4 - Novel Nicotine Products and Harm Reduction: A Cloud of Controversy

E-Cigarette (Electronic Cigarette)
An electrical device that attempts to simulate the act of cigarette smoking by producing
an inhaled mist bearing the physical sensation, appearance, and often the flavor and
nicotine content of inhaled cigarette smoke.
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Electronic Nicotine Delivery Systems (ENDS)
Scientific term describing electronic cigarettes and other products that deliver nicotine
without combustion.
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Emphysema
A pathological condition of the lungs marked by an abnormal increase in the size of the
air spaces, resulting in labored breathing and an increased susceptibility to infection. It
can be caused by irreversible expansion of the alveoli or by the destruction of alveolar
walls. See Chronic obstructive pulmonary disease (COPD).
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Environmental Tobacco Smoke (ETS)
See Secondhand smoke (SHS).
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Excess Mortality
Absolute difference between two rates of mortality. The amount by which death rates for a
given population group (e.g., smokers) exceeds that of another population group chosen
as a reference or standard (e.g., nonsmokers).
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Framework Convention On Tobacco Control
The World Health Organization Framework Convention on Tobacco Control (WHO FCTC)
is the first treaty negotiated under the auspices of the WHO. WHO FCTC establishes the
international public health and legal template for national tobacco control activities.
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Global Tobacco Surveillance System (GTSS)
The World Health Organization (WHO) and the US Centers for Disease Control and
Prevention (CDC) developed these surveys to track tobacco use using a common
methodology and core questionnaire. The GTSS includes the Global Youth Tobacco
Survey (GYTS), Global School Personnel Survey (GSPS), Global Health Professional
Student Survey (GHPSS), and Global Adult Tobacco Survey (GATS).
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Harm Reduction
A public health philosophy that seeks to mitigate health hazards by replacing high-risk
products with lower-risk products or activities. In tobacco control, harm reduction is
proposed for smokers who do not want to stop smoking or are unable to do so despite
many attempts. Harm reduction seeks to reduce the adverse health effects of smoking by
removing harmful constituents or encouraging smokers to switch to alternative modes of
tobacco consumption that are considered less harmful than smoking—e.g., smokeless
tobacco. Some consider the approach controversial and believe the main focus should be
on smoking cessation.
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Health Professionals
Dentists, health science practitioners, hospital staff, medical doctors, nurses, pharmacists,
ancillary medical staff, and students in these disciplines.
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Chapter 15 - Global Tobacco Consumption Projections

Health Warnings
Government-mandated medical statements or graphic images placed on tobacco
products, packaging, or advertisements.
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Hill’s Postulates
A set of criteria defining the minimal conditions needed to establish a causal relationship
between two items
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Ingredient
Every component of the tobacco product that is smoked, chewed, or inhaled, including all
genetically modified, blended, and introduced components, additives, flavorings, and
other constituents, including paper, ink, adhesives, hardening agents, filters, and other
materials used in the manufacturing process and present in the finished product in
burned or unburned form.
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Marketing
A range of activities aimed at identifying, anticipating, and satisfying customer
requirements profitably.
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MPOWER
To make the WHO Framework Convention on Tobacco Control (WHO FCTC) a reality,
WHO introduced the MPOWER measures, intended to assist in country-level
implementation of effective interventions to reduce the demand for tobacco. Measures
are: Monitor tobacco use and prevention policies; Protect people from tobacco smoke;
Offer help to quit tobacco use; Warn about the dangers of tobacco; Enforce bans on
tobacco advertising, promotion, and sponsorship; and Raise taxes on tobacco.
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Negative externality
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Nicotiana Tabacum
The tobacco plant. Its leaves contain high levels of the addictive chemical nicotine and
many cancer-causing chemicals, especially polyaromatic hydrocarbons (PAHs). The leaves
may be smoked (in cigarettes, cigars, and pipes), used orally (as dipping and chewing
tobacco), or inhaled (as snuff).
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Nicotine
An addictive, poisonous alkaloid chemical found in tobacco that acts as a stimulant,
increasing heart rate and use of oxygen by the heart. Also used as an insecticide. The
lethal dose for an adult is about 50mg.
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Nicotine replacement therapy (NRT
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Chapter 4 - Novel Nicotine Products and Harm Reduction: A Cloud of Controversy
Chapter 12 - Clinical or Individual-Level Cessation

Nicotine replacement therapy (NRT)
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Nicotine Replacement Therapy (NRT)
A type of smoking cessation treatment that provides a low dose of nicotine to ease
cravings experienced by addicted smokers. NRTs include devices such as transdermal
patches, nicotine gum, nicotine nasal sprays, and inhalers.
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Novel Nicotine Products
Newly marketed products including items such as nicotine water, wafers, candy, and ecigarettes. These products deliver nicotine to consumers in an innovative yet unregulated
manner, and the side effects and potential benefits and dangers are largely unknown.
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Opportunity Cost
The cost associated with the lost opportunity of using resources in an alternative way. For
example, the resources used for treating smoking related illnesses could be used to build
schools.
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Passive Smoking
Inhaling cigarette, cigar, or pipe smoke produced by another individual. See also
Secondhand smoke (SHS).
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Chapter 10 - As Price Goes Up, Consumption Goes Down

Polyaromatic Hydrocarbon (PAH)
A type of organic compound composed of several benzene rings. PAHs, many of which
are carcinogenic, are produced during charbroiling of meat, incomplete combustion of
fossil fuels, and the burning of tobacco. Tobacco smoke is the most common source of
human exposure.
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Potential reduced exposure products (PREPs)
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Chapter 4 - Novel Nicotine Products and Harm Reduction: A Cloud of Controversy

Potential reduced exposure products, or PREPs
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor
incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
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Chapter 4 - Tobacco Companies Respond to Smoking’s Harm

Prevalence
Smoking prevalence is the percentage of smokers in the total population. Prevalence of
current smokers and prevalence of current daily smokers are two common point estimates
of prevalence. Meanwhile, the prevalence of ever-smokers is a measure of lifetime
prevalence. Commonly, estimates of prevalence are presented separately by groups of
age, gender, and location (urban/ rural), although overall estimates also are informative.
Adult smoking prevalence is usually defined as the percentage of smokers among those
ages 15 years and older.
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Promotion
Includes special offers, gifts, price discounts, coupons, company websites, specialty item
distribution, and telephone advertising used to facilitate the sale or placement of any
tobacco product. Also includes allowances paid to retailers, wholesalers, full-time
company employees, or any other persons involved in tobacco distribution.
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Chapter 3 - U.S. Youth Tobacco Use
Chapter 6 - The Tobacco Industry as an Opponent to Public Health

Relative Income Price (RIP) Of Cigarettes
A percentage of annual per capita income (measured by per capita GDP) required for
purchase of 100 packs of cigarettes. The lower the RIP, the more affordable cigarettes are.
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Risk
The probability of incurring a particular event or circumstance (e.g., risk of disease
measures the chances of an individual contracting a disease).
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Secondhand Smoke (SHS)
Smoke resulting from the combustion of tobacco products. SHS is composed of
mainstream smoke (exhaled by smokers) and side-stream smoke (from the tip of the
cigarette, cigar, or pipe). Secondhand smoke contains the same harmful chemicals that
smokers inhale. Also known as environmental tobacco smoke (ETS).
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Chapter 9 - Smoke-Free Air Laws Work

Smoke-Free Area
Area where smoking or holding a lighted cigarette, cigar, or pipe is banned, and where it
is expected that no evidence of SHS will be found, if measured.
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Smokeless Tobacco
Includes snuff and chewing tobacco; not a safe alternative to smoking. Smokeless tobacco
is as addictive as smoking and can cause cancers of the gum, cheek, lip, mouth, tongue,
and throat.
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Smoker
Someone who smokes any tobacco product either daily or occasionally.
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Smoking highway
The tissue in the body that becomes directly exposed to tars during the act of smoking,
including the lips, cheeks, tongue, throat, and bronchial passages
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Chapter 1 - Cigarettes are Instruments of Death
Chapter 1 - Cigarettes are Instruments of Death

Stroke
A condition in which a blood vessel in the brain bursts or is clogged by a blood clot. This
leads to an inadequate blood supply to the brain and to the death of brain cells, and
usually results in temporary or permanent neurological deficits. Smoking significantly
increases the risk of stroke.
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Sufficient Evidence
Term used by the US Surgeon General to indicate that current available evidence strongly
supports the inference of a causal relationship between smoking and specific health
outcomes.
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Chapter 1 - Forced Smoking Harms and Kills
Chapter 1 - Forced Smoking Harms and Kills
Chapter 13 - Litigation

Suggestive Evidence
Term used by the US Surgeon General to indicate that current available evidence,
although indicative, is not sufficient to infer a causal relationship between smoking and
specific health outcomes.
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Chapter 1 - Forced Smoking Harms and Kills

Tar
The raw anhydrous nicotine-free condensate of smoke.
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Chapter 4 - It’s All About Nicotine
Chapter 4 - It’s All About Nicotine
Chapter 4 - Tobacco Companies Respond to Smoking’s Harm

Tar And Nicotine Yield
The amount of tar and nicotine in one cigarette, as determined by a machine designed to
measure the chemical content of cigarette smoke. Machine yields of cigarette tar and
nicotine levels do not reflect the actual level of exposure experienced by smokers. See
also Tobacco smoke condensate (TSC).
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Tobacco Control Organization
An organization with a goal of reducing tobacco consumption and/ or protecting
nonsmokers from the effects of secondhand smoke, as well as monitoring compliance
with legislation and reporting tobacco industry maneuvers.
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Tobacco Excise Tax
A tax levied specifically on tobacco products. There are two basic types of tobacco excise
tax: Specific tax: set as a specific amount of money per unit (e.g., cigarette, pack, etc.) or
per weight (e.g., gram) of tobacco. Ad valorem tax: set as a percentage markup on some
determined value (tax base), usually the retail selling price or the wholesale (ex-factory)
price of tobacco products. Excise taxes are often differentiated according to the type of
tobacco product (e.g., filtered vs. nonfiltered cigarettes, pipe tobacco vs. cigars).
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Chapter 10 - The Tobacco Industry Claims that Tobacco Taxes are Regressive and Create Illicit Trade
Chapter 10 - The Tobacco Industry Claims that Tobacco Taxes are Regressive and Create Illicit Trade
Chapter 13 - Laws
Chapter 13 - Laws

Tobacco Industry Documents
Previously secret internal industry records that are now available in the public domain as a
result of court rulings.
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Chapter 6 - The Tobacco Industry as an Opponent to Public Health
Chapter 13 - Litigation
Chapter 13 - Litigation

Tobacco Product
Any product manufactured wholly or partly from tobacco that is ingested by smoking,
inhalation, chewing, sniffing, or sucking.
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Tobacco Production
The volume of actual tobacco leaves harvested from the field, excluding harvesting and
threshing losses and any part of the unharvested tobacco crop.
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Chapter 5 - Growing and Manufacturing Tobacco
Chapter 5 - Growing and Manufacturing Tobacco
Chapter 10 - Tobacco Taxes Vary Widely Throughout The World

Tobacco Smoke Condensate (TSC)
Sticky particles comprising thousands of chemicals created by burning tobacco.
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Tobacco Tax Avoidance
Legal methods of circumventing tobacco taxes. Cross-border shopping involves individual
tobacco users residing in higher-tax jurisdictions purchasing tobacco products in nearby
lower tax jurisdictions for their own consumption within the customs constraints. Tourist
shopping is similar to cross-border shopping, but involves the purchase of tobacco
products in more distant jurisdictions. Duty-free shopping involves the purchase of taxfree tobacco products purchased in airports, on airplanes, and in other travel-related
venues. Most governments impose limits on how much an individual can purchase and
bring home from duty free sources. Industry reformulation and/or repositioning refers to
strategies of tobacco companies to reduce the tax imposed on their products—for
example, by increasing the length of cigarettes when the taxes are based on quantity.
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Tobacco Tax Evasion
Illegal methods of circumventing tobacco taxes. Small-scale smuggling involves the
purchase, by individuals or small groups, of tobacco products in low-tax jurisdictions in
amounts that exceed the limits set by customs regulations, for smuggling or resale in
high-tax jurisdictions. Large-scale smuggling involves the illegal transportation,
distribution, and sale of large quantities of tobacco products that generally avoid all taxes.
Illicit manufacturing refers to the production of tobacco products contrary to law.
Counterfeiting involves the production and distribution of products bearing a trademark
without the approval of the trademark owner.
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Tobacco Use
The consumption of tobacco products by burning, chewing, inhaling, or other forms of
ingestion
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Tobacco-Attributable Mortality
The number of deaths attributable to tobacco use within a specific population.
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Tobacco-Specific Nitrosamine (TSN OR TSNA)
A group of toxic chemicals found only in tobacco products. The most carcinogenic
include • N’-nitrosonornicotine (NNN) • (4-methylnitrosamino)-1-(3-pyridyl)- 1-butanone
(NNK) • N-oxide, 4-(methylnitrosamino)-1- (3-pyridylN-oxide)-1-butanol (NNAL; a
metabolic product of NNK).
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Tobacco-specific nitrosamines (TSNAs)
one of the most important groups of carcinogens in tobacco products
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Varenicline
A smoking cessation aid that works by blocking nicotine receptors so nicotine is not
needed for dopamine release. Brand name: Chantix in the US, Champix in Europe and
Canada.
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Volatile Organic Compound (VOC)
An organic (carbon-containing) compound that evaporates at room temperature. VOCs
contribute significantly to indoor air pollution and respiratory disease.
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